SVB FINANCIAL GROUP, 10-K filed on 2/28/2020
Annual Report
v3.19.3.a.u2
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2019
Jan. 31, 2020
Jun. 30, 2019
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2019    
Entity File Number 000-15637    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Entity Registrant Name SVB FINANCIAL GROUP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 91-1962278    
Entity Central Index Key 0000719739    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Emerging Growth Company false    
Entity Small Business false    
Entity Shell Company false    
Amendment Flag false    
Entity Common Stock, Shares Outstanding   51,622,841  
Entity Address, Address Line One 3003 Tasman Drive    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95054-1191    
City Area Code 408    
Local Phone Number 654-7400    
Entity Public Float     $ 11,580,246,470
Common Stock      
Entity Information [Line Items]      
Title of 12(b) Security Common stock, par value $0.001 per share    
Trading Symbol SIVB    
Security Exchange Name NASDAQ    
Preferred Stock, Series A      
Entity Information [Line Items]      
Title of 12(b) Security Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A    
Trading Symbol SIVBP    
Security Exchange Name NASDAQ    
v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 6,781,783 $ 3,571,539
Available-for-sale securities, at fair value (cost of $13,894,348 and $7,862,311, respectively) 14,014,919 7,790,043
Held-to-maturity securities, at cost (fair value of $14,115,272 and $15,188,236, respectively) 13,842,946 15,487,442
Non-marketable and other equity securities 1,213,829 941,104
Total investment securities 29,071,694 24,218,589
Loans, net of unearned income 33,164,636 28,338,280
Allowance for loan losses (304,924) (280,903)
Net loans 32,859,712 28,057,377
Premises and equipment, net of accumulated depreciation and amortization 161,876 129,213
Goodwill 137,823 0
Other intangible assets, net 49,417 0
Lease right-of-use assets 197,365 0
Accrued interest receivable and other assets 1,745,233 951,261
Total assets 71,004,903 56,927,979
Liabilities:    
Noninterest-bearing demand deposits 40,841,570 39,103,422
Interest-bearing deposits 20,916,237 10,225,478
Total deposits 61,757,807 49,328,900
Short-term borrowings 17,430 631,412
Lease liabilities 218,847 0
Other liabilities 2,041,752 1,006,359
Long-term debt 347,987 696,465
Total liabilities 64,383,823 51,663,136
Commitments and contingencies (Note 22 and Note 28)
SVBFG stockholders’ equity:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 350,000 shares and no shares issued and outstanding, respectively 340,138 0
Common stock, $0.001 par value, 150,000,000 shares authorized; 51,655,607 shares and 52,586,498 shares issued and outstanding, respectively 52 53
Additional paid-in capital 1,470,071 1,378,438
Retained earnings 4,575,601 3,791,838
Accumulated other comprehensive income (loss) 84,445 (54,120)
Total SVBFG stockholders’ equity 6,470,307 5,116,209
Noncontrolling interests 150,773 148,634
Total equity 6,621,080 5,264,843
Total liabilities and total equity $ 71,004,903 $ 56,927,979
v3.19.3.a.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Available-for-sale securities, amortized cost $ 13,894,348 $ 7,862,311
Held-to-maturity securities $ 14,115,272 $ 15,188,236
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 20,000,000 20,000,000
Preferred stock, shares issued 350,000 0
Preferred stock, shares outstanding 350,000 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 150,000,000 150,000,000
Common stock, shares, issued 51,655,607 52,586,498
Common stock, shares outstanding 51,655,607 52,586,498
v3.19.3.a.u2
Consolidated Statements of Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Interest income:      
Loans $ 1,599,165 $ 1,358,480 $ 1,025,788
Investment securities:      
Taxable 568,851 541,605 412,133
Non-taxable 44,952 34,616 5,714
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities 96,440 35,208 21,505
Total interest income 2,309,408 1,969,909 1,465,140
Interest expense:      
Deposits 177,672 29,306 8,676
Borrowings 35,135 46,615 36,095
Total interest expense 212,807 75,921 44,771
Net interest income 2,096,601 1,893,988 1,420,369
Provision for credit losses 106,416 87,870 92,304
Net interest income after provision for credit losses 1,990,185 1,806,118 1,328,065
Noninterest income:      
Gains on investment securities, net 134,670 88,094 64,603
Gains on equity warrant assets, net 138,078 89,142 54,555
Client investment fees 182,068 130,360 56,136
Foreign exchange fees 159,262 138,812 115,760
Credit card fees 118,719 94,072 76,543
Deposit service charges 89,200 76,097 58,715
Lending related fees 49,920 41,949 43,265
Letters of credit and standby letters of credit fees 42,669 34,600 28,544
Investment banking revenue 195,177 0 0
Commissions 56,346 0 0
Other 55,370 51,858 59,110
Noninterest income 1,221,479 744,984 557,231
Noninterest expense:      
Compensation and benefits 989,734 726,980 606,402
Professional services 205,479 158,835 121,935
Premises and equipment 96,770 77,918 71,753
Net occupancy 69,279 54,753 48,397
Business development and travel 68,912 48,180 41,978
FDIC and state assessments 18,509 34,276 35,069
Other 152,579 87,251 85,121
Total noninterest expense 1,601,262 1,188,193 1,010,655
Income before income tax expense 1,610,402 1,362,909 874,641
Income tax expense 425,685 351,561 355,463
Net income before noncontrolling interests 1,184,717 1,011,348 519,178
Net income attributable to noncontrolling interests (47,861) (37,508) (28,672)
Net income available to common stockholders $ 1,136,856 $ 973,840 $ 490,506
Earnings per common share—basic (usd per share) $ 21.90 $ 18.35 $ 9.33
Earnings per common share—diluted (usd per share) $ 21.73 $ 18.11 $ 9.20
v3.19.3.a.u2
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Statement of Comprehensive Income [Abstract]      
Net income before noncontrolling interests $ 1,184,717 $ 1,011,348 $ 519,178
Change in foreign currency cumulative translation gains and losses:      
Foreign currency translation gains (losses) 3,208 (5,999) 6,355
Related tax (expense) benefit (889) 1,669 (2,587)
Change in unrealized gains and losses on available-for-sale securities:      
Unrealized holding gains (losses) 189,813 (22,348) (47,161)
Related tax (expense) benefit (52,697) 6,315 19,282
Reclassification adjustment for losses included in net income 3,905 740 5,189
Related tax benefit (1,087) (205) (2,098)
Reclassification of unrealized gains on equity securities to retained earnings for ASU 2016-01 0 (40,316) 0
Related tax expense 0 11,145 0
Amortization of unrealized gains on securities transferred from available-for-sale to held-to-maturity (2,158) (4,607) (6,475)
Related tax benefit 600 1,277 2,593
Reclassification of stranded tax effect to retained earnings for ASU 2018-02 0 (319) 0
Change in unrealized gains and losses on cash flow hedges:      
Unrealized losses (8,305) 0 0
Related tax benefit 2,306 0 0
Reclassification adjustment for losses included in net income 5,358 0 0
Related tax benefit (1,489) 0 0
Other comprehensive income (loss), net of tax 138,565 (52,648) (24,902)
Comprehensive income 1,323,282 958,700 494,276
Comprehensive income attributable to noncontrolling interests (47,861) (37,508) (28,672)
Comprehensive income attributable to SVBFG $ 1,275,421 $ 921,192 $ 465,604
v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total SVBFG Stockholders’ Equity
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2016     52,254,074          
Balance, beginning of period, net of tax at Dec. 31, 2016 $ 3,777,037,000 $ 0 $ 52,000 $ 1,242,741,000 $ 2,376,331,000 $ 23,430,000 $ 3,642,554,000 $ 134,483,000
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)     570,276          
Common stock issued under employee benefit plans, net of restricted stock cancellations 24,909,000   $ 1,000 24,908,000     24,909,000  
Common stock issued under ESOP (in shares)     10,838          
Common stock issued under ESOP 2,094,000     2,094,000     2,094,000  
Net income 519,178,000       490,506,000   490,506,000 28,672,000
Capital calls and distributions, net (23,535,000)             (23,535,000)
Net change in unrealized gains and losses on AFS securities, net of tax (24,788,000)         (24,788,000) (24,788,000)  
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax (3,882,000)         (3,882,000) (3,882,000)  
Foreign currency translation adjustments, net of tax 3,768,000         3,768,000 3,768,000  
Share-based compensation, net 44,634,000     44,634,000     44,634,000  
Reclassification of stranded tax effect for ASU 2018-02 0              
Balance (in shares) at Dec. 31, 2017     52,835,188          
Balance, end of period, net of tax at Dec. 31, 2017 4,319,415,000 0 $ 53,000 1,314,377,000 2,866,837,000 (1,472,000) 4,179,795,000 139,620,000
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)     456,845          
Common stock issued under employee benefit plans, net of restricted stock cancellations 15,810,000   $ 1,000 15,809,000     15,810,000  
Common stock issued under ESOP (in shares)     9,672          
Common stock issued under ESOP 2,577,000     2,577,000     2,577,000  
Net income 1,011,348,000       973,840,000   973,840,000 37,508,000
Capital calls and distributions, net (28,494,000)             (28,494,000)
Net change in unrealized gains and losses on AFS securities, net of tax (15,498,000)         (15,498,000) (15,498,000)  
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax (3,330,000)         (3,330,000) (3,330,000)  
Foreign currency translation adjustments, net of tax (4,330,000)         (4,330,000) (4,330,000)  
Share-based compensation, net 45,675,000     45,675,000     45,675,000  
Reclassification of stranded tax effect for ASU 2018-02 319,000              
Reclassification of stranded tax effect for ASU 2018-02 | Accounting Standards Update 2018-02         319,000 (319,000)    
Common stock repurchases (in shares)     (715,207)          
Common stock repurchases (147,123,000)   $ (1,000)   (147,122,000)   (147,123,000)  
Balance (in shares) at Dec. 31, 2018     52,586,498          
Balance, end of period, net of tax at Dec. 31, 2018 5,264,843,000 0 $ 53,000 1,378,438,000 3,791,838,000 (54,120,000) 5,116,209,000 148,634,000
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)     586,877          
Common stock issued under employee benefit plans, net of restricted stock cancellations 21,312,000   $ 0 21,312,000     21,312,000  
Common stock issued under ESOP (in shares)     14,442          
Common stock issued under ESOP 3,506,000     3,506,000     3,506,000  
Net income 1,184,717,000       1,136,856,000   1,136,856,000 47,861,000
Capital calls and distributions, net (50,978,000)             (50,978,000)
Net change in unrealized gains and losses on AFS securities, net of tax 139,934,000         139,934,000 139,934,000  
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax (1,558,000)         (1,558,000) (1,558,000)  
Foreign currency translation adjustments, net of tax 2,319,000         2,319,000 2,319,000  
Share-based compensation, net 66,815,000     66,815,000     66,815,000  
Reclassification of stranded tax effect for ASU 2018-02 0              
Common stock repurchases (in shares)     (1,532,210)          
Common stock repurchases (352,511,000)   $ (1,000)   (352,510,000)   (352,511,000)  
Acquisition of SVB Leerink 5,256,000             5,256,000
Issuance of Series A Preferred Stock 340,138,000 340,138,000         340,138,000  
Net change in unrealized gains and losses on cash flow hedges, net of tax (2,130,000)         (2,130,000) (2,130,000)  
Balance (in shares) at Dec. 31, 2019     51,655,607          
Balance, end of period, net of tax at Dec. 31, 2019 $ 6,621,080,000 $ 340,138,000 $ 52,000 $ 1,470,071,000 $ 4,575,601,000 $ 84,445,000 $ 6,470,307,000 $ 150,773,000
v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income before noncontrolling interests $ 1,184,717 $ 1,011,348 $ 519,178
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for credit losses 106,416 87,870 92,304
Gains on investment securities, net (134,670) (88,094) (45,547)
Distributions of earnings from non-marketable and other equity securities 95,131 72,015 45,867
Depreciation and amortization 82,717 57,906 56,123
Amortization of premiums and discounts on investment securities, net 15,513 (28) 2,530
Amortization of share-based compensation 66,815 45,675 36,900
Amortization of deferred loan fees (155,429) (128,077) (111,738)
Deferred income tax (benefit) expense (3,072) (21,061) 25,187
Excess tax benefit from exercise of stock options and vesting of restricted shares (9,588) (17,989) (18,014)
Losses from the write-off of premises and equipment 5,219 7,278 0
Other losses (gains) 8,959 0 (3,308)
Changes in other assets and liabilities:      
Accrued interest receivable and payable, net (24,189) (55,834) (31,372)
Accounts receivable and payable, net (17,019) (23,020) 3,481
Income tax receivable and payable, net (11,630) (5,820) 46,168
Accrued compensation (15,253) 56,874 31,689
Foreign exchange spot contracts, net 59,998 24,018 (20,891)
Other, net (74,240) (54,039) 15,909
Net cash provided by operating activities 1,164,129 933,562 646,865
Cash flows from investing activities:      
Purchases of available-for-sale securities (9,872,095) (668,264) (2,420,741)
Proceeds from sales of available-for-sale securities 2,189,087 474,482 580,871
Proceeds from maturities and paydowns of available-for-sale securities 1,643,357 3,436,064 3,339,574
Purchases of held-to-maturity securities (492,502) (4,726,595) (5,967,223)
Proceeds from maturities and paydowns of held-to-maturity securities 2,124,513 1,891,761 1,708,001
Purchases of non-marketable and other equity securities (136,186) (81,574) (44,047)
Proceeds from sales and distributions of capital of non-marketable and other equity securities 113,526 95,025 51,052
Net increase in loans (4,773,775) (5,175,409) (3,170,099)
Purchases of premises and equipment (65,479) (45,865) (50,884)
Proceeds from sale of equity valuation services business 0 0 3,000
Acquisition of SVB Leerink (102,328) 0 0
Net cash used for investing activities (9,371,882) (4,800,375) (5,970,496)
Cash flows from financing activities:      
Net increase in deposits 12,428,907 5,074,825 5,274,207
Net (decrease) increase in short-term borrowings (613,982) (402,318) 521,062
Principal payments of long-term debt (358,395) 0 (97,781)
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests (50,978) (28,494) (23,535)
Net proceeds from the issuance of preferred stock 340,138 0 0
Common stock repurchase (352,511) (147,123) 0
Proceeds from issuance of common stock, ESPP and ESOP 24,818 18,387 27,003
Net cash provided by financing activities 11,417,997 4,515,277 5,700,956
Net increase in cash and cash equivalents 3,210,244 648,464 377,325
Cash and cash equivalents at beginning of period 3,571,539 2,923,075 2,545,750
Cash and cash equivalents at end of period 6,781,783 3,571,539 2,923,075
Cash paid during the period for:      
Interest 217,961 75,601 45,592
Income taxes 422,346 376,425 277,823
Noncash items during the period:      
Changes in unrealized gains and losses on available-for-sale securities, net of tax 139,934 (15,498) (24,788)
Distributions of stock from investments 8,917 5,277 6,807
Equity warrant assets      
Adjustments to reconcile net income to net cash provided by operating activities:      
Changes in fair value of derivatives 2,240 (24,417) (11,862)
Derivative      
Adjustments to reconcile net income to net cash provided by operating activities:      
Changes in fair value of derivatives $ (18,506) $ (11,043) $ 14,261
v3.19.3.a.u2
Nature of Business
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business
Nature of Business
SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our consolidated financial statements, when we refer to “SVB Financial Group,” “SVBFG”, the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company entity, SVB Financial Group (not including subsidiaries).
We offer commercial banking products and services through our principal subsidiary, the Bank, which is a California-chartered bank founded in 1983 and a member of the Federal Reserve System. Through its subsidiaries, the Bank also offers asset management, private wealth management and other investment services. In addition, through SVB Financial's other subsidiaries and divisions, we offer investment banking and non-banking products and services, such as funds management and M&A advisory services. We primarily focus on serving corporate clients in the following niches: technology, life science/healthcare, private equity/venture capital and premium wine. Our corporate clients range widely in terms of size and stage of maturity. Additionally, we focus on cultivating strong relationships with firms within the venture capital and private equity community worldwide, many of which are also our clients and may invest in our corporate clients.
Headquartered in Santa Clara, California, we operate in centers of innovation in the United States and around the world.
For reporting purposes, SVB Financial Group has four operating segments for which we report financial information in this report: Global Commercial Bank, SVB Private Bank, SVB Capital and SVB Leerink. Financial information, results of operations and a description of the services provided by our operating segments are set forth in Note 25—“Segment Reporting” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
v3.19.3.a.u2
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies
Use of Estimates and Assumptions
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Significant items that are subject to such estimates include measurements of fair value, the valuation of non-marketable and other equity securities, the valuation of equity warrant assets and the adequacy of the allowance for loan losses and the allowance for unfunded credit commitments. The following discussion provides additional background on our significant accounting policies.
Principles of Consolidation and Presentation
Our consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. We consolidate voting entities in which we have control through voting interests or entities through which we have a controlling financial interest in a variable interest entity ("VIE"). We determine whether we have a controlling financial interest in a VIE by determining if we have (a) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses or (c) the right to receive the expected returns of the entity. Generally, we have significant variable interests if our commitments to a limited partnership investment represent a significant amount of the total commitments to the entity. We also evaluate the impact of related parties on our determination of variable interests in our consolidation conclusions. We consolidate VIEs in which we are the primary beneficiary based on a controlling financial interest. If we are not the primary beneficiary of a VIE, we record our pro-rata interests based on our ownership percentage.
VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or equity investors and, as a group, lack one of the following characteristics: (a) the power to direct the activities that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses of the entity or (c) the right to receive the expected returns of the entity. We assess VIEs to determine if we are the primary beneficiary of a VIE. A primary beneficiary is defined as a variable interest holder that has a controlling financial interest. A controlling financial interest requires both: (a) the power to direct the activities that most significantly impact the VIEs economic performance, and (b) the obligation to absorb losses or receive benefits of a VIE that could potentially be significant to a VIE. Under this analysis, we also evaluate kick-out rights and other participating rights, which could provide us a controlling financial interest. The primary beneficiary of a VIE is required to consolidate the VIE.
We also evaluate fees paid to managers of our limited partnership investments. We exclude those fee arrangements that are not deemed to be variable interests from the analysis of our interests in our investments in VIEs and the determination of a primary beneficiary, if any. Fee arrangements based on terms that are customary and commensurate with the services provided are deemed not to be variable interests and are, therefore, excluded.
All significant intercompany accounts and transactions with consolidated entities have been eliminated. We have not provided financial or other support during the periods presented to any VIE that we were not previously contractually required to provide.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand, cash balances due from banks, interest-earning deposits, Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities. For the consolidated statements of cash flows, we consider cash equivalents to be investments that are readily convertible to known amounts of cash, so near to their maturity that they present an insignificant risk of change in fair value due to changes in market interest rates, and purchased in conjunction with our cash management activities.
Investment Securities
Available-for-Sale Securities
Our available-for-sale securities portfolio is a fixed income investment portfolio that is managed to earn an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification and meeting our asset/liability management objectives. Unrealized gains and losses on available-for-sale securities, net of applicable taxes, are reported in accumulated other comprehensive income, which is a separate component of SVBFG's stockholders' equity, until realized.
We analyze available-for-sale securities for other-than-temporary impairment each quarter. Market valuations represent the current fair value of a security at a specified point in time and incorporates the risk of timing of interest due and the return of principal over the contractual life of each security. Gains and losses on securities are realized when there is a sale of the security prior to maturity. A credit downgrade represents an increased level of risk of other-than-temporary impairment, and as a part of our consideration of recording an other-than-temporary impairment we will assess the issuer's ability to service the debt and to repay the principal at contractual maturity.
We apply the other-than-temporary impairment standards of ASC 320, Investments-Debt and Equity Securities. For our debt securities, we have the intent and ability to hold these securities until we recover our cost less any credit-related loss. We separate the amount of the other-than-temporary impairment, if any, into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security's amortized cost basis and the present value of expected future cash flows discounted at the security's effective interest rate. The amount due to all other factors is recognized in other comprehensive income.
We consider numerous factors in determining whether a credit loss exists and the period over which the debt security is expected to recover. The following list is not meant to be all inclusive. All of the following factors are considered:
The length of time and the extent to which the fair value has been less than the amortized cost basis (severity and duration);
Adverse conditions specifically related to the security, an industry or geographic area; for example, changes in the financial condition of the issuer of the security, or in the case of an asset-backed debt security, changes in the financial condition of the underlying loan obligors. Examples of those changes include any of the following:
Changes in technology;
The discontinuance of a segment of the business that may affect the future earnings potential of the issuer or underlying loan obligors of the security; and
Changes in the quality of the credit enhancement.

The historical and implied volatility of the fair value of the security;
The payment structure of the debt security and the likelihood of the issuer being able to make payments that increase in the future;
Failure of the issuer of the security to make scheduled interest or principal payments;
Any changes to the rating of the security by a rating agency; and
Recoveries or additional declines in fair value after the balance sheet date.
In accordance with ASC 310-20, Receivables-Nonrefundable Fees and Other Costs, we use estimates of future principal prepayments, provided by third-party market-data vendors, in addition to actual principal prepayment experience to calculate the constant effective yield necessary to apply the effective interest method in the amortization of purchase discounts or premiums on mortgage-backed securities and fixed rate collateralized mortgage obligations. The accretion and amortization of discounts and premiums, respectively, are included in interest income over the contractual terms of the underlying securities replicating the effective interest method.
Held-to-Maturity Securities
Debt securities purchased in which we have the positive intent and ability to hold to its maturity are classified as held-to-maturity securities and are recorded at amortized cost.
Transfers of investment securities into the held-to-maturity category from the available-for-sale category are made at fair value at the date of transfer. The net unrealized gains, net of tax, are retained in other comprehensive income, and the carrying value of the held-to-maturity securities are amortized over the life of the securities in a manner consistent with the amortization of a premium or discount.
Non-Marketable and Other Equity Securities
Non-marketable and other equity securities include investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised, and investments in qualified affordable housing projects. A majority of these investments are managed through our SVB Capital funds business in funds of funds and direct venture funds. Our accounting for investments in non-marketable and other equity securities depends on several factors, including the level of ownership, power to control and the legal structure of the subsidiary making the investment. As further described below, we base our accounting for such securities on: (i) fair value accounting, (ii) other investments without a readily determinable fair value, (iii) equity method accounting and (iv) the proportional amortization method which is used only for qualified affordable housing projects.
Fair Value Accounting
Our managed funds are investment companies under the AICPA Audit and Accounting Guide for Investment Companies (codified in ASC 946) and accordingly, these funds report their investments at estimated fair value, with unrealized gains and losses resulting from changes in fair value reflected as investment gains or losses in our consolidated statements of income. Our non-marketable and other equity securities recorded pursuant to fair value accounting consist of our investments through the following funds:
Funds of funds, which make investments in venture capital and private equity funds, and
Direct venture funds, which make equity investments in privately held companies.
A summary of our ownership interests in the investments held under fair value accounting as of December 31, 2019 is presented in the following table:
Limited partnership
 
Company Direct and Indirect Ownership in Limited Partnership
Managed funds of funds
 
 
Strategic Investors Fund, LP
 
12.6
%
Capital Preferred Return Fund, LP
 
20.0

Growth Partners, LP
 
33.0

Managed direct venture funds
 
 
CP I, LP
 
10.7

The general partner interests of these funds are controlled, and in some cases, owned by SVB Financial. The limited partners of these funds do not have substantive participating or kick-out rights. Therefore, these funds are consolidated and any gains or losses resulting from changes in the estimated fair value of the investments are recorded as investment gains or losses in our consolidated net income.
Under fair value accounting, investments are carried at their estimated fair value based on financial information obtained as the general partner of the fund or obtained from the funds' respective general partner. For direct private company investments, valuations are based upon consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. For direct equity investments in public companies, valuations are based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Sales restriction discounts generally range from ten percent to twenty percent depending on the sale restrictions which typically range from three to six months. The valuation of non-marketable securities in shares of private company capital stock and the valuation of other securities in shares of public company stock with certain sales restrictions is subject to significant judgment. The inherent uncertainty in the process of valuing securities for which a ready market does not exist may cause our estimated values of these securities to differ significantly from the values that would have been derived had a ready market for the securities existed, and those differences could be material.
For our fund investments, we utilize the net asset value as obtained from the general partners of the fund investments as the funds do not have a readily determinable fair value. The general partners of our fund investments prepare their financial statements using guidance consistent with fair value accounting. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period.
Gains or losses resulting from changes in the estimated fair value of the investments and from distributions received are recorded as gains on investment securities, net, a component of noninterest income. The portion of any investment gains or losses attributable to the limited partners is reflected as net income attributable to noncontrolling interests and adjusts our net income to reflect its percentage ownership.
Other Investments without a Readily Determinable Fair Value

Effective January 1, 2018 we adopted ASU 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities which eliminated the concept of cost method accounting and created an additional method of accounting, other investments without a readily determinable fair value. These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired less any impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.
Equity Method
Our equity method non-marketable securities consist of investments in venture capital and private equity funds, privately-held companies, debt funds, and joint ventures. Our equity method non-marketable securities and related accounting policies are described as follows:
Equity securities, such as preferred or common stock in privately-held companies in which we hold a voting interest of at least 20 percent, or in which we have the ability to exercise significant influence over the investees' operating and financial policies through board involvement or other influence, are accounted for under the equity method,
Investments in limited partnerships in which we hold voting interests of more than 5 percent, or in which we have the ability to exercise significant influence over the partnerships' operating and financial policies, are accounted for using the equity method, and
Our China Joint Venture partnership, for which we have 50 percent ownership, is accounted for under the equity method.
We recognize our proportionate share of the results of operations of these equity method investees in our results of operations, based on the most current financial information available from the investee. We review our investments accounted for under the equity method at least quarterly for possible other-than-temporary impairment. Our review typically includes an analysis of facts and circumstances for each investment, the expectations of the investment's future cash flows and capital needs, variability of its business and the company's exit strategy. For our fund investments, we utilize the net asset value per share as provided by the general partners of the fund investments. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment, and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period.
We reduce our investment value when we consider declines in value to be other-than-temporary and recognize the estimated loss as a loss on investment securities, a component of noninterest income.
Proportional Amortization Method
In order to fulfill our responsibilities under the Community Reinvestment Act, we invest as a limited partner in low income housing partnerships that operate qualified affordable housing projects and generate tax benefits, including federal low income housing tax credits, for investors. The partnerships are deemed to be VIEs because they do not have sufficient equity investment at risk and are structured with non-substantive voting rights. We are not the primary beneficiary of the VIEs and do not consolidate them. Our investments in low income housing partnerships are recorded in non-marketable and other equity securities within our investment securities portfolio on the consolidated balance sheet. As a practical expedient, we amortize the investment in proportion to the allocated tax benefits under the proportional amortization method of accounting and present such benefits net of investment amortization in income tax expense.
Loans
Loans are reported at the principal amount outstanding, net of unearned loan fees. Unearned loan fees reflect unamortized deferred loan origination and commitment fees net of unamortized deferred loan origination costs. In addition to cash loan fees, we often obtain equity warrant assets that give us an option to purchase a position in a client company's stock in consideration for providing credit facilities. The grant date fair values of these equity warrant assets are deemed to be loan fees and are deferred as unearned income and recognized as an adjustment of loan yield through loan interest income. The net amount of unearned loan fees is amortized into loan interest income over the contractual terms of the underlying loans and commitments using the constant effective yield method, adjusted for actual loan prepayment experience, or the straight-line method, as applicable.
Allowance for Loan Losses
The allowance for loan losses considers credit risk and is established through a provision for loan losses charged to expense. Our allowance for loan losses is established for estimated loan losses that are probable and incurred but not yet realized. Our evaluation process is designed to determine that the allowance for loan losses is appropriate at the balance sheet date. The process of estimating loan losses is inherently imprecise.
We maintain a systematic process for the evaluation of individual loans and pools of loans for inherent risk of loan losses. At the time of approval, each loan in our portfolio is assigned a Credit Risk Rating and industry niche. Credit Risk Ratings are assigned on a scale of 1 to 10, with 1 representing loans with a low risk of nonpayment, 9 representing loans with the highest risk of nonpayment, and 10 representing loans which have been charged-off. The credit risk ratings for each loan are monitored and updated on an ongoing basis. This Credit Risk Rating process includes, but is not limited to, consideration of such factors as payment status, the financial condition and operating performance of the borrower, borrower compliance with loan covenants, underlying collateral values and performance trends, the degree of access to additional capital, the presence of credit enhancements such as third party guarantees (where applicable), the degree to which the borrower is sensitive to external factors, the depth and experience of the borrower's management team, potential loan concentrations, and general economic conditions. Our policies require a committee of senior management to review, at least quarterly, credit relationships with a credit risk rating of 5 through 9 that exceed specific dollar values. Our review process evaluates the appropriateness of the credit risk rating and allocation of the allowance for loan losses, as well as other account management functions. The allowance for loan losses is determined based on a qualitative analysis and a formula allocation for similarly risk-rated loans by portfolio segment and
individually for impaired loans. The formula allocation provides the average loan loss experience for each portfolio segment, which considers our quarterly historical loss experience since the year 2000, both by risk-rating category and client industry sector. The resulting loan loss factors for each risk-rating category and client industry sector are ultimately applied to the respective period-end client loan balances for each corresponding risk-rating category by client industry sector to provide an estimation of the allowance for loan losses. The probable loan loss experience for any one year period of time is reasonably expected to be greater or less than the average as determined by the loss factors. As such, management applies a qualitative allocation to the results of the aforementioned model to ascertain the total allowance for loan losses. This qualitative allocation is based on management's assessment of the risks that may lead to a loan loss experience different from our historical loan loss experience. Based on management's prediction or estimate of changing risks in the lending environment, the qualitative allocation may vary significantly from period to period and includes, but is not limited to, consideration of the following factors:
Changes in lending policies and procedures, including underwriting standards and collections, and charge-off and recovery practices;
Changes in national and local economic business conditions, including the market and economic condition of our clients' industry sectors;
Changes in the nature of our loan portfolio;
Changes in experience, ability, and depth of lending management and staff;
Changes in the trend of the volume and severity of past due and classified loans;
Changes in the trend of the volume of nonaccrual loans, troubled debt restructurings and other loan modifications;
Reserve floor for portfolio segments that would not draw a minimum reserve based on the lack of historical loan loss experience;
Reserve for large funded loan exposure;
Reserve for performing impaired loan exposure; and
Other factors as determined by management from time to time.
While the evaluation process of our allowance for loan losses uses historical and other objective information, the classification of loans and the establishment of the allowance for loan losses rely, to a great extent, on the judgment and experience of our management.
Allowance for Unfunded Credit Commitments
We record a liability for probable and estimable incurred losses associated with our unfunded credit commitments being funded and subsequently being charged off. Each quarter, every unfunded client credit commitment is allocated to a credit risk-rating in accordance with each client's credit risk rating and portfolio segment. We use the segment specific historical loan loss factors described under our allowance for loan losses to calculate the loan loss experience if unfunded credit commitments are funded. Separately, we use historical trends to calculate a probability of an unfunded credit commitment being funded. We apply the loan funding probability factor to risk-factor adjusted unfunded credit commitments by credit risk-rating and portfolio segment to derive the allowance for unfunded credit commitments, similar to funded loans. The allowance for unfunded credit commitments also includes certain qualitative allocations as deemed appropriate by management. We include the allowance for unfunded credit commitments in other liabilities and the related provision in our provision for credit losses.
Uncollectible Loans and Write-offs
Our charge-off policy applies to all loans, regardless of portfolio segment. Commercial loans are considered for a full or partial charge-off in the event that principal or interest is over 180 days past due and the loan lacks sufficient collateral and it is not in the process of collection, provided that a loss event has been defined and the charge-off is consistent with GAAP. Consumer loans are considered for a full or partial charge-off in the event that principal or interest is over 120 days past due and the loan lacks sufficient collateral and it is not in the process of collection, provided that a loss event has been defined and the charge-off is consistent with GAAP. We also consider writing off loans in the event of any of the following circumstances: 1) the loan, or a portion of the loan is deemed uncollectible due to: a) the borrower's inability to make recurring payments, b) material changes in the borrower's financial condition, or c) the expected sale of all or a portion of the borrower's business is insufficient to repay the loan in full, or 2) the loan has been identified for charge-off by regulatory authorities.
Troubled Debt Restructurings
A TDR arises from the modification of a loan where we have granted a concession to the borrower related to the borrower's financial difficulties that we would not have otherwise considered for economic or legal reasons. These concessions may include: (1) deferral of payment for more than an insignificant period of time that does not include sufficient offsetting borrower concessions; (2) interest rate reductions; (3) extension of the maturity date outside of ordinary course extension; (4) principal forgiveness; and/or (5) reduction of accrued interest.
We use the factors in ASC 310-40, Receivables, Troubled Debt Restructurings by Creditors, in analyzing when a borrower is experiencing financial difficulty, and when we have granted a concession, both of which must be present for a restructuring to meet the criteria of a TDR. If we determine that a TDR exists, we measure impairment based on the present value of expected future cash flows discounted at the loan's effective interest rate, except that as a practical expedient, we may also measure impairment based on a loan's observable market price, or the fair value of the collateral less selling costs if the loan is a collateral-dependent loan.
Impaired Loans
A loan is considered impaired when, based upon currently known information, it is deemed probable that we will be unable to collect all amounts due according to the contractual terms of the agreement. On a quarterly basis, we review our loan portfolio for impairment. Within each class of loans, we review individual loans for impairment based on credit risk ratings. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of "Performing (Criticized)" and could be classified as a performing impaired loan.
For each loan identified as impaired, we measure the impairment based upon the present value of expected future cash flows discounted at the loan's effective interest rate. In limited circumstances, we may measure impairment based on the loan's observable market price or the fair value of the collateral less selling costs if the loan is collateral dependent. Impaired collateral-dependent loans will have independent appraisals completed and accepted at least annually. The fair value of the collateral will be determined by the most recent appraisal, as adjusted to reflect a reasonable marketing period for the sale of the asset(s) and an estimate of reasonable selling expenses.
If it is determined that the value of an impaired loan is less than the recorded investment in the loan, net of previous charge-offs and payments collected, we recognize impairment through the allowance for loan losses as determined by our analysis.
Nonaccrual Loans
Loans are placed on nonaccrual status when they become 90 days past due as to principal or interest payments (unless the principal and interest are well secured and in the process of collection); or when we have determined, based upon currently known information, that the timely collection of principal or interest is not probable.
When a loan is placed on nonaccrual status, the accrued interest and fees are reversed against interest income and the loan is accounted for using the cost recovery method thereafter until qualifying for return to accrual status. For a loan to be returned to accrual status, all delinquent principal and interest must become current in accordance with the terms of the loan agreement and future collection of remaining principal and interest must be deemed probable. We apply a cost recovery method in which all cash received is applied to the loan principal until it has been collected. Under this approach, interest income is recognized after total cash flows received exceed the recorded investment at the date of initial nonaccrual. All of our nonaccrual loans have credit risk ratings of 8 or 9 and are classified under the nonperforming impaired category.
Premises and Equipment
Premises and equipment are reported at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets or the terms of the related leases, whichever is shorter. The maximum estimated useful lives by asset classification are as follows:
Leasehold improvements
 
 Lesser of lease term or asset life
Furniture and equipment
 
7 years
Computer software
 
 3-7 years
Computer hardware
 
 3-5 years

We capitalize the costs of computer software developed or obtained for internal use, including costs related to developed software, purchased software licenses and certain implementation costs.
For property and equipment that is retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is included in noninterest expense in consolidated net income.
Lease Obligations
We have entered into leases for real estate and various equipment utilized for the business. At the inception of the lease, each lease is evaluated to determine whether the lease will be accounted for as an operating or finance lease. We had no finance lease obligations at December 31, 2019 and 2018. We have made an accounting policy election not to recognize right-of-use assets and lease liabilities that arise from short-term leases for any class of underlying asset. In addition to excluding short-term leases, we have implemented an accounting policy in which non-lease components are not separated from lease components in the measurement of right-of-use ("ROU") asset and lease liabilities for all lease contracts.
ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
Business Combinations
Business combinations are accounted for under the acquisition method of accounting. Acquired assets, including separately identifiable intangible assets, and assumed liabilities are recorded at their acquisition-date estimated fair values. The excess of the cost of acquisition over these fair values is recognized as goodwill. During the measurement period, which cannot exceed one year from the acquisition date, changes to estimated fair values are recognized as an adjustment to goodwill. Certain transaction costs are expensed as incurred.
Goodwill and Other Intangible Assets
Goodwill is not amortized and is subject, at a minimum, to an annual impairment assessment. A quantitative assessment will be completed if we have not recently completed a fair value assessment of the associated reporting unit and compared the assessed fair value of that reporting unit with its carrying amount, including goodwill. Should we be required to calculate the fair value of the entity, we would generally apply a discounted cash flow analysis that uses forecasted performance estimates, and a discount rate leveraging a reporting unit specific capital asset pricing model, which in turn uses assumptions related to market performance and various macroeconomic and reporting unit specific risks. If this quantitative assessment was recently completed and if we deem the estimate to be current and reliable, we will not perform a full quantitative assessment of the reporting unit’s fair value for that reporting period. Instead, we will qualitatively determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount, including goodwill. As part of this qualitative analysis we consider macroeconomic factors that might impact the entity’s performance, entity-specific financial performance of the reporting unit, changes in management or strategy and other factors. We will evaluate goodwill for impairment more frequently if circumstances indicate that the fair value of our reporting units is less than their carrying value, including goodwill.
Intangible assets with finite lives are amortized over their estimated useful lives and all intangible assets are subject to impairment if events or circumstances indicate that the fair value is less than the carrying amount.
Fair Value Measurements
Our available-for-sale securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements.
Fair Value Measurement-Definition and Hierarchy
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows:
Level 1
Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities and certain marketable securities accounted for under fair value accounting.
Level 2
Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Valuations for the available-for-sale securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third parties to ensure that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. We ensure prices received from independent brokers represent a reasonable estimate of the fair value through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities:
U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark market interest rates, generally U.S. Treasury securities.
Agency-issued mortgage-backed securities: Agency-issued mortgage-backed securities are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor, and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark market interest rates taking into consideration estimated loan prepayment speeds.
Agency-issued collateralized mortgage obligations: Agency-issued collateralized mortgage obligations are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above.
Agency-issued commercial mortgage-backed securities: Fair value measurements of these securities are based on spreads to benchmark market interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans.
Foreign exchange forward and option contract assets and liabilities: Fair value measurements of these assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions.
Interest rate derivative and interest rate swap assets and liabilities: Fair value measurements of interest rate derivatives and interest rate swaps are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty.
Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions which typically range from three to six months.
Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions.
Level 3
The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach and/or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets:
Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Significant changes to any one of these inputs in isolation could result in a significant change in the fair value measurement; however, we generally consider all factors available through ongoing communication with the portfolio companies and venture capital fund managers to determine whether there are changes to the portfolio company or the environment that indicate a change in the fair value measurement.
Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.
Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement.

It is our policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements. When available, we use quoted market prices to measure fair value. If market prices are not available,
fair value measurement is based upon valuation approaches that use primarily market-based or independently-sourced market parameters, including interest rate yield curves, prepayment speeds, option volatilities and currency rates. Substantially all of our financial instruments use the foregoing methodologies, and are categorized as a Level 1 or Level 2 measurement in the fair value hierarchy. However, in certain cases, when market observable inputs for our valuation techniques may not be readily available, we are required to make judgments about assumptions we believe market participants would use in estimating the fair value of the financial instrument, and based on the significance of those judgments, the measurement may be determined to be a Level 3 fair value measurement.
The degree of management judgment involved in determining the fair value of a financial instrument is dependent upon the availability of quoted market prices or observable market parameters. For financial instruments that trade actively and have quoted market prices or observable market parameters, there is minimal subjectivity involved in measuring fair value. When observable market prices and parameters are not fully available, management judgment is necessary to estimate fair value. For inactive markets, there is little information, if any, to evaluate if individual transactions are orderly. Accordingly, we are required to estimate, based upon all available facts and circumstances, the degree to which orderly transactions are occurring and provide more weighting to price quotes that are based upon orderly transactions. In addition, changes in the market conditions may reduce the availability of quoted prices or observable data. For example, reduced liquidity in the capital markets or changes in secondary market activities could result in observable market inputs becoming unavailable. Therefore, when market data is not available, we use valuation techniques requiring more management judgment to estimate the appropriate fair value measurement. Accordingly, the degree of judgment exercised by management in determining fair value is greater for financial assets and liabilities categorized as Level 3.
Fee-based Services Revenue Recognition
Refer to Note 17—“Noninterest Income” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for our fee-based services revenue recognition policies for our contracts with customers.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Our federal, state and foreign income tax provisions are based upon taxes payable for the current year, current year changes in deferred taxes related to temporary differences between the tax basis and financial statement balances of assets and liabilities, and a reserve for uncertain tax positions. Deferred tax assets and liabilities are included in the consolidated financial statements at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. A valuation allowance is provided, when it is determined based upon available evidence, that it is more likely than not that some portion of the deferred tax asset will not be realized. We file a consolidated federal income tax return, and consolidated, combined, or separate state income tax returns as appropriate. Our foreign incorporated subsidiaries file tax returns in the applicable foreign jurisdictions. We record interest and penalties related to unrecognized tax benefits in other noninterest expense, a component of consolidated net income.
Share-Based Compensation
For all stock-based awards granted, stock-based compensation expense is amortized on a straight-line basis over the requisite service period, including consideration of vesting conditions and anticipated forfeitures. The fair value of stock options are measured using the Black-Scholes option-pricing model and the fair value for restricted stock awards and restricted stock units are based on the quoted price of our common stock on the date of grant.
Earnings Per Share
Basic earnings per common share is computed using the weighted average number of common stock shares outstanding during the period. Diluted earnings per common share is computed using the weighted average number of common stock shares and potential common shares outstanding during the period. Potential common shares consist of stock options, ESPP shares and restricted stock units. Common stock equivalent shares are excluded from the computation if the effect is antidilutive.    
Derivative Financial Instruments
All derivative instruments are recorded on the balance sheet at fair value. The accounting for changes in fair value of a derivative financial instrument depends on whether the derivative financial instrument is designated and qualifies as part of a hedging relationship and, if so, the nature of the hedging activity. Changes in fair value are recognized through earnings for derivatives that do not qualify for hedge accounting treatment, or that have not been designated in a hedging relationship.
Cash Flow Hedges
For derivative instruments that are designated and qualify as a cash flow hedge, changes in the fair value of the derivative are recorded in accumulated other comprehensive income and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815, Derivatives and Hedging ("ASC 815"), on a quarterly basis to ensure all hedges remain highly effective to ensure hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in accumulated other comprehensive income are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income.
Equity Warrant Assets
In connection with negotiated credit facilities and certain other services, we may obtain equity warrant assets giving us the right to acquire stock in primarily private, venture-backed companies in the technology and life science/healthcare industries. We hold these assets for prospective investment gains. We do not use them to hedge any economic risks nor do we use other derivative instruments to hedge economic risks stemming from equity warrant assets.
We account for equity warrant assets in certain private and public client companies as derivatives when they contain net settlement terms and other qualifying criteria under ASC 815. In general, equity warrant assets entitle us to buy a specific number of shares of stock at a specific price within a specific time period. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of certain future events. Substantially all of our warrant agreements contain net share settlement provisions, which permit us to receive at exercise a share count equal to the intrinsic value of the warrant divided by the share price (otherwise known as a “cashless” exercise). These equity warrant assets are recorded at fair value and are classified as derivative assets, a component of other assets, on our consolidated balance sheet at the time they are obtained.
The grant date fair values of equity warrant assets received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility.
Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income. We value our equity warrant assets using a Black-Scholes option pricing model, which incorporates the following significant inputs:
An underlying asset value, which is estimated based on current information available in valuation reports, including any information regarding subsequent rounds of funding or performance of a company.
Stated strike price, which can be adjusted for certain warrants upon the occurrence of subsequent funding rounds or other future events.
Price volatility or risk associated with possible changes in the warrant price. The volatility assumption is based on historical price volatility of publicly traded companies within indices similar in nature to the underlying client companies issuing the warrant. The actual volatility input is based on the mean and median volatility for an individual public company within an index for the past 16 quarters, from which an average volatility was derived.
Actual data on terminations and exercises of our warrants are utilized as the basis for determining the expected remaining life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or IPOs, and cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants.
The risk-free interest rate is derived from the Treasury yield curve and is calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant.
Other adjustments, including a marketability discount, are estimated based on management's judgment about the general industry environment.
Number of shares and contingencies associated with obtaining warrant positions such as the funding of associated loans.
When a portfolio company completes an IPO on a publicly reported market or is acquired, we may exercise these equity warrant assets for shares or cash. In the event of an exercise for common stock shares, the basis or value in the common stock shares is reclassified from other assets to investment securities on the balance sheet on the latter of the exercise date or corporate action date. The common stock of public companies are classified as non-marketable and other equity securities. Changes in the fair value of the common stock shares is recorded as gains or losses on investments securities, in noninterest income, a component of consolidated net income. The common stock of private companies are classified as non-marketable and other equity securities. We account for these securities under the methodology under ASU 2016-01, other investments without a readily determinable fair value. The carrying value in the private common stock without a readily determinable fair value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments and are recorded as gains or losses on investments securities, in noninterest income, a component of consolidated net income.
Foreign Exchange Forwards and Foreign Currency Option Contracts
We enter into foreign exchange forward contracts and foreign currency option contracts with clients involved in international activities, either as the purchaser or seller, depending upon the clients' need. We also enter into an opposite-way forward or option contract with a correspondent bank to economically hedge client contracts to mitigate the fair value risk to us from fluctuations in currency rates. Settlement, credit and operational risks remain. We also enter into forward contracts with correspondent banks to economically hedge currency exposure risk related to certain foreign currency denominated assets and liabilities. These contracts are not designated as hedging instruments and are recorded at fair value in our consolidated balance sheets. The contracts generally have terms of one year or less, although we may have contracts extending for up to five years. Generally, we have not experienced nonperformance on these contracts, have not incurred credit losses and anticipate performance by all counterparties to such agreements. Changes in the fair value of these contracts are recognized in consolidated net income under other noninterest income, a component of noninterest income. Period-end gross positive fair values are recorded in other assets and gross negative fair values are recorded in other liabilities.
Interest Rate Contracts
We sell interest rate contracts to clients who wish to mitigate their interest rate exposure. We economically reduce the interest rate risk from this business by entering into opposite-way contracts with correspondent banks. We do not designate any of these contracts (which are derivative instruments) as qualifying for hedge accounting. Contracts in an asset position are included in other assets and contracts in a liability position are included in other liabilities. The net change in the fair value of these derivatives is recorded through other noninterest income, in noninterest income, a component of consolidated net income.
Adoption of New Accounting Standards
In February 2016, the FASB issued a new Accounting Standard Update (ASU 2016-02, Leases (Topic 842)), which requires for all operating leases the recognition of a right-of-use ("ROU") asset and a corresponding lease liability, in the statement of financial position. For short term leases (term of 12 months or less), a lessee is permitted to make an accounting election not to recognize lease assets and lease liabilities. The lease cost is allocated over the lease term on a straight-line basis. There were further amendments, including practical expedients, with the issuance of ASU 2018-01, “Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842” in January 2018. In July 2018 the FASB issued ASU No. 2018-11, "Leases (Topic 842): Targeted Improvements", which provides us with the option to apply the new leasing standard to all open leases as of the adoption date, on a prospective basis.
On January 1, 2019, we adopted the new accounting standard ASU 2016-02, Leases (Topic 842) and all the related amendments ("new lease standard", "ASC 842" or "ASU 2016-02") utilizing the practical expedient to apply the new lease standard as of January 1, 2019 on a prospective basis. We also elected the "package of expedients" and elected as an accounting policy to exclude recording ROU assets and lease liabilities for leases that meet the definition of short-term leases. In addition to excluding short-term leases, we have implemented an accounting policy in which non-lease components are not separated from lease components in the measurement of ROU assets and lease liabilities for all lease contracts. The "package of expedients" allowed us to continue to account for existing leases for which the commencement date is before January 1, 2019, in accordance with
the previous guidance, Leases (Topic 840), throughout the lease term, including periods after adoption of the new guidance. We recognized $146 million in ROU assets and $178 million in lease liabilities as a result of applying the new lease standard as an adjustment to our opening consolidated balance sheet on January 1, 2019. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. See Note 12—"Leases" of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional disclosures related to our leases.
In March 2017, the FASB issued ASU No. 2017-08, Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which amends the amortization period for certain purchased callable debt securities held at a premium. The ASU requires entities to amortize premiums on debt securities by the first call date when the securities have fixed and determinable call dates and prices. The scope of the ASU includes all accounting premiums, such as purchase premiums and cumulative fair value hedge adjustments. The ASU does not change the accounting for discounts, which continue to be recognized over the contractual life of a security. Adoption of the ASU is on a modified retrospective basis through a cumulative effect adjustment to retained earnings as of the beginning of the year of adoption. Adoption of the ASU primarily affected our HTM portfolio of callable state and municipal debt securities. On January 1, 2019, we adopted the ASU and recognized a net reduction to retained earnings of $0.6 million.
Reclassifications
Certain prior period amounts related to presentation changes to our financial statement line items have been reclassified to conform to current period presentations.
v3.19.3.a.u2
Business Combination
12 Months Ended
Dec. 31, 2019
Business Combinations [Abstract]  
Business Combination
Business Combination
On January 4, 2019, we completed the acquisition of Leerink Holdings LLC, the Boston-based parent company of healthcare and life science investment bank Leerink Partners LLC, now SVB Leerink Holdings LLC ("SVB Leerink"). SVB Leerink is an investment bank specializing in equity and convertible capital markets, M&A, equity research and sales and trading for growth- and innovation-minded healthcare and life science companies and operates as a wholly-owned subsidiary of SVB Financial.

The acquisition was accounted for as a business combination and accordingly, the results of SVB Leerink's operations have been included in the Company's consolidated financial statements for the year ended December 31, 2019 from the date of acquisition. We acquired SVB Leerink for $273.2 million comprised of cash and share-based replacement award liabilities. In addition, we provided a retention pool for employees of $60.0 million to be paid over five years comprised of a mix of cash and equity issued under the Company's current Equity Incentive Plan. Refer to Note 5—“Share-Based Compensation” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report of this report for more information. The following table summarizes the allocation of the purchase price to the net assets of SVB Leerink as of January 4, 2019:
(Dollars in thousands)
 
January 4, 2019
Cash paid
 
$
265,601

Replacement award liabilities (1)
 
7,629

Total purchase consideration
 
$
273,230

Fair value of net assets acquired
 
135,407

Goodwill
 
$
137,823

 
 
(1)
The replacement award liabilities recognized as part of the total purchase consideration and the post-combination expenses of $9.1 million related to share-based replacement awards will be paid out in cash in accordance with SVB Leerink's original grant date vesting schedules.
The following table summarizes the estimated fair value of assets acquired and liabilities assumed upon the finalization of the purchase:
(Dollars in thousands)
 
January 4, 2019
Assets acquired:
 
 
Cash and cash equivalents
 
$
163,273

Investment securities
 
33,644

Accounts receivable
 
36,538

Intangible assets
 
60,900

Other assets
 
35,128

Total assets acquired
 
329,483

Liabilities assumed:
 
 
Accrued compensation
 
137,206

Due to broker-dealers
 
18,483

Other liabilities
 
33,131

Noncontrolling interests
 
5,256

Total liabilities assumed
 
194,076

Fair value of net assets acquired
 
$
135,407


The Company recognized identifiable intangible assets of $60.9 million and goodwill of $137.8 million as a result of the acquisition. Intangible assets of $60.9 million are subject to amortization over their estimated useful lives. The goodwill recorded includes revenue generating synergies expected from collaboration between SVB Leerink and the Company. All reported goodwill amounts have been allocated to the SVB Leerink reporting segment and are expected to be deductible for tax purposes. The fair value of the noncontrolling interests in SVB Leerink Holdings LLC represents the noncontrolling ownership percentage for SVB Leerink's consolidated VIE investment securities which are measured at net asset value.
The following table summarizes the fair value and estimated useful lives of the other intangible assets at the date of acquisition:
(Dollars in thousands)
 
Estimated Fair Value
 
Weighted Average Estimated Useful Life - in Years
Other intangible assets:
 
 
 
 
Customer relationships
 
$
42,000

 
11.0
Other
 
18,900

 
9.9
Total other intangible assets
 
$
60,900

 
 


SVB Leerink's net income from January 4, 2019 through December 31, 2019 was approximately $9.5 million. Supplementary pro forma financial information related to the acquisition is not included because the impact to the Company's consolidated statements of income is not material. The following table represents the amount of revenue and earnings attributable to SVB Leerink that is included in our financial results for the year ended December 31, 2019:
(Dollars in thousands)
 
Year ended December 31, 2019
Net interest income
 
$
1,252

Noninterest income
 
265,841

Noninterest expense
 
252,678

Income before income tax expense
 
14,415

Income tax expense
 
3,566

Net income attributable to noncontrolling interests
 
1,325

Net income available to common stockholders
 
$
9,524


The following table shows the components of acquisition-related activities expense for the year ended December 31, 2019:
(Dollars in thousands)
 
Year ended December 31, 2019
Professional fees
 
$
919

Other
 
396

Total acquisition-related expenses
 
$
1,315


v3.19.3.a.u2
Stockholders' Equity and EPS
12 Months Ended
Dec. 31, 2019
Equity and Earnings Per Share [Abstract]  
Stockholders' Equity and EPS
Stockholders' Equity and EPS
Accumulated Other Comprehensive Income
The following table summarizes the items reclassified out of accumulated other comprehensive income into the Consolidated Statements of Income for 2019, 2018 and 2017:
 
 
 
 
Year ended December 31,
(Dollars in thousands)
 
Income Statement Location
 
2019
 
2018
 
2017
Reclassification adjustment for losses on available-for-sale securities included in net income
 
Gains on investment securities, net
 
$
3,905

 
$
740

 
$
5,189

Related tax benefit
 
Income tax expense
 
(1,087
)
 
(205
)
 
(2,098
)
Reclassification adjustment for losses on cash flow hedges included in net income
 
Net interest income
 
5,358

 

 

Related tax benefit
 
Income tax expense
 
(1,489
)
 

 

Total reclassification adjustment for losses included in net income, net of tax
 
 
 
$
6,687

 
$
535

 
$
3,091



The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in accumulated other comprehensive income for 2019, 2018 and 2017. Over the next 12 months, we expect that approximately $3.2 million in accumulated other comprehensive income ("AOCI") at December 31, 2019, related to our cash flow hedges will be reclassified out of AOCI and recognized in net income.
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Balance, beginning of period, net of tax
 
$

 
$

 
$

Net decrease in fair value, net of tax
 
(5,999
)
 

 

Net realized loss reclassified to net income, net of tax
 
3,869

 

 

Balance, end of period, net of tax
 
$
(2,130
)
 
$

 
$



EPS
Basic EPS is the amount of earnings available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issuable for stock option and restricted stock unit awards outstanding under our 2006 Equity Incentive Plan and our ESPP. Potentially dilutive common shares are excluded from the computation of dilutive EPS in periods in which the effect would be antidilutive. The following is a reconciliation of basic EPS to diluted EPS for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars and shares in thousands, except per share amounts)
 
2019
 
2018
 
2017
Numerator:
 
 
 
 
 
 
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Denominator:
 
 
 
 
 
 
Weighted average common shares outstanding—basic
 
51,915

 
53,078

 
52,588

Weighted average effect of dilutive securities:
 
 
 
 
 
 
Stock options and ESPP
 
227

 
377

 
385

Restricted stock units
 
169

 
317

 
333

Weighted average common shares outstanding—diluted
 
52,311

 
53,772

 
53,306

Earnings per common share:
 
 
 
 
 
 
Basic
 
$
21.90

 
$
18.35

 
$
9.33

Diluted
 
21.73

 
18.11

 
9.20


The following table summarizes the weighted average common shares excluded from the diluted EPS calculation due to the antidilutive effect for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Shares in thousands)
 
2019

2018

2017
Stock options
 
167

 
59

 
73

Restricted stock units
 
250

 
85

 
1

Total
 
417

 
144

 
74


Stock Repurchase Programs
On November 13, 2018, the Company announced the Stock Repurchase Program to repurchase up to $500 million of our outstanding common stock. The program completed on July 1, 2019, after we repurchased 2.2 million shares of common stock for $499.6 million under the Stock Repurchase Program.
On October 24, 2019, our Board of Directors authorized a new stock repurchase program that enables us to repurchase up to $350 million of our outstanding common stock. This program expires on October 29, 2020. As of December 31, 2019, we have not repurchased any shares of our common stock under the new stock repurchase program.
Preferred Stock
On December 9, 2019, the Company issued depositary shares representing an ownership interest in 350,000 shares of Series A Preferred Stock with $0.001 par value and liquidation preference of $1,000 per share, or $25 per depositary share. All preferred shares were issued in the form of depositary shares, with each depositary share representing a 1/40th ownership interest in a share of the preferred stock. The Series A Preferred Stock has no stated maturity and is not subject to any sinking fund or other obligation of the Company. Dividends are approved by the Board of Directors and, if declared, are payable quarterly, in arrears, at a rate per annum equal to 5.25 percent. The Series A Preferred Stock is redeemable at the Company’s option, in whole or in part, on or after February 15, 2025. Prior to February 15, 2025, the Series A Preferred Stock is redeemable at the Company’s option, in whole and not in part, following any change in laws or regulations that would not allow the Company to treat the full
liquidation value of the Series A Preferred Stock as Tier 1 capital for purposes of the capital adequacy guidelines of the FRB. The redemption amount is computed at the per share liquidation preference plus any declared but unpaid dividends. Redemptions are subject to certain regulatory provisions, including approval of FRB.
As of December 31, 2019, there were 350,000 shares issued and outstanding of Series A Preferred Shares, which had a carrying value of $340.1 million and liquidation preference of $350.0 million.
The following table summarizes our preferred stock at December 31, 2019:
Series
 
Description
 
Amount outstanding (in millions)
 
Carrying value
(in millions)
 
Shares issued and outstanding
 
Par Value
 
Ownership interest per depository share
 
Liquidation preference per depository share
 
2019 dividends paid per depository share
Series A
 
5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock
 
$
350

 
$
340.1

 
350,000
 
$
0.001

 
1/40th
 
$
25

 
$


v3.19.3.a.u2
Share-Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation
Share-Based Compensation
Share-based compensation expense was recorded net of estimated forfeitures for 2019, 2018 and 2017, such that expense was recorded only for those share-based awards that are expected to vest. In 2019, 2018 and 2017, we recorded share-based compensation and related benefits as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Share-based compensation expense
 
$
66,815

 
$
45,675

 
$
36,900

Income tax benefit related to share-based compensation expense
 
(16,152
)
 
(10,997
)
 
(12,845
)
Capitalized compensation costs
 
1,517

 
1,466

 
1,071


Equity Incentive Plan
Our 2006 Equity Incentive Plan (the “2006 Incentive Plan”) was adopted in May 2006, and is amended from time to time. The 2006 Incentive Plan provides for the grant of various types of incentive awards, of which the following have been granted: (i) stock options; (ii) restricted stock awards; (iii) restricted stock units (subject to either time-and/or performance-based vesting); and (iv) other cash or stock settled equity awards. Eligible participants in the 2006 Incentive Plan include directors, employees and consultants.
Subject to the provisions of Section 16 of the 2006 Incentive Plan, the maximum aggregate number of shares that may be awarded and sold thereunder is 12,028,505.
Restricted stock awards/units are counted against the available-for-issuance limits of the 2006 Incentive Plan as two shares for every one share awarded. Further, if shares acquired under any such award are forfeited, repurchased by SVB Financial, used to satisfy the tax withholding obligations related to an award or otherwise canceled and would otherwise return to the 2006 Incentive Plan, two times the number of such shares will return to the 2006 Incentive Plan and will again become available for issuance.
Under the terms of the 2006 Incentive Plan and subject to certain exceptions: (i) restricted stock awards/units are subject to a minimum of at least three years of annual vesting, and (ii) performance-based restricted stock awards/units and stock options are subject to a minimum of at least one year of vesting. Generally in practice, restricted stock awards/units vest annually over four years and require continued employment or other service through the vesting period. Performance-based restricted stock awards/units granted to executives generally vest upon meeting certain performance-based objectives over a three year period and, typically the passage of time, and require continued employment or other service through the vesting period. Stock options typically vest annually over four years, from the grant date based on continued employment or other service, and expire no later than seven years after the grant date.
Employee Stock Purchase Plan
We maintain the 1999 ESPP under which participating employees may annually contribute up to 10 percent of their gross compensation (not to exceed $25,000) to purchase shares of our common stock at 85 percent of its fair market value at either the beginning or end of each six-month offering period, whichever price is less. To be eligible to participate in the ESPP, an employee must, among other requirements, be employed by the Company on both the date of offering and date of purchase, and be employed customarily for at least 20 hours per week and at least five months per calendar year. We issued 161,410 shares and received $27.9 million in cash under the ESPP in 2019. At December 31, 2019, a total of 1,337,808 shares of our common stock were still available for future issuance under the ESPP.
Unrecognized Compensation Expense
As of December 31, 2019, unrecognized share-based compensation expense was as follows:
(Dollars in thousands)
 
Unrecognized 
Expense
 
Weighted Average Expected Recognition Period - in Years  
Stock options
 
$
14,313

 
2.52
Restricted stock awards/units
 
101,310

 
2.66
Total unrecognized share-based compensation expense
 
$
115,623

 
 

Valuation Assumptions
The fair values of share-based awards for employee stock options and employee stock purchases made under our ESPP were estimated using the Black-Scholes option pricing model. The fair values of restricted stock units were based on our closing stock price on the date of grant. The following weighted average assumptions and fair values were used for our employee stock options and restricted stock units:
Equity Incentive Plan Awards
 
2019
 
2018
 
2017
Weighted average expected term of options - in years
 
4.6

 
4.8

 
4.9

Weighted average expected volatility of the Company's underlying common stock
 
35.5
%
 
34.7
%
 
33.7
%
Risk-free interest rate
 
2.26

 
2.82

 
1.81

Expected dividend yield
 

 

 

Weighted average grant date fair value - stock options
 
$
83.50

 
$
105.81

 
$
57.81

Weighted average grant date fair value - restricted stock units
 
243.65

 
294.50

 
181.23


The following weighted average assumptions and fair values were used for our ESPP:
ESPP
 
2019
 
2018
 
2017
Expected term in years
 
0.5

 
0.5

 
0.5

Weighted average expected volatility of the Company's underlying common stock
 
38.1
%
 
32.2
%
 
31.2
%
Risk-free interest rate
 
2.40

 
1.79

 
0.80

Expected dividend yield
 

 

 

Weighted average grant date fair value
 
$
52.90

 
$
62.76

 
$
41.70


The expected term is based on the implied term of the stock options using factors based on historical exercise behavior. The expected volatilities are based on a blended rate consisting of our historic volatility and our expected volatility over a five-year term which is an indicator of expected volatility and future stock price trends. For 2019, 2018 and 2017, expected volatilities for the ESPP were equal to the historical volatility for the previous six-month periods. The expected risk-free interest rates were based on the yields of U.S. Treasury securities, as reported by the Federal Reserve Bank of New York, with maturities equal to the expected terms of the employee stock options.
Share-Based Payment Award Activity
The table below provides stock option information related to the 2006 Equity Incentive Plan for the year ended December 31, 2019:
 
 
Options
 
Weighted
Average
 Exercise Price 
 
Weighted Average Remaining Contractual Life - in Years  
 
Aggregate Intrinsic Value of 
In-The-Money Options
Outstanding at December 31, 2018
 
679,659

 
$
137.19

 
 
 
 
Granted
 
126,945

 
249.15

 
 
 
 
Exercised
 
(154,897
)
 
86.96

 
 
 
 
Forfeited
 
(25,580
)
 
213.26

 
 
 
 
Expired
 
(720
)
 
64.37

 
 
 
 
Outstanding at December 31, 2019
 
625,407

 
169.33

 
3.63
 
$
55,364,613

Vested and expected to vest at December 31, 2019
 
609,849

 
167.31

 
3.58
 
55,128,404

Exercisable at December 31, 2019
 
361,503

 
124.70

 
2.35
 
46,760,360


The aggregate intrinsic value of outstanding options shown in the table above represents the pre-tax intrinsic value based on our closing stock price of $251.04 as of December 31, 2019. The following table summarizes information regarding stock options outstanding and exercisable as of December 31, 2019:
 
 
Outstanding Options
 
Exercisable Options
Range of Exercise Prices
 
Shares
 
Weighted Average Remaining Contractual Life - in Years
 
Weighted Average Exercise Price
 
Shares
 
Weighted Average Exercise Price
$71.11 - 105.14
 
55,724

 
0.43
 
$
73.67

 
55,724

 
$
73.67

105.15 - 105.84
 
114,449

 
3.33
 
105.18

 
79,188

 
105.18

105.85 - 108.59
 
99,936

 
1.33
 
107.94

 
99,936

 
107.94

108.60 - 149.65
 
67,573

 
2.26
 
129.13

 
67,573

 
129.13

149.66 - 180.62
 
80,583

 
4.34
 
178.07

 
37,320

 
178.04

180.63 - 247.01
 
11,966

 
6.18
 
226.22

 
1,578

 
210.73

247.02 - 255.58
 
117,265

 
6.33
 
250.43

 

 

255.59 - 315.12
 
75,647

 
5.33
 
305.18

 
19,617

 
304.39

315.13 - 324.77
 
2,264

 
5.60
 
324.77

 
567

 
324.77

Total
 
625,407

 
3.63
 
169.33

 
361,503

 
124.70


We expect to satisfy the exercise of stock options by issuing shares under the 2006 Incentive Plan. All future awards of stock options and restricted stock units will be issued from the 2006 Incentive Plan. At December 31, 2019, 3,421,734 shares were available for future issuance.
The table below provides information for restricted stock units under the 2006 Equity Incentive Plan for the year ended December 31, 2019:
 
 
Shares    
 
Weighted Average Grant Date Fair Value
Nonvested at December 31, 2018
 
597,296

 
$
194.48

Granted (1)
 
543,938

 
243.65

Vested
 
(227,707
)
 
154.96

Forfeited
 
(65,555
)
 
195.69

Nonvested at December 31, 2019
 
847,972

 
236.54

 
(1)
On February 1, 2019, we granted 125,160 restricted stock awards to SVB Leerink employees at a market price of $238.28 under the retention plan previously announced on November 13, 2018. The restricted stock awards will vest over a five-year period.

The following table summarizes information regarding stock option and restricted stock unit activity during 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Total intrinsic value of stock options exercised
 
$
23,088

 
$
40,681

 
$
36,173

Total grant date fair value of stock options vested
 
5,735

 
5,823

 
6,094

Total intrinsic value of restricted stock vested
 
56,101

 
63,917

 
40,925

Total grant date fair value of restricted stock vested
 
35,191

 
28,813

 
23,383


v3.19.3.a.u2
Variable Interest Entities
12 Months Ended
Dec. 31, 2019
Investments In Variable Interest Entities [Abstract]  
Variable Interest Entities
Variable Interest Entities
Our involvement with VIEs includes our investments in venture capital and private equity funds, debt funds, private and public portfolio companies and our investments in qualified affordable housing projects.
The following table presents the carrying amounts and classification of significant variable interests in consolidated and unconsolidated VIEs as of December 31, 2019 and December 31, 2018:
(Dollars in thousands)
 
Consolidated VIEs
 
Unconsolidated VIEs
 
Maximum Exposure to Loss in Unconsolidated VIEs
December 31, 2019:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
7,629

 
$

 
$

Non-marketable and other equity securities (1)
 
270,057

 
689,360

 
689,360

Accrued interest receivable and other assets
 
1,117

 

 

Total assets
 
$
278,803

 
$
689,360

 
$
689,360

Liabilities:
 
 
 
 
 
 
Other liabilities (1)
 
2,854

 
302,031

 

Total liabilities
 
$
2,854

 
$
302,031

 
$

December 31, 2018:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
9,058

 
$

 
$

Non-marketable and other equity securities (1)
 
221,646

 
568,272

 
568,272

Accrued interest receivable and other assets
 
228

 

 

Total assets
 
$
230,932

 
$
568,272

 
$
568,272

Liabilities:
 
 
 
 
 
 
Other liabilities (1)
 
919

 
205,685

 

Total liabilities
 
$
919

 
$
205,685

 
$

 
(1)
Included in our unconsolidated non-marketable and other equity securities portfolio at December 31, 2019 and December 31, 2018 are investments in qualified affordable housing projects of $458.5 million and $318.6 million, respectively, and related other liabilities consisting of unfunded commitments of $302.0 million and $205.7 million, respectively.

Non-marketable and other equity securities
Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised and investments in qualified affordable housing projects. A majority of these investments are through third-party funds held by SVB Financial in which we do not have controlling or significant variable interests. These investments represent our unconsolidated VIEs in the table above. Our non-marketable and other equity securities portfolio also includes investments from SVB Capital. SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. We have a controlling and significant variable interest in four of these SVB Capital funds and consolidate these funds for financial reporting purposes.
All investments are generally non-redeemable and distributions are expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreement. Subject to applicable regulatory requirements, including the Volcker Rule, we also make commitments to invest in venture capital and private equity funds. For additional details, see Note 22—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
The Bank also has variable interests in low income housing tax credit funds, in connection with fulfilling its responsibilities under the Community Reinvestment Act ("CRA"), that are designed to generate a return primarily through the realization of federal tax credits. These investments are typically limited partnerships in which the general partner, other than the Bank, holds the power over significant activities of the VIE; therefore, these investments are not consolidated. For additional information on our investments in qualified affordable housing projects see Note 9—“Investment Securities" of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
As of December 31, 2019, our exposure to loss with respect to the consolidated VIEs is limited to our net assets of $275.9 million and our exposure to loss for our unconsolidated VIEs is equal to our investment in these assets of $689.4 million.
v3.19.3.a.u2
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock
12 Months Ended
Dec. 31, 2019
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]  
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock
The Bank is required to maintain reserves against customer deposits by keeping balances with the Federal Reserve. The cash balances at the Federal Reserve are classified as cash and cash equivalents. Additionally, as a member of the FHLB and FRB, we are required to hold shares of FHLB and FRB stock under the Bank's borrowing agreement. FHLB and FRB stock are recorded at cost as a component of other assets, and any cash dividends received are recorded as a component of other noninterest income.
The tables below provide information on the required reserve balances at the Federal Reserve, as well as shares held at the FHLB and FRB for the years ended and as of December 31, 2019 and 2018:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Average required reserve balances at FRB San Francisco
 
$
315,784

 
$
455,866


 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
FHLB stock holdings
 
$
17,250

 
$
17,250

FRB stock holdings
 
43,008

 
41,628


v3.19.3.a.u2
Cash and Cash Equivalents
12 Months Ended
Dec. 31, 2019
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents
Cash and Cash Equivalents
The following table details our cash and cash equivalents at December 31, 2019 and December 31, 2018:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Cash and due from banks (1)
 
$
6,492,443

 
$
3,444,971

Securities purchased under agreements to resell (2)
 
289,340

 
123,611

Other short-term investment securities
 

 
2,957

Total cash and cash equivalents
 
$
6,781,783

 
$
3,571,539

 
(1)
At December 31, 2019 and 2018, $3.7 billion and $1.7 billion, respectively, of our cash and due from banks was deposited at the FRB and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were $2.1 billion and $1.2 billion, respectively.
(2)
At December 31, 2019 and 2018, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $295 million and $126 million, respectively. None of these securities were sold or repledged as of December 31, 2019 and 2018.

Additional information regarding our securities purchased under agreements to resell for 2019 and 2018 are as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Average securities purchased under agreements to resell
 
$
166,205

 
$
132,938

Maximum amount outstanding at any month-end during the year
 
613,247

 
375,180


v3.19.3.a.u2
Investment Securities
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Investment Securities
Investment Securities
Our investment securities portfolio consists of (i) an available-for-sale securities portfolio and a held-to-maturity securities portfolio, both of which represent interest-earning investment securities; and (ii) a non-marketable and other equity securities portfolio, which primarily represents investments managed as part of our funds management business as well as public equity securities held as a result of equity warrant assets exercised.
Available-for-Sale Securities
The major components of our AFS investment securities portfolio at 2019 and 2018 are as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Carrying
Value
Available-for-sale securities, at fair value:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
6,815,874

 
$
82,267

 
$
(4,131
)
 
6,894,010

U.S. agency debentures
 
100,000

 

 
(453
)
 
99,547

Foreign government debt securities
 
9,037

 
1

 

 
9,038

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
4,109,372

 
39,438

 
(19
)
 
4,148,791

Agency-issued collateralized mortgage obligations—fixed rate
 
1,520,414

 
17,929

 

 
1,538,343

Agency-issued commercial mortgage-backed securities
 
1,339,651

 
1,078

 
(15,539
)
 
1,325,190

Total available-for-sale securities
 
$
13,894,348

 
$
140,713

 
$
(20,142
)
 
$
14,014,919

 
 
December 31, 2018
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Carrying
Value
Available-for-sale securities, at fair value:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
4,762,182

 
$
11,638

 
$
(35,562
)
 
$
4,738,258

U.S. agency debentures
 
1,090,426

 
61

 
(6,370
)
 
1,084,117

Foreign government debt securities
 
5,815

 

 
(3
)
 
5,812

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage obligations—fixed rate
 
1,922,618

 

 
(42,400
)
 
1,880,218

Agency-issued collateralized mortgage obligations—variable rate
 
81,270

 
383

 
(15
)
 
81,638

Total available-for-sale securities
 
$
7,862,311

 
$
12,082

 
$
(84,350
)
 
$
7,790,043


The following table summarizes sale activity of available-for-sale securities as recorded in the line item “Gains on investment securities, net," a component of noninterest income:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Sales proceeds
 
$
2,189,087

 
$
474,482

 
$
580,871

Net realized gains and losses:
 

 

 

Gross realized gains
 
1,250

 
127

 
5,113

Gross realized losses
 
(5,155
)
 
(867
)
 
(10,302
)
Net realized losses
 
$
(3,905
)
 
$
(740
)
 
$
(5,189
)

The following tables summarize our unrealized losses on our AFS securities portfolio into categories of less than 12 months, or 12 months or longer as of December 31, 2019 and 2018:
 
 
December 31, 2019
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
971,572

 
$
(3,996
)
 
$
449,850

 
$
(135
)
 
$
1,421,422

 
$
(4,131
)
U.S. agency debentures
 
99,547

 
(453
)
 

 

 
99,547

 
(453
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
4,014

 
(19
)
 

 

 
4,014

 
(19
)
Agency-issued commercial mortgage-backed securities
 
1,027,232

 
(15,539
)
 

 

 
1,027,232

 
(15,539
)
Total temporarily impaired securities (1)
 
$
2,102,365

 
$
(20,007
)
 
$
449,850

 
$
(135
)
 
$
2,552,215

 
$
(20,142
)
 
(1)
As of December 31, 2019, we identified a total of 58 investments that were in unrealized loss positions, of which 12 investments totaling $0.4 billion with unrealized losses of $0.1 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis.
 
 
December 31, 2018
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
494,287

 
$
(3,785
)
 
$
3,568,119

 
$
(31,777
)
 
$
4,062,406

 
$
(35,562
)
U.S. agency debentures
 
443,790

 
(1,602
)
 
591,216

 
(4,768
)
 
1,035,006

 
(6,370
)
Foreign government debt securities
 
5,812

 
(3
)
 

 

 
5,812

 
(3
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage obligations—fixed rate
 
13,430

 
(22
)
 
1,866,788

 
(42,378
)
 
1,880,218

 
(42,400
)
Agency-issued collateralized mortgage obligations—variable rate
 

 

 
13,516

 
(15
)
 
13,516

 
(15
)
Total temporarily impaired securities (1)
 
$
957,319

 
$
(5,412
)
 
$
6,039,639

 
$
(78,938
)
 
$
6,996,958

 
$
(84,350
)
 
(1)
As of December 31, 2018, we identified a total of 200 investments that were in unrealized loss positions, of which 162 investments totaling $6.0 billion with unrealized losses of $78.9 million have been in an impaired position for a period of time greater than 12 months.
The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of December 31, 2019 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for mortgage-backed securities may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. Mortgage-backed securities classified as AFS typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.
 
 
December 31, 2019
(Dollars in thousands)
 
Total
 
One Year
or Less
 
After One
Year to
Five Years
 
After Five
Years to
Ten Years
 
After
Ten Years
U.S. Treasury securities
 
$
6,894,010

 
$
1,835,971

 
$
1,890,778

 
$
3,167,261

 
$

U.S. agency debentures
 
99,547

 

 

 
99,547

 

Foreign government debt securities
 
9,038

 
9,038

 

 

 

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage-backed securities
 
4,148,791

 

 

 

 
4,148,791

Agency-issued collateralized mortgage obligations—fixed rate
 
1,538,343

 

 

 
1,858

 
1,536,485

Agency -issued commercial mortgage-backed securities
 
1,325,190

 

 

 
743,874

 
581,316

Total
 
$
14,014,919

 
$
1,845,009

 
$
1,890,778

 
$
4,012,540

 
$
6,266,592


Held-to-Maturity Securities
The components of our HTM investment securities portfolio at December 31, 2019 and 2018 are as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Held-to-maturity securities, at cost:
 
 
 
 
 
 
 
 
U.S. agency debentures (1)
 
$
518,728

 
$
6,640

 
$
(668
)
 
$
524,700

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
6,992,009

 
142,209

 
(2,066
)
 
7,132,152

Agency-issued collateralized mortgage obligations—fixed rate
 
1,608,032

 
592

 
(8,502
)
 
1,600,122

Agency-issued collateralized mortgage obligations—variable rate
 
178,611

 
94

 
(259
)
 
178,446

Agency-issued commercial mortgage-backed securities
 
2,759,615

 
56,914

 
(4,508
)
 
2,812,021

Municipal bonds and notes
 
1,785,951

 
83,314

 
(1,434
)
 
1,867,831

Total held-to-maturity securities
 
$
13,842,946

 
$
289,763

 
$
(17,437
)
 
$
14,115,272

 
(1)
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
 
 
December 31, 2018
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Held-to-maturity securities, at cost:
 
 
 
 
 
 
 
 
U.S. agency debentures (1)
 
$
640,990

 
$
2,148

 
$
(4,850
)
 
$
638,288

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
8,103,638

 
5,011

 
(157,767
)
 
7,950,882

Agency-issued collateralized mortgage obligations—fixed rate
 
2,183,204

 

 
(62,272
)
 
2,120,932

Agency-issued collateralized mortgage obligations—variable rate
 
214,483

 
608

 
(14
)
 
215,077

Agency-issued commercial mortgage-backed securities
 
2,769,706

 
6,969

 
(64,374
)
 
2,712,301

Municipal bonds and notes
 
1,575,421

 
2,304

 
(26,969
)
 
1,550,756

Total held-to-maturity securities
 
$
15,487,442

 
$
17,040

 
$
(316,246
)
 
$
15,188,236

 
(1)
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
 
The following tables summarize our unrealized losses on our HTM securities portfolio into categories of less than 12 months and 12 months or longer as of December 31, 2019 and 2018:
 
 
December 31, 2019
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Held-to-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. agency debentures
 
$
125,304

 
$
(668
)
 
$

 
$

 
$
125,304

 
$
(668
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
132,042

 
(420
)
 
181,585

 
(1,646
)
 
313,627

 
(2,066
)
Agency-issued collateralized mortgage
    obligations—fixed rate
 
350,868

 
(1,131
)
 
872,527

 
(7,371
)
 
1,223,395

 
(8,502
)
Agency-issued collateralized mortgage
    obligations—variable rate
 
143,265

 
(256
)
 
4,615

 
(3
)
 
147,880

 
(259
)
Agency-issued commercial mortgage-backed
    securities
 
307,087

 
(1,818
)
 
310,229

 
(2,690
)
 
617,316

 
(4,508
)
Municipal bonds and notes
 
160,414

 
(1,434
)
 

 

 
160,414

 
(1,434
)
Total temporarily impaired securities (1)
 
$
1,218,980

 
$
(5,727
)
 
$
1,368,956

 
$
(11,710
)
 
$
2,587,936

 
$
(17,437
)
 

(1)
As of December 31, 2019, we identified a total of 266 investments that were in unrealized loss positions, of which 143 investments totaling $1.4 billion with unrealized losses of $11.7 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis, which is consistent with our classification of these securities. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary. Market valuations and impairment analyses on assets in the HTM securities portfolio are reviewed and monitored on a quarterly basis.
 
 
December 31, 2018
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Held-to-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. agency debentures
 
$
291,432

 
$
(2,915
)
 
$
66,624

 
$
(1,935
)
 
$
358,056

 
$
(4,850
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
2,493,156

 
(34,956
)
 
3,972,690

 
(122,811
)
 
6,465,846

 
(157,767
)
Agency-issued collateralized mortgage obligations—fixed rate
 
16,952

 
(109
)
 
2,103,980

 
(62,163
)
 
2,120,932

 
(62,272
)
Agency-issued collateralized mortgage
  obligations—variable rate
 
3,364

 
(1
)
 
8,101

 
(13
)
 
11,465

 
(14
)
Agency-issued commercial mortgage-backed securities
 
177,697

 
(1,580
)
 
1,600,277

 
(62,794
)
 
1,777,974

 
(64,374
)
Municipal bonds and notes
 
868,751

 
(17,075
)
 
340,413

 
(9,894
)
 
1,209,164

 
(26,969
)
Total temporarily impaired securities (1)
 
$
3,851,352

 
$
(56,636
)
 
$
8,092,085

 
$
(259,610
)
 
$
11,943,437

 
$
(316,246
)
 
(1)
As of December 31, 2018, we identified a total of 1,244 investments that were in unrealized loss positions, of which 695 investments totaling $8.1 billion with unrealized losses of $259.6 million have been in an impaired position for a period of time greater than 12 months.
The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of December 31, 2019. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected maturities for mortgage-backed securities may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. Mortgage-backed securities classified as HTM typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.
 
 
December 31, 2019
 
 
Total
 
One Year
or Less
 
After One Year to
Five Years
 
After Five Years to
Ten Years
 
After
Ten Years
(Dollars in thousands)
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
U.S. agency debentures
 
$
518,728

 
$
524,700

 
$

 
$

 
$
123,100

 
$
123,969

 
$
395,628

 
$
400,731

 
$

 
$

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
6,992,009

 
7,132,152

 
2,066

 
2,117

 
76,759

 
76,956

 
726,422

 
725,854

 
6,186,762

 
6,327,225

Agency-issued collateralized mortgage obligations - fixed rate
 
1,608,032

 
1,600,122

 

 

 

 

 
624,128

 
619,180

 
983,904

 
980,942

Agency-issued collateralized mortgage obligations - variable rate
 
178,611

 
178,446

 

 

 

 

 

 

 
178,611

 
178,446

Agency-issued commercial mortgage-backed securities
 
2,759,615

 
2,812,021

 

 

 

 

 
102,633

 
110,836

 
2,656,982

 
2,701,185

Municipal bonds and notes
 
1,785,951

 
1,867,831

 
13,973

 
13,984

 
83,368

 
84,773

 
387,278

 
403,736

 
1,301,332

 
1,365,338

Total
 
$
13,842,946

 
$
14,115,272

 
$
16,039

 
$
16,101

 
$
283,227

 
$
285,698

 
$
2,236,089

 
$
2,260,337

 
$
11,307,591

 
$
11,553,136


Non-marketable and Other Equity Securities
The major components of our non-marketable and other equity securities portfolio at December 31, 2019 and 2018 are as follows:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Non-marketable and other equity securities:
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
Consolidated venture capital and private equity fund investments (1)
 
$
87,180

 
$
118,333

Unconsolidated venture capital and private equity fund investments (2)
 
178,217

 
201,098

Other investments without a readily determinable fair value (3)
 
55,255

 
25,668

Other equity securities in public companies (fair value accounting) (4)
 
59,200

 
20,398

Non-marketable securities (equity method accounting) (5):
 
 
 
 
Venture capital and private equity fund investments
 
215,367

 
129,485

Debt funds
 
7,271

 
5,826

Other investments
 
152,863

 
121,721

Investments in qualified affordable housing projects, net (6)
 
458,476

 
318,575

Total non-marketable and other equity securities
 
$
1,213,829

 
$
941,104

 
(1)
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at December 31, 2019 and 2018 (fair value accounting):
 
 
December 31, 2019
 
December 31, 2018
(Dollars in thousands)
 
Amount
 
Ownership %
 
Amount
 
Ownership %
Strategic Investors Fund, LP
 
$
5,729

 
12.6
%
 
$
12,452

 
12.6
%
Capital Preferred Return Fund, LP
 
45,341

 
20.0

 
53,957

 
20.0

Growth Partners, LP
 
35,976

 
33.0

 
50,845

 
33.0

CP I, LP
 
134

 
10.7

 
1,079

 
10.7

Total consolidated venture capital and private equity fund investments
 
$
87,180

 
 
 
$
118,333

 
 


(2)
The carrying value represents investments in 205 and 213 funds (primarily venture capital funds) at December 31, 2019 and December 31, 2018, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30th for our December 31st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)
These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.
The following table shows the carrying amount of other investments without a readily determinable fair value at December 31, 2019, and the amounts recognized in earnings for the year ended December 31, 2019 and on a cumulative basis:

(Dollars in thousands)
 
Year ended December 31, 2019
 
Cumulative Adjustments
Measurement alternative:
 
 
 
 
Carrying value at December 31, 2019
 
$
55,255

 
 
Carrying value adjustments:
 
 
 
 
Impairment
 
$
(460
)
 
$
(460
)
Upward changes for observable prices
 
1,929

 
2,348

Downward changes for observable prices
 
(3,511
)
 
(5,030
)
(4)
Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets, direct equity investments in public companies held by our consolidated funds, and exchange traded funds held by SVB Leerink. Changes in equity securities measured at fair value are recognized through net income.

(5)
The following table shows the carrying value and our ownership percentage of each investment at December 31, 2019 and 2018 (equity method accounting):
 
 
December 31, 2019
 
December 31, 2018
(Dollars in thousands)
 
Amount
 
Ownership %
 
Amount
 
Ownership %
Venture capital and private equity fund investments:
 
 
 
 
 
 
 
 
Strategic Investors Fund II, LP
 
$
3,612

 
8.6
%
 
$
4,670

 
8.6
%
Strategic Investors Fund III, LP
 
15,668

 
5.9

 
17,396

 
5.9

Strategic Investors Fund IV, LP
 
27,064

 
5.0

 
28,974

 
5.0

Strategic Investors Fund V funds
 
46,830

 
Various

 
28,189

 
Various

CP II, LP (i)
 
5,907

 
5.1

 
7,122

 
5.1

Other venture capital and private equity fund investments
 
116,286

 
Various

 
43,134

 
Various

 Total venture capital and private equity fund investments
 
$
215,367

 


 
$
129,485

 
 
Debt funds:
 
 
 
 
 
 
 
 
Gold Hill Capital 2008, LP (ii)
 
$
5,525

 
15.5
%
 
$
3,901

 
15.5
%
Other debt funds
 
1,746

 
Various

 
1,925

 
Various

Total debt funds
 
$
7,271

 
 
 
$
5,826

 
 
Other investments:
 
 
 
 
 
 
 
 
SPD Silicon Valley Bank Co., Ltd.
 
$
74,190

 
50.0
%
 
$
76,412

 
50.0
%
Other investments
 
78,673

 
Various

 
45,309

 
Various

Total other investments
 
$
152,863

 
 
 
$
121,721

 
 
 

(i)
Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.
(ii)
Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

(6)
The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of "other liabilities" on our consolidated balance sheets at December 31, 2019 and 2018:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Investments in qualified affordable housing projects, net
 
$
458,476

 
$
318,575

Other liabilities
 
302,031

 
205,685


The following table presents other information relating to our investments in qualified affordable housing projects for the years ended December 31, 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Tax credits and other tax benefits recognized
 
$
35,037

 
$
24,047

 
$
17,296

Amortization expense included in provision for income taxes (i)
 
28,267

 
18,876

 
17,362

 
 
(i)
All investments are amortized using the proportional amortization method and amortization expense is included in the provision for income taxes. Included in amortization expense for the year ended December 31, 2017 is a one-time cumulative effect adjustment of $3.8 million due to the decrease in value of deductions in the 2018 tax year and going forward, due to the TCJ Act federal corporate income tax rate reduction.
The following table presents the net gains and losses on non-marketable and other equity securities in 2019, 2018 and 2017 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Net gains (losses) on non-marketable and other equity securities:
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Consolidated venture capital and private equity fund investments
 
$
22,507

 
$
20,999

 
$
27,186

Unconsolidated venture capital and private equity fund investments (1)
 
31,482

 
39,075

 
21,377

Other investments without a readily determinable fair value (1)
 
2,742

 
3,206

 
3,842

Other equity securities in public companies (fair value accounting) (1)
 
7,772

 
(25,483
)
 
241

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments
 
73,813

 
49,341

 
14,472

Debt funds
 
1,647

 
541

 
8,950

Other investments
 
(1,388
)
 
1,155

 
(6,276
)
Total net gains on non-marketable and other equity securities
 
$
138,575

 
$
88,834

 
$
69,792

Less: Realized net gains (losses) on the sales and OTTI of non-marketable and other equity securities (2)
 
4,744

 
(26,097
)
 
(355
)
Net gains on non-marketable and other equity securities still held
 
$
133,831

 
$
114,931

 
$
70,147

 
 
(1)
Presentation for year-ended December 31, 2017 amounts are not determined in a manner consistent with the December 31, 2018 and 2019 presentation due to the adoption of ASU 2016-01.
(2)
Realized gains and losses include sales and OTTI of non-marketable and other equity securities. Includes gains of $5.2 million on sales and $0.4 million of OTTI for the period ended December 31, 2019. Includes losses of $20.8 million and gains of $3.8 million on sales and $5.3 million and $4.2 million of OTTI for the periods ended December 31, 2018 and 2017, respectively.
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments
12 Months Ended
Dec. 31, 2019
Receivables [Abstract]  
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments
We serve a variety of commercial clients in the technology, life science/healthcare, private equity/venture capital and premium wine industries. Our technology clients generally tend to be in the industries of hardware (semiconductors, communications, data, storage and electronics), software/internet (such as infrastructure software, applications, software services, digital content and advertising technology), and energy and resource innovation ("ERI"). Because of the diverse nature of ERI products and services, for our loan-related reporting purposes, ERI-related loans are reported under our hardware, software/internet, life science/healthcare and other commercial loan categories, as applicable. Our life science/healthcare clients primarily tend to be in the industries of biotechnology, medical devices, healthcare information technology and healthcare services. Loans made to private equity/venture capital firm clients typically enable them to fund investments prior to their receipt of funds from capital calls. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality.
In addition to commercial loans, we make consumer loans through SVB Private Bank and provide real estate secured loans to eligible employees through our EHOP. Our private banking clients are primarily private equity/venture capital professionals and executive leaders in the innovation companies they support. These products and services include real estate secured home equity lines of credit, which may be used to finance real estate investments and loans used to purchase, renovate or refinance personal residences. These products and services also include restricted stock purchase loans and capital call lines of credit.
We also provide community development loans made as part of our responsibilities under the Community Reinvestment Act. These loans are included within “Construction loans” below and are primarily secured by real estate.
The composition of loans, net of unearned income of $163 million and $173 million at December 31, 2019 and 2018, respectively, is presented in the following table:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Commercial loans:
 
 
 
 
Software/internet
 
$
6,199,548

 
$
6,154,755

Hardware
 
1,371,159

 
1,234,557

Private equity/venture capital
 
17,801,324

 
14,110,560

Life science/healthcare
 
2,368,048

 
2,385,612

Premium wine
 
267,487

 
249,266

Other
 
420,555

 
321,978

Total commercial loans
 
28,428,121

 
24,456,728

Real estate secured loans:
 
 
 
 
Premium wine (1)
 
820,730

 
710,397

Consumer loans (2)
 
3,286,737

 
2,612,971

Other
 
38,880

 
40,435

Total real estate secured loans
 
4,146,347

 
3,363,803

Construction loans
 
100,219

 
97,077

Consumer loans
 
489,949

 
420,672

Total loans, net of unearned income (3)
 
$
33,164,636

 
$
28,338,280

 
(1)
Included in our premium wine portfolio are gross construction loans of $83 million and $99 million at December 31, 2019 and 2018, respectively.
(2)
Consumer loans secured by real estate at December 31, 2019 and 2018 were comprised of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loans for personal residence
 
$
2,829,880

 
$
2,251,292

Loans to eligible employees
 
401,396

 
290,194

Home equity lines of credit
 
55,461

 
71,485

Consumer loans secured by real estate
 
$
3,286,737

 
$
2,612,971


(3)
Included within our total loan portfolio are credit card loans of $395 million and $335 million at December 31, 2019 and 2018, respectively.
Credit Quality
The composition of loans, net of unearned income of $163 million and $173 million at December 31, 2019 and 2018, respectively, broken out by portfolio segment and class of financing receivable, is as follows:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Commercial loans:
 
 
 
 
Software/internet
 
$
6,199,548

 
$
6,154,755

Hardware
 
1,371,159

 
1,234,557

Private equity/venture capital
 
17,801,324

 
14,110,560

Life science/healthcare
 
2,368,048

 
2,385,612

Premium wine
 
1,088,217

 
959,663

Other
 
559,654

 
459,490

Total commercial loans
 
29,387,950

 
25,304,637

Consumer loans:
 
 
 
 
Real estate secured loans
 
3,286,737

 
2,612,971

Other consumer loans
 
489,949

 
420,672

Total consumer loans
 
3,776,686

 
3,033,643

Total loans, net of unearned income
 
$
33,164,636

 
$
28,338,280


The following table summarizes the aging of our gross loans, broken out by portfolio segment and class of financing receivable as of December 31, 2019 and 2018:
(Dollars in thousands)
 
30 - 59
  Days Past  
Due
 
60 - 89
  Days Past  
Due
 
Equal to or Greater Than 90 Days Past Due
 
  Total Past  
Due
 
Current  
 
  Loans Past Due 90 Days or More Still Accruing Interest
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
19,839

 
$
4,225

 
$

 
$
24,064

 
$
6,136,230

 
$

Hardware
 
104

 
18,084

 

 
18,188

 
1,357,379

 

Private equity/venture capital
 
97,893

 
383

 
3,150

 
101,426

 
17,715,964

 
3,150

Life science/healthcare
 
445

 
8,420

 

 
8,865

 
2,387,203

 

Premium wine
 
7,543

 

 

 
7,543

 
1,070,111

 

Other
 
9

 
24

 

 
33

 
579,446

 

Total commercial loans
 
125,833

 
31,136

 
3,150

 
160,119

 
29,246,333

 
3,150

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
6,282

 

 
365

 
6,647

 
3,271,318

 
365

Other consumer loans
 
164

 
283

 

 
447

 
489,831

 

Total consumer loans
 
6,446

 
283

 
365

 
7,094

 
3,761,149

 
365

Total gross loans excluding impaired loans
 
132,279

 
31,419

 
3,515

 
167,213

 
33,007,482

 
3,515

Impaired loans
 
5,096

 
6,805

 
12,473

 
24,374

 
128,635

 

Total gross loans
 
$
137,375

 
$
38,224

 
$
15,988

 
$
191,587

 
$
33,136,117

 
$
3,515

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
28,134

 
$
6,944

 
$
378

 
$
35,456

 
$
6,059,672

 
$
378

Hardware
 
300

 
34

 
4

 
338

 
1,233,956

 
4

Private equity/venture capital
 
59,481

 
11

 

 
59,492

 
14,054,940

 

Life science/healthcare
 
16,082

 
817

 
19

 
16,918

 
2,410,091

 
19

Premium wine
 
2,953

 
14

 

 
2,967

 
956,285

 

Other
 
7,391

 
163

 
1

 
7,555

 
477,442

 
1

Total commercial loans
 
114,341

 
7,983

 
402

 
122,726

 
25,192,386

 
402

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,598

 
1,750

 
1,562

 
6,910

 
2,598,496

 
1,562

Other consumer loans
 
361

 

 

 
361

 
420,359

 

Total consumer loans
 
3,959

 
1,750

 
1,562

 
7,271

 
3,018,855

 
1,562

Total gross loans excluding impaired loans
 
118,300

 
9,733

 
1,964

 
129,997

 
28,211,241

 
1,964

Impaired loans
 
2,843

 
1,181

 
25,092

 
29,116

 
140,958

 

Total gross loans
 
$
121,143

 
$
10,914

 
$
27,056

 
$
159,113

 
$
28,352,199

 
$
1,964






The following table summarizes our impaired loans as they relate to our allowance for loan losses, broken out by portfolio segment and class of financing receivable for the years ended December 31, 2019 and 2018:
(Dollars in thousands)
 
Impaired loans for 
which there is a related allowance for loan losses
 
Impaired loans for 
which there is no related allowance for loan losses
 
Total carrying value of impaired loans
 
Total unpaid principal of impaired loans   
December 31, 2019:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software/internet
 
$
64,100

 
$
31,472

 
$
95,572

 
$
109,736

Hardware
 
2,143

 
3,315

 
5,458

 
10,049

Private equity/venture capital
 

 

 

 

Life science/healthcare
 
25,941

 
5,671

 
31,612

 
70,600

Premium wine
 
204

 
11,718

 
11,922

 
12,010

Other
 
1,284

 
1,681

 
2,965

 
3,114

Total commercial loans
 
93,672

 
53,857

 
147,529

 
205,509

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
1,766

 
3,714

 
5,480

 
8,527

Total consumer loans
 
1,766

 
3,714

 
5,480

 
8,527

Total
 
$
95,438

 
$
57,571

 
$
153,009

 
$
214,036

December 31, 2018:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software/internet
 
$
49,625

 
$
65,225

 
$
114,850

 
$
131,858

Hardware
 
1,256

 
10,250

 
11,506

 
12,159

Private equity/venture capital
 

 
3,700

 
3,700

 
3,700

Life science/healthcare
 
17,791

 
16,276

 
34,067

 
44,446

Premium wine
 

 
1,301

 
1,301

 
1,365

Other
 
411

 

 
411

 
411

Total commercial loans
 
69,083

 
96,752

 
165,835

 
193,939

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,919

 
320

 
4,239

 
5,969

Total consumer loans
 
3,919

 
320

 
4,239

 
5,969

Total
 
$
73,002

 
$
97,072

 
$
170,074

 
$
199,908



The following table summarizes our average impaired loans and interest income recognized on impaired loans, broken out by portfolio segment and class of financing receivable during 2019, 2018 and 2017:
Year ended December 31,
(Dollars in thousands)
 
Average impaired loans
 
Interest income recognized on impaired loans
 
2019

2018

2017
 
2019
 
2018
 
2017
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
88,628

 
$
112,493

 
$
119,557

 
$
2,813

 
$
1,513

 
$
2,263

Hardware
 
12,500

 
28,540

 
35,022

 
464

 
312

 
1,061

Private equity/venture capital
 
2,264

 
1,327

 
556

 

 

 

Life science/healthcare
 
44,827

 
30,144

 
30,842

 
919

 
756

 
90

Premium wine
 
2,912

 
2,605

 
3,249

 
311

 
68

 
152

Other
 
2,050

 
171

 
576

 
21

 

 

Total commercial loans
 
153,181

 
175,280

 
189,802

 
4,528

 
2,649

 
3,566

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
7,159

 
4,028

 
1,514

 
54

 
15

 

Other consumer loans
 
7

 
358

 
1,804

 

 

 

Total consumer loans
 
7,166

 
4,386

 
3,318

 
54

 
15

 

Total average impaired loans
 
$
160,347

 
$
179,666

 
$
193,120

 
$
4,582

 
$
2,664

 
$
3,566


The following tables summarize the activity relating to our allowance for loan losses for 2019, 2018 and 2017 broken out by portfolio segment:
Year ended December 31, 2019
(Dollars in thousands)
 
Beginning Balance December 31, 2018
 
Charge-offs
 
Recoveries
 
Provision for Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2019
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
103,567

 
$
(46,930
)
 
$
11,363

 
$
31,766

 
$
457

 
$
100,223

Hardware
 
19,725

 
(10,056
)
 
7,069

 
2,740

 
166

 
19,644

Private equity/venture capital
 
98,581

 
(2,047
)
 
2,047

 
16,989

 
235

 
115,805

Life science/healthcare
 
32,180

 
(31,950
)
 
267

 
38,178

 
570

 
39,245

Premium wine
 
3,355

 
(174
)
 

 
1,813

 
154

 
5,148

Other
 
3,558

 
(415
)
 
36

 
328

 
(154
)
 
3,353

Total commercial loans
 
260,966

 
(91,572
)
 
20,782

 
91,814

 
1,428

 
283,418

Consumer loans
 
19,937

 
(1,031
)
 
256

 
2,369

 
(25
)
 
21,506

Total allowance for loan losses
 
$
280,903

 
$
(92,603
)
 
$
21,038

 
$
94,183

 
$
1,403

 
$
304,924

Year ended December 31, 2018
(Dollars in thousands)
 
Beginning Balance December 31, 2017
 
Charge-offs
 
Recoveries
 
Provision for (Reduction of) Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2018
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
96,104

 
$
(42,315
)
 
$
5,664

 
$
45,068

 
$
(954
)
 
$
103,567

Hardware
 
27,614

 
(16,148
)
 
1,849

 
6,555

 
(145
)
 
19,725

Private equity/venture capital
 
82,468

 
(112
)
 
13

 
16,485

 
(273
)
 
98,581

Life science/healthcare
 
24,924

 
(6,662
)
 
348

 
14,347

 
(777
)
 
32,180

Premium wine
 
3,532

 

 

 
(182
)
 
5

 
3,355

Other
 
3,941

 
(2,391
)
 
3,275

 
(1,320
)
 
53

 
3,558

Total commercial loans
 
238,583

 
(67,628
)
 
11,149

 
80,953

 
(2,091
)
 
260,966

Consumer loans
 
16,441

 
(289
)
 
487

 
3,339

 
(41
)
 
19,937

Total allowance for loan losses
 
$
255,024

 
$
(67,917
)
 
$
11,636

 
$
84,292

 
$
(2,132
)
 
$
280,903


    
Year ended December 31, 2017
(Dollars in thousands)
 
Beginning Balance December 31, 2016
 
Charge-offs
 
Recoveries
 
Provision for (Reduction of) Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2017
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
97,388

 
$
(45,012
)
 
$
4,649

 
$
38,462

 
$
617

 
$
96,104

Hardware
 
31,166

 
(10,414
)
 
487

 
6,051

 
324

 
27,614

Private equity/venture capital
 
50,299

 
(323
)
 

 
31,625

 
867

 
82,468

Life science/healthcare
 
25,446

 
(8,210
)
 
189

 
7,414

 
85

 
24,924

Premium wine
 
4,115

 

 

 
(540
)
 
(43
)
 
3,532

Other
 
4,768

 
(1,156
)
 
1,850

 
(1,459
)
 
(62
)
 
3,941

Total commercial loans
 
213,182

 
(65,115
)
 
7,175

 
81,553

 
1,788

 
238,583

Consumer loans
 
12,184

 
(1,567
)
 
1,363

 
4,386

 
75

 
16,441

Total allowance for loan losses
 
$
225,366

 
$
(66,682
)
 
$
8,538

 
$
85,939

 
$
1,863

 
$
255,024


The following table summarizes the activity relating to our allowance for unfunded credit commitments for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Allowance for unfunded credit commitments, beginning balance
 
$
55,183

 
$
51,770

 
$
45,265

Provision for unfunded credit commitments
 
12,233

 
3,578

 
6,365

Foreign currency translation adjustments
 
240

 
(165
)
 
140

Allowance for unfunded credit commitments, ending balance (1)
 
$
67,656

 
$
55,183

 
$
51,770

 
(1)
The “allowance for unfunded credit commitments” is included as a component of “other liabilities” on our consolidated balance sheets. See Note 22—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional disclosures related to our commitments to extend credit.
The following table summarizes the allowance for loan losses individually and collectively evaluated for impairment as of December 31, 2019 and 2018, broken out by portfolio segment:
 
 
December 31, 2019
 
December 31, 2018
 
 
Individually Evaluated for Impairment
 
Collectively Evaluated for  
Impairment
 
Individually Evaluated for Impairment
 
Collectively Evaluated for  
Impairment
(Dollars in thousands)
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
26,613

 
$
95,572

 
$
73,610

 
$
6,103,976

 
$
28,527

 
$
114,850

 
$
75,040

 
$
6,039,905

Hardware
 
1,214

 
5,458

 
18,430

 
1,365,701

 
1,253

 
11,506

 
18,472

 
1,223,051

Private equity/venture capital
 

 

 
115,805

 
17,801,324

 

 
3,700

 
98,581

 
14,106,860

Life science/healthcare
 
16,414

 
31,612

 
22,831

 
2,336,436

 
7,484

 
34,067

 
24,696

 
2,351,545

Premium wine
 
204

 
11,922

 
4,944

 
1,076,295

 

 
1,301

 
3,355

 
958,362

Other
 
203

 
2,965

 
3,150

 
556,689

 
411

 
411

 
3,147

 
459,079

Total commercial loans
 
44,648

 
147,529

 
238,770

 
29,240,421

 
37,675

 
165,835

 
223,291

 
25,138,802

Total consumer loans
 
211

 
5,480

 
21,295

 
3,771,206

 
266

 
4,239

 
19,671

 
3,029,404

Total
 
$
44,859

 
$
153,009

 
$
260,065

 
$
33,011,627

 
$
37,941

 
$
170,074

 
$
242,962

 
$
28,168,206


Credit Quality Indicators
For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass,” with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of “Performing (Criticized).” When full repayment of a criticized loan has been deemed improbable under the original contractual terms but full repayment remains probable overall, the loan is considered to be a “Performing Impaired (Criticized)” loan. All of our nonaccrual loans are risk-rated 8 or 9 and are classified under the nonperforming impaired category. (For a further description of nonaccrual loans, refer to Note 2—“Summary of Significant Accounting Policies” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report). Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators for performance and appropriateness of risk ratings as part of our evaluation process for our allowance for loan losses.

The following table summarizes the credit quality indicators, broken out by portfolio segment and class of financing receivables as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Pass
 
  Performing 
(Criticized)  
 
Performing Impaired (Criticized)
 
Nonperforming Impaired (Nonaccrual)
 
Total
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
5,704,283

 
$
456,011

 
$
28,417

 
$
67,155

 
$
6,255,866

Hardware
 
1,266,077

 
109,490

 
3,315

 
2,143

 
1,381,025

Private equity/venture capital
 
17,813,128

 
4,262

 

 

 
17,817,390

Life science/healthcare
 
2,197,679

 
198,389

 
5,211

 
26,401

 
2,427,680

Premium wine
 
1,053,021

 
24,633

 
11,717

 
205

 
1,089,576

Other
 
571,040

 
8,439

 
1,680

 
1,285

 
582,444

Total commercial loans
 
28,605,228

 
801,224

 
50,340


97,189

 
29,553,981

Consumer loans:
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,266,748

 
11,217

 

 
5,480

 
3,283,445

Other consumer loans
 
489,903

 
375

 

 

 
490,278

Total consumer loans
 
3,756,651

 
11,592

 

 
5,480

 
3,773,723

Total gross loans
 
$
32,361,879

 
$
812,816

 
$
50,340

 
$
102,669

 
$
33,327,704

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
5,574,332

 
$
520,796

 
$
48,069

 
$
66,781

 
$
6,209,978

Hardware
 
1,146,985

 
87,309

 
10,250

 
1,256

 
1,245,800

Private equity/venture capital
 
14,098,281

 
16,151

 

 
3,700

 
14,118,132

Life science/healthcare
 
2,291,356

 
135,653

 
16,276

 
17,791

 
2,461,076

Premium wine
 
909,965

 
49,287

 
1,017

 
284

 
960,553

Other
 
467,653

 
17,344

 

 
411

 
485,408

Total commercial loans
 
24,488,572

 
826,540

 
75,612

 
90,223

 
25,480,947

Consumer loans:
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
2,584,261

 
21,145

 
320

 
3,919

 
2,609,645

Other consumer loans
 
419,771

 
949

 

 

 
420,720

Total consumer loans
 
3,004,032

 
22,094

 
320

 
3,919

 
3,030,365

Total gross loans
 
$
27,492,604

 
$
848,634

 
$
75,932

 
$
94,142

 
$
28,511,312


Troubled Debt Restructurings
As of December 31, 2019 we had 23 TDRs with a total carrying value of $109.0 million where concessions have been granted to borrowers experiencing financial difficulties, in an attempt to maximize collection. This compares to 17 TDRs with a total carrying value of $83.7 million as of December 31, 2018. There were unfunded commitments available for funding of $0.8 million to the clients associated with these TDRs as of December 31, 2019. The following table summarizes our loans modified in TDRs, broken out by portfolio segment and class of financing receivables at December 31, 2019 and 2018:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loans modified in TDRs:
 
 
 
 
Commercial loans:
 
 
 
 
Software/internet
 
$
71,136

 
$
58,089

Hardware
 
1,685

 
9,665

Life science/healthcare
 
20,600

 
12,738

Premium wine
 
13,457

 
2,883

Total commercial loans
 
106,878

 
83,375

Consumer loans:
 
 
 
 
Other consumer loans
 
2,104

 
320

Total loans modified in TDRs
 
$
108,982

 
$
83,695


The following table summarizes the recorded investment in loans modified in TDRs, broken out by portfolio segment and class of financing receivable, for modifications made during 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Loans modified in TDRs during the period:
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
Software/internet
 
$
62,367

 
$
30,429

 
$
42,184

Hardware
 
1,685

 
9,665

 
51,132

Private equity/venture capital
 

 

 
350

Life science/healthcare
 
13,309

 
660

 

Premium wine
 
11,017

 

 
177

Total commercial loans
 
88,378

 
40,754

 
93,843

Consumer loans:
 
 
 
 
 
 
Other consumer loans
 
1,793

 
320

 

Total loans modified in TDRs during the period (1)
 
$
90,171

 
$
41,074

 
$
93,843

 
(1)
There were $11.3 million, $4.6 million and $3.0 million of partial charge-offs during 2019, 2018 and 2017, respectively.
During 2019, $86.9 million of new TDRs were modified through payment deferrals granted to our clients and $3.3 million were modified through partial forgiveness of principal. During 2018, all new TDRs of $41.1 million were modified through payment deferrals granted to our clients. During 2017, $93.5 million of new TDRs were modified through payment deferrals granted to our clients and $0.3 million were modified through partial forgiveness of principal.
The related allowance for loan losses for the majority of our TDRs is determined on an individual basis by comparing the carrying value of the loan to the present value of the estimated future cash flows, discounted at the pre-modification contractual interest rate. For certain TDRs, the related allowance for loan losses is determined based on the fair value of the collateral if the loan is collateral dependent.
The following table summarizes the recorded investment in loans modified in TDRs within the previous 12 months that subsequently defaulted during their respective periods, broken out by portfolio segment and class of financing receivable, during 2019, 2018 and 2017:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
TDRs modified within the previous 12 months that defaulted during the period:
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
Software/internet
 
$
37,294

 
$

 
$

Life science/healthcare
 
10,639

 

 

Total TDRs modified within the previous 12 months that defaulted in the period
 
$
47,933

 
$

 
$


Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the allowance for loan losses, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and impaired loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs we determined that no change to our reserving methodology for TDRs was necessary to determine the allowance for loan losses as of December 31, 2019.
v3.19.3.a.u2
Premises and Equipment
12 Months Ended
Dec. 31, 2019
Property, Plant and Equipment [Abstract]  
Premises and Equipment
Premises and Equipment
Premises and equipment at December 31, 2019 and 2018 consisted of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Computer software
 
$
261,643

 
$
217,017

Computer hardware
 
82,643

 
70,247

Leasehold improvements
 
121,907

 
98,237

Furniture and equipment
 
46,300

 
42,319

Total
 
512,493

 
427,820

Accumulated depreciation and amortization
 
(350,617
)
 
(298,607
)
Premises and equipment, net
 
$
161,876

 
$
129,213


Depreciation and amortization expense for premises and equipment was $42.0 million, $38.1 million and $38.0 million for the years ended 2019, 2018 and 2017, respectively.
v3.19.3.a.u2
Leases
12 Months Ended
Dec. 31, 2019
Leases [Abstract]  
Leases Leases

We have operating leases for our corporate offices, data centers and certain equipment utilized at those properties. We are obligated under a number of noncancelable operating leases for premises and equipment that expire at various dates, through 2030, and in most instances, include options to renew or extend at market rates and terms. Such leases may provide for periodic adjustments of rentals during the term of the lease based on changes in various economic indicators.
On January 1, 2019, we adopted the new lease standard ASC 842 and all the related amendments. There were no significant assumptions or judgments required upon applying the new lease standard. We have no leases that meet the definition of a finance lease under ASC 842 and our lessor accounting treatment for subleases is not material. The comparative information below has not been restated and continues to be reported under the accounting standards in effect for those periods.
Total recorded balances for the lease assets and liabilities are as follows:
(Dollars in thousands)
 
December 31, 2019

Assets:
 
 
Right-of-use assets - operating leases (1)
 
$
197,365

Liabilities:
 
 
Lease liabilities - operating leases (1)
 
218,847


 
(1)
Included in these amounts are $21.7 million and $30.0 million of ROU assets and lease liabilities, respectively, attributable to the inclusion of SVB Leerink in our financial results at December 31, 2019.
The components of our lease cost and supplemental cash flow information related to leases for the year ended December 31, 2019 were as follows:
 (Dollars in thousands)
 
2019
Operating lease cost
 
$
41,049

Short-term lease cost
 
1,823

Variable lease cost
 
3,477

Less: sublease income
 
(4,492
)
Total lease expense, net
 
$
41,857

Supplemental cash flows information:
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Cash paid for operating leases
 
$
44,976

Noncash items during the period:
 
 
Lease obligations in exchange for obtaining right-of-use assets:
 
 
Operating leases
 
$
33,167



The table below presents additional information related to the Company's leases as of December 31, 2019:
 
 
December 31, 2019
Weighted-average remaining term (in years) - operating leases
 
6.29

Weighted-average discount rate - operating leases (1)
 
2.92
%
 
(1)
The incremental borrowing rate used to calculate the lease liability was determined based on the facts and circumstances of the economic environment and the Company’s credit standing as of the effective date of ASC 842. Additionally, the total lease term and total lease payments were also considered in determining the rate. Based on these considerations the Company identified credit terms available under its existing credit lines which represent a collateralized borrowing rate that has varying credit terms that could be matched to total lease terms and total lease payments in ultimately determining the implied borrowing rate in each lease contract.

The following table presents our undiscounted future cash payments for our operating lease liabilities as of December 31, 2019:
Years ended December 31,
(Dollars in thousands)
 
Operating Leases
2020
 
$
44,791

2021
 
42,683

2022
 
37,669

2023
 
36,914

2024
 
26,602

2025 and thereafter
 
52,128

Total lease payments (1)
 
$
240,787

Less: imputed interest
 
(21,940
)
Total lease liabilities
 
$
218,847

 
(1)
As of December 31, 2019, we have additional leases that have not yet commenced. We estimate that we will record additional lease liabilities of $29.1 million upon commencement. These leases will commence in 2020 with lease terms of two to five years.
The following table presents minimum future payments under noncancelable operating leases under ASC 840 as of December 31, 2018:
(Dollars in thousands)
 
Amount
2019
 
$
38,609

2020
 
37,575

2021
 
35,854

2022
 
31,659

2023
 
30,904

2024 and thereafter
 
49,071

Total minimum future payments
 
$
223,672


Rent expense for premises and equipment leased under operating leases, under ASC 840 totaled $34.6 million and $31.3 million in 2018 and 2017, respectively.
v3.19.3.a.u2
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets

Goodwill
On January 4, 2019, we completed the acquisition of Leerink Holdings LLC, now SVB Leerink. We recognized identifiable intangible assets of $60.9 million and goodwill of $137.8 million as a result of the acquisition. For additional information, refer to Note 3—“Business Combination” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report. The goodwill of $137.8 million includes revenue generating synergies expected from collaboration between SVB Leerink and the Company.
The changes in goodwill were as follows for the year ended December 31, 2019:
(Dollars in thousands)
 
Goodwill
Beginning balance at December 31, 2018
 
$

Acquisitions (1)
 
137,823

Ending balance at December 31, 2019
 
$
137,823

 
(1)
All reported goodwill amounts have been allocated to the SVB Leerink reporting segment and are expected to be deductible for tax purposes. Refer to Note 25—“Segment Reporting” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional information.
During 2019, we completed our annual goodwill impairment test as of September 30, 2019. As a result, we determined there was no impairment as of December 31, 2019. For more information on our annual impairment policies, see Note 2—“Summary of Significant Accounting Policies” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.

Other Intangible Assets
The components of net other intangible assets related to the acquisition of SVB Leerink were as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Gross Amount
 
Accumulated Amortization
 
Net Carrying Amount
Other intangible assets:
 
 
 
 
 
 
Customer relationships
 
$
42,000

 
$
3,818

 
$
38,182

Other
 
18,900

 
7,665

 
11,235

Total other intangible assets
 
$
60,900

 
$
11,483

 
$
49,417



For the year ended December 31, 2019, we recorded amortization expense of $11.5 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of December 31, 2019:
Years ended December 31,
(Dollars in thousands)
 
Other
Intangible Assets
2020
 
$
5,382

2021
 
4,732

2022
 
4,732

2023
 
4,732

2024
 
4,732

2025 and thereafter
 
25,107

Total future amortization expense
 
$
49,417


v3.19.3.a.u2
Deposits
12 Months Ended
Dec. 31, 2019
Deposits [Abstract]  
Deposits
Deposits
The following table presents the composition of our deposits at December 31, 2019 and 2018:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Noninterest-bearing demand
 
$
40,841,570

 
$
39,103,422

Interest-bearing checking and savings accounts
 
568,256

 
648,468

Money market
 
17,749,736

 
7,498,205

Money market deposits in foreign offices
 
352,437

 
152,781

Sweep deposits in foreign offices
 
2,057,715

 
1,875,298

Time
 
188,093

 
50,726

Total deposits
 
$
61,757,807

 
$
49,328,900


The aggregate amount of time deposit accounts individually equal to or greater than $250,000 totaled $180 million and $42 million at December 31, 2019 and 2018, respectively. At December 31, 2019, time deposit accounts individually equal to or greater than $250,000 totaling $177 million were scheduled to mature within one year.
v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt
12 Months Ended
Dec. 31, 2019
Debt Disclosure [Abstract]  
Short-Term Borrowings and Long-Term Debt
Short-Term Borrowings and Long-Term Debt
The following table represents outstanding short-term borrowings and long-term debt at December 31, 2019 and 2018:
 
 
 
 
 
 
Carrying Value
(Dollars in thousands)
 
Maturity
 
Principal value at December 31, 2019
 
December 31,
2019
 
December 31,
2018
Short-term borrowings:
 
 
 
 
 
 
 
 
Short-term FHLB advances
 

 


 
$

 
$
300,000

Securities sold under agreement to repurchase
 
(1)
 

 

 
319,414

Other short-term borrowings
 
(2)
 
$
17,430

 
17,430

 
11,998

Total short-term borrowings
 
 
 
 
 
$
17,430

 
$
631,412

Long-term debt:
 
 
 
 
 
 
 
 
3.50% Senior Notes
 
January 29, 2025
 
$
350,000

 
$
347,987

 
$
347,639

5.375% Senior Notes
 

 


 

 
348,826

Total long-term debt
 
 
 
 
 
$
347,987

 
$
696,465

 
(1)
Securities sold under repurchase agreements are effectively short-term borrowings collateralized by U.S. Treasury securities.
(2)
Represents cash collateral received from certain counterparties in relation to market value exposures of derivative contracts in our favor.

The aggregate annual maturities of long-term debt obligations as of December 31, 2019 are as follows:
Year ended December 31,
(Dollars in thousands)
 
Amount
2020
 
$

2021
 

2022
 

2023
 

2024
 

2025 and thereafter
 
347,987

Total
 
$
347,987


Interest expense related to short-term borrowings and long-term debt was $35.1 million, $46.6 million and $36.1 million in 2019, 2018 and 2017, respectively. For the year ended December 31, 2017, interest expense is net of the hedge accounting impact from our interest rate swap agreements related to our 6.05% Subordinated Notes. The weighted average interest rate associated with our short-term borrowings was 2.62 percent as of December 31, 2018. There were no overnight short-term borrowings as of December 31, 2019.

3.50% Senior Notes
In January 2015, SVB Financial issued $350 million of 3.50% Senior Notes due in January 2025. We received net proceeds of approximately $346.4 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 3.50% Senior Notes at December 31, 2019 was $348.0 million, which is reflective of $1.8 million of debt issuance costs and a $0.2 million discount.
5.375% Senior Notes
In September 2010, SVB Financial issued $350 million of 5.375% Senior Notes due in September 2020. We received net proceeds of $345 million after deducting underwriting discounts and commissions and other expenses. We used approximately $250 million of the net proceeds from the sale of the notes to meet obligations due on our 3.875% Convertible Notes, which matured in April 2011. The remaining net proceeds were used for general corporate purposes, including working capital. On December 20, 2019, we redeemed in full the outstanding aggregate principle amount of our $350 million 5.375% Senior Notes due 2020 at a redemption price of $358.4 million. The amount paid in excess of the principal amount of the 5.375% Senior Notes represented a $9.0 million premium due to holders upon early redemption and was recorded as a loss in other noninterest income.
Short-term Borrowings
We have certain facilities in place to enable us to access short-term borrowings on a secured and unsecured basis. Our secured facilities include collateral pledged to the FHLB of San Francisco and the discount window at the FRB (using both fixed income securities and loans as collateral). Our unsecured facility consists of our uncommitted federal funds lines. As of December 31, 2019, collateral pledged to the FHLB of San Francisco was comprised primarily of fixed income investment securities and loans and had a carrying value of $4.7 billion, of which $4.3 billion was available to support additional borrowings. As of December 31, 2019, collateral pledged to the discount window at the FRB was comprised of fixed income investment securities and had a carrying value of $1.0 billion, all of which was unused and available to support additional borrowings. Our total unused and available borrowing capacity for our uncommitted federal funds lines totaled $1.9 billion at December 31, 2019. Our total unused and available borrowing capacity under our master repurchase agreements with various financial institutions totaled $3.3 billion at December 31, 2019.
v3.19.3.a.u2
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
We primarily use derivative financial instruments to manage interest rate risk, currency exchange rate risk and to assist customers with their risk management objectives, which may include currency exchange rate risks and interest rate risks. Also, in connection with negotiating credit facilities and certain other services, we often obtain equity warrant assets giving us the right to acquire stock in private, venture-backed companies in the technology and life science/healthcare industries.
Interest Rate Risk
Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our interest rate sensitive assets and liabilities and changes in market interest rates. To manage interest rate risk on our variable-interest rate loan portfolio, we enter into interest rate swap contracts to hedge against future changes in interest rates by using hedging instruments to lock in future cash inflows that would otherwise be impacted by movements in the market interest rates. We designate these interest rate swap contracts as cash flow hedges that qualify for hedge accounting under ASC 815, Derivatives and Hedging ("ASC 815"), and record them in other assets and other liabilities. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in accumulated other comprehensive income and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income.
We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective to ensure hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in accumulated other comprehensive income are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. As of December 31, 2019, no derivatives classified as hedges were terminated or were disqualified for hedge accounting. The maximum length of time over which the forecasted transactions are hedged is approximately five years.
Currency Exchange Risk
We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure risk associated with the net difference between foreign currency denominated assets and liabilities. We do not designate any foreign exchange forward contracts as derivative instruments that qualify for hedge accounting. Gains or losses from changes in currency rates on foreign currency denominated instruments are recorded in the line item "other" as part of noninterest income, a component of consolidated net income. We may experience ineffectiveness in the economic hedging relationship, because the instruments are revalued based upon changes in the currency’s spot rate on the principal value, while the forwards are revalued on a discounted cash flow basis. We record forward agreements in gain positions in other assets and loss positions in other liabilities, while net changes in fair value are recorded in the line item "other" as part of noninterest income, a component of consolidated net income.
Other Derivative Instruments
Also included in our derivative instruments are equity warrant assets and client forward and option contracts, and client interest rate contracts. For further description of these other derivative instruments, refer to Note 2—“Summary of Significant Accounting Policies” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
Counterparty Credit Risk
We are exposed to credit risk if counterparties to our derivative contracts do not perform as expected. We mitigate counterparty credit risk through credit approvals, limits, monitoring procedures and obtaining collateral, as appropriate. With respect to measuring counterparty credit risk for derivative instruments, we measure the fair value of a group of financial assets and financial liabilities on a net risk basis by counterparty portfolio.
The total notional or contractual amounts and fair value of our derivative financial instruments at December 31, 2019 and 2018 were as follows:
 
 
December 31, 2019
 
December 31, 2018
 
 
Notional or
Contractual
Amount
 
Fair Value
 
Notional or
Contractual
Amount
 
Fair Value
(Dollars in thousands)
 
 
Derivative Assets (1)
 
Derivative Liabilities (1)
 
 
Derivative Assets (1)
 
Derivative Liabilities (1)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 Interest rate risks:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
1,915,000

 
$
22,676

 
$

 
$

 
$

 
$

Interest rate swaps
 
3,085,000

 

 
25,623

 

 

 

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 Currency exchange risks:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
 

 

 

 
263,733

 
4,767

 

Foreign exchange forwards
 
300,250

 

 
2,154

 
178,310

 

 
1,094

 Other derivative instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets
 
225,893

 
165,473

 

 
223,532

 
149,238

 

Client foreign exchange forwards
 
4,661,517

 
114,546

 

 
2,759,878

 
93,876

 

Client foreign exchange forwards
 
4,326,059

 

 
94,745

 
2,568,085

 

 
85,706

Client foreign currency options
 
154,985

 
1,308

 

 
93,556

 
1,759

 

Client foreign currency options
 
154,985

 

 
1,308

 
93,579

 

 
1,759

Client interest rate derivatives (2)
 
1,275,190

 
28,811

 

 
1,020,416

 
8,499

 

Client interest rate derivatives (2)
 
1,372,914

 

 
14,154

 
1,337,328

 

 
9,491

Total Derivatives not designated as hedging instruments
 
 
 
310,138

 
112,361

 


 
258,139

 
98,050

Total derivatives
 
 
 
$
332,814

 
$
137,984

 
 
 
$
258,139

 
$
98,050

 
(1)
Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.
(2)
The amount reported reflects reductions of approximately $17.4 million of derivative liabilities and $0.4 million of derivative assets at December 31, 2019 and 2018, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.
A summary of our derivative activity and the related impact on our consolidated statements of income for 2019, 2018 and 2017 is as follows:
 
 
 
 
Year ended December 31,
(Dollars in thousands)
 
Statement of income location   
 
2019
 
2018
 
2017
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 Interest rate risks:
 
 
 
 
 
 
 
 
Amounts reclassified from accumulated other comprehensive income into income
 
Interest income—loans
 
$
(5,358
)
 
$

 
$

Net cash benefit associated with interest rate swaps
 
Interest expense—borrowings
 

 

 
1,053

Changes in fair value of interest rate swaps
 
Other noninterest income
 

 

 
(7
)
Net (losses) gains associated with interest rate risk derivatives
 
 
 
$
(5,358
)
 
$

 
$
1,046

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 Currency exchange risks:
 
 
 
 
 
 
 
 
Gains (losses) on revaluations of internal foreign currency instruments, net
 
Other noninterest income
 
$
1,444

 
$
(373
)
 
$
33,161

(Losses) gains on internal foreign exchange forward contracts, net
 
Other noninterest income
 
(1,853
)
 
52

 
(32,286
)
Net (losses) gains associated with internal currency risk
 
 
 
$
(409
)
 
$
(321
)
 
$
875

 Other derivative instruments:
 
 
 
 
 
 
 
 
(Losses) gains on revaluations of client foreign currency instruments, net
 
Other noninterest income
 
$
(15,146
)
 
$
4,998

 
$
10,882

Gains (losses) on client foreign exchange forward contracts, net
 
Other noninterest income
 
15,900

 
(4,011
)
 
(9,969
)
Net gains associated with client currency risk
 
 
 
$
754

 
$
987

 
$
913

Net gains on equity warrant assets
 
Gains on equity warrant assets, net
 
$
138,078

 
$
89,142

 
$
54,555

Net losses on other derivatives
 
Other noninterest income
 
$
(1,190
)
 
$
(179
)
 
$
(564
)



Balance Sheet Offsetting
Certain of our derivative and other financial instruments are subject to enforceable master netting arrangements with our counterparties. These agreements provide for the net settlement of multiple contracts with a single counterparty through a single payment, in a single currency, in the event of default on or termination of any one contract. The following table summarizes our assets subject to enforceable master netting arrangements as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Gross Amounts of Recognized Assets
 
Gross Amounts offset in the Statement of Financial Position
 
Net Amounts of Assets Presented in the Statement of Financial Position
 
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
 
Net Amount
 
 
 
 
Financial Instruments
 
Cash Collateral Received (1)
 
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
22,676

 
$

 
$
22,676

 
$
(22,598
)
 
$

 
$
78

Foreign exchange forwards
 
114,546

 

 
114,546

 
(36,855
)
 
(17,095
)
 
60,596

Foreign currency options
 
1,308

 

 
1,308

 
(848
)
 
(335
)
 
125

Client interest rate derivatives
 
28,811

 

 
28,811

 
(28,811
)
 

 

Total derivative assets:
 
167,341

 

 
167,341

 
(89,112
)
 
(17,430
)
 
60,799

Reverse repurchase, securities borrowing, and similar arrangements
 
289,340

 

 
289,340

 
(289,340
)
 

 

Total
 
$
456,681

 
$

 
$
456,681

 
$
(378,452
)
 
$
(17,430
)
 
$
60,799

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
 
$
98,643

 
$

 
$
98,643

 
$
(38,213
)
 
$
(11,825
)
 
$
48,605

Foreign currency options
 
1,759

 

 
1,759

 
(613
)
 
(90
)
 
1,056

Client interest rate derivatives
 
8,499

 

 
8,499

 
(8,416
)
 
(83
)
 

Total derivative assets:
 
108,901

 

 
108,901

 
(47,242
)
 
(11,998
)
 
49,661

Reverse repurchase, securities borrowing, and similar arrangements
 
123,611

 

 
123,611

 
(123,611
)
 

 

Total
 
$
232,512

 
$

 
$
232,512

 
$
(170,853
)
 
$
(11,998
)
 
$
49,661


 
(1)
Cash collateral received from our counterparties in relation to market value exposures of derivative contracts in our favor is recorded as a component of “short-term borrowings” on our consolidated balance sheets.
The following table summarizes our liabilities subject to enforceable master netting arrangements as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts offset in the Statement of Financial Position
 
Net Amounts of Liabilities Presented in the Statement of Financial Position
 
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
 
Net Amount
 
 
 
 
Financial Instruments
 
Cash Collateral Pledged (1)
 
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
   Interest rate swaps
 
$
25,623

 
$

 
$
25,623

 
$
(22,676
)
 
$
(2,947
)
 
$

   Foreign exchange forwards
 
96,899

 

 
96,899

 
(33,314
)
 
(22,030
)
 
41,555

   Foreign currency options
 
1,308

 

 
1,308

 
(531
)
 

 
777

   Client interest rate derivatives
 
14,154

 

 
14,154

 

 
(13,936
)
 
218

Total derivative liabilities:
 
137,984

 

 
137,984

 
(56,521
)
 
(38,913
)
 
42,550

Repurchase, securities lending, and similar arrangements
 

 

 

 

 

 

Total
 
$
137,984

 
$

 
$
137,984

 
$
(56,521
)
 
$
(38,913
)
 
$
42,550

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
   Foreign exchange forwards
 
$
86,800

 
$

 
$
86,800

 
$
(24,778
)
 
$
(20,732
)
 
$
41,290

   Foreign currency options
 
1,759

 

 
1,759

 
(1,054
)
 

 
705

   Client interest rate derivatives
 
9,491

 

 
9,491

 

 
(9,207
)
 
284

Total derivative liabilities:
 
98,050

 

 
98,050

 
(25,832
)
 
(29,939
)
 
42,279

Repurchase, securities lending, and similar arrangements
 
319,414

 

 
319,414

 

 

 
319,414

Total
 
$
417,464

 
$

 
$
417,464

 
$
(25,832
)
 
$
(29,939
)
 
$
361,693

 
(1)
Cash collateral pledged to our counterparties in relation to market value exposures of derivative contracts in a liability position and repurchase agreements are recorded as a component of “cash and cash equivalents" on our consolidated balance sheets.
v3.19.3.a.u2
Noninterest Income
12 Months Ended
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]  
Noninterest Income
Noninterest Income
On January 1, 2018, we adopted accounting standard ASU 2014-09, Revenue from Contracts with Customers and all the related amendments ("ASC 606" or "ASU 2014-09"). Results for the reporting periods ended December 31, 2019 and 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our previous accounting methodology under ASC 605. A summary of noninterest income for the years ended December 31, 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Noninterest income:
 
 
 
 
 
 
Gains on investment securities, net
 
$
134,670

 
$
88,094

 
$
64,603

Gains on equity warrant assets, net
 
138,078

 
89,142

 
54,555

Client investment fees
 
182,068

 
130,360

 
56,136

Foreign exchange fees
 
159,262

 
138,812

 
115,760

Credit card fees
 
118,719

 
94,072

 
76,543

Deposit service charges
 
89,200

 
76,097

 
58,715

Lending related fees
 
49,920

 
41,949

 
43,265

Letters of credit and standby letters of credit fees
 
42,669

 
34,600

 
28,544

Investment banking revenue
 
195,177

 

 

Commissions
 
56,346

 

 

Other
 
55,370

 
51,858

 
59,110

Total noninterest income
 
$
1,221,479

 
$
744,984

 
$
557,231


Gains on investment securities, net
Net gains on investment securities include both gains and losses from our non-marketable and other equity securities, gains and losses from sales of our AFS debt securities portfolio, when applicable, and carried interest.
Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, our China Joint Venture, debt funds, private and public portfolio companies, which include public equity securities held as a result of exercised equity warrant assets, and investments in qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains from non-marketable and other equity securities for any single period are typically driven by valuation changes.
The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (i.e., lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities, and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes.
Carried interest is comprised of preferential allocations of profits recognizable when the return on assets of our individual managed fund of funds and direct venture funds exceeds certain performance targets and is payable to us, as the general partners of the managed funds. The carried interest we earn is often shared with employees, who are also members of the general partner entities. We record carried interest on a quarterly basis by measuring fund performance to date versus the performance target.  For our unconsolidated managed funds, carried interest is recorded as gains on investment securities, net. For our consolidated managed funds, it is recorded as a component of net income attributable to noncontrolling interests. Carried interest allocated to others is recorded as a component of net income attributable to noncontrolling interests. Any carried interest paid to us (or our employees) may be subject to reversal to the extent fund performance declines to a level where inception to date carried interest is lower than actual payments made by the funds. The limited partnership agreements for our funds provide that carried interest is generally not paid to the general partners until the funds have provided a full return of contributed capital to the limited partners. Accrued, but unpaid carried interest may be subject to reversal to the extent that the fund performance declines to a level where inception-to-date carried interest is less than prior amounts recognized. Carried interest income is accounted for under an ownership model based on ASC 323 — Equity Method of Accounting and ASC 810 — Consolidation.
Our available-for-sale securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio
may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk.
Gains on investment securities are recognized outside of the scope of the new revenue standard as it explicitly excludes noninterest income earned from our investment-related activities. A summary of gains and losses on investment securities for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Gains on non-marketable and other equity securities, net
 
$
138,575

 
$
88,834

 
$
69,792

Losses on sales of available-for-sale debt securities, net
 
(3,905
)
 
(740
)
 
(5,189
)
Total gains on investment securities, net
 
$
134,670

 
$
88,094

 
$
64,603


Gains on equity warrant assets, net
In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income.
Gains on equity warrant assets are recognized outside of the scope of the new revenue standard as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of net gains on equity warrant assets for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Equity warrant assets:
 
 
 
 
 
 
Gains on exercises, net
 
$
107,168

 
$
58,186

 
$
48,275

Terminations
 
(3,502
)
 
(5,964
)
 
(4,422
)
Changes in fair value, net
 
34,412

 
36,920

 
10,702

Total net gains on equity warrant assets
 
$
138,078

 
$
89,142

 
$
54,555


Client investment fees
Client investment fees include fees earned from discretionary investment management services for substantially all clients, managing clients’ portfolios based on their investment policies, strategies and objectives and investment advisory fees. Revenue is recognized on a monthly basis upon completion of our performance obligation and consideration is typically received in the subsequent month. Included in our sweep money market fees are Rule 12(b)-1 fees, revenue sharing and customer transactional-based fees. Rule 12(b)-1 fees and revenue sharing are recognized as earned based on client funds that are invested in the period, typically monthly. Transactional based fees are earned and recognized on fixed income securities when the transaction is executed on the clients' behalf. Amounts paid to third-party service providers are predominantly expensed, such that client investment fees are recorded gross of payments made to third parties. A summary of client investment fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Client investment fees by type:
 
 
 
 
 
 
Sweep money market fees
 
$
104,236

 
$
75,654

 
$
28,485

Asset management fees (1)
 
28,665

 
23,882

 
16,831

Repurchase agreement fees
 
49,167

 
30,824

 
10,820

Total client investment fees (2)
 
$
182,068

 
$
130,360

 
$
56,136

 
(1)
Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.
(2)
Represents fees earned on client investment funds which are maintained at third-party financial institutions and are not recorded on our balance sheet.
Foreign exchange fees
Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients, primarily from spot contracts. Foreign exchange spot contract fees are recognized upon the completion of the single performance obligation, the execution of a spot trade in exchange for a fee. In line with customary business practice, the legal right transfers to the client upon execution of a foreign exchange contract on the trade date, and as such, we currently recognize our fees based on the trade date and are typically settled within two business days.
Forward contract and option premium fees are recognized outside of the scope of the new revenue standard as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of foreign exchange fee income by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Foreign exchange fees by instrument type:
 
 
 
 
 
 
Spot contract commissions
 
$
145,915

 
$
127,459

 
$
104,344

Forward contract commissions
 
13,068

 
10,940

 
10,934

Option premium fees
 
279

 
413

 
482

Total foreign exchange fees
 
$
159,262

 
$
138,812

 
$
115,760


Credit card fees
Credit card fees include interchange income from credit and debit cards and fees earned from processing transactions for merchants. Interchange income is earned after satisfying our performance obligation of providing nightly settlement services to a payment network. Costs related to rewards programs are recorded when the rewards are earned by the customer and presented as a reduction to interchange fee income. Rewards programs continue to be accounted for under ASC 310 - Receivables. Our performance obligations for merchant service fees are to transmit data and funds between the merchant and the payment network. Credit card interchange and merchant service fees are earned daily upon completion of transaction settlement services.
Annual card service fees are recognized on a straight-line basis over a 12-month period and continue to be accounted for under ASC 310 - Receivables. A summary of credit card fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Credit card fees by instrument type:
 
 
 
 
 
 
Card interchange fees, net
 
$
93,553

 
$
74,381

 
$
60,224

Merchant service fees
 
18,355

 
14,420

 
11,584

Card service fees
 
6,811

 
5,271

 
4,735

Total credit card fees
 
$
118,719

 
$
94,072

 
$
76,543


Deposit service charges
Deposit service charges include fees earned from performing cash management activities and other deposit account services. Deposit services include, but are not limited to, the following: receivables services, which include merchant services, remote capture, lockbox, electronic deposit capture, and fraud control services. Payment and cash management products and services include wire transfer and automated clearing house payment services to enable clients to transfer funds more quickly, as well as business bill pay, business credit and debit cards, account analysis, and disbursement services. Deposit service charges
are recognized over the period in which the related performance obligation is provided, generally on a monthly basis, and are presented in the "Disaggregation of Revenue from Contracts with Customers" table below.
Lending related fees
Unused commitment fees, minimum finance fees and unused line fees are recognized as earned on a monthly basis. Fees that qualify for syndication treatment are recognized at the completion of the syndicated loan deal for which the fees were received.
Lending related fees are recognized outside of the scope of the new revenue standard as it explicitly excludes noninterest income earned from our lending-related activities. A summary of lending related fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Lending related fees by instrument type:
 
 
 
 
 
 
Unused commitment fees
 
$
34,829

 
$
32,452

 
$
34,110

Other
 
15,091

 
9,497

 
9,155

Total lending related fees
 
$
49,920

 
$
41,949

 
$
43,265


Letters of credit and standby letters of credit fees
Commercial and standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Fees generated from letters of credit and standby letters of credit are deferred as a component of other liabilities and recognized in noninterest income over the commitment period using the straight-line method, based on the likelihood that the commitment being drawn down will be remote. Letters of credit and standby letters of credit fees are recognized outside of the scope of the new revenue standard as it explicitly excludes noninterest income earned from our lending related activities.
Investment banking revenue
We earn investment banking revenue from clients for providing services related to securities underwriting, private placements and advisory services on strategic matters such as mergers and acquisitions. Underwriting fees are attributable to public and private offerings of equity and debt securities and are recognized at the point in time when the offering has been deemed to be completed by the lead manager of the underwriting group. Once the offering is completed, the performance obligation has been satisfied; we recognize the applicable management fee as well the underwriting fee, net of consideration payable to customers. Private placement fees are recognized at the point in time when the private placement is completed, which is generally when the client accepts capital from the fund raise. Advisory fees from mergers and acquisitions engagements are generally recognized at the point in time when the related transaction is completed. Expenses are deferred only to the extent they are explicitly reimbursable by the client and the related revenue is recognized at a point in time. All other deal-related expenses are expensed as incurred. We have determined that we act as principal in the majority of these transactions and therefore presents expenses gross within other operating expenses.
A summary of investment banking revenue by instrument type for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Investment banking revenue:
 
 
 
 
 
 
Underwriting fees
 
$
153,306

 
$

 
$

Advisory fees
 
37,846

 

 

Private placements and other
 
4,025

 

 

Total investment banking revenue
 
$
195,177

 
$

 
$


Commissions
Commissions include commissions received from clients for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The execution of each trade order represents a distinct performance obligation and the transaction price is fixed at the point in time or trade order execution. Trade execution is satisfied at the point in time that the customer has control of the asset and as such, fees are recorded on a trade date basis. Commissions are presented in the "Disaggregation of revenue from contracts with customers" table below.
Other
Other noninterest income primarily includes income from fund management fees and service revenue. Fund management fees are comprised of fees charged directly to our managed funds of funds and direct venture funds. Fund management fees are based upon the contractual terms of the limited partnership agreements and are generally recognized as earned over the specified contract period, which is generally equal to the life of the individual fund. Fund management fees are calculated as a percentage of committed capital and collected in advance and are received quarterly. Fund management fees for certain of our limited partnership agreements are calculated as a percentage of distributions made by the funds and revenue is recorded only at the time of a distribution event. As distribution events are not predetermined for these certain funds, management fees are considered variable and constrained under the new revenue standard.
Other service revenue primarily consists of dividend income on FHLB/FRB stock, correspondent bank rebate income, incentive fees related to carried interest, gains or losses on early debt redemption and other fee income. We recognize revenue when our performance obligations are met and record revenues on a daily/monthly basis, quarterly, semi-annually or annual basis. For event driven revenue sources, we recognize revenue when: (i) persuasive evidence of an arrangement exists, (ii) we have performed the service, provided we have no other remaining obligations to the customer, (iii) the fee is fixed or determinable and (iv) collectability is probable.
A summary of other noninterest income by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Other noninterest income by instrument type:
 
 
 
 
 
 
Fund management fees
 
$
32,522

 
$
23,016

 
$
21,214

Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)
 
345

 
666

 
1,788

(Losses) gains on extinguishment of debt
 
(8,960
)
 

 
2,731

Other service revenue
 
31,463

 
28,176

 
33,377

Total other noninterest income
 
$
55,370

 
$
51,858

 
$
59,110


 

(1)
Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.

Disaggregation of Revenue from Contracts with Customers
The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the years ended December 31, 2019 and 2018:

(Dollars in thousands)
 
Global
Commercial
Bank (2)
 
SVB Private  
Bank
 
SVB Capital (2)
 
SVB Leerink (2)
 
Other Income
 
Total      
Revenue from contracts with customers:
 
 
 
 
 
 
 
 
 
 
 
 
Client investment fees
 
$
180,152

 
$
1,916

 
$

 
$

 
$

 
$
182,068

Spot contract commissions
 
144,930

 
510

 

 

 
475

 
145,915

Card interchange fees, gross
 
154,197

 

 

 

 
756

 
154,953

Merchant service fees
 
18,355

 

 

 

 

 
18,355

Deposit service charges
 
88,136

 
137

 

 

 
927

 
89,200

Investment banking revenue
 

 

 

 
195,177

 

 
195,177

Commissions
 

 

 

 
56,346

 

 
56,346

Fund management fees
 

 

 
26,850

 
5,672

 

 
32,522

Correspondent bank rebates
 
6,415

 

 

 

 

 
6,415

Total revenue from contracts with customers
 
$
592,185

 
$
2,563

 
$
26,850

 
$
257,195

 
$
2,158

 
$
880,951

Revenues outside the scope of ASC 606 (1)
 
45,737

 
803

 
95,544

 
7,321

 
191,123

 
340,528

Total noninterest income
 
$
637,922

 
$
3,366

 
$
122,394

 
$
264,516

 
$
193,281

 
$
1,221,479

 
(1)
Amounts are accounted for under separate guidance than ASC 606.
(2)
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

(Dollars in thousands)
 
Global
Commercial
Bank (2)
 
SVB Private  
Bank
 
SVB Capital (2)
 
Other Income
 
Total      
Revenue from contracts with customers:
 
 
 
 
 
 
 
 
 
 
Client investment fees (3)
 
$
128,834

 
$
1,526

 
$

 
$

 
$
130,360

Spot contract commissions
 
126,445

 
691

 

 
323

 
127,459

Card interchange fees, gross
 
134,074

 

 

 
428

 
134,502

Merchant service fees
 
14,415

 
4

 

 
1

 
14,420

Deposit service charges
 
74,348

 
108

 

 
1,641

 
76,097

Fund management fees
 

 

 
23,016

 

 
23,016

Correspondent bank rebates
 
5,802

 

 

 

 
5,802

Total revenue from contracts with customers
 
$
483,918

 
$
2,329

 
$
23,016

 
$
2,393

 
$
511,656

Revenues outside the scope of ASC 606 (1)
 
36,384

 
(48
)
 
78,165

 
118,827

 
233,328

Total noninterest income
 
$
520,302

 
$
2,281

 
$
101,181

 
$
121,220

 
$
744,984

 
(1)
Amounts are accounted for under separate guidance than ASC 606.
(2)
Global Commercial Bank’s and SVB Capital’s components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."
(3)
For the year ended December 31, 2018, the amount of client investment fees previously reported as "Other Items" has been correctly allocated to the reportable segment "Global Commercial Bank" to properly reflect the source of such revenue. The correction of this immaterial error had no impact on the "Total" amount of client investment fees.
v3.19.3.a.u2
Other Noninterest Expense
12 Months Ended
Dec. 31, 2019
Other Income and Expenses [Abstract]  
Other Noninterest Expense Other Noninterest Expense
A summary of other noninterest expense for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Lending and other client related processing costs
 
$
28,491

 
$
24,237

 
$
23,768

Correspondent bank fees
 
14,503

 
13,713

 
12,976

Investment banking activities
 
13,733

 

 

Trade order execution costs
 
10,813

 

 

Data processing services
 
12,536

 
10,811

 
10,251

Telephone
 
9,861

 
9,404

 
10,647

Dues and publications
 
4,603

 
4,605

 
3,263

Postage and supplies
 
3,198

 
2,799

 
2,797

Other
 
54,841

 
21,682

 
21,419

Total other noninterest expense
 
$
152,579

 
$
87,251

 
$
85,121


v3.19.3.a.u2
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
We are subject to income tax in the U.S. federal jurisdiction and various state and foreign jurisdictions. The components of our provision for income taxes for 2019, 2018 and 2017 were as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Current provision:
 
 
 
 
 
 
Federal
 
$
296,400

 
$
249,358

 
$
263,231

State
 
132,357

 
123,264

 
67,046

Deferred (benefit) expense:
 
 
 
 
 
 
Federal
 
(1,530
)
 
(11,777
)
 
24,654

State
 
(1,542
)
 
(9,284
)
 
532

Income tax expense
 
$
425,685

 
$
351,561

 
$
355,463


Our effective tax rate is calculated by dividing income tax expense by the sum of income before income tax expense and the net income attributable to noncontrolling interests. The reconciliation between the federal statutory income tax rate and our effective income tax rate for 2019, 2018 and 2017, is as follows:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Federal statutory income tax rate
 
21.0
 %
 
21.0
 %
 
35.0
 %
State income taxes, net of the federal tax effect
 
7.0

 
7.2

 
5.8

Net deferred tax assets revaluation (TCJ Act)
 

 

 
4.3

Meals and entertainment
 
0.4

 
0.3

 
0.3

Disallowed officers' compensation
 
0.2

 
0.2

 
0.1

FDIC premiums
 
0.2

 
0.5

 

Share-based compensation expense on incentive stock options and ESPP
 
(0.6
)
 
(1.4
)
 
(2.1
)
Qualified affordable housing project tax credits
 
(0.3
)
 
(0.3
)
 
(0.4
)
Tax-exempt interest income
 
(0.6
)
 
(0.6
)
 
(0.3
)
Other, net
 
(0.1
)
 
(0.4
)
 
(0.7
)
Effective income tax rate
 
27.2
 %
 
26.5
 %
 
42.0
 %

Deferred tax assets and liabilities at December 31, 2019 and 2018, consisted of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Deferred tax assets:
 
 
 
 
Allowance for loan losses
 
$
103,267

 
$
93,580

Net unrealized losses on AFS debt securities
 

 
19,704

Share-based compensation expense
 
14,233

 
10,642

State income taxes
 
16,097

 
13,854

Accrued compensation
 
22,578

 
8,291

Deferred rent
 

 
7,940

Lease liability
 
60,635

 

Other accruals
 
12,383

 
7,061

Net operating loss
 
6,386

 
2,447

Goodwill and intangibles
 
3,141

 

Other
 
7,923

 
11,339

Deferred tax assets
 
246,643

 
174,858

Valuation allowance
 
(5,919
)
 
(2,107
)
Net deferred tax assets after valuation allowance
 
240,724

 
172,751

 
 
 
 
 
Deferred tax liabilities:
 
 
 
 
Derivative equity warrant assets
 
(45,533
)
 
(32,861
)
Change in accounting method (section 481(a))
 
(1,841
)
 
(8,034
)
Net unrealized gains on AFS debt securities
 
(33,480
)
 

Non-marketable and other equity securities
 
(54,239
)
 
(45,759
)
Premises and equipment and other intangibles
 
(16,459
)
 
(10,284
)
Right-of-use asset and deferred rent assets
 
(50,493
)
 

Other
 
(10,246
)
 
(10,380
)
Deferred tax liabilities
 
(212,291
)
 
(107,318
)
Net deferred tax assets
 
$
28,433

 
$
65,433


Net Deferred Tax Assets
U.S. federal net operating loss carryforwards totaled $2.2 million for both December 31, 2019 and 2018. Our foreign net operating loss carryforwards totaled $20.8 million and $7.6 million at December 31, 2019 and 2018, respectively. These net operating loss carryforwards expire at various dates beginning in 2022.
Currently, we believe that it is more likely than not that the benefit from the foreign net operating loss carryforwards, which are associated with our Germany and Canada operations, will not be realized in the near term due to uncertainties in the timing of future profitability in the course of business. In recognition of this, our valuation allowance is $5.9 million on the deferred tax assets related to our German and Canadian net operating loss carryforwards as of December 31, 2019. We believe it is more likely than not that the remaining deferred tax assets will be realized through recovery of taxes previously paid and/or future taxable income. Therefore, no valuation allowance was provided for the remaining deferred tax assets.
We are subject to income tax in the U.S. federal jurisdiction and various state and foreign jurisdictions and have identified our federal and California tax returns as major tax filings. Our U.S. federal tax returns for 2016 and subsequent years remain open to full examination. Our California tax returns for 2015 and subsequent tax years remain open to full examination.
At December 31, 2019, our unrecognized tax benefit was $12.6 million, the recognition of which would reduce our income tax expense by $9.9 million. We do not expect that our unrecognized tax benefit will materially change in the next 12 months.
We recognize interest and penalties related to income tax matters as part of income before income taxes. Interest and penalties were not material for the years ended December 31, 2019, 2018 and 2017.
A summary of changes in our unrecognized tax benefit (including interest and penalties) for December 31, 2019, 2018 and 2017 is as follows:
(Dollars in thousands)
 
Reconciliation of Unrecognized Tax Benefit
 
Interest and Penalties
 
Total
Balance at December 31, 2016
 
$
5,269

 
$
442

 
$
5,711

Additions for tax positions for current year
 
3,141

 

 
3,141

Additions for tax positions for prior years
 
3,378

 
754

 
4,132

Reduction for tax positions for prior years
 
(223
)
 
(1
)
 
(224
)
Lapse of the applicable statute of limitations
 
(60
)
 
(17
)
 
(77
)
Balance at December 31, 2017
 
$
11,505

 
$
1,178

 
$
12,683

Additions for tax positions for current year
 
4,171

 

 
4,171

Additions for tax positions for prior years
 
631

 
823

 
1,454

Reduction for tax positions for prior years
 
(1,865
)
 
(243
)
 
(2,108
)
Lapse of the applicable statute of limitations
 
(435
)
 
(86
)
 
(521
)
Reduction as a result of settlement
 
(1,318
)
 
(222
)
 
(1,540
)
Balance at December 31, 2018
 
$
12,689

 
$
1,450

 
$
14,139

Additions for tax positions for current year
 
3,712

 

 
3,712

Additions for tax positions for prior years
 
63

 
826

 
889

Reduction for tax positions for prior years
 
(884
)
 
(524
)
 
(1,408
)
Lapse of the applicable statute of limitations
 
(1,826
)
 
(569
)
 
(2,395
)
Reduction as a result of settlement
 
(1,142
)
 
$
(17
)
 
$
(1,159
)
Balance at December 31, 2019
 
$
12,612

 
$
1,166

 
$
13,778


v3.19.3.a.u2
Employee Compensation and Benefit Plans
12 Months Ended
Dec. 31, 2019
Retirement Benefits [Abstract]  
Employee Compensation and Benefit Plans
Employee Compensation and Benefit Plans
Our employee compensation and benefit plans include: (i) Incentive Compensation Plan; (ii) Direct Drive Incentive Compensation Plan; (iii) Retention Program; (iv) Warrant Incentive Plan; (v) Deferred Compensation Plan; (vi) 401(k) and ESOP; (vii) SVB Leerink Incentive Compensation Plan; (viii) SVB Leerink Retention Award; (ix) EHOP; (x) 2006 Incentive Plan; and (xi) ESPP.
The 2006 Incentive Plan and the ESPP are described in Note 5—“Share-Based Compensation” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
A summary of expenses incurred under certain employee compensation and benefit plans for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Incentive Compensation Plan
 
$
143,888

 
$
160,293

 
$
125,584

Direct Drive Incentive Compensation Plan
 
37,315

 
40,578

 
18,721

Retention Program
 
2,438

 
1,438

 
1,317

Warrant Incentive Plan
 
14,881

 
9,112

 
15,386

Deferred Compensation Plan
 

 

 
203

SVBFG 401(k) Plan
 
25,687

 
21,323

 
17,860

SVBFG ESOP
 
4,197

 
6,435

 
4,719

SVB Leerink Incentive Compensation Plan
 
106,871

 

 

SVB Leerink Retention Award
 
12,015

 

 


Incentive Compensation Plan
Our Incentive Compensation Plan (“ICP”) is an annual cash incentive plan that rewards performance based on our financial results and other performance criteria. Awards are made based on company performance, the employee's target bonus level and management's assessment of individual employee performance.
Direct Drive Incentive Compensation Plan
The Direct Drive Incentive Compensation Plan (“Direct Drive”) is an annual sales cash incentive program. Awards are based on sales teams' performance as to predetermined financial targets and other company/individual performance criteria. Actual awards for each sales team member under Direct Drive are based on: (i) the actual results and financial performance with respect to the incentive gross profit targets; (ii) the sales team payout targets; and (iii) the sales team member's sales position and team payout allocation.
Retention Program
The Retention Program (“RP”) is a long-term incentive plan that allows designated employees to share directly in our investment success. Plan participants were granted an interest in the distributions of gains from certain designated investments made by us during the applicable year. Specifically, participants share in: (i) returns from designated investments made by us, including investments in certain venture capital and private equity funds, debt funds and direct equity investments in companies; (ii) net income realized from the exercise of, and the subsequent sale of shares obtained through the exercise of, warrants held by us; and (iii) other designated amounts as determined by us. Since 2009, no new participants have been added and no new investments have been designated to the plan.
Warrant Incentive Plan
The Warrant Incentive Plan provides individual and team awards to those employees who negotiate warrants on our behalf. Designated participants, as determined by the Company, share in the cash proceeds received by the Company from the exercise of equity warrant assets.
Deferred Compensation Plan
Under the Deferred Compensation Plan (the “DC Plan”), eligible employees may elect to defer up to 50 percent of their base salary and/or up to 100 percent of any eligible bonus payment earned during the plan year. Any amounts deferred under the DC Plan will be invested and administered by us (or such person we designate). We generally do not match employee deferrals to the DC Plan. From time to time, we may also offer deferred special retention incentives and employer contributions under
this plan to key plan participants. The deferred incentives and employer contributions are eligible for investment in the DC Plan during the retention qualifying period or vesting period.
Voluntary deferrals under the DC Plan were $6.9 million in 2019 and $5.5 million in both 2018 and 2017. The DC Plan overall, had investment gains of $6.9 million, losses of $1.7 million and gains of $4.7 million in 2019, 2018 and 2017, respectively.
401(k) and ESOP
The 401(k) Plan and ESOP, collectively referred to as the “Plan”, is a combined 401(k) tax-deferred savings plan and employee stock ownership plan in which all regular U.S. employees are eligible to participate.
Employees participating in the 401(k) Plan are allowed to contribute up to 75 percent of their pre-tax pay as defined in the Plan, up to the maximum annual amount allowable under federal income tax regulations of $19,000 for 2019, $18,500 for 2018 and $18,000 for 2017. We match the employee's contributions dollar-for-dollar, up to five percent of the employee's pre-tax pay as defined in the Plan. Our matching contributions vest immediately. The amount of salary deferred, up to the allowed maximum, is not subject to federal or state income taxes at the time of deferral.
Discretionary ESOP contributions, based on our company performance, are made by us to all eligible individuals employed by us on the last day of the fiscal year. We may elect to contribute cash or our common stock (or a combination of cash and stock), in an amount not exceeding ten percent of the employee's eligible pay earned in the fiscal year. The ESOP contributions vest in equal annual increments over a participant's first five years of service (thereafter, all subsequent ESOP contributions are fully vested).
SVB Leerink Incentive Compensation Plan
Our SVB Leerink Incentive Compensation Plan is an annual cash incentive plan that rewards performance of SVB Leerink employees based on SVB Leerink's financial results. This plan requires employees who exceed certain compensation levels to defer a portion of their compensation, of which, 25% will be settled in the form of restricted stock awards and 75% will be settled in the form of cash. The deferred compensation vests over a period of up to five years.
SVB Leerink Retention Award
The SVB Leerink Retention Award is an incentive award that granted designated SVB Leerink employees restricted stock awards and cash after the close of the acquisition of SVB Leerink in January 2019. The aggregate amount of the awards was $60 million, of which 50% will be settled in the form of cash and 50% in the form of restricted stock awards. The awards vest in equal annual increments over five years.
EHOP Program
The EHOP is a benefit plan that provides for the issuance of mortgage loans at discounted interest rates to eligible employees. Eligible employees may apply for either an adjustable rate mortgage (ARM) or a fixed rate loan for their primary residence. The ARM is a 30 year loan and has an initial fixed interest rate for five, seven or ten years after which a floating rate will be set annually. The fixed rate loan program offers a 15 or 30 years loan and the interest rate is fixed for the life of the loan. Applicants must qualify for a loan through the normal mortgage review and approval process, which is typical of industry standards. The maximum loan amount generally cannot be greater than 85 percent of the lesser of the purchase price or the appraised value. The interest rate on the fixed-rate loan is written at a discount to SVB Private Bank client mortgage rates and determined at SVB's discretion. Floating rates applied at the end of the fixed-rate period will be reset annually at 12 month LIBOR plus two and one quarter percent. For additional details, see Note 10—“Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
v3.19.3.a.u2
Related Parties
12 Months Ended
Dec. 31, 2019
Related Party Transactions [Abstract]  
Related Parties
Related Parties
We have no material related party transactions requiring disclosure. In the ordinary course of business, the Bank may extend credit to related parties, including executive officers, directors, principal shareholders and their related interests. Additionally, we also provide real estate secured loans to eligible employees through our EHOP. For additional details, see Note 20—“Employee Compensation and Benefit Plans” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our customers. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. These instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract.
Commitments to Extend Credit
A commitment to extend credit is a formal agreement to lend funds to a client as long as there is no violation of any condition established in the agreement. Such commitments generally have fixed expiration dates, or other termination clauses, and usually require a fee paid by the client upon us issuing the commitment. The following table summarizes information related to our commitments to extend credit at December 31, 2019 and 2018, respectively:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loan commitments available for funding: (1)
 
 
 
 
Fixed interest rate commitments
 
$
2,434,042

 
$
1,839,190

Variable interest rate commitments
 
19,309,317

 
14,821,815

Total loan commitments available for funding
 
21,743,359

 
16,661,005

Commercial and standby letters of credit (2)
 
2,778,561

 
2,252,016

Total unfunded credit commitments
 
$
24,521,920

 
$
18,913,021

Commitments unavailable for funding (3)
 
$
3,051,075

 
$
2,723,835

Allowance for unfunded credit commitments (4)
 
67,656

 
55,183

 
(1)
Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.
(2)
See below for additional information on our commercial and standby letters of credit.
(3)
Represents commitments which are currently unavailable for funding due to clients failing to meet all collateral, compliance and financial covenants under loan commitment agreements.
(4)
Our allowance for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
Our potential exposure to credit loss for commitments to extend credit, in the event of nonperformance by the other party to the financial instrument, is the contractual amount of the available unused loan commitment. We use the same credit approval and monitoring process in extending credit commitments as we do in making loans. The actual liquidity needs and the credit risk that we have experienced have historically been lower than the contractual amount of commitments to extend credit because a significant portion of these commitments expire without being drawn upon. We evaluate each potential borrower and the necessary collateral on an individual basis. The type of collateral varies, but may include real property, intellectual property, bank deposits or business and personal assets. The credit risk associated with these commitments is considered in the allowance for unfunded credit commitments.
Commercial and Standby Letters of Credit
Commercial and standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature. We provide two types of standby letters of credit: performance and financial standby letters of credit. Performance standby letters of credit are issued to guarantee the performance of a client to a third party when certain specified future events have occurred and are primarily used to support performance instruments such as bid bonds, performance bonds, lease obligations, repayment of loans and past due notices. Financial standby letters of credit are conditional commitments issued by us to guarantee the payment by a client to a third party (beneficiary) and are primarily used to support many types of domestic and international payments. These standby letters of credit have fixed expiration dates and generally require a fee to be paid by the client at the time we issue the commitment.
The credit risk involved in issuing letters of credit is essentially the same as that involved with extending credit commitments to clients, and accordingly, we use a credit evaluation process and collateral requirements similar to those for credit commitments. Our standby letters of credit often are cash secured by our clients. The actual liquidity needs and the credit risk that we have experienced historically have been lower than the contractual amount of letters of credit issued because a significant portion of these conditional commitments expire without being drawn upon.
The table below summarizes our commercial and standby letters of credit at December 31, 2019. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged.
(Dollars in thousands)
 
Expires In One Year or Less
 
Expires After One Year
 
Total Amount Outstanding
 
Maximum Amount of Future Payments
Financial standby letters of credit
 
$
2,566,623

 
$
79,207

 
$
2,645,830

 
$
2,645,830

Performance standby letters of credit
 
105,993

 
19,618

 
125,611

 
125,611

Commercial letters of credit
 
7,120

 

 
7,120

 
7,120

Total
 
$
2,679,736

 
$
98,825

 
$
2,778,561

 
$
2,778,561


Deferred fees related to financial and performance standby letters of credit were $17.2 million at December 31, 2019 and $14.1 million at December 31, 2018. At December 31, 2019, collateral in the form of cash of $1.6 billion was available to us to reimburse losses, if any, under financial and performance standby letters of credit.
Commitments to Invest in Venture Capital and Private Equity Funds
We make commitments to invest in venture capital and private equity funds, which generally makes investments in privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to call most of the capital commitments over 5 to 7 years, and in certain cases, the funds may not call 100% of committed capital. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions, and the nature and type of industry in which the privately held companies operate. The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at December 31, 2019:

(Dollars in thousands)
 
SVBFG Capital Commitments    
 
SVBFG Unfunded 
Commitments
 
SVBFG Ownership 
of each Fund (3)
CP I, LP
 
$
6,000

 
$
270

 
10.7
%
CP II, LP (1)
 
1,200

 
162

 
5.1

Capital Preferred Return Fund, LP
 
12,688

 

 
20.0

Growth Partners, LP
 
24,670

 
1,340

 
33.0

Strategic Investors Fund, LP
 
15,300

 
688

 
12.6

Strategic Investors Fund II, LP
 
15,000

 
1,050

 
8.6

Strategic Investors Fund III, LP
 
15,000

 
1,275

 
5.9

Strategic Investors Fund IV, LP
 
12,239

 
2,325

 
5.0

Strategic Investors Fund V funds
 
515

 
131

 
Various

Other venture capital and private equity fund investments (equity method accounting)
 
21,801

 
5,732

 
Various

Debt funds (equity method accounting)
 
58,493

 

 
Various

Other fund investments (2)
 
284,758

 
6,119

 
Various

Total
 
$
467,664

 
$
19,092

 
 
 
(1)
Our ownership includes direct ownership of 1.3 percent and indirect ownership of 3.8 percent through our investment in Strategic Investors Fund II, LP.
(2)
Represents commitments to 211 funds (primarily venture capital funds) where our ownership interest is generally less than five percent of the voting interests of each such fund.
(3)
We are subject to the Volcker Rule which restricts or limits us from sponsoring or having ownership interests in “covered” funds including venture capital and private equity funds. See “Business - Supervision and Regulation” under Part I, Item 1 of this report.

The following table details the amounts of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the noncontrolling interests) at December 31, 2019:

(Dollars in thousands)
 
Unfunded Commitments    
Strategic Investors Fund, LP
 
$
1,338

Capital Preferred Return Fund, LP
 
1,540

Growth Partners, LP
 
2,468

Total
 
$
5,346


v3.19.3.a.u2
Fair Value of Financial Instruments
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Fair Value Measurements
Our available-for-sale securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements. We disclose our method and approach for fair value measurements of assets and liabilities in Note 2—“Summary of Significant Accounting Policies” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2019:
(Dollars in thousands)
 

Level 1
 

Level 2
 

Level 3
 
Balance at December 31, 2019
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
6,894,010

 
$

 
$

 
$
6,894,010

U.S. agency debentures
 

 
99,547

 

 
99,547

Foreign government debt securities
 
9,038

 

 

 
9,038

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 

 
4,148,791

 

 
4,148,791

Agency-issued collateralized mortgage obligations— fixed rate
 

 
1,538,343

 

 
1,538,343

Agency-issued commercial mortgage-backed securities
 

 
1,325,190

 

 
1,325,190

Total available-for-sale securities
 
6,903,048

 
7,111,871

 

 
14,014,919

Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
Non-marketable securities:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments measured at net asset value
 

 

 

 
265,263

Venture capital and private equity fund investments not measured at net asset value (1)
 

 

 
134

 
134

Other equity securities in public companies
 
17,290

 
41,910

 

 
59,200

Total non-marketable and other equity securities (fair value
   accounting)
 
17,290

 
41,910

 
134

 
324,597

Other assets:
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 

 
115,854

 

 
115,854

Equity warrant assets
 

 
4,435

 
161,038

 
165,473

Interest rate swaps
 

 
22,676

 

 
22,676

Client interest rate derivatives
 

 
28,811

 

 
28,811

Total assets
 
$
6,920,338

 
$
7,325,557

 
$
161,172

 
$
14,672,330

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
98,207

 
$

 
$
98,207

Interest rate swaps
 

 
25,623

 

 
25,623

Client interest rate derivatives
 

 
14,154

 

 
14,154

Total liabilities
 
$

 
$
137,984

 
$

 
$
137,984

 
(1)
Included in Level 3 assets is $120 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2018:
(Dollars in thousands)
 
Level 1
 
Level 2
 
Level 3
 
Balance at December 31, 2018
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
4,738,258

 
$

 
$

 
$
4,738,258

U.S. agency debentures
 

 
1,084,117

 

 
1,084,117

Foreign government debt securities
 
5,812

 

 

 
5,812

Residential mortgage-backed securities:
 
 
 
 
 
 
 

Agency-issued collateralized mortgage obligations— fixed rate
 

 
1,880,218

 

 
1,880,218

Agency-issued collateralized mortgage obligations— variable rate
 

 
81,638

 

 
81,638

Total available-for-sale securities
 
4,744,070

 
3,045,973

 

 
7,790,043

Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
Non-marketable securities:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments measured at net asset value
 

 

 

 
318,352

Venture capital and private equity fund investments not measured at net asset value (1)
 

 

 
1,079

 
1,079

Other equity securities in public companies (1)
 
1,181

 
19,217

 

 
20,398

Total non-marketable and other equity securities (fair value
   accounting)
 
1,181

 
19,217

 
1,079

 
339,829

Other assets:
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 

 
100,402

 

 
100,402

Equity warrant assets
 

 
4,039

 
145,199

 
149,238

Client interest rate derivatives
 

 
8,499

 

 
8,499

Total assets
 
$
4,745,251

 
$
3,178,130

 
$
146,278


$
8,388,011

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
88,559

 
$

 
$
88,559

Client interest rate derivatives
 

 
9,491

 

 
9,491

Total liabilities
 
$

 
$
98,050

 
$

 
$
98,050

 
(1)
Included in Level 3 assets is $964 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for 2019, 2018 and 2017, respectively:
(Dollars in thousands)
 
Beginning
Balance
 
Total Realized and Unrealized Gains, net Included in Income
 
Purchases  
 
Sales/Exits
 
Issuances  
 
Distributions and Other Settlements
 
Transfers Out of Level 3
 
Ending
Balance
Year ended December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
1,079

 
$
12

 
$

 
$
(960
)
 
$

 
$
3

 
$

 
$
134

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
145,199

 
133,910

 
575

 
(130,392
)
 
16,453

 

 
(4,707
)
 
161,038

Total assets
 
$
146,278


$
133,922


$
575


$
(131,352
)

$
16,453


$
3


$
(4,707
)

$
161,172

Year ended December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
919

 
$
457

 
$

 
$

 
$

 
$
(297
)
 
$

 
$
1,079

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
121,331

 
87,982

 

 
(78,752
)
 
17,941

 

 
(3,303
)
 
145,199

Total assets
 
$
122,250


$
88,439


$


$
(78,752
)

$
17,941


$
(297
)

$
(3,303
)

$
146,278

Year ended December 31, 2017:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
2,040

 
$
971

 
$

 
$
(2,092
)
 
$

 
$

 
$

 
$
919

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
128,813

 
54,263

 

 
(74,769
)
 
14,537

 

 
(1,513
)
 
121,331

Total assets
 
$
130,853

 
$
55,234

 
$

 
$
(76,861
)
 
$
14,537

 
$

 
$
(1,513
)
 
$
122,250

 

(1)
Realized and unrealized gains (losses) are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
(2)
Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
The following table presents the amount of unrealized gains (losses) included in earnings (which is inclusive of noncontrolling interest) attributable to Level 3 assets still held at December 31, 2019 and 2018, respectively:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
(222
)
 
$
160

Other assets:
 
 
 
 
Equity warrant assets (2)
 
34,691

 
37,564

Total unrealized gains, net
 
$
34,469

 
$
37,724

Unrealized (losses) gains attributable to noncontrolling interests (1)
 
$
(199
)
 
$
143

 

(1)
Unrealized gains are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
(2)
Unrealized gains are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of current sales restrictions to which these securities are subject, the actual sales of securities and the timing of such actual sales.
The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at December 31, 2019 and 2018. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.
(Dollars in thousands)
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted Average
December 31, 2019:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments (fair value accounting)
 
$
134

 
Private company equity pricing
 
(1)
 
(1)
Equity warrant assets (public portfolio)
 
346

 
Black-Scholes option pricing model
 
Volatility
 
50.7
%
Risk-Free interest rate
1.9

Sales restrictions discount (2)
13.6

Equity warrant assets (private portfolio)
 
160,692

 
Black-Scholes option pricing model
 
Volatility
 
38.2

Risk-Free interest rate
1.6

Marketability discount (3)
17.5

Remaining life assumption (4)
45.0

December 31, 2018:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments (fair value accounting)
 
$
1,079

 
Private company equity pricing
 
(1)
 
(1)
Equity warrant assets (public portfolio)
 
2,757

 
Black-Scholes option pricing model
 
Volatility
 
54.7
%
Risk-Free interest rate
2.6

Sales restrictions discount (2)
18.5

Equity warrant assets (private portfolio)
 
142,442

 
Black-Scholes option pricing model
 
Volatility
 
38.5

Risk-Free interest rate
2.5

Marketability discount (3)
17.7

Remaining life assumption (4)
45.0

 
 
(1)
In determining the fair value of our venture capital and private equity fund investment portfolio (not measured at net asset value), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation
assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
(2)
We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions which typically range from three to six months.
(3)
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
(4)
We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At December 31, 2019, the weighted average contractual remaining term was 6.1 years, compared to our estimated remaining life of 2.8 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
During 2019, 2018 and 2017, we did not have any transfers between Level 2 and Level 1 or transfers between Level 3 and Level 1. All other transfers from Level 3 to Level 2 during 2019, 2018 and 2017 were due to the transfer of equity warrant assets from our private portfolio to our public portfolio (see our Level 3 reconciliation above). All amounts reported as transfers represent the fair value as of the date of the change in circumstances that caused the transfer.
Financial Instruments not Carried at Fair Value
FASB guidance over financial instruments requires that we disclose estimated fair values for our financial instruments not carried at fair value. The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at December 31, 2019 and 2018:
 
 
 
 
Estimated Fair Value
(Dollars in thousands)
 
Carrying Amount
 
Total
 

Level 1
 

Level 2
 

Level 3
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
6,781,783

 
$
6,781,783

 
$
6,781,783

 
$

 
$

Held-to-maturity securities
 
13,842,946

 
14,115,272

 

 
14,115,272

 

Non-marketable securities not measured at net asset value
 
195,405

 
195,405

 

 

 
195,405

Non-marketable securities measured at net asset value
 
235,351

 
235,351

 

 

 

Net commercial loans
 
29,104,532

 
29,615,176

 

 

 
29,615,176

Net consumer loans
 
3,755,180

 
3,820,804

 

 

 
3,820,804

FHLB and Federal Reserve Bank stock
 
60,258

 
60,258

 

 

 
60,258

Financial liabilities:
 
 
 


 
 
 
 
 
 
Short-term borrowings
 
17,430

 
17,430

 

 
17,430

 

Non-maturity deposits (1)
 
61,569,714

 
61,569,714

 
61,569,714

 

 

Time deposits
 
188,093

 
187,980

 

 
187,980

 

3.50% Senior Notes
 
347,987

 
366,856

 

 
366,856

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 
27,197

 

 

 
27,197

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,571,539

 
$
3,571,539

 
$
3,571,539

 
$

 
$

Held-to-maturity securities
 
15,487,442

 
15,188,236

 

 
15,188,236

 

Non-marketable securities not measured at net asset value
 
131,453

 
131,453

 

 

 
131,453

Non-marketable securities measured at net asset value
 
151,247

 
151,247

 

 

 

Net commercial loans
 
25,043,671

 
25,463,968

 

 

 
25,463,968

Net consumer loans
 
3,013,706

 
3,064,093

 

 

 
3,064,093

FHLB and Federal Reserve Bank stock
 
58,878

 
58,878

 

 

 
58,878

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
631,412

 
631,412

 

 
631,412

 

Non-maturity deposits (1)
 
49,278,174

 
49,278,174

 
49,278,174

 

 

Time deposits
 
50,726

 
50,337

 

 
50,337

 

3.50% Senior Notes
 
347,639

 
336,088

 

 
336,088

 

5.375% Senior Notes
 
348,826

 
361,281

 

 
361,281

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 
22,930

 

 

 
22,930

 
(1)
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
Investments in Entities that Calculate Net Asset Value Per Share
FASB guidance over certain fund investments requires that we disclose the fair value of funds, significant investment strategies of the investees, redemption features of the investees, restrictions on the ability to sell investments, estimate of the period of time over which the underlying assets are expected to be liquidated by the investee, and unfunded commitments related to the investments.
Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed. Alternatively, we expect distributions, if any, to be received primarily through IPOs and M&A activity of the underlying assets of the fund. Subject to applicable requirements under the Volcker Rule, we do not have any plans to sell any of these fund investments. If we decide to sell these investments in the future, the investee fund’s management must approve of the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of December 31, 2019:
(Dollars in thousands)
 
Carrying Amount      
 
Fair Value        
 
Unfunded Commitments      
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
265,263

 
$
265,263

 
$
10,579

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (2)
 
215,367

 
215,367

 
10,675

Debt funds (2)
 
7,271

 
7,271

 

Other investments (2)
 
12,713

 
12,713

 
886

Total
 
$
500,614

 
$
500,614

 
$
22,140

 
(1)
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $64.6 million and $4.0 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2)
Venture capital and private equity fund investments, debt funds and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.
v3.19.3.a.u2
Regulatory Matters
12 Months Ended
Dec. 31, 2019
Banking and Thrift [Abstract]  
Regulatory Matters
Regulatory Matters
SVB Financial and the Bank are subject to various regulatory capital adequacy requirements administered by the Federal Reserve Board and the DBO. The Federal Deposit Insurance Corporation Improvement Act of 1991 required that the federal regulatory agencies adopt regulations defining five capital categories for banks: well-capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized.
In July 2013, the Federal Reserve, the FDIC and the Office of the Comptroller of the Currency published final rules establishing a comprehensive capital framework for U.S. banking organizations (the “Capital Rules”), which implement the Basel III regulatory capital reforms and changes required by the Dodd-Frank Act. “Basel III” refers to the internationally agreed regulatory capital framework adopted by the Basel Committee.
There are three categories of capital under the new Basel III standards; CET 1, additional Tier 1 and Tier 2. CET 1 includes common stock plus related surplus and retained earnings, less certain deductions. Additional Tier 1 capital includes qualifying preferred stock and trust preferred securities, less certain deductions. Additional Tier 1, together with CET 1, equal total Tier 1 capital. Tier 2 capital includes primarily certain qualifying unsecured subordinated debt and qualifying allowances for loan and lease losses. Tier 1 capital together with Tier 2 capital equal total capital.
Under the Capital Rules, the minimum capital ratios applicable to SVB Financial and the Bank are as follows: 4.5% CET1 capital, 6.0% Tier 1 capital, 8.0% Total capital and 4.0% Tier 1 leverage. In addition, banking organizations must meet a 2.5% CET1 risk-based capital conservation buffer requirement in order to avoid constraints on capital distributions, such as dividends and equity repurchases, and certain bonus compensation for executive officers. The severity of the constraints would depend on the amount of the shortfall and the banking organization’s “eligible retained income” (that is, four-quarter trailing net income, net of distributions and tax effects not reflected in net income).
As of December 31, 2019, both SVB Financial and the Bank exceed the required ratios under the Capital Rules and were considered “well-capitalized” for regulatory purposes under existing capital guidelines as well. The following table presents the capital ratios for the Company and the Bank under federal regulatory guidelines, compared to the minimum regulatory capital requirements, as of December 31, 2019 and 2018:
 
 
Capital Ratios
 
Capital Amounts
(Dollars in thousands)
 
Actual
 
Required Minimum (1)
 
Well Capitalized Minimum
 
Actual
 
Required Minimum (1)
 
Well Capitalized Minimum
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
CET 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
12.58
%
 
7.0
%
 
N/A
 
$
5,857,744

 
$
3,260,424

 
N/A

Bank
 
11.12

 
7.0

 
6.5
 
4,949,393

 
3,115,151

 
$
2,892,640

Tier 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.43

 
8.5

 
6.0
 
6,257,442

 
3,959,086

 
2,794,649

Bank
 
11.12

 
8.5

 
8.0
 
4,949,393

 
3,782,683

 
3,560,172

Total risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
14.23

 
10.5

 
10.0
 
6,630,022

 
4,890,636

 
4,657,748

Bank
 
11.96

 
10.5

 
10.0
 
5,321,850

 
4,672,726

 
4,450,215

Tier 1 leverage:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
9.06

 
4.0

 
N/A
 
6,257,442

 
2,763,146

 
N/A

Bank
 
7.30

 
4.0

 
5.0
 
4,949,393

 
2,713,367

 
3,391,709

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
CET 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.41
%
 
6.4
%
 
N/A
 
$
5,167,270

 
$
2,456,151

 
N/A

Bank
 
12.41

 
6.4

 
6.5
 
4,604,689

 
2,365,385

 
$
2,411,765

Tier 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.58

 
7.9

 
6.0
 
5,231,476

 
3,034,068

 
2,311,671

Bank
 
12.41

 
7.9

 
8.0
 
4,604,689

 
2,921,946

 
2,968,326

Total risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
14.45

 
9.9

 
10.0
 
5,567,562

 
3,804,625

 
3,852,785

Bank
 
13.32

 
9.9

 
10.0
 
4,940,776

 
3,664,028

 
3,710,408

Tier 1 leverage:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
9.06

 
4.0

 
N/A
 
5,231,476

 
2,308,592

 
N/A

Bank
 
8.10

 
4.0

 
5.0
 
4,604,689

 
2,272,912

 
2,841,139

 
N/A
"Well-Capitalized Minimum" CET 1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies.
(1)
The percentages as of December 31,2019 represent the minimum capital ratios plus, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.
v3.19.3.a.u2
Segment Reporting
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
We have four reportable segments for management reporting purposes: Global Commercial Bank, SVB Private Bank, SVB Capital and SVB Leerink. SVB Leerink is a new reportable segment and was created as a result of the acquisition of Leerink Holdings LLC effective January 4, 2019. The results of our operating segments are based on our internal management reporting process.
Our Global Commercial Bank and SVB Private Bank segments’ primary source of revenue is from net interest income, which is primarily the difference between interest earned on loans, net of funds transfer pricing ("FTP") and interest paid on deposits, net of FTP. Accordingly, these segments are reported using net interest income, net of FTP. FTP is an internal measurement framework designed to assess the financial impact of a financial institution’s sources and uses of funds. It is the mechanism by which an earnings credit is given for deposits raised, and an earnings charge is made for funded loans. FTP is calculated at an instrument level based on account characteristics.
We also evaluate performance based on provision for credit losses, noninterest income and noninterest expense, which are presented as components of segment operating profit or loss. In calculating each operating segment’s noninterest expense, we consider the direct costs incurred by the operating segment as well as certain allocated direct costs. As part of this review, we allocate certain corporate overhead costs to a corporate account. We do not allocate income tax expense or the provision for unfunded credit commitments (included in provision for credit losses) to our segments. Additionally, our management reporting model is predicated on average asset balances; therefore, period-end asset balances are not presented for segment reporting purposes. Changes in an individual client’s primary relationship designation have resulted, and in the future may result, in the inclusion of certain clients in different segments in different periods.
Unlike financial reporting, which benefits from the comprehensive structure provided by GAAP, our internal management reporting process is highly subjective, as there is no comprehensive, authoritative guidance for management reporting. Our management reporting process measures the performance of our operating segments based on our internal operating structure, which is subject to change from time to time, and is not necessarily comparable with similar information for other financial services companies. For reporting purposes, SVB Financial Group has four operating segments for which we report our financial information (for further description of these reportable segments, refer to "Business–Business Overview" under Part I, Item 1 of this report):
Global Commercial Bank is comprised of results from the following:
Our Commercial Bank products and services are provided by the Bank and its subsidiaries to commercial clients primarily in the technology, life science/healthcare and private equity/venture capital industries. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance and other services. We broadly serve clients within the U.S., as well as non-U.S. clients in key international innovation markets. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets. 
Our Global Funds Banking (formerly Private Equity) Division provides banking products and services primarily to our private equity and venture capital clients.
SVB Wine provides banking products and services to our premium wine industry clients, including vineyard development loans. 
Debt Fund Investments is comprised of our investments in certain debt funds in which we are a strategic investor.
SVB Private Bank is the private banking division of the Bank, which provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted stock purchase loans, capital call lines of credit and other secured and unsecured lending products, as well as cash and wealth management services. 
SVB Capital is the funds management business of SVBFG, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees.
SVB Leerink is an investment bank specializing in the equity and convertible capital markets, mergers and acquisitions, equity research and sales and trading for growth and innovation-minded healthcare and life science companies and operates as a wholly-owned subsidiary of SVB Financial. SVB Leerink provides investment banking
services across all subsectors of healthcare including biotechnology, pharmaceuticals, medical devices, diagnostic and life science tools, healthcare services and digital health. SVB Leerink focuses on two primary lines of business: (i) investment banking focused on providing companies with capital-raising services, financial advice on mergers and acquisitions, sales and trading services and equity research, and (ii) sponsorship of private investment funds.
The summary financial results of our operating segments are presented along with a reconciliation to our consolidated results.
Our segment information for 2019, 2018 and 2017 is as follows:
(Dollars in thousands)
 
Global
Commercial
Bank (1)
 
SVB Private  
Bank
 
SVB Capital 
(1)  
 
SVB Leerink (1)
 
Other Items
(2)
 
Total      
Year ended December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,850,391

 
$
51,022

 
$
38

 
$
1,252

 
$
193,898

 
$
2,096,601

Provision for credit losses
 
(91,814
)
 
(2,369
)
 

 

 
(12,233
)
 
(106,416
)
Noninterest income
 
637,922

 
3,366

 
122,394

 
264,516

 
193,281

 
1,221,479

Noninterest expense (3)
 
(874,854
)
 
(40,151
)
 
(30,798
)
 
(252,678
)
 
(402,781
)
 
(1,601,262
)
Income (loss) before income tax expense (4)
 
$
1,521,645

 
$
11,868

 
$
91,634

 
$
13,090

 
$
(27,835
)
 
$
1,610,402

Total average loans, net of unearned income
 
$
26,031,284

 
$
3,341,188

 
$

 
$

 
$
543,735

 
$
29,916,207

Total average assets (5) (6)
 
56,043,321

 
3,371,052

 
405,152

 
397,650

 
2,994,455

 
63,211,630

Total average deposits
 
53,053,665

 
1,524,232

 

 

 
479,053

 
55,056,950

Year ended December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,623,488

 
$
64,902

 
$
23

 
$

 
$
205,575

 
$
1,893,988

Provision for credit losses
 
(80,953
)
 
(3,339
)
 

 

 
(3,578
)
 
(87,870
)
Noninterest income (7)
 
520,302

 
2,281

 
101,181

 

 
121,220

 
744,984

Noninterest expense (3)
 
(793,159
)
 
(25,064
)
 
(22,792
)
 

 
(347,178
)
 
(1,188,193
)
Income (loss) before income tax expense (4)
 
$
1,269,678

 
$
38,780

 
$
78,412

 
$

 
$
(23,961
)
 
$
1,362,909

Total average loans, net of unearned income
 
$
22,354,305

 
$
2,850,271

 
$

 
$

 
$
425,944

 
$
25,630,520

Total average assets (5) (8)
 
48,854,416

 
2,871,743

 
380,543

 

 
3,122,358

 
55,229,060

Total average deposits
 
46,039,570

 
1,502,308

 

 

 
533,466

 
48,075,344

Year ended December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,274,366

 
$
58,131

 
$
48

 
$

 
$
87,824

 
$
1,420,369

Provision for credit losses
 
(81,553
)
 
(4,386
)
 

 

 
(6,365
)
 
(92,304
)
Noninterest income (7)
 
392,101

 
2,175

 
58,992

 

 
103,963

 
557,231

Noninterest expense (3)
 
(707,666
)
 
(17,693
)
 
(19,340
)
 

 
(265,956
)
 
(1,010,655
)
Income (loss) before income tax expense (4)
 
$
877,248

 
$
38,227

 
$
39,700

 
$

 
$
(80,534
)
 
$
874,641

Total average loans, net of unearned income
 
$
18,479,793

 
$
2,423,078

 
$

 
$

 
$
256,523

 
$
21,159,394

Total average assets (5) (8)
 
43,704,667

 
2,445,220

 
325,939

 

 
1,904,446

 
48,380,272

Total average deposits
 
41,043,731

 
1,303,542

 

 

 
397,875

 
42,745,148

 
(1)
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within "Other Items."
(2)
The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest
earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains on equity warrant assets and gains or losses on the sale of fixed income investments and equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.
(3)
The Global Commercial Bank segment includes direct depreciation and amortization of $20.4 million, $21.8 million and $25.3 million for 2019, 2018 and 2017, respectively.
(4)
The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.
(5)
Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.
(6)
Included in the total average assets for SVB Leerink is goodwill of $137.8 million for the year ended December 31, 2019 related to the acquisition effective January 4, 2019.
(7)
For the years ended December 31, 2018 and 2017, amounts of client investment fees included in the line item "Noninterest Income" previously reported as "Other Items" have been correctly allocated to our reportable segment "Global Commercial Bank" to properly reflect the source of such revenue. The correction of this immaterial error had no impact on the "Total" amount of noninterest income.
(8)
For the years ended December 31, 2018 and 2017, amounts for average assets previously reported as "Other Items" have been correctly allocated to the reportable segments "Global Commercial Bank" and “SVB Private Bank” to properly reflect the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for “Global Commercial Bank” and “SVB Private Bank.” The correction of this immaterial error had no impact on the "Total" amount of average assets.
v3.19.3.a.u2
Parent Company Only Condensed Financial Information
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Parent Company Only Condensed Financial Information
Parent Company Only Condensed Financial Information
The condensed balance sheets of SVB Financial at December 31, 2019 and 2018, and the related condensed statements of income, comprehensive income and cash flows for 2019, 2018 and 2017, are presented below:
Condensed Balance Sheets
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Assets:
 
 
 
 
Cash and cash equivalents
 
$
800,926

 
$
553,049

Investment securities
 
474,842

 
510,836

Loans, net of unearned income
 
15,245

 

Lease right-of-use assets
 
71,847

 

Other assets
 
214,167

 
204,301

Investment in subsidiaries:
 
 
 
 
   Bank subsidiary
 
5,034,095

 
4,554,813

   Nonbank subsidiaries
 
432,073

 
116,968

Total assets
 
$
7,043,195

 
$
5,939,967

 
 
 
 
 
Liabilities and SVBFG stockholders’ equity:
 
 
 
 
3.50% Senior Notes
 
$
347,987

 
$
347,639

5.375% Senior Notes
 

 
348,826

Lease liabilities
 
87,999

 

Other liabilities
 
136,903

 
127,293

Total liabilities
 
$
572,889

 
$
823,758

SVBFG stockholders’ equity
 
6,470,306

 
5,116,209

Total liabilities and SVBFG stockholders’ equity
 
$
7,043,195

 
$
5,939,967


Condensed Statements of Income
 
 
Year ended December 31,
(Dollars in thousands)
 
2019

2018

2017
Interest income
 
$
4,473

 
$
3,307

 
$
2,077

Interest expense
 
(31,666
)
 
(32,037
)
 
(34,932
)
Dividend income from bank subsidiary
 
733,000

 
140,000

 
90,000

Gains on equity warrant assets, net
 
138,078

 
89,142

 
54,555

Gains on investment securities, net
 
45,345

 
13,546

 
37,132

Fund management fees and other noninterest income
 
21,567

 
26,388

 
24,613

General and administrative expenses
 
(94,712
)
 
(70,976
)
 
(63,077
)
Income tax (expense) benefit
 
(40,218
)
 
(14,383
)
 
10,367

Income before net income of subsidiaries
 
775,867

 
154,987

 
120,735

Equity in undistributed net income of bank subsidiary
 
303,618

 
793,641

 
356,769

Equity in undistributed net income of nonbank subsidiaries
 
57,371

 
25,212

 
13,002

Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506



Condensed Statements of Comprehensive Income
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
Foreign currency translation gains (losses)
 
2,319

 
(4,107
)
 
3,769

Changes in fair value on cash flow hedges
 
(2,130
)
 

 

Changes in unrealized holding gains and losses on AFS securities
 
2,310

 
120

 
22,285

Equity in other comprehensive income (loss) of bank and nonbank subsidiaries
 
136,066

 
(19,171
)
 
(50,956
)
Reclassifications to retained earnings for the adoption of new accounting guidance
 

 
(29,490
)
 

Other comprehensive income (loss), net of tax
 
138,565

 
(52,648
)
 
(24,902
)
Total comprehensive income
 
$
1,275,421

 
$
921,192

 
$
465,604




Condensed Statements of Cash Flows
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Cash flows from operating activities:
 
 
 
 
 
 
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
Gains on equity warrant assets, net
 
(138,078
)
 
(89,142
)
 
(54,555
)
Gains on investment securities, net
 
(45,345
)
 
(13,546
)
 
(17,060
)
Distributions of earnings from investment securities
 
49,776

 
47,596

 
14,015

Net income of bank subsidiary
 
(1,036,618
)
 
(933,641
)
 
(446,769
)
Net income on nonbank subsidiaries
 
(57,371
)
 
(25,212
)
 
(13,002
)
Cash dividends from bank subsidiary
 
733,000

 
140,000

 
90,000

Amortization of share-based compensation
 
66,815

 
45,675

 
36,900

Decrease in other assets
 
27,205

 
51,169

 
12,959

Increase in other liabilities
 
21,391

 
21,619

 
11,774

Other, net
 
8,084

 
(31,024
)
 
316

Net cash provided by operating activities
 
765,715

 
187,334

 
125,084

 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
Net decrease (increase) in investment securities from purchases, sales and maturities
 
128,635

 
73,742

 
(152,015
)
Net (increase) decrease in loans
 
(15,245
)
 

 
13,337

Increase in investment in bank subsidiary
 
(42,952
)
 
(31,292
)
 
(38,927
)
Decrease (increase) in investment in nonbank subsidiaries
 
23,275

 
(5,323
)
 
34,374

Acquisition of SVB Leerink

 
(265,601
)
 

 

Net cash (used for) provided by investing activities
 
(171,888
)
 
37,127

 
(143,231
)
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
Principal payments of long-term debt
 
(358,395
)
 

 
(51,546
)
Proceeds from issuance of common stock, ESPP and ESOP
 
24,818

 
18,387

 
27,003

Net proceeds from the issuance of preferred stock

 
340,138

 

 

Common stock repurchase
 
(352,511
)
 
(147,123
)
 

Net cash (used for) by financing activities
 
(345,950
)
 
(128,736
)
 
(24,543
)
Net increase (decrease) in cash and cash equivalents
 
247,877

 
95,725

 
(42,690
)
Cash and cash equivalents at beginning of period
 
553,049

 
457,324

 
500,014

Cash and cash equivalents at end of period
 
$
800,926

 
$
553,049

 
$
457,324


v3.19.3.a.u2
Unaudited Quarterly Financial Data
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Unaudited Quarterly Financial Data
Unaudited Quarterly Financial Data
Our supplemental consolidated financial information for each three month period in 2019 and 2018 are as follows:
 
 
 Three months ended
(Dollars in thousands, except per share amounts)
 
March 31,
 
June 30,
 
September 30,
 
December 31,
2019:
 
 
 
 
 
 
 
 
Interest income
 
$
551,014

 
$
585,767

 
$
583,892

 
$
588,735

Interest expense
 
38,128

 
56,364

 
63,248

 
55,067

Net interest income
 
512,886

 
529,403

 
520,644

 
533,668

Provision for credit losses
 
28,551

 
23,946

 
36,536

 
17,383

Noninterest income
 
280,376

 
333,750

 
294,009

 
313,344

Noninterest expense
 
365,664

 
383,522

 
391,324

 
460,752

Income before income tax expense
 
399,047

 
455,685

 
386,793

 
368,877

Income tax expense
 
107,435

 
119,114

 
105,075

 
94,061

Net income before noncontrolling interests
 
291,612

 
336,571

 
281,718

 
274,816

Net income attributable to noncontrolling interests
 
(2,880
)
 
(18,584
)
 
(14,437
)
 
(11,960
)
Net income available to common stockholders
 
$
288,732

 
$
317,987

 
$
267,281

 
$
262,856

Earnings per common share—basic
 
$
5.49

 
$
6.12

 
$
5.19

 
$
5.10

Earnings per common share—diluted
 
5.44

 
6.08

 
5.15

 
5.06

2018:
 
 
 
 
 
 
 
 
Interest income
 
$
432,398

 
$
481,301

 
$
513,313

 
$
542,897

Interest expense
 
12,535

 
14,858

 
20,091

 
28,437

Net interest income
 
419,863

 
466,443

 
493,222

 
514,460

Provision for credit losses
 
27,972

 
29,080

 
17,174

 
13,644

Noninterest income
 
155,518

 
192,689

 
210,070

 
186,707

Noninterest expense
 
265,417

 
305,739

 
309,445

 
307,592

Income before income tax expense
 
281,992

 
324,313

 
376,673

 
379,931

Income tax expense
 
73,966

 
77,287

 
95,308

 
105,000

Net income before noncontrolling interests
 
208,026

 
247,026

 
281,365

 
274,931

Net income attributable to noncontrolling interests
 
(13,065
)
 
(9,228
)
 
(6,548
)
 
(8,667
)
Net income available to common stockholders
 
$
194,961

 
$
237,798

 
$
274,817

 
$
266,264

Earnings per common share—basic
 
$
3.69

 
$
4.48

 
$
5.16

 
$
5.01

Earnings per common share—diluted
 
3.63

 
4.42

 
5.10

 
4.96


v3.19.3.a.u2
Legal Matters
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Legal Matters
Legal Matters
Certain lawsuits and claims arising in the ordinary course of business have been filed or are pending against us and/or our affiliates, and we may from time to time be involved in other legal or regulatory proceedings. In accordance with applicable accounting guidance, we establish accruals for all such matters, including expected settlements, when we believe it is probable that a loss has been incurred and the amount of the loss is reasonably estimable. When a loss contingency is not both probable and estimable, we do not establish an accrual. Any such loss estimates are inherently uncertain, based on currently available information and are subject to management’s judgment and various assumptions. Due to the inherent subjectivity of these estimates and unpredictability of outcomes of legal proceedings, any amounts accrued may not represent the ultimate resolution of such matters.
To the extent we believe any potential loss relating to such matters may have a material impact on our liquidity, consolidated financial position, results of operations and/or our business as a whole and is reasonably possible but not probable, we aim to
disclose information relating to such potential loss. We also aim to disclose information relating to any material potential loss that is probable but not reasonably estimable. In such cases, where reasonably practicable, we aim to provide an estimate of loss or range of potential loss. No disclosures are generally made for any loss contingencies that are deemed to be remote.
Based upon information available to us, our review of lawsuits and claims filed or pending against us to date and consultation with our outside legal counsel, we have not recognized a material liability for any such matters, nor do we currently expect that these matters will result in a material liability to the Company. However, the outcome of litigation and other legal and regulatory matters is inherently uncertain, and it is possible that one or more of such matters currently pending or threatened could have an unanticipated material adverse effect on our liquidity, consolidated financial position, results of operations and/or our business as a whole, in the future.
v3.19.3.a.u2
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Use of Estimates and Assumptions
Use of Estimates and Assumptions
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Significant items that are subject to such estimates include measurements of fair value, the valuation of non-marketable and other equity securities, the valuation of equity warrant assets and the adequacy of the allowance for loan losses and the allowance for unfunded credit commitments. The following discussion provides additional background on our significant accounting policies.
Principles of Consolidation and Presentation
Principles of Consolidation and Presentation
Our consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. We consolidate voting entities in which we have control through voting interests or entities through which we have a controlling financial interest in a variable interest entity ("VIE"). We determine whether we have a controlling financial interest in a VIE by determining if we have (a) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses or (c) the right to receive the expected returns of the entity. Generally, we have significant variable interests if our commitments to a limited partnership investment represent a significant amount of the total commitments to the entity. We also evaluate the impact of related parties on our determination of variable interests in our consolidation conclusions. We consolidate VIEs in which we are the primary beneficiary based on a controlling financial interest. If we are not the primary beneficiary of a VIE, we record our pro-rata interests based on our ownership percentage.
VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or equity investors and, as a group, lack one of the following characteristics: (a) the power to direct the activities that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses of the entity or (c) the right to receive the expected returns of the entity. We assess VIEs to determine if we are the primary beneficiary of a VIE. A primary beneficiary is defined as a variable interest holder that has a controlling financial interest. A controlling financial interest requires both: (a) the power to direct the activities that most significantly impact the VIEs economic performance, and (b) the obligation to absorb losses or receive benefits of a VIE that could potentially be significant to a VIE. Under this analysis, we also evaluate kick-out rights and other participating rights, which could provide us a controlling financial interest. The primary beneficiary of a VIE is required to consolidate the VIE.
We also evaluate fees paid to managers of our limited partnership investments. We exclude those fee arrangements that are not deemed to be variable interests from the analysis of our interests in our investments in VIEs and the determination of a primary beneficiary, if any. Fee arrangements based on terms that are customary and commensurate with the services provided are deemed not to be variable interests and are, therefore, excluded.
All significant intercompany accounts and transactions with consolidated entities have been eliminated. We have not provided financial or other support during the periods presented to any VIE that we were not previously contractually required to provide.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand, cash balances due from banks, interest-earning deposits, Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities. For the consolidated statements of cash flows, we consider cash equivalents to be investments that are readily convertible to known amounts of cash, so near to their maturity that they present an insignificant risk of change in fair value due to changes in market interest rates, and purchased in conjunction with our cash management activities.
Available-for-Sale and Held-to-Maturity Securities
Available-for-Sale Securities
Our available-for-sale securities portfolio is a fixed income investment portfolio that is managed to earn an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification and meeting our asset/liability management objectives. Unrealized gains and losses on available-for-sale securities, net of applicable taxes, are reported in accumulated other comprehensive income, which is a separate component of SVBFG's stockholders' equity, until realized.
We analyze available-for-sale securities for other-than-temporary impairment each quarter. Market valuations represent the current fair value of a security at a specified point in time and incorporates the risk of timing of interest due and the return of principal over the contractual life of each security. Gains and losses on securities are realized when there is a sale of the security prior to maturity. A credit downgrade represents an increased level of risk of other-than-temporary impairment, and as a part of our consideration of recording an other-than-temporary impairment we will assess the issuer's ability to service the debt and to repay the principal at contractual maturity.
We apply the other-than-temporary impairment standards of ASC 320, Investments-Debt and Equity Securities. For our debt securities, we have the intent and ability to hold these securities until we recover our cost less any credit-related loss. We separate the amount of the other-than-temporary impairment, if any, into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security's amortized cost basis and the present value of expected future cash flows discounted at the security's effective interest rate. The amount due to all other factors is recognized in other comprehensive income.
We consider numerous factors in determining whether a credit loss exists and the period over which the debt security is expected to recover. The following list is not meant to be all inclusive. All of the following factors are considered:
The length of time and the extent to which the fair value has been less than the amortized cost basis (severity and duration);
Adverse conditions specifically related to the security, an industry or geographic area; for example, changes in the financial condition of the issuer of the security, or in the case of an asset-backed debt security, changes in the financial condition of the underlying loan obligors. Examples of those changes include any of the following:
Changes in technology;
The discontinuance of a segment of the business that may affect the future earnings potential of the issuer or underlying loan obligors of the security; and
Changes in the quality of the credit enhancement.

The historical and implied volatility of the fair value of the security;
The payment structure of the debt security and the likelihood of the issuer being able to make payments that increase in the future;
Failure of the issuer of the security to make scheduled interest or principal payments;
Any changes to the rating of the security by a rating agency; and
Recoveries or additional declines in fair value after the balance sheet date.
In accordance with ASC 310-20, Receivables-Nonrefundable Fees and Other Costs, we use estimates of future principal prepayments, provided by third-party market-data vendors, in addition to actual principal prepayment experience to calculate the constant effective yield necessary to apply the effective interest method in the amortization of purchase discounts or premiums on mortgage-backed securities and fixed rate collateralized mortgage obligations. The accretion and amortization of discounts and premiums, respectively, are included in interest income over the contractual terms of the underlying securities replicating the effective interest method.
Held-to-Maturity Securities
Debt securities purchased in which we have the positive intent and ability to hold to its maturity are classified as held-to-maturity securities and are recorded at amortized cost.
Transfers of investment securities into the held-to-maturity category from the available-for-sale category are made at fair value at the date of transfer. The net unrealized gains, net of tax, are retained in other comprehensive income, and the carrying value of the held-to-maturity securities are amortized over the life of the securities in a manner consistent with the amortization of a premium or discount.
Non-Marketable and Other Securities
Non-Marketable and Other Equity Securities
Non-marketable and other equity securities include investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised, and investments in qualified affordable housing projects. A majority of these investments are managed through our SVB Capital funds business in funds of funds and direct venture funds. Our accounting for investments in non-marketable and other equity securities depends on several factors, including the level of ownership, power to control and the legal structure of the subsidiary making the investment. As further described below, we base our accounting for such securities on: (i) fair value accounting, (ii) other investments without a readily determinable fair value, (iii) equity method accounting and (iv) the proportional amortization method which is used only for qualified affordable housing projects.
Fair Value Accounting
The general partner interests of these funds are controlled, and in some cases, owned by SVB Financial. The limited partners of these funds do not have substantive participating or kick-out rights. Therefore, these funds are consolidated and any gains or losses resulting from changes in the estimated fair value of the investments are recorded as investment gains or losses in our consolidated net income.
Under fair value accounting, investments are carried at their estimated fair value based on financial information obtained as the general partner of the fund or obtained from the funds' respective general partner. For direct private company investments, valuations are based upon consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. For direct equity investments in public companies, valuations are based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Sales restriction discounts generally range from ten percent to twenty percent depending on the sale restrictions which typically range from three to six months. The valuation of non-marketable securities in shares of private company capital stock and the valuation of other securities in shares of public company stock with certain sales restrictions is subject to significant judgment. The inherent uncertainty in the process of valuing securities for which a ready market does not exist may cause our estimated values of these securities to differ significantly from the values that would have been derived had a ready market for the securities existed, and those differences could be material.
For our fund investments, we utilize the net asset value as obtained from the general partners of the fund investments as the funds do not have a readily determinable fair value. The general partners of our fund investments prepare their financial statements using guidance consistent with fair value accounting. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period.
Gains or losses resulting from changes in the estimated fair value of the investments and from distributions received are recorded as gains on investment securities, net, a component of noninterest income. The portion of any investment gains or losses attributable to the limited partners is reflected as net income attributable to noncontrolling interests and adjusts our net income to reflect its percentage ownership.
Fair Value Accounting
Our managed funds are investment companies under the AICPA Audit and Accounting Guide for Investment Companies (codified in ASC 946) and accordingly, these funds report their investments at estimated fair value, with unrealized gains and losses resulting from changes in fair value reflected as investment gains or losses in our consolidated statements of income. Our non-marketable and other equity securities recorded pursuant to fair value accounting consist of our investments through the following funds:
Funds of funds, which make investments in venture capital and private equity funds, and
Direct venture funds, which make equity investments in privately held companies.
Other Investments without a Readily Determinable Fair Value
Other Investments without a Readily Determinable Fair Value

Effective January 1, 2018 we adopted ASU 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities which eliminated the concept of cost method accounting and created an additional method of accounting, other investments without a readily determinable fair value. These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired less any impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.
Equity Method
Equity Method
Our equity method non-marketable securities consist of investments in venture capital and private equity funds, privately-held companies, debt funds, and joint ventures. Our equity method non-marketable securities and related accounting policies are described as follows:
Equity securities, such as preferred or common stock in privately-held companies in which we hold a voting interest of at least 20 percent, or in which we have the ability to exercise significant influence over the investees' operating and financial policies through board involvement or other influence, are accounted for under the equity method,
Investments in limited partnerships in which we hold voting interests of more than 5 percent, or in which we have the ability to exercise significant influence over the partnerships' operating and financial policies, are accounted for using the equity method, and
Our China Joint Venture partnership, for which we have 50 percent ownership, is accounted for under the equity method.
We recognize our proportionate share of the results of operations of these equity method investees in our results of operations, based on the most current financial information available from the investee. We review our investments accounted for under the equity method at least quarterly for possible other-than-temporary impairment. Our review typically includes an analysis of facts and circumstances for each investment, the expectations of the investment's future cash flows and capital needs, variability of its business and the company's exit strategy. For our fund investments, we utilize the net asset value per share as provided by the general partners of the fund investments. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment, and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period.
We reduce our investment value when we consider declines in value to be other-than-temporary and recognize the estimated loss as a loss on investment securities, a component of noninterest income.
Proportional Amortization Method
Proportional Amortization Method
In order to fulfill our responsibilities under the Community Reinvestment Act, we invest as a limited partner in low income housing partnerships that operate qualified affordable housing projects and generate tax benefits, including federal low income housing tax credits, for investors. The partnerships are deemed to be VIEs because they do not have sufficient equity investment at risk and are structured with non-substantive voting rights. We are not the primary beneficiary of the VIEs and do not consolidate them. Our investments in low income housing partnerships are recorded in non-marketable and other equity securities within our investment securities portfolio on the consolidated balance sheet. As a practical expedient, we amortize the investment in proportion to the allocated tax benefits under the proportional amortization method of accounting and present such benefits net of investment amortization in income tax expense.
Loans
Loans
Loans are reported at the principal amount outstanding, net of unearned loan fees. Unearned loan fees reflect unamortized deferred loan origination and commitment fees net of unamortized deferred loan origination costs. In addition to cash loan fees, we often obtain equity warrant assets that give us an option to purchase a position in a client company's stock in consideration for providing credit facilities. The grant date fair values of these equity warrant assets are deemed to be loan fees and are deferred as unearned income and recognized as an adjustment of loan yield through loan interest income. The net amount of unearned loan fees is amortized into loan interest income over the contractual terms of the underlying loans and commitments using the constant effective yield method, adjusted for actual loan prepayment experience, or the straight-line method, as applicable.
Allowance for Loan Losses
Allowance for Loan Losses
The allowance for loan losses considers credit risk and is established through a provision for loan losses charged to expense. Our allowance for loan losses is established for estimated loan losses that are probable and incurred but not yet realized. Our evaluation process is designed to determine that the allowance for loan losses is appropriate at the balance sheet date. The process of estimating loan losses is inherently imprecise.
We maintain a systematic process for the evaluation of individual loans and pools of loans for inherent risk of loan losses. At the time of approval, each loan in our portfolio is assigned a Credit Risk Rating and industry niche. Credit Risk Ratings are assigned on a scale of 1 to 10, with 1 representing loans with a low risk of nonpayment, 9 representing loans with the highest risk of nonpayment, and 10 representing loans which have been charged-off. The credit risk ratings for each loan are monitored and updated on an ongoing basis. This Credit Risk Rating process includes, but is not limited to, consideration of such factors as payment status, the financial condition and operating performance of the borrower, borrower compliance with loan covenants, underlying collateral values and performance trends, the degree of access to additional capital, the presence of credit enhancements such as third party guarantees (where applicable), the degree to which the borrower is sensitive to external factors, the depth and experience of the borrower's management team, potential loan concentrations, and general economic conditions. Our policies require a committee of senior management to review, at least quarterly, credit relationships with a credit risk rating of 5 through 9 that exceed specific dollar values. Our review process evaluates the appropriateness of the credit risk rating and allocation of the allowance for loan losses, as well as other account management functions. The allowance for loan losses is determined based on a qualitative analysis and a formula allocation for similarly risk-rated loans by portfolio segment and
individually for impaired loans. The formula allocation provides the average loan loss experience for each portfolio segment, which considers our quarterly historical loss experience since the year 2000, both by risk-rating category and client industry sector. The resulting loan loss factors for each risk-rating category and client industry sector are ultimately applied to the respective period-end client loan balances for each corresponding risk-rating category by client industry sector to provide an estimation of the allowance for loan losses. The probable loan loss experience for any one year period of time is reasonably expected to be greater or less than the average as determined by the loss factors. As such, management applies a qualitative allocation to the results of the aforementioned model to ascertain the total allowance for loan losses. This qualitative allocation is based on management's assessment of the risks that may lead to a loan loss experience different from our historical loan loss experience. Based on management's prediction or estimate of changing risks in the lending environment, the qualitative allocation may vary significantly from period to period and includes, but is not limited to, consideration of the following factors:
Changes in lending policies and procedures, including underwriting standards and collections, and charge-off and recovery practices;
Changes in national and local economic business conditions, including the market and economic condition of our clients' industry sectors;
Changes in the nature of our loan portfolio;
Changes in experience, ability, and depth of lending management and staff;
Changes in the trend of the volume and severity of past due and classified loans;
Changes in the trend of the volume of nonaccrual loans, troubled debt restructurings and other loan modifications;
Reserve floor for portfolio segments that would not draw a minimum reserve based on the lack of historical loan loss experience;
Reserve for large funded loan exposure;
Reserve for performing impaired loan exposure; and
Other factors as determined by management from time to time.
While the evaluation process of our allowance for loan losses uses historical and other objective information, the classification of loans and the establishment of the allowance for loan losses rely, to a great extent, on the judgment and experience of our management.
Allowance for Unfunded Credit Commitments
Allowance for Unfunded Credit Commitments
We record a liability for probable and estimable incurred losses associated with our unfunded credit commitments being funded and subsequently being charged off. Each quarter, every unfunded client credit commitment is allocated to a credit risk-rating in accordance with each client's credit risk rating and portfolio segment. We use the segment specific historical loan loss factors described under our allowance for loan losses to calculate the loan loss experience if unfunded credit commitments are funded. Separately, we use historical trends to calculate a probability of an unfunded credit commitment being funded. We apply the loan funding probability factor to risk-factor adjusted unfunded credit commitments by credit risk-rating and portfolio segment to derive the allowance for unfunded credit commitments, similar to funded loans. The allowance for unfunded credit commitments also includes certain qualitative allocations as deemed appropriate by management. We include the allowance for unfunded credit commitments in other liabilities and the related provision in our provision for credit losses.
Uncollectible Loans and Write-offs
Uncollectible Loans and Write-offs
Our charge-off policy applies to all loans, regardless of portfolio segment. Commercial loans are considered for a full or partial charge-off in the event that principal or interest is over 180 days past due and the loan lacks sufficient collateral and it is not in the process of collection, provided that a loss event has been defined and the charge-off is consistent with GAAP. Consumer loans are considered for a full or partial charge-off in the event that principal or interest is over 120 days past due and the loan lacks sufficient collateral and it is not in the process of collection, provided that a loss event has been defined and the charge-off is consistent with GAAP. We also consider writing off loans in the event of any of the following circumstances: 1) the loan, or a portion of the loan is deemed uncollectible due to: a) the borrower's inability to make recurring payments, b) material changes in the borrower's financial condition, or c) the expected sale of all or a portion of the borrower's business is insufficient to repay the loan in full, or 2) the loan has been identified for charge-off by regulatory authorities.
Troubled Debt Restructurings (TDRs)
Troubled Debt Restructurings
A TDR arises from the modification of a loan where we have granted a concession to the borrower related to the borrower's financial difficulties that we would not have otherwise considered for economic or legal reasons. These concessions may include: (1) deferral of payment for more than an insignificant period of time that does not include sufficient offsetting borrower concessions; (2) interest rate reductions; (3) extension of the maturity date outside of ordinary course extension; (4) principal forgiveness; and/or (5) reduction of accrued interest.
We use the factors in ASC 310-40, Receivables, Troubled Debt Restructurings by Creditors, in analyzing when a borrower is experiencing financial difficulty, and when we have granted a concession, both of which must be present for a restructuring to meet the criteria of a TDR. If we determine that a TDR exists, we measure impairment based on the present value of expected future cash flows discounted at the loan's effective interest rate, except that as a practical expedient, we may also measure impairment based on a loan's observable market price, or the fair value of the collateral less selling costs if the loan is a collateral-dependent loan.
Impaired Loans
Impaired Loans
A loan is considered impaired when, based upon currently known information, it is deemed probable that we will be unable to collect all amounts due according to the contractual terms of the agreement. On a quarterly basis, we review our loan portfolio for impairment. Within each class of loans, we review individual loans for impairment based on credit risk ratings. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of "Performing (Criticized)" and could be classified as a performing impaired loan.
For each loan identified as impaired, we measure the impairment based upon the present value of expected future cash flows discounted at the loan's effective interest rate. In limited circumstances, we may measure impairment based on the loan's observable market price or the fair value of the collateral less selling costs if the loan is collateral dependent. Impaired collateral-dependent loans will have independent appraisals completed and accepted at least annually. The fair value of the collateral will be determined by the most recent appraisal, as adjusted to reflect a reasonable marketing period for the sale of the asset(s) and an estimate of reasonable selling expenses.
If it is determined that the value of an impaired loan is less than the recorded investment in the loan, net of previous charge-offs and payments collected, we recognize impairment through the allowance for loan losses as determined by our analysis.
Nonaccrual Loans
Nonaccrual Loans
Loans are placed on nonaccrual status when they become 90 days past due as to principal or interest payments (unless the principal and interest are well secured and in the process of collection); or when we have determined, based upon currently known information, that the timely collection of principal or interest is not probable.
When a loan is placed on nonaccrual status, the accrued interest and fees are reversed against interest income and the loan is accounted for using the cost recovery method thereafter until qualifying for return to accrual status. For a loan to be returned to accrual status, all delinquent principal and interest must become current in accordance with the terms of the loan agreement and future collection of remaining principal and interest must be deemed probable. We apply a cost recovery method in which all cash received is applied to the loan principal until it has been collected. Under this approach, interest income is recognized after total cash flows received exceed the recorded investment at the date of initial nonaccrual. All of our nonaccrual loans have credit risk ratings of 8 or 9 and are classified under the nonperforming impaired category.
Premises and Equipment
Premises and Equipment
Premises and equipment are reported at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets or the terms of the related leases, whichever is shorter. The maximum estimated useful lives by asset classification are as follows:
Leasehold improvements
 
 Lesser of lease term or asset life
Furniture and equipment
 
7 years
Computer software
 
 3-7 years
Computer hardware
 
 3-5 years

We capitalize the costs of computer software developed or obtained for internal use, including costs related to developed software, purchased software licenses and certain implementation costs.
For property and equipment that is retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is included in noninterest expense in consolidated net income.
Lease Obligations
Lease Obligations
We have entered into leases for real estate and various equipment utilized for the business. At the inception of the lease, each lease is evaluated to determine whether the lease will be accounted for as an operating or finance lease. We had no finance lease obligations at December 31, 2019 and 2018. We have made an accounting policy election not to recognize right-of-use assets and lease liabilities that arise from short-term leases for any class of underlying asset. In addition to excluding short-term leases, we have implemented an accounting policy in which non-lease components are not separated from lease components in the measurement of right-of-use ("ROU") asset and lease liabilities for all lease contracts.
ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
Business Combinations
Business Combinations
Business combinations are accounted for under the acquisition method of accounting. Acquired assets, including separately identifiable intangible assets, and assumed liabilities are recorded at their acquisition-date estimated fair values. The excess of the cost of acquisition over these fair values is recognized as goodwill. During the measurement period, which cannot exceed one year from the acquisition date, changes to estimated fair values are recognized as an adjustment to goodwill. Certain transaction costs are expensed as incurred.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
Goodwill is not amortized and is subject, at a minimum, to an annual impairment assessment. A quantitative assessment will be completed if we have not recently completed a fair value assessment of the associated reporting unit and compared the assessed fair value of that reporting unit with its carrying amount, including goodwill. Should we be required to calculate the fair value of the entity, we would generally apply a discounted cash flow analysis that uses forecasted performance estimates, and a discount rate leveraging a reporting unit specific capital asset pricing model, which in turn uses assumptions related to market performance and various macroeconomic and reporting unit specific risks. If this quantitative assessment was recently completed and if we deem the estimate to be current and reliable, we will not perform a full quantitative assessment of the reporting unit’s fair value for that reporting period. Instead, we will qualitatively determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount, including goodwill. As part of this qualitative analysis we consider macroeconomic factors that might impact the entity’s performance, entity-specific financial performance of the reporting unit, changes in management or strategy and other factors. We will evaluate goodwill for impairment more frequently if circumstances indicate that the fair value of our reporting units is less than their carrying value, including goodwill.
Fair Value Measurements
Fair Value Measurements
Our available-for-sale securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements.
Fair Value Measurement-Definition and Hierarchy
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows:
Level 1
Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities and certain marketable securities accounted for under fair value accounting.
Level 2
Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Valuations for the available-for-sale securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third parties to ensure that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. We ensure prices received from independent brokers represent a reasonable estimate of the fair value through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities:
U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark market interest rates, generally U.S. Treasury securities.
Agency-issued mortgage-backed securities: Agency-issued mortgage-backed securities are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor, and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark market interest rates taking into consideration estimated loan prepayment speeds.
Agency-issued collateralized mortgage obligations: Agency-issued collateralized mortgage obligations are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above.
Agency-issued commercial mortgage-backed securities: Fair value measurements of these securities are based on spreads to benchmark market interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans.
Foreign exchange forward and option contract assets and liabilities: Fair value measurements of these assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions.
Interest rate derivative and interest rate swap assets and liabilities: Fair value measurements of interest rate derivatives and interest rate swaps are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty.
Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions which typically range from three to six months.
Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions.
Level 3
The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach and/or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets:
Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Significant changes to any one of these inputs in isolation could result in a significant change in the fair value measurement; however, we generally consider all factors available through ongoing communication with the portfolio companies and venture capital fund managers to determine whether there are changes to the portfolio company or the environment that indicate a change in the fair value measurement.
Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.
Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement.

It is our policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements. When available, we use quoted market prices to measure fair value. If market prices are not available,
fair value measurement is based upon valuation approaches that use primarily market-based or independently-sourced market parameters, including interest rate yield curves, prepayment speeds, option volatilities and currency rates. Substantially all of our financial instruments use the foregoing methodologies, and are categorized as a Level 1 or Level 2 measurement in the fair value hierarchy. However, in certain cases, when market observable inputs for our valuation techniques may not be readily available, we are required to make judgments about assumptions we believe market participants would use in estimating the fair value of the financial instrument, and based on the significance of those judgments, the measurement may be determined to be a Level 3 fair value measurement.
The degree of management judgment involved in determining the fair value of a financial instrument is dependent upon the availability of quoted market prices or observable market parameters. For financial instruments that trade actively and have quoted market prices or observable market parameters, there is minimal subjectivity involved in measuring fair value. When observable market prices and parameters are not fully available, management judgment is necessary to estimate fair value. For inactive markets, there is little information, if any, to evaluate if individual transactions are orderly. Accordingly, we are required to estimate, based upon all available facts and circumstances, the degree to which orderly transactions are occurring and provide more weighting to price quotes that are based upon orderly transactions. In addition, changes in the market conditions may reduce the availability of quoted prices or observable data. For example, reduced liquidity in the capital markets or changes in secondary market activities could result in observable market inputs becoming unavailable. Therefore, when market data is not available, we use valuation techniques requiring more management judgment to estimate the appropriate fair value measurement. Accordingly, the degree of judgment exercised by management in determining fair value is greater for financial assets and liabilities categorized as Level 3.
Fee-based Services Revenue Recognition
Fee-based Services Revenue Recognition
Refer to Note 17—“Noninterest Income” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for our fee-based services revenue recognition policies for our contracts with customers.
Income Taxes
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Our federal, state and foreign income tax provisions are based upon taxes payable for the current year, current year changes in deferred taxes related to temporary differences between the tax basis and financial statement balances of assets and liabilities, and a reserve for uncertain tax positions. Deferred tax assets and liabilities are included in the consolidated financial statements at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. A valuation allowance is provided, when it is determined based upon available evidence, that it is more likely than not that some portion of the deferred tax asset will not be realized. We file a consolidated federal income tax return, and consolidated, combined, or separate state income tax returns as appropriate. Our foreign incorporated subsidiaries file tax returns in the applicable foreign jurisdictions. We record interest and penalties related to unrecognized tax benefits in other noninterest expense, a component of consolidated net income.
Share-Based Compensation
Share-Based Compensation
For all stock-based awards granted, stock-based compensation expense is amortized on a straight-line basis over the requisite service period, including consideration of vesting conditions and anticipated forfeitures. The fair value of stock options are measured using the Black-Scholes option-pricing model and the fair value for restricted stock awards and restricted stock units are based on the quoted price of our common stock on the date of grant.
Earnings Per Share
Earnings Per Share
Basic earnings per common share is computed using the weighted average number of common stock shares outstanding during the period. Diluted earnings per common share is computed using the weighted average number of common stock shares and potential common shares outstanding during the period. Potential common shares consist of stock options, ESPP shares and restricted stock units. Common stock equivalent shares are excluded from the computation if the effect is antidilutive.
Derivative Financial Instruments
Derivative Financial Instruments
All derivative instruments are recorded on the balance sheet at fair value. The accounting for changes in fair value of a derivative financial instrument depends on whether the derivative financial instrument is designated and qualifies as part of a hedging relationship and, if so, the nature of the hedging activity. Changes in fair value are recognized through earnings for derivatives that do not qualify for hedge accounting treatment, or that have not been designated in a hedging relationship.
Cash Flow Hedges
For derivative instruments that are designated and qualify as a cash flow hedge, changes in the fair value of the derivative are recorded in accumulated other comprehensive income and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815, Derivatives and Hedging ("ASC 815"), on a quarterly basis to ensure all hedges remain highly effective to ensure hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in accumulated other comprehensive income are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income.
Equity Warrant Assets
In connection with negotiated credit facilities and certain other services, we may obtain equity warrant assets giving us the right to acquire stock in primarily private, venture-backed companies in the technology and life science/healthcare industries. We hold these assets for prospective investment gains. We do not use them to hedge any economic risks nor do we use other derivative instruments to hedge economic risks stemming from equity warrant assets.
We account for equity warrant assets in certain private and public client companies as derivatives when they contain net settlement terms and other qualifying criteria under ASC 815. In general, equity warrant assets entitle us to buy a specific number of shares of stock at a specific price within a specific time period. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of certain future events. Substantially all of our warrant agreements contain net share settlement provisions, which permit us to receive at exercise a share count equal to the intrinsic value of the warrant divided by the share price (otherwise known as a “cashless” exercise). These equity warrant assets are recorded at fair value and are classified as derivative assets, a component of other assets, on our consolidated balance sheet at the time they are obtained.
The grant date fair values of equity warrant assets received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility.
Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income. We value our equity warrant assets using a Black-Scholes option pricing model, which incorporates the following significant inputs:
An underlying asset value, which is estimated based on current information available in valuation reports, including any information regarding subsequent rounds of funding or performance of a company.
Stated strike price, which can be adjusted for certain warrants upon the occurrence of subsequent funding rounds or other future events.
Price volatility or risk associated with possible changes in the warrant price. The volatility assumption is based on historical price volatility of publicly traded companies within indices similar in nature to the underlying client companies issuing the warrant. The actual volatility input is based on the mean and median volatility for an individual public company within an index for the past 16 quarters, from which an average volatility was derived.
Actual data on terminations and exercises of our warrants are utilized as the basis for determining the expected remaining life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or IPOs, and cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants.
The risk-free interest rate is derived from the Treasury yield curve and is calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant.
Other adjustments, including a marketability discount, are estimated based on management's judgment about the general industry environment.
Number of shares and contingencies associated with obtaining warrant positions such as the funding of associated loans.
When a portfolio company completes an IPO on a publicly reported market or is acquired, we may exercise these equity warrant assets for shares or cash. In the event of an exercise for common stock shares, the basis or value in the common stock shares is reclassified from other assets to investment securities on the balance sheet on the latter of the exercise date or corporate action date. The common stock of public companies are classified as non-marketable and other equity securities. Changes in the fair value of the common stock shares is recorded as gains or losses on investments securities, in noninterest income, a component of consolidated net income. The common stock of private companies are classified as non-marketable and other equity securities. We account for these securities under the methodology under ASU 2016-01, other investments without a readily determinable fair value. The carrying value in the private common stock without a readily determinable fair value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments and are recorded as gains or losses on investments securities, in noninterest income, a component of consolidated net income.
Foreign Exchange Forwards and Foreign Currency Option Contracts
We enter into foreign exchange forward contracts and foreign currency option contracts with clients involved in international activities, either as the purchaser or seller, depending upon the clients' need. We also enter into an opposite-way forward or option contract with a correspondent bank to economically hedge client contracts to mitigate the fair value risk to us from fluctuations in currency rates. Settlement, credit and operational risks remain. We also enter into forward contracts with correspondent banks to economically hedge currency exposure risk related to certain foreign currency denominated assets and liabilities. These contracts are not designated as hedging instruments and are recorded at fair value in our consolidated balance sheets. The contracts generally have terms of one year or less, although we may have contracts extending for up to five years. Generally, we have not experienced nonperformance on these contracts, have not incurred credit losses and anticipate performance by all counterparties to such agreements. Changes in the fair value of these contracts are recognized in consolidated net income under other noninterest income, a component of noninterest income. Period-end gross positive fair values are recorded in other assets and gross negative fair values are recorded in other liabilities.
Interest Rate Contracts
We sell interest rate contracts to clients who wish to mitigate their interest rate exposure. We economically reduce the interest rate risk from this business by entering into opposite-way contracts with correspondent banks. We do not designate any of these contracts (which are derivative instruments) as qualifying for hedge accounting. Contracts in an asset position are included in other assets and contracts in a liability position are included in other liabilities. The net change in the fair value of these derivatives is recorded through other noninterest income, in noninterest income, a component of consolidated net income.
Recent Accounting Pronouncements
Adoption of New Accounting Standards
In February 2016, the FASB issued a new Accounting Standard Update (ASU 2016-02, Leases (Topic 842)), which requires for all operating leases the recognition of a right-of-use ("ROU") asset and a corresponding lease liability, in the statement of financial position. For short term leases (term of 12 months or less), a lessee is permitted to make an accounting election not to recognize lease assets and lease liabilities. The lease cost is allocated over the lease term on a straight-line basis. There were further amendments, including practical expedients, with the issuance of ASU 2018-01, “Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842” in January 2018. In July 2018 the FASB issued ASU No. 2018-11, "Leases (Topic 842): Targeted Improvements", which provides us with the option to apply the new leasing standard to all open leases as of the adoption date, on a prospective basis.
On January 1, 2019, we adopted the new accounting standard ASU 2016-02, Leases (Topic 842) and all the related amendments ("new lease standard", "ASC 842" or "ASU 2016-02") utilizing the practical expedient to apply the new lease standard as of January 1, 2019 on a prospective basis. We also elected the "package of expedients" and elected as an accounting policy to exclude recording ROU assets and lease liabilities for leases that meet the definition of short-term leases. In addition to excluding short-term leases, we have implemented an accounting policy in which non-lease components are not separated from lease components in the measurement of ROU assets and lease liabilities for all lease contracts. The "package of expedients" allowed us to continue to account for existing leases for which the commencement date is before January 1, 2019, in accordance with
the previous guidance, Leases (Topic 840), throughout the lease term, including periods after adoption of the new guidance. We recognized $146 million in ROU assets and $178 million in lease liabilities as a result of applying the new lease standard as an adjustment to our opening consolidated balance sheet on January 1, 2019. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. See Note 12—"Leases" of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional disclosures related to our leases.
In March 2017, the FASB issued ASU No. 2017-08, Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which amends the amortization period for certain purchased callable debt securities held at a premium. The ASU requires entities to amortize premiums on debt securities by the first call date when the securities have fixed and determinable call dates and prices. The scope of the ASU includes all accounting premiums, such as purchase premiums and cumulative fair value hedge adjustments. The ASU does not change the accounting for discounts, which continue to be recognized over the contractual life of a security. Adoption of the ASU is on a modified retrospective basis through a cumulative effect adjustment to retained earnings as of the beginning of the year of adoption. Adoption of the ASU primarily affected our HTM portfolio of callable state and municipal debt securities. On January 1, 2019, we adopted the ASU and recognized a net reduction to retained earnings of $0.6 million.
Reclassifications
Reclassifications
Certain prior period amounts related to presentation changes to our financial statement line items have been reclassified to conform to current period presentations.
v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Summary of Ownership Interests in Investments Held Under Fair Value Accounting
A summary of our ownership interests in the investments held under fair value accounting as of December 31, 2019 is presented in the following table:
Limited partnership
 
Company Direct and Indirect Ownership in Limited Partnership
Managed funds of funds
 
 
Strategic Investors Fund, LP
 
12.6
%
Capital Preferred Return Fund, LP
 
20.0

Growth Partners, LP
 
33.0

Managed direct venture funds
 
 
CP I, LP
 
10.7

Maximum Estimated Useful Lives by Asset Classification The maximum estimated useful lives by asset classification are as follows:
Leasehold improvements
 
 Lesser of lease term or asset life
Furniture and equipment
 
7 years
Computer software
 
 3-7 years
Computer hardware
 
 3-5 years

v3.19.3.a.u2
Business Combination (Tables)
12 Months Ended
Dec. 31, 2019
Business Combinations [Abstract]  
Schedule of Business Combination, Consideration Transferred The following table summarizes the allocation of the purchase price to the net assets of SVB Leerink as of January 4, 2019:
(Dollars in thousands)
 
January 4, 2019
Cash paid
 
$
265,601

Replacement award liabilities (1)
 
7,629

Total purchase consideration
 
$
273,230

Fair value of net assets acquired
 
135,407

Goodwill
 
$
137,823

 
 
(1)
The replacement award liabilities recognized as part of the total purchase consideration and the post-combination expenses of $9.1 million related to share-based replacement awards will be paid out in cash in accordance with SVB Leerink's original grant date vesting schedules.
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the estimated fair value of assets acquired and liabilities assumed upon the finalization of the purchase:
(Dollars in thousands)
 
January 4, 2019
Assets acquired:
 
 
Cash and cash equivalents
 
$
163,273

Investment securities
 
33,644

Accounts receivable
 
36,538

Intangible assets
 
60,900

Other assets
 
35,128

Total assets acquired
 
329,483

Liabilities assumed:
 
 
Accrued compensation
 
137,206

Due to broker-dealers
 
18,483

Other liabilities
 
33,131

Noncontrolling interests
 
5,256

Total liabilities assumed
 
194,076

Fair value of net assets acquired
 
$
135,407


Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination
The following table summarizes the fair value and estimated useful lives of the other intangible assets at the date of acquisition:
(Dollars in thousands)
 
Estimated Fair Value
 
Weighted Average Estimated Useful Life - in Years
Other intangible assets:
 
 
 
 
Customer relationships
 
$
42,000

 
11.0
Other
 
18,900

 
9.9
Total other intangible assets
 
$
60,900

 
 

The components of net other intangible assets related to the acquisition of SVB Leerink were as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Gross Amount
 
Accumulated Amortization
 
Net Carrying Amount
Other intangible assets:
 
 
 
 
 
 
Customer relationships
 
$
42,000

 
$
3,818

 
$
38,182

Other
 
18,900

 
7,665

 
11,235

Total other intangible assets
 
$
60,900

 
$
11,483

 
$
49,417


Business Combination, Results of Acquiree Included in Combined Entity The following table represents the amount of revenue and earnings attributable to SVB Leerink that is included in our financial results for the year ended December 31, 2019:
(Dollars in thousands)
 
Year ended December 31, 2019
Net interest income
 
$
1,252

Noninterest income
 
265,841

Noninterest expense
 
252,678

Income before income tax expense
 
14,415

Income tax expense
 
3,566

Net income attributable to noncontrolling interests
 
1,325

Net income available to common stockholders
 
$
9,524


Restructuring and Related Costs
The following table shows the components of acquisition-related activities expense for the year ended December 31, 2019:
(Dollars in thousands)
 
Year ended December 31, 2019
Professional fees
 
$
919

Other
 
396

Total acquisition-related expenses
 
$
1,315


v3.19.3.a.u2
Stockholders' Equity and EPS (Tables)
12 Months Ended
Dec. 31, 2019
Equity and Earnings Per Share [Abstract]  
Reclassification out of Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
The following table summarizes the items reclassified out of accumulated other comprehensive income into the Consolidated Statements of Income for 2019, 2018 and 2017:
 
 
 
 
Year ended December 31,
(Dollars in thousands)
 
Income Statement Location
 
2019
 
2018
 
2017
Reclassification adjustment for losses on available-for-sale securities included in net income
 
Gains on investment securities, net
 
$
3,905

 
$
740

 
$
5,189

Related tax benefit
 
Income tax expense
 
(1,087
)
 
(205
)
 
(2,098
)
Reclassification adjustment for losses on cash flow hedges included in net income
 
Net interest income
 
5,358

 

 

Related tax benefit
 
Income tax expense
 
(1,489
)
 

 

Total reclassification adjustment for losses included in net income, net of tax
 
 
 
$
6,687

 
$
535

 
$
3,091


Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in accumulated other comprehensive income for 2019, 2018 and 2017. Over the next 12 months, we expect that approximately $3.2 million in accumulated other comprehensive income ("AOCI") at December 31, 2019, related to our cash flow hedges will be reclassified out of AOCI and recognized in net income.
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Balance, beginning of period, net of tax
 
$

 
$

 
$

Net decrease in fair value, net of tax
 
(5,999
)
 

 

Net realized loss reclassified to net income, net of tax
 
3,869

 

 

Balance, end of period, net of tax
 
$
(2,130
)
 
$

 
$



Reconciliation of Basic EPS to Diluted EPS The following is a reconciliation of basic EPS to diluted EPS for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars and shares in thousands, except per share amounts)
 
2019
 
2018
 
2017
Numerator:
 
 
 
 
 
 
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Denominator:
 
 
 
 
 
 
Weighted average common shares outstanding—basic
 
51,915

 
53,078

 
52,588

Weighted average effect of dilutive securities:
 
 
 
 
 
 
Stock options and ESPP
 
227

 
377

 
385

Restricted stock units
 
169

 
317

 
333

Weighted average common shares outstanding—diluted
 
52,311

 
53,772

 
53,306

Earnings per common share:
 
 
 
 
 
 
Basic
 
$
21.90

 
$
18.35

 
$
9.33

Diluted
 
21.73

 
18.11

 
9.20


Weighted Average Common Shares Excluded from Diluted EPS Calculation
The following table summarizes the weighted average common shares excluded from the diluted EPS calculation due to the antidilutive effect for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Shares in thousands)
 
2019

2018

2017
Stock options
 
167

 
59

 
73

Restricted stock units
 
250

 
85

 
1

Total
 
417

 
144

 
74


Schedule of Preferred Stock
The following table summarizes our preferred stock at December 31, 2019:
Series
 
Description
 
Amount outstanding (in millions)
 
Carrying value
(in millions)
 
Shares issued and outstanding
 
Par Value
 
Ownership interest per depository share
 
Liquidation preference per depository share
 
2019 dividends paid per depository share
Series A
 
5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock
 
$
350

 
$
340.1

 
350,000
 
$
0.001

 
1/40th
 
$
25

 
$


v3.19.3.a.u2
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Share Based Compensation and Related Benefits In 2019, 2018 and 2017, we recorded share-based compensation and related benefits as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Share-based compensation expense
 
$
66,815

 
$
45,675

 
$
36,900

Income tax benefit related to share-based compensation expense
 
(16,152
)
 
(10,997
)
 
(12,845
)
Capitalized compensation costs
 
1,517

 
1,466

 
1,071


Unrecognized Share Based Compensation Expense
As of December 31, 2019, unrecognized share-based compensation expense was as follows:
(Dollars in thousands)
 
Unrecognized 
Expense
 
Weighted Average Expected Recognition Period - in Years  
Stock options
 
$
14,313

 
2.52
Restricted stock awards/units
 
101,310

 
2.66
Total unrecognized share-based compensation expense
 
$
115,623

 
 

Weighted Average Assumptions and Fair Values Used for Employee Stock Options and Restricted Stock Units The following weighted average assumptions and fair values were used for our employee stock options and restricted stock units:
Equity Incentive Plan Awards
 
2019
 
2018
 
2017
Weighted average expected term of options - in years
 
4.6

 
4.8

 
4.9

Weighted average expected volatility of the Company's underlying common stock
 
35.5
%
 
34.7
%
 
33.7
%
Risk-free interest rate
 
2.26

 
2.82

 
1.81

Expected dividend yield
 

 

 

Weighted average grant date fair value - stock options
 
$
83.50

 
$
105.81

 
$
57.81

Weighted average grant date fair value - restricted stock units
 
243.65

 
294.50

 
181.23


Weighted Average Assumptions and Fair Values Used for ESPP
The following weighted average assumptions and fair values were used for our ESPP:
ESPP
 
2019
 
2018
 
2017
Expected term in years
 
0.5

 
0.5

 
0.5

Weighted average expected volatility of the Company's underlying common stock
 
38.1
%
 
32.2
%
 
31.2
%
Risk-free interest rate
 
2.40

 
1.79

 
0.80

Expected dividend yield
 

 

 

Weighted average grant date fair value
 
$
52.90

 
$
62.76

 
$
41.70


Stock Option Information Related to Equity Incentive Plan
The table below provides stock option information related to the 2006 Equity Incentive Plan for the year ended December 31, 2019:
 
 
Options
 
Weighted
Average
 Exercise Price 
 
Weighted Average Remaining Contractual Life - in Years  
 
Aggregate Intrinsic Value of 
In-The-Money Options
Outstanding at December 31, 2018
 
679,659

 
$
137.19

 
 
 
 
Granted
 
126,945

 
249.15

 
 
 
 
Exercised
 
(154,897
)
 
86.96

 
 
 
 
Forfeited
 
(25,580
)
 
213.26

 
 
 
 
Expired
 
(720
)
 
64.37

 
 
 
 
Outstanding at December 31, 2019
 
625,407

 
169.33

 
3.63
 
$
55,364,613

Vested and expected to vest at December 31, 2019
 
609,849

 
167.31

 
3.58
 
55,128,404

Exercisable at December 31, 2019
 
361,503

 
124.70

 
2.35
 
46,760,360


Stock Options Outstanding The following table summarizes information regarding stock options outstanding and exercisable as of December 31, 2019:
 
 
Outstanding Options
 
Exercisable Options
Range of Exercise Prices
 
Shares
 
Weighted Average Remaining Contractual Life - in Years
 
Weighted Average Exercise Price
 
Shares
 
Weighted Average Exercise Price
$71.11 - 105.14
 
55,724

 
0.43
 
$
73.67

 
55,724

 
$
73.67

105.15 - 105.84
 
114,449

 
3.33
 
105.18

 
79,188

 
105.18

105.85 - 108.59
 
99,936

 
1.33
 
107.94

 
99,936

 
107.94

108.60 - 149.65
 
67,573

 
2.26
 
129.13

 
67,573

 
129.13

149.66 - 180.62
 
80,583

 
4.34
 
178.07

 
37,320

 
178.04

180.63 - 247.01
 
11,966

 
6.18
 
226.22

 
1,578

 
210.73

247.02 - 255.58
 
117,265

 
6.33
 
250.43

 

 

255.59 - 315.12
 
75,647

 
5.33
 
305.18

 
19,617

 
304.39

315.13 - 324.77
 
2,264

 
5.60
 
324.77

 
567

 
324.77

Total
 
625,407

 
3.63
 
169.33

 
361,503

 
124.70


Information for Restricted Stock Units under Equity Incentive Plan
The table below provides information for restricted stock units under the 2006 Equity Incentive Plan for the year ended December 31, 2019:
 
 
Shares    
 
Weighted Average Grant Date Fair Value
Nonvested at December 31, 2018
 
597,296

 
$
194.48

Granted (1)
 
543,938

 
243.65

Vested
 
(227,707
)
 
154.96

Forfeited
 
(65,555
)
 
195.69

Nonvested at December 31, 2019
 
847,972

 
236.54

 
(1)
On February 1, 2019, we granted 125,160 restricted stock awards to SVB Leerink employees at a market price of $238.28 under the retention plan previously announced on November 13, 2018. The restricted stock awards will vest over a five-year period.

Summary of Information Regarding Stock Option and Restricted Stock Activity
The following table summarizes information regarding stock option and restricted stock unit activity during 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Total intrinsic value of stock options exercised
 
$
23,088

 
$
40,681

 
$
36,173

Total grant date fair value of stock options vested
 
5,735

 
5,823

 
6,094

Total intrinsic value of restricted stock vested
 
56,101

 
63,917

 
40,925

Total grant date fair value of restricted stock vested
 
35,191

 
28,813

 
23,383


v3.19.3.a.u2
Variable Interest Entities (Tables)
12 Months Ended
Dec. 31, 2019
Investments In Variable Interest Entities [Abstract]  
Schedule of Variable Interest Entities
The following table presents the carrying amounts and classification of significant variable interests in consolidated and unconsolidated VIEs as of December 31, 2019 and December 31, 2018:
(Dollars in thousands)
 
Consolidated VIEs
 
Unconsolidated VIEs
 
Maximum Exposure to Loss in Unconsolidated VIEs
December 31, 2019:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
7,629

 
$

 
$

Non-marketable and other equity securities (1)
 
270,057

 
689,360

 
689,360

Accrued interest receivable and other assets
 
1,117

 

 

Total assets
 
$
278,803

 
$
689,360

 
$
689,360

Liabilities:
 
 
 
 
 
 
Other liabilities (1)
 
2,854

 
302,031

 

Total liabilities
 
$
2,854

 
$
302,031

 
$

December 31, 2018:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
9,058

 
$

 
$

Non-marketable and other equity securities (1)
 
221,646

 
568,272

 
568,272

Accrued interest receivable and other assets
 
228

 

 

Total assets
 
$
230,932

 
$
568,272

 
$
568,272

Liabilities:
 
 
 
 
 
 
Other liabilities (1)
 
919

 
205,685

 

Total liabilities
 
$
919

 
$
205,685

 
$

 
(1)
Included in our unconsolidated non-marketable and other equity securities portfolio at December 31, 2019 and December 31, 2018 are investments in qualified affordable housing projects of $458.5 million and $318.6 million, respectively, and related other liabilities consisting of unfunded commitments of $302.0 million and $205.7 million, respectively.

v3.19.3.a.u2
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock (Tables)
12 Months Ended
Dec. 31, 2019
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]  
Average Required Reserve Balances
The tables below provide information on the required reserve balances at the Federal Reserve, as well as shares held at the FHLB and FRB for the years ended and as of December 31, 2019 and 2018:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Average required reserve balances at FRB San Francisco
 
$
315,784

 
$
455,866


Shares Held at Federal Reserve Bank and Federal Home Loan Bank
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
FHLB stock holdings
 
$
17,250

 
$
17,250

FRB stock holdings
 
43,008

 
41,628


v3.19.3.a.u2
Cash and Cash Equivalents (Tables)
12 Months Ended
Dec. 31, 2019
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents
The following table details our cash and cash equivalents at December 31, 2019 and December 31, 2018:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Cash and due from banks (1)
 
$
6,492,443

 
$
3,444,971

Securities purchased under agreements to resell (2)
 
289,340

 
123,611

Other short-term investment securities
 

 
2,957

Total cash and cash equivalents
 
$
6,781,783

 
$
3,571,539

 
(1)
At December 31, 2019 and 2018, $3.7 billion and $1.7 billion, respectively, of our cash and due from banks was deposited at the FRB and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were $2.1 billion and $1.2 billion, respectively.
(2)
At December 31, 2019 and 2018, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $295 million and $126 million, respectively. None of these securities were sold or repledged as of December 31, 2019 and 2018.
Securities Purchased Under Agreements to Resell
Additional information regarding our securities purchased under agreements to resell for 2019 and 2018 are as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Average securities purchased under agreements to resell
 
$
166,205

 
$
132,938

Maximum amount outstanding at any month-end during the year
 
613,247

 
375,180


v3.19.3.a.u2
Investment Securities (Tables)
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Major Components of Investment Securities Portfolio
The major components of our AFS investment securities portfolio at 2019 and 2018 are as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Carrying
Value
Available-for-sale securities, at fair value:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
6,815,874

 
$
82,267

 
$
(4,131
)
 
6,894,010

U.S. agency debentures
 
100,000

 

 
(453
)
 
99,547

Foreign government debt securities
 
9,037

 
1

 

 
9,038

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
4,109,372

 
39,438

 
(19
)
 
4,148,791

Agency-issued collateralized mortgage obligations—fixed rate
 
1,520,414

 
17,929

 

 
1,538,343

Agency-issued commercial mortgage-backed securities
 
1,339,651

 
1,078

 
(15,539
)
 
1,325,190

Total available-for-sale securities
 
$
13,894,348

 
$
140,713

 
$
(20,142
)
 
$
14,014,919

 
 
December 31, 2018
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Carrying
Value
Available-for-sale securities, at fair value:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
4,762,182

 
$
11,638

 
$
(35,562
)
 
$
4,738,258

U.S. agency debentures
 
1,090,426

 
61

 
(6,370
)
 
1,084,117

Foreign government debt securities
 
5,815

 

 
(3
)
 
5,812

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage obligations—fixed rate
 
1,922,618

 

 
(42,400
)
 
1,880,218

Agency-issued collateralized mortgage obligations—variable rate
 
81,270

 
383

 
(15
)
 
81,638

Total available-for-sale securities
 
$
7,862,311

 
$
12,082

 
$
(84,350
)
 
$
7,790,043


Schedule of Realized Gain (Loss)
The following table summarizes sale activity of available-for-sale securities as recorded in the line item “Gains on investment securities, net," a component of noninterest income:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Sales proceeds
 
$
2,189,087

 
$
474,482

 
$
580,871

Net realized gains and losses:
 

 

 

Gross realized gains
 
1,250

 
127

 
5,113

Gross realized losses
 
(5,155
)
 
(867
)
 
(10,302
)
Net realized losses
 
$
(3,905
)
 
$
(740
)
 
$
(5,189
)

Summary of Unrealized Losses on Available for Sale Securities
The following tables summarize our unrealized losses on our AFS securities portfolio into categories of less than 12 months, or 12 months or longer as of December 31, 2019 and 2018:
 
 
December 31, 2019
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
971,572

 
$
(3,996
)
 
$
449,850

 
$
(135
)
 
$
1,421,422

 
$
(4,131
)
U.S. agency debentures
 
99,547

 
(453
)
 

 

 
99,547

 
(453
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
4,014

 
(19
)
 

 

 
4,014

 
(19
)
Agency-issued commercial mortgage-backed securities
 
1,027,232

 
(15,539
)
 

 

 
1,027,232

 
(15,539
)
Total temporarily impaired securities (1)
 
$
2,102,365

 
$
(20,007
)
 
$
449,850

 
$
(135
)
 
$
2,552,215

 
$
(20,142
)
 
(1)
As of December 31, 2019, we identified a total of 58 investments that were in unrealized loss positions, of which 12 investments totaling $0.4 billion with unrealized losses of $0.1 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis.
 
 
December 31, 2018
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
494,287

 
$
(3,785
)
 
$
3,568,119

 
$
(31,777
)
 
$
4,062,406

 
$
(35,562
)
U.S. agency debentures
 
443,790

 
(1,602
)
 
591,216

 
(4,768
)
 
1,035,006

 
(6,370
)
Foreign government debt securities
 
5,812

 
(3
)
 

 

 
5,812

 
(3
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage obligations—fixed rate
 
13,430

 
(22
)
 
1,866,788

 
(42,378
)
 
1,880,218

 
(42,400
)
Agency-issued collateralized mortgage obligations—variable rate
 

 

 
13,516

 
(15
)
 
13,516

 
(15
)
Total temporarily impaired securities (1)
 
$
957,319

 
$
(5,412
)
 
$
6,039,639

 
$
(78,938
)
 
$
6,996,958

 
$
(84,350
)
 
(1)
As of December 31, 2018, we identified a total of 200 investments that were in unrealized loss positions, of which 162 investments totaling $6.0 billion with unrealized losses of $78.9 million have been in an impaired position for a period of time greater than 12 months.
Summary of Remaining Contractual Principal Maturities and Fully Taxable Equivalent Yields on Securities
The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of December 31, 2019 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for mortgage-backed securities may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. Mortgage-backed securities classified as AFS typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.
 
 
December 31, 2019
(Dollars in thousands)
 
Total
 
One Year
or Less
 
After One
Year to
Five Years
 
After Five
Years to
Ten Years
 
After
Ten Years
U.S. Treasury securities
 
$
6,894,010

 
$
1,835,971

 
$
1,890,778

 
$
3,167,261

 
$

U.S. agency debentures
 
99,547

 

 

 
99,547

 

Foreign government debt securities
 
9,038

 
9,038

 

 

 

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
Agency-issued collateralized mortgage-backed securities
 
4,148,791

 

 

 

 
4,148,791

Agency-issued collateralized mortgage obligations—fixed rate
 
1,538,343

 

 

 
1,858

 
1,536,485

Agency -issued commercial mortgage-backed securities
 
1,325,190

 

 

 
743,874

 
581,316

Total
 
$
14,014,919

 
$
1,845,009

 
$
1,890,778

 
$
4,012,540

 
$
6,266,592


The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of December 31, 2019. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected maturities for mortgage-backed securities may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. Mortgage-backed securities classified as HTM typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.
 
 
December 31, 2019
 
 
Total
 
One Year
or Less
 
After One Year to
Five Years
 
After Five Years to
Ten Years
 
After
Ten Years
(Dollars in thousands)
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
 
Amortized Cost
 
Fair Value
U.S. agency debentures
 
$
518,728

 
$
524,700

 
$

 
$

 
$
123,100

 
$
123,969

 
$
395,628

 
$
400,731

 
$

 
$

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
6,992,009

 
7,132,152

 
2,066

 
2,117

 
76,759

 
76,956

 
726,422

 
725,854

 
6,186,762

 
6,327,225

Agency-issued collateralized mortgage obligations - fixed rate
 
1,608,032

 
1,600,122

 

 

 

 

 
624,128

 
619,180

 
983,904

 
980,942

Agency-issued collateralized mortgage obligations - variable rate
 
178,611

 
178,446

 

 

 

 

 

 

 
178,611

 
178,446

Agency-issued commercial mortgage-backed securities
 
2,759,615

 
2,812,021

 

 

 

 

 
102,633

 
110,836

 
2,656,982

 
2,701,185

Municipal bonds and notes
 
1,785,951

 
1,867,831

 
13,973

 
13,984

 
83,368

 
84,773

 
387,278

 
403,736

 
1,301,332

 
1,365,338

Total
 
$
13,842,946

 
$
14,115,272

 
$
16,039

 
$
16,101

 
$
283,227

 
$
285,698

 
$
2,236,089

 
$
2,260,337

 
$
11,307,591

 
$
11,553,136


Held-to-maturity Securities
The components of our HTM investment securities portfolio at December 31, 2019 and 2018 are as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Held-to-maturity securities, at cost:
 
 
 
 
 
 
 
 
U.S. agency debentures (1)
 
$
518,728

 
$
6,640

 
$
(668
)
 
$
524,700

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
6,992,009

 
142,209

 
(2,066
)
 
7,132,152

Agency-issued collateralized mortgage obligations—fixed rate
 
1,608,032

 
592

 
(8,502
)
 
1,600,122

Agency-issued collateralized mortgage obligations—variable rate
 
178,611

 
94

 
(259
)
 
178,446

Agency-issued commercial mortgage-backed securities
 
2,759,615

 
56,914

 
(4,508
)
 
2,812,021

Municipal bonds and notes
 
1,785,951

 
83,314

 
(1,434
)
 
1,867,831

Total held-to-maturity securities
 
$
13,842,946

 
$
289,763

 
$
(17,437
)
 
$
14,115,272

 
(1)
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
 
 
December 31, 2018
(Dollars in thousands)
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Held-to-maturity securities, at cost:
 
 
 
 
 
 
 
 
U.S. agency debentures (1)
 
$
640,990

 
$
2,148

 
$
(4,850
)
 
$
638,288

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
8,103,638

 
5,011

 
(157,767
)
 
7,950,882

Agency-issued collateralized mortgage obligations—fixed rate
 
2,183,204

 

 
(62,272
)
 
2,120,932

Agency-issued collateralized mortgage obligations—variable rate
 
214,483

 
608

 
(14
)
 
215,077

Agency-issued commercial mortgage-backed securities
 
2,769,706

 
6,969

 
(64,374
)
 
2,712,301

Municipal bonds and notes
 
1,575,421

 
2,304

 
(26,969
)
 
1,550,756

Total held-to-maturity securities
 
$
15,487,442

 
$
17,040

 
$
(316,246
)
 
$
15,188,236

 
(1)
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
 
The following tables summarize our unrealized losses on our HTM securities portfolio into categories of less than 12 months and 12 months or longer as of December 31, 2019 and 2018:
 
 
December 31, 2019
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Held-to-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. agency debentures
 
$
125,304

 
$
(668
)
 
$

 
$

 
$
125,304

 
$
(668
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
132,042

 
(420
)
 
181,585

 
(1,646
)
 
313,627

 
(2,066
)
Agency-issued collateralized mortgage
    obligations—fixed rate
 
350,868

 
(1,131
)
 
872,527

 
(7,371
)
 
1,223,395

 
(8,502
)
Agency-issued collateralized mortgage
    obligations—variable rate
 
143,265

 
(256
)
 
4,615

 
(3
)
 
147,880

 
(259
)
Agency-issued commercial mortgage-backed
    securities
 
307,087

 
(1,818
)
 
310,229

 
(2,690
)
 
617,316

 
(4,508
)
Municipal bonds and notes
 
160,414

 
(1,434
)
 

 

 
160,414

 
(1,434
)
Total temporarily impaired securities (1)
 
$
1,218,980

 
$
(5,727
)
 
$
1,368,956

 
$
(11,710
)
 
$
2,587,936

 
$
(17,437
)
 

(1)
As of December 31, 2019, we identified a total of 266 investments that were in unrealized loss positions, of which 143 investments totaling $1.4 billion with unrealized losses of $11.7 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis, which is consistent with our classification of these securities. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary. Market valuations and impairment analyses on assets in the HTM securities portfolio are reviewed and monitored on a quarterly basis.
 
 
December 31, 2018
 
 
Less than 12 months
 
12 months or longer (1)
 
Total
(Dollars in thousands)
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
 
Fair Value of
Investments
 
Unrealized
Losses
Held-to-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. agency debentures
 
$
291,432

 
$
(2,915
)
 
$
66,624

 
$
(1,935
)
 
$
358,056

 
$
(4,850
)
Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
2,493,156

 
(34,956
)
 
3,972,690

 
(122,811
)
 
6,465,846

 
(157,767
)
Agency-issued collateralized mortgage obligations—fixed rate
 
16,952

 
(109
)
 
2,103,980

 
(62,163
)
 
2,120,932

 
(62,272
)
Agency-issued collateralized mortgage
  obligations—variable rate
 
3,364

 
(1
)
 
8,101

 
(13
)
 
11,465

 
(14
)
Agency-issued commercial mortgage-backed securities
 
177,697

 
(1,580
)
 
1,600,277

 
(62,794
)
 
1,777,974

 
(64,374
)
Municipal bonds and notes
 
868,751

 
(17,075
)
 
340,413

 
(9,894
)
 
1,209,164

 
(26,969
)
Total temporarily impaired securities (1)
 
$
3,851,352

 
$
(56,636
)
 
$
8,092,085

 
$
(259,610
)
 
$
11,943,437

 
$
(316,246
)
 
(1)
As of December 31, 2018, we identified a total of 1,244 investments that were in unrealized loss positions, of which 695 investments totaling $8.1 billion with unrealized losses of $259.6 million have been in an impaired position for a period of time greater than 12 months.
Schedule of Nonmarketable and Other Securities
The major components of our non-marketable and other equity securities portfolio at December 31, 2019 and 2018 are as follows:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Non-marketable and other equity securities:
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
Consolidated venture capital and private equity fund investments (1)
 
$
87,180

 
$
118,333

Unconsolidated venture capital and private equity fund investments (2)
 
178,217

 
201,098

Other investments without a readily determinable fair value (3)
 
55,255

 
25,668

Other equity securities in public companies (fair value accounting) (4)
 
59,200

 
20,398

Non-marketable securities (equity method accounting) (5):
 
 
 
 
Venture capital and private equity fund investments
 
215,367

 
129,485

Debt funds
 
7,271

 
5,826

Other investments
 
152,863

 
121,721

Investments in qualified affordable housing projects, net (6)
 
458,476

 
318,575

Total non-marketable and other equity securities
 
$
1,213,829

 
$
941,104

 
(1)
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at December 31, 2019 and 2018 (fair value accounting):
 
 
December 31, 2019
 
December 31, 2018
(Dollars in thousands)
 
Amount
 
Ownership %
 
Amount
 
Ownership %
Strategic Investors Fund, LP
 
$
5,729

 
12.6
%
 
$
12,452

 
12.6
%
Capital Preferred Return Fund, LP
 
45,341

 
20.0

 
53,957

 
20.0

Growth Partners, LP
 
35,976

 
33.0

 
50,845

 
33.0

CP I, LP
 
134

 
10.7

 
1,079

 
10.7

Total consolidated venture capital and private equity fund investments
 
$
87,180

 
 
 
$
118,333

 
 


(2)
The carrying value represents investments in 205 and 213 funds (primarily venture capital funds) at December 31, 2019 and December 31, 2018, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30th for our December 31st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)
These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.
The following table shows the carrying amount of other investments without a readily determinable fair value at December 31, 2019, and the amounts recognized in earnings for the year ended December 31, 2019 and on a cumulative basis:

(Dollars in thousands)
 
Year ended December 31, 2019
 
Cumulative Adjustments
Measurement alternative:
 
 
 
 
Carrying value at December 31, 2019
 
$
55,255

 
 
Carrying value adjustments:
 
 
 
 
Impairment
 
$
(460
)
 
$
(460
)
Upward changes for observable prices
 
1,929

 
2,348

Downward changes for observable prices
 
(3,511
)
 
(5,030
)
(4)
Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets, direct equity investments in public companies held by our consolidated funds, and exchange traded funds held by SVB Leerink. Changes in equity securities measured at fair value are recognized through net income.

(5)
The following table shows the carrying value and our ownership percentage of each investment at December 31, 2019 and 2018 (equity method accounting):
 
 
December 31, 2019
 
December 31, 2018
(Dollars in thousands)
 
Amount
 
Ownership %
 
Amount
 
Ownership %
Venture capital and private equity fund investments:
 
 
 
 
 
 
 
 
Strategic Investors Fund II, LP
 
$
3,612

 
8.6
%
 
$
4,670

 
8.6
%
Strategic Investors Fund III, LP
 
15,668

 
5.9

 
17,396

 
5.9

Strategic Investors Fund IV, LP
 
27,064

 
5.0

 
28,974

 
5.0

Strategic Investors Fund V funds
 
46,830

 
Various

 
28,189

 
Various

CP II, LP (i)
 
5,907

 
5.1

 
7,122

 
5.1

Other venture capital and private equity fund investments
 
116,286

 
Various

 
43,134

 
Various

 Total venture capital and private equity fund investments
 
$
215,367

 


 
$
129,485

 
 
Debt funds:
 
 
 
 
 
 
 
 
Gold Hill Capital 2008, LP (ii)
 
$
5,525

 
15.5
%
 
$
3,901

 
15.5
%
Other debt funds
 
1,746

 
Various

 
1,925

 
Various

Total debt funds
 
$
7,271

 
 
 
$
5,826

 
 
Other investments:
 
 
 
 
 
 
 
 
SPD Silicon Valley Bank Co., Ltd.
 
$
74,190

 
50.0
%
 
$
76,412

 
50.0
%
Other investments
 
78,673

 
Various

 
45,309

 
Various

Total other investments
 
$
152,863

 
 
 
$
121,721

 
 
 

(i)
Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.
(ii)
Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

(6)
The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of "other liabilities" on our consolidated balance sheets at December 31, 2019 and 2018:
(Dollars in thousands)
 
December 31, 2019
 
December 31, 2018
Investments in qualified affordable housing projects, net
 
$
458,476

 
$
318,575

Other liabilities
 
302,031

 
205,685


The following table presents other information relating to our investments in qualified affordable housing projects for the years ended December 31, 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Tax credits and other tax benefits recognized
 
$
35,037

 
$
24,047

 
$
17,296

Amortization expense included in provision for income taxes (i)
 
28,267

 
18,876

 
17,362

 
 
(i)
All investments are amortized using the proportional amortization method and amortization expense is included in the provision for income taxes. Included in amortization expense for the year ended December 31, 2017 is a one-time cumulative effect adjustment of $3.8 million due to the decrease in value of deductions in the 2018 tax year and going forward, due to the TCJ Act federal corporate income tax rate reduction.
Net Gains on Non-marketable and Other Equity Securities
The following table presents the net gains and losses on non-marketable and other equity securities in 2019, 2018 and 2017 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Net gains (losses) on non-marketable and other equity securities:
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Consolidated venture capital and private equity fund investments
 
$
22,507

 
$
20,999

 
$
27,186

Unconsolidated venture capital and private equity fund investments (1)
 
31,482

 
39,075

 
21,377

Other investments without a readily determinable fair value (1)
 
2,742

 
3,206

 
3,842

Other equity securities in public companies (fair value accounting) (1)
 
7,772

 
(25,483
)
 
241

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments
 
73,813

 
49,341

 
14,472

Debt funds
 
1,647

 
541

 
8,950

Other investments
 
(1,388
)
 
1,155

 
(6,276
)
Total net gains on non-marketable and other equity securities
 
$
138,575

 
$
88,834

 
$
69,792

Less: Realized net gains (losses) on the sales and OTTI of non-marketable and other equity securities (2)
 
4,744

 
(26,097
)
 
(355
)
Net gains on non-marketable and other equity securities still held
 
$
133,831

 
$
114,931

 
$
70,147

 
 
(1)
Presentation for year-ended December 31, 2017 amounts are not determined in a manner consistent with the December 31, 2018 and 2019 presentation due to the adoption of ASU 2016-01.
(2)
Realized gains and losses include sales and OTTI of non-marketable and other equity securities. Includes gains of $5.2 million on sales and $0.4 million of OTTI for the period ended December 31, 2019. Includes losses of $20.8 million and gains of $3.8 million on sales and $5.3 million and $4.2 million of OTTI for the periods ended December 31, 2018 and 2017, respectively.A summary of gains and losses on investment securities for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Gains on non-marketable and other equity securities, net
 
$
138,575

 
$
88,834

 
$
69,792

Losses on sales of available-for-sale debt securities, net
 
(3,905
)
 
(740
)
 
(5,189
)
Total gains on investment securities, net
 
$
134,670

 
$
88,094

 
$
64,603


v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments (Tables)
12 Months Ended
Dec. 31, 2019
Receivables [Abstract]  
Loans and Allowance for Loan Losses
The composition of loans, net of unearned income of $163 million and $173 million at December 31, 2019 and 2018, respectively, is presented in the following table:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Commercial loans:
 
 
 
 
Software/internet
 
$
6,199,548

 
$
6,154,755

Hardware
 
1,371,159

 
1,234,557

Private equity/venture capital
 
17,801,324

 
14,110,560

Life science/healthcare
 
2,368,048

 
2,385,612

Premium wine
 
267,487

 
249,266

Other
 
420,555

 
321,978

Total commercial loans
 
28,428,121

 
24,456,728

Real estate secured loans:
 
 
 
 
Premium wine (1)
 
820,730

 
710,397

Consumer loans (2)
 
3,286,737

 
2,612,971

Other
 
38,880

 
40,435

Total real estate secured loans
 
4,146,347

 
3,363,803

Construction loans
 
100,219

 
97,077

Consumer loans
 
489,949

 
420,672

Total loans, net of unearned income (3)
 
$
33,164,636

 
$
28,338,280

 
(1)
Included in our premium wine portfolio are gross construction loans of $83 million and $99 million at December 31, 2019 and 2018, respectively.
(2)
Consumer loans secured by real estate at December 31, 2019 and 2018 were comprised of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loans for personal residence
 
$
2,829,880

 
$
2,251,292

Loans to eligible employees
 
401,396

 
290,194

Home equity lines of credit
 
55,461

 
71,485

Consumer loans secured by real estate
 
$
3,286,737

 
$
2,612,971


(3)
Included within our total loan portfolio are credit card loans of $395 million and $335 million at December 31, 2019 and 2018, respectively.
Composition of Loans, Net of Unearned Income, Broken Out by Portfolio Segment and Class of Financing Receivable
The composition of loans, net of unearned income of $163 million and $173 million at December 31, 2019 and 2018, respectively, broken out by portfolio segment and class of financing receivable, is as follows:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Commercial loans:
 
 
 
 
Software/internet
 
$
6,199,548

 
$
6,154,755

Hardware
 
1,371,159

 
1,234,557

Private equity/venture capital
 
17,801,324

 
14,110,560

Life science/healthcare
 
2,368,048

 
2,385,612

Premium wine
 
1,088,217

 
959,663

Other
 
559,654

 
459,490

Total commercial loans
 
29,387,950

 
25,304,637

Consumer loans:
 
 
 
 
Real estate secured loans
 
3,286,737

 
2,612,971

Other consumer loans
 
489,949

 
420,672

Total consumer loans
 
3,776,686

 
3,033,643

Total loans, net of unearned income
 
$
33,164,636

 
$
28,338,280


Aging of Gross Loans, Broken out by Portfolio Segment and Class of Financing Receivable
The following table summarizes the aging of our gross loans, broken out by portfolio segment and class of financing receivable as of December 31, 2019 and 2018:
(Dollars in thousands)
 
30 - 59
  Days Past  
Due
 
60 - 89
  Days Past  
Due
 
Equal to or Greater Than 90 Days Past Due
 
  Total Past  
Due
 
Current  
 
  Loans Past Due 90 Days or More Still Accruing Interest
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
19,839

 
$
4,225

 
$

 
$
24,064

 
$
6,136,230

 
$

Hardware
 
104

 
18,084

 

 
18,188

 
1,357,379

 

Private equity/venture capital
 
97,893

 
383

 
3,150

 
101,426

 
17,715,964

 
3,150

Life science/healthcare
 
445

 
8,420

 

 
8,865

 
2,387,203

 

Premium wine
 
7,543

 

 

 
7,543

 
1,070,111

 

Other
 
9

 
24

 

 
33

 
579,446

 

Total commercial loans
 
125,833

 
31,136

 
3,150

 
160,119

 
29,246,333

 
3,150

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
6,282

 

 
365

 
6,647

 
3,271,318

 
365

Other consumer loans
 
164

 
283

 

 
447

 
489,831

 

Total consumer loans
 
6,446

 
283

 
365

 
7,094

 
3,761,149

 
365

Total gross loans excluding impaired loans
 
132,279

 
31,419

 
3,515

 
167,213

 
33,007,482

 
3,515

Impaired loans
 
5,096

 
6,805

 
12,473

 
24,374

 
128,635

 

Total gross loans
 
$
137,375

 
$
38,224

 
$
15,988

 
$
191,587

 
$
33,136,117

 
$
3,515

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
28,134

 
$
6,944

 
$
378

 
$
35,456

 
$
6,059,672

 
$
378

Hardware
 
300

 
34

 
4

 
338

 
1,233,956

 
4

Private equity/venture capital
 
59,481

 
11

 

 
59,492

 
14,054,940

 

Life science/healthcare
 
16,082

 
817

 
19

 
16,918

 
2,410,091

 
19

Premium wine
 
2,953

 
14

 

 
2,967

 
956,285

 

Other
 
7,391

 
163

 
1

 
7,555

 
477,442

 
1

Total commercial loans
 
114,341

 
7,983

 
402

 
122,726

 
25,192,386

 
402

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,598

 
1,750

 
1,562

 
6,910

 
2,598,496

 
1,562

Other consumer loans
 
361

 

 

 
361

 
420,359

 

Total consumer loans
 
3,959

 
1,750

 
1,562

 
7,271

 
3,018,855

 
1,562

Total gross loans excluding impaired loans
 
118,300

 
9,733

 
1,964

 
129,997

 
28,211,241

 
1,964

Impaired loans
 
2,843

 
1,181

 
25,092

 
29,116

 
140,958

 

Total gross loans
 
$
121,143

 
$
10,914

 
$
27,056

 
$
159,113

 
$
28,352,199

 
$
1,964






Impaired Loans and Allowance for Loan Losses, Broken out by Portfolio Segment and Class of Financing Receivable
The following table summarizes our impaired loans as they relate to our allowance for loan losses, broken out by portfolio segment and class of financing receivable for the years ended December 31, 2019 and 2018:
(Dollars in thousands)
 
Impaired loans for 
which there is a related allowance for loan losses
 
Impaired loans for 
which there is no related allowance for loan losses
 
Total carrying value of impaired loans
 
Total unpaid principal of impaired loans   
December 31, 2019:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software/internet
 
$
64,100

 
$
31,472

 
$
95,572

 
$
109,736

Hardware
 
2,143

 
3,315

 
5,458

 
10,049

Private equity/venture capital
 

 

 

 

Life science/healthcare
 
25,941

 
5,671

 
31,612

 
70,600

Premium wine
 
204

 
11,718

 
11,922

 
12,010

Other
 
1,284

 
1,681

 
2,965

 
3,114

Total commercial loans
 
93,672

 
53,857

 
147,529

 
205,509

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
1,766

 
3,714

 
5,480

 
8,527

Total consumer loans
 
1,766

 
3,714

 
5,480

 
8,527

Total
 
$
95,438

 
$
57,571

 
$
153,009

 
$
214,036

December 31, 2018:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software/internet
 
$
49,625

 
$
65,225

 
$
114,850

 
$
131,858

Hardware
 
1,256

 
10,250

 
11,506

 
12,159

Private equity/venture capital
 

 
3,700

 
3,700

 
3,700

Life science/healthcare
 
17,791

 
16,276

 
34,067

 
44,446

Premium wine
 

 
1,301

 
1,301

 
1,365

Other
 
411

 

 
411

 
411

Total commercial loans
 
69,083

 
96,752

 
165,835

 
193,939

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,919

 
320

 
4,239

 
5,969

Total consumer loans
 
3,919

 
320

 
4,239

 
5,969

Total
 
$
73,002

 
$
97,072

 
$
170,074

 
$
199,908



Average Impaired Loans, Broken out by Portfolio Segment and Class of Financing Receivable
The following table summarizes our average impaired loans and interest income recognized on impaired loans, broken out by portfolio segment and class of financing receivable during 2019, 2018 and 2017:
Year ended December 31,
(Dollars in thousands)
 
Average impaired loans
 
Interest income recognized on impaired loans
 
2019

2018

2017
 
2019
 
2018
 
2017
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
88,628

 
$
112,493

 
$
119,557

 
$
2,813

 
$
1,513

 
$
2,263

Hardware
 
12,500

 
28,540

 
35,022

 
464

 
312

 
1,061

Private equity/venture capital
 
2,264

 
1,327

 
556

 

 

 

Life science/healthcare
 
44,827

 
30,144

 
30,842

 
919

 
756

 
90

Premium wine
 
2,912

 
2,605

 
3,249

 
311

 
68

 
152

Other
 
2,050

 
171

 
576

 
21

 

 

Total commercial loans
 
153,181

 
175,280

 
189,802

 
4,528

 
2,649

 
3,566

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
7,159

 
4,028

 
1,514

 
54

 
15

 

Other consumer loans
 
7

 
358

 
1,804

 

 

 

Total consumer loans
 
7,166

 
4,386

 
3,318

 
54

 
15

 

Total average impaired loans
 
$
160,347

 
$
179,666

 
$
193,120

 
$
4,582

 
$
2,664

 
$
3,566


Activity in Allowance for Loan Losses Broken out by Portfolio Segment
The following tables summarize the activity relating to our allowance for loan losses for 2019, 2018 and 2017 broken out by portfolio segment:
Year ended December 31, 2019
(Dollars in thousands)
 
Beginning Balance December 31, 2018
 
Charge-offs
 
Recoveries
 
Provision for Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2019
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
103,567

 
$
(46,930
)
 
$
11,363

 
$
31,766

 
$
457

 
$
100,223

Hardware
 
19,725

 
(10,056
)
 
7,069

 
2,740

 
166

 
19,644

Private equity/venture capital
 
98,581

 
(2,047
)
 
2,047

 
16,989

 
235

 
115,805

Life science/healthcare
 
32,180

 
(31,950
)
 
267

 
38,178

 
570

 
39,245

Premium wine
 
3,355

 
(174
)
 

 
1,813

 
154

 
5,148

Other
 
3,558

 
(415
)
 
36

 
328

 
(154
)
 
3,353

Total commercial loans
 
260,966

 
(91,572
)
 
20,782

 
91,814

 
1,428

 
283,418

Consumer loans
 
19,937

 
(1,031
)
 
256

 
2,369

 
(25
)
 
21,506

Total allowance for loan losses
 
$
280,903

 
$
(92,603
)
 
$
21,038

 
$
94,183

 
$
1,403

 
$
304,924

Year ended December 31, 2018
(Dollars in thousands)
 
Beginning Balance December 31, 2017
 
Charge-offs
 
Recoveries
 
Provision for (Reduction of) Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2018
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
96,104

 
$
(42,315
)
 
$
5,664

 
$
45,068

 
$
(954
)
 
$
103,567

Hardware
 
27,614

 
(16,148
)
 
1,849

 
6,555

 
(145
)
 
19,725

Private equity/venture capital
 
82,468

 
(112
)
 
13

 
16,485

 
(273
)
 
98,581

Life science/healthcare
 
24,924

 
(6,662
)
 
348

 
14,347

 
(777
)
 
32,180

Premium wine
 
3,532

 

 

 
(182
)
 
5

 
3,355

Other
 
3,941

 
(2,391
)
 
3,275

 
(1,320
)
 
53

 
3,558

Total commercial loans
 
238,583

 
(67,628
)
 
11,149

 
80,953

 
(2,091
)
 
260,966

Consumer loans
 
16,441

 
(289
)
 
487

 
3,339

 
(41
)
 
19,937

Total allowance for loan losses
 
$
255,024

 
$
(67,917
)
 
$
11,636

 
$
84,292

 
$
(2,132
)
 
$
280,903


    
Year ended December 31, 2017
(Dollars in thousands)
 
Beginning Balance December 31, 2016
 
Charge-offs
 
Recoveries
 
Provision for (Reduction of) Loan Losses
 
Foreign Currency Translation Adjustments
 
Ending Balance December 31, 2017
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
97,388

 
$
(45,012
)
 
$
4,649

 
$
38,462

 
$
617

 
$
96,104

Hardware
 
31,166

 
(10,414
)
 
487

 
6,051

 
324

 
27,614

Private equity/venture capital
 
50,299

 
(323
)
 

 
31,625

 
867

 
82,468

Life science/healthcare
 
25,446

 
(8,210
)
 
189

 
7,414

 
85

 
24,924

Premium wine
 
4,115

 

 

 
(540
)
 
(43
)
 
3,532

Other
 
4,768

 
(1,156
)
 
1,850

 
(1,459
)
 
(62
)
 
3,941

Total commercial loans
 
213,182

 
(65,115
)
 
7,175

 
81,553

 
1,788

 
238,583

Consumer loans
 
12,184

 
(1,567
)
 
1,363

 
4,386

 
75

 
16,441

Total allowance for loan losses
 
$
225,366

 
$
(66,682
)
 
$
8,538

 
$
85,939

 
$
1,863

 
$
255,024


Allowance for Unfunded Commitments
The following table summarizes the activity relating to our allowance for unfunded credit commitments for 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Allowance for unfunded credit commitments, beginning balance
 
$
55,183

 
$
51,770

 
$
45,265

Provision for unfunded credit commitments
 
12,233

 
3,578

 
6,365

Foreign currency translation adjustments
 
240

 
(165
)
 
140

Allowance for unfunded credit commitments, ending balance (1)
 
$
67,656

 
$
55,183

 
$
51,770

 
(1)
The “allowance for unfunded credit commitments” is included as a component of “other liabilities” on our consolidated balance sheets. See Note 22—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional disclosures related to our commitments to extend credit.
Allowance for Loan Losses Individually and Collectively Evaluated for Impairment
The following table summarizes the allowance for loan losses individually and collectively evaluated for impairment as of December 31, 2019 and 2018, broken out by portfolio segment:
 
 
December 31, 2019
 
December 31, 2018
 
 
Individually Evaluated for Impairment
 
Collectively Evaluated for  
Impairment
 
Individually Evaluated for Impairment
 
Collectively Evaluated for  
Impairment
(Dollars in thousands)
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
 
Allowance for loan losses
 
Recorded investment in loans
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
26,613

 
$
95,572

 
$
73,610

 
$
6,103,976

 
$
28,527

 
$
114,850

 
$
75,040

 
$
6,039,905

Hardware
 
1,214

 
5,458

 
18,430

 
1,365,701

 
1,253

 
11,506

 
18,472

 
1,223,051

Private equity/venture capital
 

 

 
115,805

 
17,801,324

 

 
3,700

 
98,581

 
14,106,860

Life science/healthcare
 
16,414

 
31,612

 
22,831

 
2,336,436

 
7,484

 
34,067

 
24,696

 
2,351,545

Premium wine
 
204

 
11,922

 
4,944

 
1,076,295

 

 
1,301

 
3,355

 
958,362

Other
 
203

 
2,965

 
3,150

 
556,689

 
411

 
411

 
3,147

 
459,079

Total commercial loans
 
44,648

 
147,529

 
238,770

 
29,240,421

 
37,675

 
165,835

 
223,291

 
25,138,802

Total consumer loans
 
211

 
5,480

 
21,295

 
3,771,206

 
266

 
4,239

 
19,671

 
3,029,404

Total
 
$
44,859

 
$
153,009

 
$
260,065

 
$
33,011,627

 
$
37,941

 
$
170,074

 
$
242,962

 
$
28,168,206


Credit Quality Indicators, Broken out by Portfolio Segment and Class of Financing Receivables
The following table summarizes the credit quality indicators, broken out by portfolio segment and class of financing receivables as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Pass
 
  Performing 
(Criticized)  
 
Performing Impaired (Criticized)
 
Nonperforming Impaired (Nonaccrual)
 
Total
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
5,704,283

 
$
456,011

 
$
28,417

 
$
67,155

 
$
6,255,866

Hardware
 
1,266,077

 
109,490

 
3,315

 
2,143

 
1,381,025

Private equity/venture capital
 
17,813,128

 
4,262

 

 

 
17,817,390

Life science/healthcare
 
2,197,679

 
198,389

 
5,211

 
26,401

 
2,427,680

Premium wine
 
1,053,021

 
24,633

 
11,717

 
205

 
1,089,576

Other
 
571,040

 
8,439

 
1,680

 
1,285

 
582,444

Total commercial loans
 
28,605,228

 
801,224

 
50,340


97,189

 
29,553,981

Consumer loans:
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
3,266,748

 
11,217

 

 
5,480

 
3,283,445

Other consumer loans
 
489,903

 
375

 

 

 
490,278

Total consumer loans
 
3,756,651

 
11,592

 

 
5,480

 
3,773,723

Total gross loans
 
$
32,361,879

 
$
812,816

 
$
50,340

 
$
102,669

 
$
33,327,704

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software/internet
 
$
5,574,332

 
$
520,796

 
$
48,069

 
$
66,781

 
$
6,209,978

Hardware
 
1,146,985

 
87,309

 
10,250

 
1,256

 
1,245,800

Private equity/venture capital
 
14,098,281

 
16,151

 

 
3,700

 
14,118,132

Life science/healthcare
 
2,291,356

 
135,653

 
16,276

 
17,791

 
2,461,076

Premium wine
 
909,965

 
49,287

 
1,017

 
284

 
960,553

Other
 
467,653

 
17,344

 

 
411

 
485,408

Total commercial loans
 
24,488,572

 
826,540

 
75,612

 
90,223

 
25,480,947

Consumer loans:
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
2,584,261

 
21,145

 
320

 
3,919

 
2,609,645

Other consumer loans
 
419,771

 
949

 

 

 
420,720

Total consumer loans
 
3,004,032

 
22,094

 
320

 
3,919

 
3,030,365

Total gross loans
 
$
27,492,604

 
$
848,634

 
$
75,932

 
$
94,142

 
$
28,511,312


Summary of Loans Modified in Troubled Debt Restructurings ("TDRs") by Portfolio Segment and Class of Financing Receivables The following table summarizes our loans modified in TDRs, broken out by portfolio segment and class of financing receivables at December 31, 2019 and 2018:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loans modified in TDRs:
 
 
 
 
Commercial loans:
 
 
 
 
Software/internet
 
$
71,136

 
$
58,089

Hardware
 
1,685

 
9,665

Life science/healthcare
 
20,600

 
12,738

Premium wine
 
13,457

 
2,883

Total commercial loans
 
106,878

 
83,375

Consumer loans:
 
 
 
 
Other consumer loans
 
2,104

 
320

Total loans modified in TDRs
 
$
108,982

 
$
83,695


Recorded Investment in Loans Modified in TDRs
The following table summarizes the recorded investment in loans modified in TDRs, broken out by portfolio segment and class of financing receivable, for modifications made during 2019, 2018 and 2017:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Loans modified in TDRs during the period:
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
Software/internet
 
$
62,367

 
$
30,429

 
$
42,184

Hardware
 
1,685

 
9,665

 
51,132

Private equity/venture capital
 

 

 
350

Life science/healthcare
 
13,309

 
660

 

Premium wine
 
11,017

 

 
177

Total commercial loans
 
88,378

 
40,754

 
93,843

Consumer loans:
 
 
 
 
 
 
Other consumer loans
 
1,793

 
320

 

Total loans modified in TDRs during the period (1)
 
$
90,171

 
$
41,074

 
$
93,843

 
(1)
There were $11.3 million, $4.6 million and $3.0 million of partial charge-offs during 2019, 2018 and 2017, respectively.
Recorded Investment in Loans Modified in TDRs within Previous 12 months Subsequently Defaulted
The following table summarizes the recorded investment in loans modified in TDRs within the previous 12 months that subsequently defaulted during their respective periods, broken out by portfolio segment and class of financing receivable, during 2019, 2018 and 2017:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
TDRs modified within the previous 12 months that defaulted during the period:
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
Software/internet
 
$
37,294

 
$

 
$

Life science/healthcare
 
10,639

 

 

Total TDRs modified within the previous 12 months that defaulted in the period
 
$
47,933

 
$

 
$


v3.19.3.a.u2
Premises and Equipment (Tables)
12 Months Ended
Dec. 31, 2019
Property, Plant and Equipment [Abstract]  
Schedule of Premises and Equipment
Premises and equipment at December 31, 2019 and 2018 consisted of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Computer software
 
$
261,643

 
$
217,017

Computer hardware
 
82,643

 
70,247

Leasehold improvements
 
121,907

 
98,237

Furniture and equipment
 
46,300

 
42,319

Total
 
512,493

 
427,820

Accumulated depreciation and amortization
 
(350,617
)
 
(298,607
)
Premises and equipment, net
 
$
161,876

 
$
129,213


v3.19.3.a.u2
Leases (Tables)
12 Months Ended
Dec. 31, 2019
Leases [Abstract]  
Schedule of Lease Assets And Liabilities
Total recorded balances for the lease assets and liabilities are as follows:
(Dollars in thousands)
 
December 31, 2019

Assets:
 
 
Right-of-use assets - operating leases (1)
 
$
197,365

Liabilities:
 
 
Lease liabilities - operating leases (1)
 
218,847


 
(1)
Included in these amounts are $21.7 million and $30.0 million of ROU assets and lease liabilities, respectively, attributable to the inclusion of SVB Leerink in our financial results at December 31, 2019.
Lease Expense Components
The components of our lease cost and supplemental cash flow information related to leases for the year ended December 31, 2019 were as follows:
 (Dollars in thousands)
 
2019
Operating lease cost
 
$
41,049

Short-term lease cost
 
1,823

Variable lease cost
 
3,477

Less: sublease income
 
(4,492
)
Total lease expense, net
 
$
41,857

Supplemental cash flows information:
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Cash paid for operating leases
 
$
44,976

Noncash items during the period:
 
 
Lease obligations in exchange for obtaining right-of-use assets:
 
 
Operating leases
 
$
33,167


Lessee, Operating Lease, Liability, Maturity
The following table presents our undiscounted future cash payments for our operating lease liabilities as of December 31, 2019:
Years ended December 31,
(Dollars in thousands)
 
Operating Leases
2020
 
$
44,791

2021
 
42,683

2022
 
37,669

2023
 
36,914

2024
 
26,602

2025 and thereafter
 
52,128

Total lease payments (1)
 
$
240,787

Less: imputed interest
 
(21,940
)
Total lease liabilities
 
$
218,847

 
(1)
As of December 31, 2019, we have additional leases that have not yet commenced. We estimate that we will record additional lease liabilities of $29.1 million upon commencement. These leases will commence in 2020 with lease terms of two to five years.
Schedule of Future Minimum Rental Payments for Operating Leases
The following table presents minimum future payments under noncancelable operating leases under ASC 840 as of December 31, 2018:
(Dollars in thousands)
 
Amount
2019
 
$
38,609

2020
 
37,575

2021
 
35,854

2022
 
31,659

2023
 
30,904

2024 and thereafter
 
49,071

Total minimum future payments
 
$
223,672


v3.19.3.a.u2
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in goodwill were as follows for the year ended December 31, 2019:
(Dollars in thousands)
 
Goodwill
Beginning balance at December 31, 2018
 
$

Acquisitions (1)
 
137,823

Ending balance at December 31, 2019
 
$
137,823

 
(1)
All reported goodwill amounts have been allocated to the SVB Leerink reporting segment and are expected to be deductible for tax purposes. Refer to Note 25—“Segment Reporting” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional information.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination
The following table summarizes the fair value and estimated useful lives of the other intangible assets at the date of acquisition:
(Dollars in thousands)
 
Estimated Fair Value
 
Weighted Average Estimated Useful Life - in Years
Other intangible assets:
 
 
 
 
Customer relationships
 
$
42,000

 
11.0
Other
 
18,900

 
9.9
Total other intangible assets
 
$
60,900

 
 

The components of net other intangible assets related to the acquisition of SVB Leerink were as follows:
 
 
December 31, 2019
(Dollars in thousands)
 
Gross Amount
 
Accumulated Amortization
 
Net Carrying Amount
Other intangible assets:
 
 
 
 
 
 
Customer relationships
 
$
42,000

 
$
3,818

 
$
38,182

Other
 
18,900

 
7,665

 
11,235

Total other intangible assets
 
$
60,900

 
$
11,483

 
$
49,417


Finite-lived Intangible Assets Amortization Expense
For the year ended December 31, 2019, we recorded amortization expense of $11.5 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of December 31, 2019:
Years ended December 31,
(Dollars in thousands)
 
Other
Intangible Assets
2020
 
$
5,382

2021
 
4,732

2022
 
4,732

2023
 
4,732

2024
 
4,732

2025 and thereafter
 
25,107

Total future amortization expense
 
$
49,417


v3.19.3.a.u2
Deposits (Tables)
12 Months Ended
Dec. 31, 2019
Deposits [Abstract]  
Composition of Deposits
The following table presents the composition of our deposits at December 31, 2019 and 2018:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Noninterest-bearing demand
 
$
40,841,570

 
$
39,103,422

Interest-bearing checking and savings accounts
 
568,256

 
648,468

Money market
 
17,749,736

 
7,498,205

Money market deposits in foreign offices
 
352,437

 
152,781

Sweep deposits in foreign offices
 
2,057,715

 
1,875,298

Time
 
188,093

 
50,726

Total deposits
 
$
61,757,807

 
$
49,328,900


v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt (Tables)
12 Months Ended
Dec. 31, 2019
Debt Disclosure [Abstract]  
Outstanding Short Term Borrowings and Long Term Debt
The following table represents outstanding short-term borrowings and long-term debt at December 31, 2019 and 2018:
 
 
 
 
 
 
Carrying Value
(Dollars in thousands)
 
Maturity
 
Principal value at December 31, 2019
 
December 31,
2019
 
December 31,
2018
Short-term borrowings:
 
 
 
 
 
 
 
 
Short-term FHLB advances
 

 


 
$

 
$
300,000

Securities sold under agreement to repurchase
 
(1)
 

 

 
319,414

Other short-term borrowings
 
(2)
 
$
17,430

 
17,430

 
11,998

Total short-term borrowings
 
 
 
 
 
$
17,430

 
$
631,412

Long-term debt:
 
 
 
 
 
 
 
 
3.50% Senior Notes
 
January 29, 2025
 
$
350,000

 
$
347,987

 
$
347,639

5.375% Senior Notes
 

 


 

 
348,826

Total long-term debt
 
 
 
 
 
$
347,987

 
$
696,465

 
(1)
Securities sold under repurchase agreements are effectively short-term borrowings collateralized by U.S. Treasury securities.
(2)
Represents cash collateral received from certain counterparties in relation to market value exposures of derivative contracts in our favor.
Aggregate Annual Maturities of Long-Term Debt Obligations
The aggregate annual maturities of long-term debt obligations as of December 31, 2019 are as follows:
Year ended December 31,
(Dollars in thousands)
 
Amount
2020
 
$

2021
 

2022
 

2023
 

2024
 

2025 and thereafter
 
347,987

Total
 
$
347,987


v3.19.3.a.u2
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments
The total notional or contractual amounts and fair value of our derivative financial instruments at December 31, 2019 and 2018 were as follows:
 
 
December 31, 2019
 
December 31, 2018
 
 
Notional or
Contractual
Amount
 
Fair Value
 
Notional or
Contractual
Amount
 
Fair Value
(Dollars in thousands)
 
 
Derivative Assets (1)
 
Derivative Liabilities (1)
 
 
Derivative Assets (1)
 
Derivative Liabilities (1)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 Interest rate risks:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
1,915,000

 
$
22,676

 
$

 
$

 
$

 
$

Interest rate swaps
 
3,085,000

 

 
25,623

 

 

 

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 Currency exchange risks:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
 

 

 

 
263,733

 
4,767

 

Foreign exchange forwards
 
300,250

 

 
2,154

 
178,310

 

 
1,094

 Other derivative instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets
 
225,893

 
165,473

 

 
223,532

 
149,238

 

Client foreign exchange forwards
 
4,661,517

 
114,546

 

 
2,759,878

 
93,876

 

Client foreign exchange forwards
 
4,326,059

 

 
94,745

 
2,568,085

 

 
85,706

Client foreign currency options
 
154,985

 
1,308

 

 
93,556

 
1,759

 

Client foreign currency options
 
154,985

 

 
1,308

 
93,579

 

 
1,759

Client interest rate derivatives (2)
 
1,275,190

 
28,811

 

 
1,020,416

 
8,499

 

Client interest rate derivatives (2)
 
1,372,914

 

 
14,154

 
1,337,328

 

 
9,491

Total Derivatives not designated as hedging instruments
 
 
 
310,138

 
112,361

 


 
258,139

 
98,050

Total derivatives
 
 
 
$
332,814

 
$
137,984

 
 
 
$
258,139

 
$
98,050

 
(1)
Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.
(2)
The amount reported reflects reductions of approximately $17.4 million of derivative liabilities and $0.4 million of derivative assets at December 31, 2019 and 2018, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.
Summary of Derivative Activity and Related Impact on Consolidated Statements of Income
A summary of our derivative activity and the related impact on our consolidated statements of income for 2019, 2018 and 2017 is as follows:
 
 
 
 
Year ended December 31,
(Dollars in thousands)
 
Statement of income location   
 
2019
 
2018
 
2017
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 Interest rate risks:
 
 
 
 
 
 
 
 
Amounts reclassified from accumulated other comprehensive income into income
 
Interest income—loans
 
$
(5,358
)
 
$

 
$

Net cash benefit associated with interest rate swaps
 
Interest expense—borrowings
 

 

 
1,053

Changes in fair value of interest rate swaps
 
Other noninterest income
 

 

 
(7
)
Net (losses) gains associated with interest rate risk derivatives
 
 
 
$
(5,358
)
 
$

 
$
1,046

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 Currency exchange risks:
 
 
 
 
 
 
 
 
Gains (losses) on revaluations of internal foreign currency instruments, net
 
Other noninterest income
 
$
1,444

 
$
(373
)
 
$
33,161

(Losses) gains on internal foreign exchange forward contracts, net
 
Other noninterest income
 
(1,853
)
 
52

 
(32,286
)
Net (losses) gains associated with internal currency risk
 
 
 
$
(409
)
 
$
(321
)
 
$
875

 Other derivative instruments:
 
 
 
 
 
 
 
 
(Losses) gains on revaluations of client foreign currency instruments, net
 
Other noninterest income
 
$
(15,146
)
 
$
4,998

 
$
10,882

Gains (losses) on client foreign exchange forward contracts, net
 
Other noninterest income
 
15,900

 
(4,011
)
 
(9,969
)
Net gains associated with client currency risk
 
 
 
$
754

 
$
987

 
$
913

Net gains on equity warrant assets
 
Gains on equity warrant assets, net
 
$
138,078

 
$
89,142

 
$
54,555

Net losses on other derivatives
 
Other noninterest income
 
$
(1,190
)
 
$
(179
)
 
$
(564
)



Offsetting Assets The following table summarizes our assets subject to enforceable master netting arrangements as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Gross Amounts of Recognized Assets
 
Gross Amounts offset in the Statement of Financial Position
 
Net Amounts of Assets Presented in the Statement of Financial Position
 
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
 
Net Amount
 
 
 
 
Financial Instruments
 
Cash Collateral Received (1)
 
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
22,676

 
$

 
$
22,676

 
$
(22,598
)
 
$

 
$
78

Foreign exchange forwards
 
114,546

 

 
114,546

 
(36,855
)
 
(17,095
)
 
60,596

Foreign currency options
 
1,308

 

 
1,308

 
(848
)
 
(335
)
 
125

Client interest rate derivatives
 
28,811

 

 
28,811

 
(28,811
)
 

 

Total derivative assets:
 
167,341

 

 
167,341

 
(89,112
)
 
(17,430
)
 
60,799

Reverse repurchase, securities borrowing, and similar arrangements
 
289,340

 

 
289,340

 
(289,340
)
 

 

Total
 
$
456,681

 
$

 
$
456,681

 
$
(378,452
)
 
$
(17,430
)
 
$
60,799

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
 
$
98,643

 
$

 
$
98,643

 
$
(38,213
)
 
$
(11,825
)
 
$
48,605

Foreign currency options
 
1,759

 

 
1,759

 
(613
)
 
(90
)
 
1,056

Client interest rate derivatives
 
8,499

 

 
8,499

 
(8,416
)
 
(83
)
 

Total derivative assets:
 
108,901

 

 
108,901

 
(47,242
)
 
(11,998
)
 
49,661

Reverse repurchase, securities borrowing, and similar arrangements
 
123,611

 

 
123,611

 
(123,611
)
 

 

Total
 
$
232,512

 
$

 
$
232,512

 
$
(170,853
)
 
$
(11,998
)
 
$
49,661


 
(1)
Cash collateral received from our counterparties in relation to market value exposures of derivative contracts in our favor is recorded as a component of “short-term borrowings” on our consolidated balance sheets.
Offsetting Liabilities
The following table summarizes our liabilities subject to enforceable master netting arrangements as of December 31, 2019 and 2018:
(Dollars in thousands)
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts offset in the Statement of Financial Position
 
Net Amounts of Liabilities Presented in the Statement of Financial Position
 
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
 
Net Amount
 
 
 
 
Financial Instruments
 
Cash Collateral Pledged (1)
 
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
   Interest rate swaps
 
$
25,623

 
$

 
$
25,623

 
$
(22,676
)
 
$
(2,947
)
 
$

   Foreign exchange forwards
 
96,899

 

 
96,899

 
(33,314
)
 
(22,030
)
 
41,555

   Foreign currency options
 
1,308

 

 
1,308

 
(531
)
 

 
777

   Client interest rate derivatives
 
14,154

 

 
14,154

 

 
(13,936
)
 
218

Total derivative liabilities:
 
137,984

 

 
137,984

 
(56,521
)
 
(38,913
)
 
42,550

Repurchase, securities lending, and similar arrangements
 

 

 

 

 

 

Total
 
$
137,984

 
$

 
$
137,984

 
$
(56,521
)
 
$
(38,913
)
 
$
42,550

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
   Foreign exchange forwards
 
$
86,800

 
$

 
$
86,800

 
$
(24,778
)
 
$
(20,732
)
 
$
41,290

   Foreign currency options
 
1,759

 

 
1,759

 
(1,054
)
 

 
705

   Client interest rate derivatives
 
9,491

 

 
9,491

 

 
(9,207
)
 
284

Total derivative liabilities:
 
98,050

 

 
98,050

 
(25,832
)
 
(29,939
)
 
42,279

Repurchase, securities lending, and similar arrangements
 
319,414

 

 
319,414

 

 

 
319,414

Total
 
$
417,464

 
$

 
$
417,464

 
$
(25,832
)
 
$
(29,939
)
 
$
361,693

 
(1)
Cash collateral pledged to our counterparties in relation to market value exposures of derivative contracts in a liability position and repurchase agreements are recorded as a component of “cash and cash equivalents" on our consolidated balance sheets.
v3.19.3.a.u2
Noninterest Income (Tables)
12 Months Ended
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]  
Summary of Noninterest Income A summary of noninterest income for the years ended December 31, 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Noninterest income:
 
 
 
 
 
 
Gains on investment securities, net
 
$
134,670

 
$
88,094

 
$
64,603

Gains on equity warrant assets, net
 
138,078

 
89,142

 
54,555

Client investment fees
 
182,068

 
130,360

 
56,136

Foreign exchange fees
 
159,262

 
138,812

 
115,760

Credit card fees
 
118,719

 
94,072

 
76,543

Deposit service charges
 
89,200

 
76,097

 
58,715

Lending related fees
 
49,920

 
41,949

 
43,265

Letters of credit and standby letters of credit fees
 
42,669

 
34,600

 
28,544

Investment banking revenue
 
195,177

 

 

Commissions
 
56,346

 

 

Other
 
55,370

 
51,858

 
59,110

Total noninterest income
 
$
1,221,479

 
$
744,984

 
$
557,231


Summary of Gains and Losses on Investment Securities
The following table presents the net gains and losses on non-marketable and other equity securities in 2019, 2018 and 2017 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Net gains (losses) on non-marketable and other equity securities:
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Consolidated venture capital and private equity fund investments
 
$
22,507

 
$
20,999

 
$
27,186

Unconsolidated venture capital and private equity fund investments (1)
 
31,482

 
39,075

 
21,377

Other investments without a readily determinable fair value (1)
 
2,742

 
3,206

 
3,842

Other equity securities in public companies (fair value accounting) (1)
 
7,772

 
(25,483
)
 
241

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments
 
73,813

 
49,341

 
14,472

Debt funds
 
1,647

 
541

 
8,950

Other investments
 
(1,388
)
 
1,155

 
(6,276
)
Total net gains on non-marketable and other equity securities
 
$
138,575

 
$
88,834

 
$
69,792

Less: Realized net gains (losses) on the sales and OTTI of non-marketable and other equity securities (2)
 
4,744

 
(26,097
)
 
(355
)
Net gains on non-marketable and other equity securities still held
 
$
133,831

 
$
114,931

 
$
70,147

 
 
(1)
Presentation for year-ended December 31, 2017 amounts are not determined in a manner consistent with the December 31, 2018 and 2019 presentation due to the adoption of ASU 2016-01.
(2)
Realized gains and losses include sales and OTTI of non-marketable and other equity securities. Includes gains of $5.2 million on sales and $0.4 million of OTTI for the period ended December 31, 2019. Includes losses of $20.8 million and gains of $3.8 million on sales and $5.3 million and $4.2 million of OTTI for the periods ended December 31, 2018 and 2017, respectively.A summary of gains and losses on investment securities for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Gains on non-marketable and other equity securities, net
 
$
138,575

 
$
88,834

 
$
69,792

Losses on sales of available-for-sale debt securities, net
 
(3,905
)
 
(740
)
 
(5,189
)
Total gains on investment securities, net
 
$
134,670

 
$
88,094

 
$
64,603


Components of Gains on Equity Warrant Assets A summary of net gains on equity warrant assets for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Equity warrant assets:
 
 
 
 
 
 
Gains on exercises, net
 
$
107,168

 
$
58,186

 
$
48,275

Terminations
 
(3,502
)
 
(5,964
)
 
(4,422
)
Changes in fair value, net
 
34,412

 
36,920

 
10,702

Total net gains on equity warrant assets
 
$
138,078

 
$
89,142

 
$
54,555


Components of Asset Management Fees A summary of client investment fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Client investment fees by type:
 
 
 
 
 
 
Sweep money market fees
 
$
104,236

 
$
75,654

 
$
28,485

Asset management fees (1)
 
28,665

 
23,882

 
16,831

Repurchase agreement fees
 
49,167

 
30,824

 
10,820

Total client investment fees (2)
 
$
182,068

 
$
130,360

 
$
56,136

 
(1)
Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.
(2)
Represents fees earned on client investment funds which are maintained at third-party financial institutions and are not recorded on our balance sheet.
Components of Foreign Exchange Fees A summary of foreign exchange fee income by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Foreign exchange fees by instrument type:
 
 
 
 
 
 
Spot contract commissions
 
$
145,915

 
$
127,459

 
$
104,344

Forward contract commissions
 
13,068

 
10,940

 
10,934

Option premium fees
 
279

 
413

 
482

Total foreign exchange fees
 
$
159,262

 
$
138,812

 
$
115,760


Components of Credit Card Fees A summary of credit card fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Credit card fees by instrument type:
 
 
 
 
 
 
Card interchange fees, net
 
$
93,553

 
$
74,381

 
$
60,224

Merchant service fees
 
18,355

 
14,420

 
11,584

Card service fees
 
6,811

 
5,271

 
4,735

Total credit card fees
 
$
118,719

 
$
94,072

 
$
76,543


Components of Lending Related Fees A summary of lending related fees by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Lending related fees by instrument type:
 
 
 
 
 
 
Unused commitment fees
 
$
34,829

 
$
32,452

 
$
34,110

Other
 
15,091

 
9,497

 
9,155

Total lending related fees
 
$
49,920

 
$
41,949

 
$
43,265


Schedule of Investment Banking Revenue
A summary of investment banking revenue by instrument type for 2019, 2018 and 2017 is as follows:
  
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Investment banking revenue:
 
 
 
 
 
 
Underwriting fees
 
$
153,306

 
$

 
$

Advisory fees
 
37,846

 

 

Private placements and other
 
4,025

 

 

Total investment banking revenue
 
$
195,177

 
$

 
$


Summary of Other Noninterest Income
A summary of other noninterest income by instrument type for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Other noninterest income by instrument type:
 
 
 
 
 
 
Fund management fees
 
$
32,522

 
$
23,016

 
$
21,214

Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)
 
345

 
666

 
1,788

(Losses) gains on extinguishment of debt
 
(8,960
)
 

 
2,731

Other service revenue
 
31,463

 
28,176

 
33,377

Total other noninterest income
 
$
55,370

 
$
51,858

 
$
59,110


 

(1)
Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.
Disaggregation of Revenue
The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the years ended December 31, 2019 and 2018:

(Dollars in thousands)
 
Global
Commercial
Bank (2)
 
SVB Private  
Bank
 
SVB Capital (2)
 
SVB Leerink (2)
 
Other Income
 
Total      
Revenue from contracts with customers:
 
 
 
 
 
 
 
 
 
 
 
 
Client investment fees
 
$
180,152

 
$
1,916

 
$

 
$

 
$

 
$
182,068

Spot contract commissions
 
144,930

 
510

 

 

 
475

 
145,915

Card interchange fees, gross
 
154,197

 

 

 

 
756

 
154,953

Merchant service fees
 
18,355

 

 

 

 

 
18,355

Deposit service charges
 
88,136

 
137

 

 

 
927

 
89,200

Investment banking revenue
 

 

 

 
195,177

 

 
195,177

Commissions
 

 

 

 
56,346

 

 
56,346

Fund management fees
 

 

 
26,850

 
5,672

 

 
32,522

Correspondent bank rebates
 
6,415

 

 

 

 

 
6,415

Total revenue from contracts with customers
 
$
592,185

 
$
2,563

 
$
26,850

 
$
257,195

 
$
2,158

 
$
880,951

Revenues outside the scope of ASC 606 (1)
 
45,737

 
803

 
95,544

 
7,321

 
191,123

 
340,528

Total noninterest income
 
$
637,922

 
$
3,366

 
$
122,394

 
$
264,516

 
$
193,281

 
$
1,221,479

 
(1)
Amounts are accounted for under separate guidance than ASC 606.
(2)
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

(Dollars in thousands)
 
Global
Commercial
Bank (2)
 
SVB Private  
Bank
 
SVB Capital (2)
 
Other Income
 
Total      
Revenue from contracts with customers:
 
 
 
 
 
 
 
 
 
 
Client investment fees (3)
 
$
128,834

 
$
1,526

 
$

 
$

 
$
130,360

Spot contract commissions
 
126,445

 
691

 

 
323

 
127,459

Card interchange fees, gross
 
134,074

 

 

 
428

 
134,502

Merchant service fees
 
14,415

 
4

 

 
1

 
14,420

Deposit service charges
 
74,348

 
108

 

 
1,641

 
76,097

Fund management fees
 

 

 
23,016

 

 
23,016

Correspondent bank rebates
 
5,802

 

 

 

 
5,802

Total revenue from contracts with customers
 
$
483,918

 
$
2,329

 
$
23,016

 
$
2,393

 
$
511,656

Revenues outside the scope of ASC 606 (1)
 
36,384

 
(48
)
 
78,165

 
118,827

 
233,328

Total noninterest income
 
$
520,302

 
$
2,281

 
$
101,181

 
$
121,220

 
$
744,984

 
(1)
Amounts are accounted for under separate guidance than ASC 606.
(2)
Global Commercial Bank’s and SVB Capital’s components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."
(3)
For the year ended December 31, 2018, the amount of client investment fees previously reported as "Other Items" has been correctly allocated to the reportable segment "Global Commercial Bank" to properly reflect the source of such revenue. The correction of this immaterial error had no impact on the "Total" amount of client investment fees.
v3.19.3.a.u2
Other Noninterest Expense (Tables)
12 Months Ended
Dec. 31, 2019
Other Income and Expenses [Abstract]  
Schedule of Other Noninterest Expense
A summary of other noninterest expense for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Lending and other client related processing costs
 
$
28,491

 
$
24,237

 
$
23,768

Correspondent bank fees
 
14,503

 
13,713

 
12,976

Investment banking activities
 
13,733

 

 

Trade order execution costs
 
10,813

 

 

Data processing services
 
12,536

 
10,811

 
10,251

Telephone
 
9,861

 
9,404

 
10,647

Dues and publications
 
4,603

 
4,605

 
3,263

Postage and supplies
 
3,198

 
2,799

 
2,797

Other
 
54,841

 
21,682

 
21,419

Total other noninterest expense
 
$
152,579

 
$
87,251

 
$
85,121


v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Components of Provision for Income Taxes The components of our provision for income taxes for 2019, 2018 and 2017 were as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Current provision:
 
 
 
 
 
 
Federal
 
$
296,400

 
$
249,358

 
$
263,231

State
 
132,357

 
123,264

 
67,046

Deferred (benefit) expense:
 
 
 
 
 
 
Federal
 
(1,530
)
 
(11,777
)
 
24,654

State
 
(1,542
)
 
(9,284
)
 
532

Income tax expense
 
$
425,685

 
$
351,561

 
$
355,463


Reconciliation between Federal Statutory Income Tax Rate and Effective Income Tax Rate
Our effective tax rate is calculated by dividing income tax expense by the sum of income before income tax expense and the net income attributable to noncontrolling interests. The reconciliation between the federal statutory income tax rate and our effective income tax rate for 2019, 2018 and 2017, is as follows:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Federal statutory income tax rate
 
21.0
 %
 
21.0
 %
 
35.0
 %
State income taxes, net of the federal tax effect
 
7.0

 
7.2

 
5.8

Net deferred tax assets revaluation (TCJ Act)
 

 

 
4.3

Meals and entertainment
 
0.4

 
0.3

 
0.3

Disallowed officers' compensation
 
0.2

 
0.2

 
0.1

FDIC premiums
 
0.2

 
0.5

 

Share-based compensation expense on incentive stock options and ESPP
 
(0.6
)
 
(1.4
)
 
(2.1
)
Qualified affordable housing project tax credits
 
(0.3
)
 
(0.3
)
 
(0.4
)
Tax-exempt interest income
 
(0.6
)
 
(0.6
)
 
(0.3
)
Other, net
 
(0.1
)
 
(0.4
)
 
(0.7
)
Effective income tax rate
 
27.2
 %
 
26.5
 %
 
42.0
 %

Deferred Tax Assets (Liabilities)
Deferred tax assets and liabilities at December 31, 2019 and 2018, consisted of the following:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Deferred tax assets:
 
 
 
 
Allowance for loan losses
 
$
103,267

 
$
93,580

Net unrealized losses on AFS debt securities
 

 
19,704

Share-based compensation expense
 
14,233

 
10,642

State income taxes
 
16,097

 
13,854

Accrued compensation
 
22,578

 
8,291

Deferred rent
 

 
7,940

Lease liability
 
60,635

 

Other accruals
 
12,383

 
7,061

Net operating loss
 
6,386

 
2,447

Goodwill and intangibles
 
3,141

 

Other
 
7,923

 
11,339

Deferred tax assets
 
246,643

 
174,858

Valuation allowance
 
(5,919
)
 
(2,107
)
Net deferred tax assets after valuation allowance
 
240,724

 
172,751

 
 
 
 
 
Deferred tax liabilities:
 
 
 
 
Derivative equity warrant assets
 
(45,533
)
 
(32,861
)
Change in accounting method (section 481(a))
 
(1,841
)
 
(8,034
)
Net unrealized gains on AFS debt securities
 
(33,480
)
 

Non-marketable and other equity securities
 
(54,239
)
 
(45,759
)
Premises and equipment and other intangibles
 
(16,459
)
 
(10,284
)
Right-of-use asset and deferred rent assets
 
(50,493
)
 

Other
 
(10,246
)
 
(10,380
)
Deferred tax liabilities
 
(212,291
)
 
(107,318
)
Net deferred tax assets
 
$
28,433

 
$
65,433


Changes in Unrecognized Tax Benefit (Including Interest and Penalties)
A summary of changes in our unrecognized tax benefit (including interest and penalties) for December 31, 2019, 2018 and 2017 is as follows:
(Dollars in thousands)
 
Reconciliation of Unrecognized Tax Benefit
 
Interest and Penalties
 
Total
Balance at December 31, 2016
 
$
5,269

 
$
442

 
$
5,711

Additions for tax positions for current year
 
3,141

 

 
3,141

Additions for tax positions for prior years
 
3,378

 
754

 
4,132

Reduction for tax positions for prior years
 
(223
)
 
(1
)
 
(224
)
Lapse of the applicable statute of limitations
 
(60
)
 
(17
)
 
(77
)
Balance at December 31, 2017
 
$
11,505

 
$
1,178

 
$
12,683

Additions for tax positions for current year
 
4,171

 

 
4,171

Additions for tax positions for prior years
 
631

 
823

 
1,454

Reduction for tax positions for prior years
 
(1,865
)
 
(243
)
 
(2,108
)
Lapse of the applicable statute of limitations
 
(435
)
 
(86
)
 
(521
)
Reduction as a result of settlement
 
(1,318
)
 
(222
)
 
(1,540
)
Balance at December 31, 2018
 
$
12,689

 
$
1,450

 
$
14,139

Additions for tax positions for current year
 
3,712

 

 
3,712

Additions for tax positions for prior years
 
63

 
826

 
889

Reduction for tax positions for prior years
 
(884
)
 
(524
)
 
(1,408
)
Lapse of the applicable statute of limitations
 
(1,826
)
 
(569
)
 
(2,395
)
Reduction as a result of settlement
 
(1,142
)
 
$
(17
)
 
$
(1,159
)
Balance at December 31, 2019
 
$
12,612

 
$
1,166

 
$
13,778


v3.19.3.a.u2
Employee Compensation and Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2019
Retirement Benefits [Abstract]  
Summary of Expenses Incurred Under Certain Employee Compensation and Benefit Plans
A summary of expenses incurred under certain employee compensation and benefit plans for 2019, 2018 and 2017 is as follows:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Incentive Compensation Plan
 
$
143,888

 
$
160,293

 
$
125,584

Direct Drive Incentive Compensation Plan
 
37,315

 
40,578

 
18,721

Retention Program
 
2,438

 
1,438

 
1,317

Warrant Incentive Plan
 
14,881

 
9,112

 
15,386

Deferred Compensation Plan
 

 

 
203

SVBFG 401(k) Plan
 
25,687

 
21,323

 
17,860

SVBFG ESOP
 
4,197

 
6,435

 
4,719

SVB Leerink Incentive Compensation Plan
 
106,871

 

 

SVB Leerink Retention Award
 
12,015

 

 


v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments (Tables)
12 Months Ended
Dec. 31, 2019
Other Commitments [Line Items]  
Summary of Commercial and Standby Letters of Credit
The table below summarizes our commercial and standby letters of credit at December 31, 2019. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged.
(Dollars in thousands)
 
Expires In One Year or Less
 
Expires After One Year
 
Total Amount Outstanding
 
Maximum Amount of Future Payments
Financial standby letters of credit
 
$
2,566,623

 
$
79,207

 
$
2,645,830

 
$
2,645,830

Performance standby letters of credit
 
105,993

 
19,618

 
125,611

 
125,611

Commercial letters of credit
 
7,120

 

 
7,120

 
7,120

Total
 
$
2,679,736

 
$
98,825

 
$
2,778,561

 
$
2,778,561


Commitments to extend credit  
Other Commitments [Line Items]  
Summary Information Related to Commitments The following table summarizes information related to our commitments to extend credit at December 31, 2019 and 2018, respectively:
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Loan commitments available for funding: (1)
 
 
 
 
Fixed interest rate commitments
 
$
2,434,042

 
$
1,839,190

Variable interest rate commitments
 
19,309,317

 
14,821,815

Total loan commitments available for funding
 
21,743,359

 
16,661,005

Commercial and standby letters of credit (2)
 
2,778,561

 
2,252,016

Total unfunded credit commitments
 
$
24,521,920

 
$
18,913,021

Commitments unavailable for funding (3)
 
$
3,051,075

 
$
2,723,835

Allowance for unfunded credit commitments (4)
 
67,656

 
55,183

 
(1)
Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.
(2)
See below for additional information on our commercial and standby letters of credit.
(3)
Represents commitments which are currently unavailable for funding due to clients failing to meet all collateral, compliance and financial covenants under loan commitment agreements.
(4)
Our allowance for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
Commitments to invest in venture capital and equity funds  
Other Commitments [Line Items]  
Summary Information Related to Commitments The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at December 31, 2019:

(Dollars in thousands)
 
SVBFG Capital Commitments    
 
SVBFG Unfunded 
Commitments
 
SVBFG Ownership 
of each Fund (3)
CP I, LP
 
$
6,000

 
$
270

 
10.7
%
CP II, LP (1)
 
1,200

 
162

 
5.1

Capital Preferred Return Fund, LP
 
12,688

 

 
20.0

Growth Partners, LP
 
24,670

 
1,340

 
33.0

Strategic Investors Fund, LP
 
15,300

 
688

 
12.6

Strategic Investors Fund II, LP
 
15,000

 
1,050

 
8.6

Strategic Investors Fund III, LP
 
15,000

 
1,275

 
5.9

Strategic Investors Fund IV, LP
 
12,239

 
2,325

 
5.0

Strategic Investors Fund V funds
 
515

 
131

 
Various

Other venture capital and private equity fund investments (equity method accounting)
 
21,801

 
5,732

 
Various

Debt funds (equity method accounting)
 
58,493

 

 
Various

Other fund investments (2)
 
284,758

 
6,119

 
Various

Total
 
$
467,664

 
$
19,092

 
 
 
(1)
Our ownership includes direct ownership of 1.3 percent and indirect ownership of 3.8 percent through our investment in Strategic Investors Fund II, LP.
(2)
Represents commitments to 211 funds (primarily venture capital funds) where our ownership interest is generally less than five percent of the voting interests of each such fund.
(3)
We are subject to the Volcker Rule which restricts or limits us from sponsoring or having ownership interests in “covered” funds including venture capital and private equity funds. See “Business - Supervision and Regulation” under Part I, Item 1 of this report.

The following table details the amounts of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the noncontrolling interests) at December 31, 2019:

(Dollars in thousands)
 
Unfunded Commitments    
Strategic Investors Fund, LP
 
$
1,338

Capital Preferred Return Fund, LP
 
1,540

Growth Partners, LP
 
2,468

Total
 
$
5,346


v3.19.3.a.u2
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2019:
(Dollars in thousands)
 

Level 1
 

Level 2
 

Level 3
 
Balance at December 31, 2019
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
6,894,010

 
$

 
$

 
$
6,894,010

U.S. agency debentures
 

 
99,547

 

 
99,547

Foreign government debt securities
 
9,038

 

 

 
9,038

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 

 
4,148,791

 

 
4,148,791

Agency-issued collateralized mortgage obligations— fixed rate
 

 
1,538,343

 

 
1,538,343

Agency-issued commercial mortgage-backed securities
 

 
1,325,190

 

 
1,325,190

Total available-for-sale securities
 
6,903,048

 
7,111,871

 

 
14,014,919

Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
Non-marketable securities:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments measured at net asset value
 

 

 

 
265,263

Venture capital and private equity fund investments not measured at net asset value (1)
 

 

 
134

 
134

Other equity securities in public companies
 
17,290

 
41,910

 

 
59,200

Total non-marketable and other equity securities (fair value
   accounting)
 
17,290

 
41,910

 
134

 
324,597

Other assets:
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 

 
115,854

 

 
115,854

Equity warrant assets
 

 
4,435

 
161,038

 
165,473

Interest rate swaps
 

 
22,676

 

 
22,676

Client interest rate derivatives
 

 
28,811

 

 
28,811

Total assets
 
$
6,920,338

 
$
7,325,557

 
$
161,172

 
$
14,672,330

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
98,207

 
$

 
$
98,207

Interest rate swaps
 

 
25,623

 

 
25,623

Client interest rate derivatives
 

 
14,154

 

 
14,154

Total liabilities
 
$

 
$
137,984

 
$

 
$
137,984

 
(1)
Included in Level 3 assets is $120 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2018:
(Dollars in thousands)
 
Level 1
 
Level 2
 
Level 3
 
Balance at December 31, 2018
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
4,738,258

 
$

 
$

 
$
4,738,258

U.S. agency debentures
 

 
1,084,117

 

 
1,084,117

Foreign government debt securities
 
5,812

 

 

 
5,812

Residential mortgage-backed securities:
 
 
 
 
 
 
 

Agency-issued collateralized mortgage obligations— fixed rate
 

 
1,880,218

 

 
1,880,218

Agency-issued collateralized mortgage obligations— variable rate
 

 
81,638

 

 
81,638

Total available-for-sale securities
 
4,744,070

 
3,045,973

 

 
7,790,043

Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
Non-marketable securities:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments measured at net asset value
 

 

 

 
318,352

Venture capital and private equity fund investments not measured at net asset value (1)
 

 

 
1,079

 
1,079

Other equity securities in public companies (1)
 
1,181

 
19,217

 

 
20,398

Total non-marketable and other equity securities (fair value
   accounting)
 
1,181

 
19,217

 
1,079

 
339,829

Other assets:
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 

 
100,402

 

 
100,402

Equity warrant assets
 

 
4,039

 
145,199

 
149,238

Client interest rate derivatives
 

 
8,499

 

 
8,499

Total assets
 
$
4,745,251

 
$
3,178,130

 
$
146,278


$
8,388,011

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
88,559

 
$

 
$
88,559

Client interest rate derivatives
 

 
9,491

 

 
9,491

Total liabilities
 
$

 
$
98,050

 
$

 
$
98,050

 
(1)
Included in Level 3 assets is $964 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.

Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis
The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for 2019, 2018 and 2017, respectively:
(Dollars in thousands)
 
Beginning
Balance
 
Total Realized and Unrealized Gains, net Included in Income
 
Purchases  
 
Sales/Exits
 
Issuances  
 
Distributions and Other Settlements
 
Transfers Out of Level 3
 
Ending
Balance
Year ended December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
1,079

 
$
12

 
$

 
$
(960
)
 
$

 
$
3

 
$

 
$
134

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
145,199

 
133,910

 
575

 
(130,392
)
 
16,453

 

 
(4,707
)
 
161,038

Total assets
 
$
146,278


$
133,922


$
575


$
(131,352
)

$
16,453


$
3


$
(4,707
)

$
161,172

Year ended December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
919

 
$
457

 
$

 
$

 
$

 
$
(297
)
 
$

 
$
1,079

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
121,331

 
87,982

 

 
(78,752
)
 
17,941

 

 
(3,303
)
 
145,199

Total assets
 
$
122,250


$
88,439


$


$
(78,752
)

$
17,941


$
(297
)

$
(3,303
)

$
146,278

Year ended December 31, 2017:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
2,040

 
$
971

 
$

 
$
(2,092
)
 
$

 
$

 
$

 
$
919

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
128,813

 
54,263

 

 
(74,769
)
 
14,537

 

 
(1,513
)
 
121,331

Total assets
 
$
130,853

 
$
55,234

 
$

 
$
(76,861
)
 
$
14,537

 
$

 
$
(1,513
)
 
$
122,250

 

(1)
Realized and unrealized gains (losses) are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
(2)
Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held
The following table presents the amount of unrealized gains (losses) included in earnings (which is inclusive of noncontrolling interest) attributable to Level 3 assets still held at December 31, 2019 and 2018, respectively:
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
Non-marketable and other equity securities (fair value accounting):
 
 
 
 
Venture capital and private equity fund investments not measured at net asset value (1)
 
$
(222
)
 
$
160

Other assets:
 
 
 
 
Equity warrant assets (2)
 
34,691

 
37,564

Total unrealized gains, net
 
$
34,469

 
$
37,724

Unrealized (losses) gains attributable to noncontrolling interests (1)
 
$
(199
)
 
$
143

 

(1)
Unrealized gains are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
(2)
Unrealized gains are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs
The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at December 31, 2019 and 2018. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.
(Dollars in thousands)
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted Average
December 31, 2019:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments (fair value accounting)
 
$
134

 
Private company equity pricing
 
(1)
 
(1)
Equity warrant assets (public portfolio)
 
346

 
Black-Scholes option pricing model
 
Volatility
 
50.7
%
Risk-Free interest rate
1.9

Sales restrictions discount (2)
13.6

Equity warrant assets (private portfolio)
 
160,692

 
Black-Scholes option pricing model
 
Volatility
 
38.2

Risk-Free interest rate
1.6

Marketability discount (3)
17.5

Remaining life assumption (4)
45.0

December 31, 2018:
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments (fair value accounting)
 
$
1,079

 
Private company equity pricing
 
(1)
 
(1)
Equity warrant assets (public portfolio)
 
2,757

 
Black-Scholes option pricing model
 
Volatility
 
54.7
%
Risk-Free interest rate
2.6

Sales restrictions discount (2)
18.5

Equity warrant assets (private portfolio)
 
142,442

 
Black-Scholes option pricing model
 
Volatility
 
38.5

Risk-Free interest rate
2.5

Marketability discount (3)
17.7

Remaining life assumption (4)
45.0

 
 
(1)
In determining the fair value of our venture capital and private equity fund investment portfolio (not measured at net asset value), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation
assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
(2)
We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions which typically range from three to six months.
(3)
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
(4)
We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At December 31, 2019, the weighted average contractual remaining term was 6.1 years, compared to our estimated remaining life of 2.8 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at December 31, 2019 and 2018:
 
 
 
 
Estimated Fair Value
(Dollars in thousands)
 
Carrying Amount
 
Total
 

Level 1
 

Level 2
 

Level 3
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
6,781,783

 
$
6,781,783

 
$
6,781,783

 
$

 
$

Held-to-maturity securities
 
13,842,946

 
14,115,272

 

 
14,115,272

 

Non-marketable securities not measured at net asset value
 
195,405

 
195,405

 

 

 
195,405

Non-marketable securities measured at net asset value
 
235,351

 
235,351

 

 

 

Net commercial loans
 
29,104,532

 
29,615,176

 

 

 
29,615,176

Net consumer loans
 
3,755,180

 
3,820,804

 

 

 
3,820,804

FHLB and Federal Reserve Bank stock
 
60,258

 
60,258

 

 

 
60,258

Financial liabilities:
 
 
 


 
 
 
 
 
 
Short-term borrowings
 
17,430

 
17,430

 

 
17,430

 

Non-maturity deposits (1)
 
61,569,714

 
61,569,714

 
61,569,714

 

 

Time deposits
 
188,093

 
187,980

 

 
187,980

 

3.50% Senior Notes
 
347,987

 
366,856

 

 
366,856

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 
27,197

 

 

 
27,197

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,571,539

 
$
3,571,539

 
$
3,571,539

 
$

 
$

Held-to-maturity securities
 
15,487,442

 
15,188,236

 

 
15,188,236

 

Non-marketable securities not measured at net asset value
 
131,453

 
131,453

 

 

 
131,453

Non-marketable securities measured at net asset value
 
151,247

 
151,247

 

 

 

Net commercial loans
 
25,043,671

 
25,463,968

 

 

 
25,463,968

Net consumer loans
 
3,013,706

 
3,064,093

 

 

 
3,064,093

FHLB and Federal Reserve Bank stock
 
58,878

 
58,878

 

 

 
58,878

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
631,412

 
631,412

 

 
631,412

 

Non-maturity deposits (1)
 
49,278,174

 
49,278,174

 
49,278,174

 

 

Time deposits
 
50,726

 
50,337

 

 
50,337

 

3.50% Senior Notes
 
347,639

 
336,088

 

 
336,088

 

5.375% Senior Notes
 
348,826

 
361,281

 

 
361,281

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 
22,930

 

 

 
22,930

 
(1)
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of December 31, 2019:
(Dollars in thousands)
 
Carrying Amount      
 
Fair Value        
 
Unfunded Commitments      
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
265,263

 
$
265,263

 
$
10,579

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (2)
 
215,367

 
215,367

 
10,675

Debt funds (2)
 
7,271

 
7,271

 

Other investments (2)
 
12,713

 
12,713

 
886

Total
 
$
500,614

 
$
500,614

 
$
22,140

 
(1)
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $64.6 million and $4.0 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2)
Venture capital and private equity fund investments, debt funds and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.
v3.19.3.a.u2
Regulatory Matters (Tables)
12 Months Ended
Dec. 31, 2019
Banking and Thrift [Abstract]  
Capital Ratios for Company and Bank under Federal Regulatory Guidelines, Compared to Minimum Regulatory Capital Requirements for Adequately Capitalized and Well Capitalized Depository Institution The following table presents the capital ratios for the Company and the Bank under federal regulatory guidelines, compared to the minimum regulatory capital requirements, as of December 31, 2019 and 2018:
 
 
Capital Ratios
 
Capital Amounts
(Dollars in thousands)
 
Actual
 
Required Minimum (1)
 
Well Capitalized Minimum
 
Actual
 
Required Minimum (1)
 
Well Capitalized Minimum
December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
CET 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
12.58
%
 
7.0
%
 
N/A
 
$
5,857,744

 
$
3,260,424

 
N/A

Bank
 
11.12

 
7.0

 
6.5
 
4,949,393

 
3,115,151

 
$
2,892,640

Tier 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.43

 
8.5

 
6.0
 
6,257,442

 
3,959,086

 
2,794,649

Bank
 
11.12

 
8.5

 
8.0
 
4,949,393

 
3,782,683

 
3,560,172

Total risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
14.23

 
10.5

 
10.0
 
6,630,022

 
4,890,636

 
4,657,748

Bank
 
11.96

 
10.5

 
10.0
 
5,321,850

 
4,672,726

 
4,450,215

Tier 1 leverage:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
9.06

 
4.0

 
N/A
 
6,257,442

 
2,763,146

 
N/A

Bank
 
7.30

 
4.0

 
5.0
 
4,949,393

 
2,713,367

 
3,391,709

December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
CET 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.41
%
 
6.4
%
 
N/A
 
$
5,167,270

 
$
2,456,151

 
N/A

Bank
 
12.41

 
6.4

 
6.5
 
4,604,689

 
2,365,385

 
$
2,411,765

Tier 1 risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
13.58

 
7.9

 
6.0
 
5,231,476

 
3,034,068

 
2,311,671

Bank
 
12.41

 
7.9

 
8.0
 
4,604,689

 
2,921,946

 
2,968,326

Total risk-based capital:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
14.45

 
9.9

 
10.0
 
5,567,562

 
3,804,625

 
3,852,785

Bank
 
13.32

 
9.9

 
10.0
 
4,940,776

 
3,664,028

 
3,710,408

Tier 1 leverage:
 
 
 
 
 
 
 
 
 
 
 
 
SVB Financial
 
9.06

 
4.0

 
N/A
 
5,231,476

 
2,308,592

 
N/A

Bank
 
8.10

 
4.0

 
5.0
 
4,604,689

 
2,272,912

 
2,841,139

v3.19.3.a.u2
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment Reporting
Our segment information for 2019, 2018 and 2017 is as follows:
(Dollars in thousands)
 
Global
Commercial
Bank (1)
 
SVB Private  
Bank
 
SVB Capital 
(1)  
 
SVB Leerink (1)
 
Other Items
(2)
 
Total      
Year ended December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,850,391

 
$
51,022

 
$
38

 
$
1,252

 
$
193,898

 
$
2,096,601

Provision for credit losses
 
(91,814
)
 
(2,369
)
 

 

 
(12,233
)
 
(106,416
)
Noninterest income
 
637,922

 
3,366

 
122,394

 
264,516

 
193,281

 
1,221,479

Noninterest expense (3)
 
(874,854
)
 
(40,151
)
 
(30,798
)
 
(252,678
)
 
(402,781
)
 
(1,601,262
)
Income (loss) before income tax expense (4)
 
$
1,521,645

 
$
11,868

 
$
91,634

 
$
13,090

 
$
(27,835
)
 
$
1,610,402

Total average loans, net of unearned income
 
$
26,031,284

 
$
3,341,188

 
$

 
$

 
$
543,735

 
$
29,916,207

Total average assets (5) (6)
 
56,043,321

 
3,371,052

 
405,152

 
397,650

 
2,994,455

 
63,211,630

Total average deposits
 
53,053,665

 
1,524,232

 

 

 
479,053

 
55,056,950

Year ended December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,623,488

 
$
64,902

 
$
23

 
$

 
$
205,575

 
$
1,893,988

Provision for credit losses
 
(80,953
)
 
(3,339
)
 

 

 
(3,578
)
 
(87,870
)
Noninterest income (7)
 
520,302

 
2,281

 
101,181

 

 
121,220

 
744,984

Noninterest expense (3)
 
(793,159
)
 
(25,064
)
 
(22,792
)
 

 
(347,178
)
 
(1,188,193
)
Income (loss) before income tax expense (4)
 
$
1,269,678

 
$
38,780

 
$
78,412

 
$

 
$
(23,961
)
 
$
1,362,909

Total average loans, net of unearned income
 
$
22,354,305

 
$
2,850,271

 
$

 
$

 
$
425,944

 
$
25,630,520

Total average assets (5) (8)
 
48,854,416

 
2,871,743

 
380,543

 

 
3,122,358

 
55,229,060

Total average deposits
 
46,039,570

 
1,502,308

 

 

 
533,466

 
48,075,344

Year ended December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
$
1,274,366

 
$
58,131

 
$
48

 
$

 
$
87,824

 
$
1,420,369

Provision for credit losses
 
(81,553
)
 
(4,386
)
 

 

 
(6,365
)
 
(92,304
)
Noninterest income (7)
 
392,101

 
2,175

 
58,992

 

 
103,963

 
557,231

Noninterest expense (3)
 
(707,666
)
 
(17,693
)
 
(19,340
)
 

 
(265,956
)
 
(1,010,655
)
Income (loss) before income tax expense (4)
 
$
877,248

 
$
38,227

 
$
39,700

 
$

 
$
(80,534
)
 
$
874,641

Total average loans, net of unearned income
 
$
18,479,793

 
$
2,423,078

 
$

 
$

 
$
256,523

 
$
21,159,394

Total average assets (5) (8)
 
43,704,667

 
2,445,220

 
325,939

 

 
1,904,446

 
48,380,272

Total average deposits
 
41,043,731

 
1,303,542

 

 

 
397,875

 
42,745,148

 
(1)
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within "Other Items."
(2)
The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest
earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains on equity warrant assets and gains or losses on the sale of fixed income investments and equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.
(3)
The Global Commercial Bank segment includes direct depreciation and amortization of $20.4 million, $21.8 million and $25.3 million for 2019, 2018 and 2017, respectively.
(4)
The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.
(5)
Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.
v3.19.3.a.u2
Parent Company Only Condensed Financial Information (Tables)
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Condensed Balance Sheets
The condensed balance sheets of SVB Financial at December 31, 2019 and 2018, and the related condensed statements of income, comprehensive income and cash flows for 2019, 2018 and 2017, are presented below:
Condensed Balance Sheets
 
 
December 31,
(Dollars in thousands)
 
2019
 
2018
Assets:
 
 
 
 
Cash and cash equivalents
 
$
800,926

 
$
553,049

Investment securities
 
474,842

 
510,836

Loans, net of unearned income
 
15,245

 

Lease right-of-use assets
 
71,847

 

Other assets
 
214,167

 
204,301

Investment in subsidiaries:
 
 
 
 
   Bank subsidiary
 
5,034,095

 
4,554,813

   Nonbank subsidiaries
 
432,073

 
116,968

Total assets
 
$
7,043,195

 
$
5,939,967

 
 
 
 
 
Liabilities and SVBFG stockholders’ equity:
 
 
 
 
3.50% Senior Notes
 
$
347,987

 
$
347,639

5.375% Senior Notes
 

 
348,826

Lease liabilities
 
87,999

 

Other liabilities
 
136,903

 
127,293

Total liabilities
 
$
572,889

 
$
823,758

SVBFG stockholders’ equity
 
6,470,306

 
5,116,209

Total liabilities and SVBFG stockholders’ equity
 
$
7,043,195

 
$
5,939,967


Condensed Statements of Income
Condensed Statements of Income
 
 
Year ended December 31,
(Dollars in thousands)
 
2019

2018

2017
Interest income
 
$
4,473

 
$
3,307

 
$
2,077

Interest expense
 
(31,666
)
 
(32,037
)
 
(34,932
)
Dividend income from bank subsidiary
 
733,000

 
140,000

 
90,000

Gains on equity warrant assets, net
 
138,078

 
89,142

 
54,555

Gains on investment securities, net
 
45,345

 
13,546

 
37,132

Fund management fees and other noninterest income
 
21,567

 
26,388

 
24,613

General and administrative expenses
 
(94,712
)
 
(70,976
)
 
(63,077
)
Income tax (expense) benefit
 
(40,218
)
 
(14,383
)
 
10,367

Income before net income of subsidiaries
 
775,867

 
154,987

 
120,735

Equity in undistributed net income of bank subsidiary
 
303,618

 
793,641

 
356,769

Equity in undistributed net income of nonbank subsidiaries
 
57,371

 
25,212

 
13,002

Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506



Condensed Statements of Comprehensive Income
Condensed Statements of Comprehensive Income
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
Foreign currency translation gains (losses)
 
2,319

 
(4,107
)
 
3,769

Changes in fair value on cash flow hedges
 
(2,130
)
 

 

Changes in unrealized holding gains and losses on AFS securities
 
2,310

 
120

 
22,285

Equity in other comprehensive income (loss) of bank and nonbank subsidiaries
 
136,066

 
(19,171
)
 
(50,956
)
Reclassifications to retained earnings for the adoption of new accounting guidance
 

 
(29,490
)
 

Other comprehensive income (loss), net of tax
 
138,565

 
(52,648
)
 
(24,902
)
Total comprehensive income
 
$
1,275,421

 
$
921,192

 
$
465,604




Condensed Statements of Cash Flows
Condensed Statements of Cash Flows
 
 
Year ended December 31,
(Dollars in thousands)
 
2019
 
2018
 
2017
Cash flows from operating activities:
 
 
 
 
 
 
Net income available to common stockholders
 
$
1,136,856

 
$
973,840

 
$
490,506

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
Gains on equity warrant assets, net
 
(138,078
)
 
(89,142
)
 
(54,555
)
Gains on investment securities, net
 
(45,345
)
 
(13,546
)
 
(17,060
)
Distributions of earnings from investment securities
 
49,776

 
47,596

 
14,015

Net income of bank subsidiary
 
(1,036,618
)
 
(933,641
)
 
(446,769
)
Net income on nonbank subsidiaries
 
(57,371
)
 
(25,212
)
 
(13,002
)
Cash dividends from bank subsidiary
 
733,000

 
140,000

 
90,000

Amortization of share-based compensation
 
66,815

 
45,675

 
36,900

Decrease in other assets
 
27,205

 
51,169

 
12,959

Increase in other liabilities
 
21,391

 
21,619

 
11,774

Other, net
 
8,084

 
(31,024
)
 
316

Net cash provided by operating activities
 
765,715

 
187,334

 
125,084

 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
Net decrease (increase) in investment securities from purchases, sales and maturities
 
128,635

 
73,742

 
(152,015
)
Net (increase) decrease in loans
 
(15,245
)
 

 
13,337

Increase in investment in bank subsidiary
 
(42,952
)
 
(31,292
)
 
(38,927
)
Decrease (increase) in investment in nonbank subsidiaries
 
23,275

 
(5,323
)
 
34,374

Acquisition of SVB Leerink

 
(265,601
)
 

 

Net cash (used for) provided by investing activities
 
(171,888
)
 
37,127

 
(143,231
)
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
Principal payments of long-term debt
 
(358,395
)
 

 
(51,546
)
Proceeds from issuance of common stock, ESPP and ESOP
 
24,818

 
18,387

 
27,003

Net proceeds from the issuance of preferred stock

 
340,138

 

 

Common stock repurchase
 
(352,511
)
 
(147,123
)
 

Net cash (used for) by financing activities
 
(345,950
)
 
(128,736
)
 
(24,543
)
Net increase (decrease) in cash and cash equivalents
 
247,877

 
95,725

 
(42,690
)
Cash and cash equivalents at beginning of period
 
553,049

 
457,324

 
500,014

Cash and cash equivalents at end of period
 
$
800,926

 
$
553,049

 
$
457,324


v3.19.3.a.u2
Unaudited Quarterly Financial Data (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Supplemental Consolidated Financial Information
Our supplemental consolidated financial information for each three month period in 2019 and 2018 are as follows:
 
 
 Three months ended
(Dollars in thousands, except per share amounts)
 
March 31,
 
June 30,
 
September 30,
 
December 31,
2019:
 
 
 
 
 
 
 
 
Interest income
 
$
551,014

 
$
585,767

 
$
583,892

 
$
588,735

Interest expense
 
38,128

 
56,364

 
63,248

 
55,067

Net interest income
 
512,886

 
529,403

 
520,644

 
533,668

Provision for credit losses
 
28,551

 
23,946

 
36,536

 
17,383

Noninterest income
 
280,376

 
333,750

 
294,009

 
313,344

Noninterest expense
 
365,664

 
383,522

 
391,324

 
460,752

Income before income tax expense
 
399,047

 
455,685

 
386,793

 
368,877

Income tax expense
 
107,435

 
119,114

 
105,075

 
94,061

Net income before noncontrolling interests
 
291,612

 
336,571

 
281,718

 
274,816

Net income attributable to noncontrolling interests
 
(2,880
)
 
(18,584
)
 
(14,437
)
 
(11,960
)
Net income available to common stockholders
 
$
288,732

 
$
317,987

 
$
267,281

 
$
262,856

Earnings per common share—basic
 
$
5.49

 
$
6.12

 
$
5.19

 
$
5.10

Earnings per common share—diluted
 
5.44

 
6.08

 
5.15

 
5.06

2018:
 
 
 
 
 
 
 
 
Interest income
 
$
432,398

 
$
481,301

 
$
513,313

 
$
542,897

Interest expense
 
12,535

 
14,858

 
20,091

 
28,437

Net interest income
 
419,863

 
466,443

 
493,222

 
514,460

Provision for credit losses
 
27,972

 
29,080

 
17,174

 
13,644

Noninterest income
 
155,518

 
192,689

 
210,070

 
186,707

Noninterest expense
 
265,417

 
305,739

 
309,445

 
307,592

Income before income tax expense
 
281,992

 
324,313

 
376,673

 
379,931

Income tax expense
 
73,966

 
77,287

 
95,308

 
105,000

Net income before noncontrolling interests
 
208,026

 
247,026

 
281,365

 
274,931

Net income attributable to noncontrolling interests
 
(13,065
)
 
(9,228
)
 
(6,548
)
 
(8,667
)
Net income available to common stockholders
 
$
194,961

 
$
237,798

 
$
274,817

 
$
266,264

Earnings per common share—basic
 
$
3.69

 
$
4.48

 
$
5.16

 
$
5.01

Earnings per common share—diluted
 
3.63

 
4.42

 
5.10

 
4.96


v3.19.3.a.u2
Nature of Business (Details)
12 Months Ended
Dec. 31, 2019
Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of operating segments 4
v3.19.3.a.u2
Summary of Significant Accounting Policies - Additional Information (Details)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Lower Limit    
Significant Accounting Policies [Line Items]    
Term of contract on forward contracts 1 year  
Upper Limit    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 5.00% 5.00%
Term of contract on forward contracts 5 years  
Equity warrant assets (public portfolio) | Lower Limit    
Significant Accounting Policies [Line Items]    
Duration of the sale restrictions 3 months  
Equity warrant assets (public portfolio) | Upper Limit    
Significant Accounting Policies [Line Items]    
Duration of the sale restrictions 6 months  
Equity warrant assets (public portfolio) | Sales restrictions discount | Lower Limit    
Significant Accounting Policies [Line Items]    
Sales restriction discounts 0.10  
Equity warrant assets (public portfolio) | Sales restrictions discount | Upper Limit    
Significant Accounting Policies [Line Items]    
Sales restriction discounts 0.20  
Non-marketable securities | Other investments | SPD Silicon Valley Bank Co., Ltd. | Equity method investee    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 50.00%  
Non-marketable securities | Lower Limit | Consolidated venture capital and private equity fund investments | Equity method investee    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 20.00%  
Non-marketable securities | Lower Limit | Investments in limited partnerships | Equity method investee    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 5.00%  
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Growth Partners, LP    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 33.00% 33.00%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Capital Preferred Return Fund, LP    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 20.00% 20.00%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund, LP    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 12.60% 12.60%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | CP I, LP    
Significant Accounting Policies [Line Items]    
Ownership interest percentage 10.70% 10.70%
v3.19.3.a.u2
Summary of Significant Accounting Policies - Maximum Estimated Useful Lives by Asset Classification (Details)
12 Months Ended
Dec. 31, 2019
Leasehold Improvements  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life  Lesser of lease term or asset life
Furniture and equipment  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life 7 years
Software | Lower Limit  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life 3 years
Software | Upper Limit  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life 7 years
Computer hardware | Lower Limit  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life 3 years
Computer hardware | Upper Limit  
Property Plant and Equipment Estimated Useful Lives [Line Items]  
Premises and equipment, estimated useful life 5 years
v3.19.3.a.u2
Summary of Significant Accounting Policies - Adoption of New Accounting Standards (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Lease right-of-use assets $ 197,365 $ 146,000 $ 0
Lease liabilities $ 218,847 178,000 $ 0
Accounting Standards Update 2017-08      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cumulative adjustment for new accounting standards [1]   (583)  
Accounting Standards Update 2017-08 | Retained Earnings      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cumulative adjustment for new accounting standards [1]   $ (583)  
[1]
See Note 2- "Summary of Significant Accounting Policies" of the "Notes to Consolidated Financial Statements" under Part II, Item 8 of this report for additional details.

v3.19.3.a.u2
Business Combination - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 04, 2019
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Business Acquisition [Line Items]                        
Intangible assets   $ 60,900               $ 60,900    
Goodwill   137,823       $ 0       137,823 $ 0  
Net income available to common stockholders   $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 1,136,856 $ 973,840 $ 490,506
SVB Leerink                        
Business Acquisition [Line Items]                        
Total purchase price $ 273,230                      
Retention pool for acquiree employees $ 60,000                      
Vesting period of retention pool for acquiree employees 5 years                      
Post-combination expenses $ 9,100                      
Intangible assets 60,900                      
Goodwill $ 137,823                      
Net income available to common stockholders                   $ 9,524    
v3.19.3.a.u2
Business Combination - Allocation of Purchase Price (Details) - USD ($)
$ in Thousands
Jan. 04, 2019
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]      
Goodwill   $ 137,823 $ 0
SVB Leerink      
Business Acquisition [Line Items]      
Cash paid $ 265,601    
Replacement award liabilities 7,629    
Total purchase price 273,230    
Fair value of net assets acquired 135,407    
Goodwill $ 137,823    
v3.19.3.a.u2
Business Combination - Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 04, 2019
Assets acquired:    
Intangible assets $ 60,900  
SVB Leerink    
Assets acquired:    
Cash and cash equivalents   $ 163,273
Investment securities   33,644
Accounts receivable   36,538
Intangible assets   60,900
Other assets   35,128
Total assets acquired   329,483
Liabilities assumed:    
Accrued compensation   137,206
Due to broker-dealers   18,483
Other liabilities   33,131
Noncontrolling interests   5,256
Total liabilities assumed   194,076
Net assets   $ 135,407
v3.19.3.a.u2
Business Combination - Fair Value of Other Intangible Assets Acquired and Useful Lives (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Jan. 04, 2019
Other intangible assets:    
Estimated Fair Value $ 60,900  
SVB Leerink    
Other intangible assets:    
Estimated Fair Value   $ 60,900
Customer relationships    
Other intangible assets:    
Estimated Fair Value $ 42,000  
Customer relationships | SVB Leerink    
Other intangible assets:    
Estimated Fair Value   42,000
Weighted Average Estimated Useful Life - in Years 11 years  
Other    
Other intangible assets:    
Estimated Fair Value $ 18,900  
Other | SVB Leerink    
Other intangible assets:    
Estimated Fair Value   $ 18,900
Weighted Average Estimated Useful Life - in Years 9 years 10 months 24 days  
v3.19.3.a.u2
Business Combination - Revenue and Expenses from SVB Leerink (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Business Acquisition [Line Items]                      
Net interest income $ 533,668 $ 520,644 $ 529,403 $ 512,886 $ 514,460 $ 493,222 $ 466,443 $ 419,863 $ 2,096,601 $ 1,893,988 $ 1,420,369
Noninterest income 313,344 294,009 333,750 280,376 186,707 210,070 192,689 155,518 1,221,479 744,984 557,231
Noninterest expense 460,752 391,324 383,522 365,664 307,592 309,445 305,739 265,417 1,601,262 1,188,193 1,010,655
Income before income tax expense                 1,610,402 1,362,909 874,641
Income tax expense 94,061 105,075 119,114 107,435 105,000 95,308 77,287 73,966 425,685 351,561 355,463
Net income attributable to noncontrolling interests 11,960 14,437 18,584 2,880 8,667 6,548 9,228 13,065 47,861 37,508 28,672
Net income available to common stockholders $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 1,136,856 $ 973,840 $ 490,506
SVB Leerink                      
Business Acquisition [Line Items]                      
Net interest income                 1,252    
Noninterest income                 265,841    
Noninterest expense                 252,678    
Income before income tax expense                 14,415    
Income tax expense                 3,566    
Net income attributable to noncontrolling interests                 1,325    
Net income available to common stockholders                 $ 9,524    
v3.19.3.a.u2
Business Combination - Acquisition-related Activities Expense (Details) - SVB Leerink
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Business Acquisition [Line Items]  
Professional fees $ 919
Other 396
Total acquisition-related expenses $ 1,315
v3.19.3.a.u2
Stockholders' Equity and EPS - Reclassification of AOCI (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]                      
Reclassification adjustment for losses on available-for-sale securities included in net income                 $ 134,670,000 $ 88,094,000 $ 64,603,000
Related tax benefit $ (94,061,000) $ (105,075,000) $ (119,114,000) $ (107,435,000) $ (105,000,000) $ (95,308,000) $ (77,287,000) $ (73,966,000) (425,685,000) (351,561,000) (355,463,000)
Net interest income 533,668,000 520,644,000 529,403,000 512,886,000 514,460,000 493,222,000 466,443,000 419,863,000 2,096,601,000 1,893,988,000 1,420,369,000
Net income available to common stockholders $ 262,856,000 $ 267,281,000 $ 317,987,000 $ 288,732,000 $ 266,264,000 $ 274,817,000 $ 237,798,000 $ 194,961,000 1,136,856,000 973,840,000 490,506,000
Reclassification out of Accumulated Other Comprehensive Income                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]                      
Net income available to common stockholders                 6,687,000 535,000 3,091,000
Accumulated Net Unrealized Investment Gain (Loss) | Reclassification out of Accumulated Other Comprehensive Income                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]                      
Reclassification adjustment for losses on available-for-sale securities included in net income                 3,905,000 740,000 5,189,000
Related tax benefit                 (1,087,000) (205,000) (2,098,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]                      
Related tax benefit                 (1,489,000) 0 0
Net interest income                 $ 5,358,000 $ 0 $ 0
v3.19.3.a.u2
Stockholders' Equity and EPS - Activity Related to Net Gains on Cash Flow Hedges in AOCI (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Cash flow hedge gains expected to reclassified out of AOCI over next 12 months $ 3,200    
Balance, beginning of period, net of tax 5,264,843 $ 4,319,415 $ 3,777,037
Balance, end of period, net of tax 6,621,080 5,264,843 4,319,415
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance, beginning of period, net of tax 0 0 0
Net decrease in fair value, net of tax (5,999) 0 0
Net realized loss reclassified to net income, net of tax 3,869 0 0
Balance, end of period, net of tax $ (2,130) $ 0 $ 0
v3.19.3.a.u2
Stockholders' Equity and EPS - Reconciliation of Basic EPS to Diluted EPS (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator:                      
Net income available to common stockholders $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 $ 1,136,856 $ 973,840 $ 490,506
Denominator:                      
Weighted average common shares outstanding-basic (in shares)                 51,915 53,078 52,588
Denominator for diluted calculation (in shares)                 52,311 53,772 53,306
Earnings per common share:                      
Basic (usd per share) $ 5.10 $ 5.19 $ 6.12 $ 5.49 $ 5.01 $ 5.16 $ 4.48 $ 3.69 $ 21.90 $ 18.35 $ 9.33
Diluted (usd per share) $ 5.06 $ 5.15 $ 6.08 $ 5.44 $ 4.96 $ 5.10 $ 4.42 $ 3.63 $ 21.73 $ 18.11 $ 9.20
Stock options and ESPP                      
Denominator:                      
Weighted average effect of dilutive securities (in shares)                 227 377 385
Restricted stock units                      
Denominator:                      
Weighted average effect of dilutive securities (in shares)                 169 317 333
v3.19.3.a.u2
Stockholders' Equity and EPS - Common Shares Excluded from Diluted EPS Calculation (Details) - shares
shares in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from diluted earnings per share calculation (in shares) 417 144 74
Stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from diluted earnings per share calculation (in shares) 167 59 73
Restricted stock units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from diluted earnings per share calculation (in shares) 250 85 1
v3.19.3.a.u2
Stockholders' Equity and EPS - Stock Repurchase Programs (Details) - USD ($)
2 Months Ended 8 Months Ended 12 Months Ended
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Oct. 24, 2019
Nov. 13, 2018
Equity and Earnings Per Share [Abstract]            
Amount of outstanding common stock authorized to be repurchased         $ 350,000,000 $ 500,000,000
Common stock repurchased (in shares) 0 2,200,000        
Common stock repurchased $ 0 $ 499,600,000 $ 352,511,000 $ 147,123,000    
v3.19.3.a.u2
Stockholders' Equity and EPS - Preferred Stock (Details)
12 Months Ended
Dec. 09, 2019
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Class of Stock [Line Items]      
Preferred stock, shares issued | shares   350,000 0
Preferred stock, par value   $ 0.001 $ 0.001
Preferred stock, shares issued, value | $   $ 340,138,000 $ 0
Preferred stock, shares outstanding | shares   350,000 0
Preferred Stock, Series A      
Class of Stock [Line Items]      
Preferred stock, shares issued | shares 350,000 350,000  
Preferred stock, par value $ 0.001 $ 0.001  
Preferred stock, liquidation preference (usd per share) $ 1,000    
Preferred stock, dividend rate, rate 5.25%    
Preferred stock, shares issued, value | $   $ 340,100,000  
Preferred stock, liquidation preference, value | $   $ 350,000,000.0  
Depositary Shares      
Class of Stock [Line Items]      
Preferred stock, liquidation preference (usd per share) $ 25 $ 25  
Preferred stock, depositary share ownership interest   25.000  
Preferred stock, dividends paid per depositary share (usd per share)   $ 0  
v3.19.3.a.u2
Stockholders' Equity and EPS - Preferred Stock Summary Schedule (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 09, 2019
$ / shares
shares
Oct. 24, 2019
USD ($)
Dec. 31, 2018
USD ($)
$ / shares
shares
Class of Stock [Line Items]        
Preferred stock, shares issued, value | $ $ 340,138     $ 0
Shares issued and outstanding | shares 350,000     0
Per Value $ 0.001     $ 0.001
Preferred Stock, Series A        
Class of Stock [Line Items]        
Amount outstanding | $     $ 350,000  
Preferred stock, shares issued, value | $ $ 340,100      
Shares issued and outstanding | shares 350,000 350,000    
Per Value $ 0.001 $ 0.001    
Liquidation preference per depository share (usd per share)   1,000    
Depositary Shares        
Class of Stock [Line Items]        
Ownership interest per depository share (usd per share) 25.000      
Liquidation preference per depository share (usd per share) $ 25 $ 25    
2019 dividends paid per depository share (usd per share) $ 0      
v3.19.3.a.u2
Share-Based Compensation - Share Based Compensation and Related Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Payment Arrangement [Abstract]      
Share-based compensation expense $ 66,815 $ 45,675 $ 36,900
Income tax benefit related to share-based compensation expense (16,152) (10,997) (12,845)
Capitalized compensation costs $ 1,517 $ 1,466 $ 1,071
v3.19.3.a.u2
Share-Based Compensation - Additional Information (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Closing stock price | $ / shares $ 251.04
Equity Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum aggregate number of shares that may be awarded and sold 12,028,505
Conversion ratio for awards granted 2
Conversion ratio for awards forfeited 2
Number of common stock shares available for future issuance 3,421,734
Employee Stock Purchase Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum percentage of gross compensation that employees may contribute annually 10.00%
Maximum amount of gross compensation employees may contribute annually | $ $ 25,000
Offering period 6 months
Percentage of fair market value of common stock at which employees may purchase shares 85.00%
Eligibility To Participate In Employee Stock Purchase Plan, Service Period Per Week 20 hours
Eligibility To Participate In Employee Stock Purchase Plan, Service Period Per Calendar Year 5 months
Number of shares issued under ESPP 161,410
Proceeds from issuance of shares under ESPP | $ $ 27,900,000
Number of common stock shares available for future issuance 1,337,808
Expected volatility term 5 years
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 5 years
Restricted stock units | Equity Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 4 years
Restricted stock units | Equity Incentive Plan | Lower Limit  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 3 years
Performance Based Restricted Stock | Equity Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 3 years
Performance Based Restricted Stock | Equity Incentive Plan | Lower Limit  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 1 year
Stock options | Equity Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options, exercisable period 4 years
Options granted under the 2006 Incentive Plan, expiration period 7 years
v3.19.3.a.u2
Share-Based Compensation - Unrecognized Share-Based Compensation Expense (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 115,623
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 14,313
Average Expected Recognition Period - in Years 2 years 6 months 7 days
Restricted stock awards/units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 101,310
Average Expected Recognition Period - in Years 2 years 7 months 28 days
v3.19.3.a.u2
Share-Based Compensation - Weighted Average Assumptions and Fair Values Used for Employee Stock Options and Restricted Stock Units (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average expected term of options - in years 4 years 7 months 6 days 4 years 9 months 18 days 4 years 10 months 24 days
Weighted average expected volatility of the Company's underlying common stock 35.50% 34.70% 33.70%
Risk-free interest rate 2.26% 2.82% 1.81%
Expected dividend yield $ 0 $ 0 $ 0
Weighted average grant date fair value - stock options (usd per share) $ 83.50 $ 105.81 $ 57.81
Weighted average grant date fair value - restricted stock units (usd per share) $ 243.65 $ 294.50 $ 181.23
v3.19.3.a.u2
Share-Based Compensation - Weighted Average Assumptions and Fair Values Used for ESPP (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items]      
Expected term in years 4 years 7 months 6 days 4 years 9 months 18 days 4 years 10 months 24 days
Weighted average expected volatility of the Company's underlying common stock 35.50% 34.70% 33.70%
Risk-free interest rate 2.26% 2.82% 1.81%
Expected dividend yield $ 0 $ 0 $ 0
Weighted average grant date fair value (usd per share) $ 83.50 $ 105.81 $ 57.81
Employee Stock Purchase Plan      
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items]      
Expected term in years 15 days 15 days 15 days
Weighted average expected volatility of the Company's underlying common stock 38.10% 32.20% 31.20%
Risk-free interest rate 2.40% 1.79% 0.80%
Expected dividend yield $ 0 $ 0 $ 0
Weighted average grant date fair value (usd per share) $ 52.90 $ 62.76 $ 41.70
v3.19.3.a.u2
Share-Based Compensation - Stock Option Information Related to Equity Incentive Plan (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Options  
Outstanding, beginning of period (in shares) | shares 679,659
Granted (in shares) | shares 126,945
Exercised (in shares) | shares (154,897)
Forfeited (in shares) | shares (25,580)
Expired (in shares) | shares (720)
Outstanding, end of period (in shares) | shares 625,407
Vested and expected to vest (in shares) | shares 609,849
Exercisable (in shares) | shares 361,503
Weighted average exercise price  
Outstanding, beginning of period (usd per share) | $ / shares $ 137.19
Granted (usd per share) | $ / shares 249.15
Exercised (usd per share) | $ / shares 86.96
Forfeited (usd per share) | $ / shares 213.26
Expired (usd per share) | $ / shares 64.37
Outstanding, end of period (usd per share) | $ / shares 169.33
Vested and expected to vest (usd per share) | $ / shares 167.31
Exercisable (usd per share) | $ / shares $ 124.70
Weighted Average Remaining Contractual Life in Years  
Outstanding (in years) 3 years 7 months 17 days
Vested and expected to vest (in years) 3 years 6 months 29 days
Exercisable (in years) 2 years 4 months 6 days
Aggregate Intrinsic Value of In-The-Money Options  
Outstanding | $ $ 55,364,613
Vested and expected to vest | $ 55,128,404
Exercisable | $ $ 46,760,360
v3.19.3.a.u2
Share-Based Compensation - Stock Options Outstanding (Details)
12 Months Ended
Dec. 31, 2019
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding Options, Shares | shares 625,407
Outstanding Options, Weighted Average Remaining Contractual Life in Years 3 years 7 months 17 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 169.33
Exercisable Options, Shares | shares 361,503
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 124.70
$71.11 - 105.14  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 71.11
Range of Exercise Prices, maximum (usd per share) $ 105.14
Outstanding Options, Shares | shares 55,724
Outstanding Options, Weighted Average Remaining Contractual Life in Years 13 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 73.67
Exercisable Options, Shares | shares 55,724
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 73.67
105.15 - 105.84  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 105.15
Range of Exercise Prices, maximum (usd per share) $ 105.84
Outstanding Options, Shares | shares 114,449
Outstanding Options, Weighted Average Remaining Contractual Life in Years 3 years 3 months 29 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 105.18
Exercisable Options, Shares | shares 79,188
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 105.18
105.85 - 108.59  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 105.85
Range of Exercise Prices, maximum (usd per share) $ 108.59
Outstanding Options, Shares | shares 99,936
Outstanding Options, Weighted Average Remaining Contractual Life in Years 1 year 3 months 29 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 107.94
Exercisable Options, Shares | shares 99,936
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 107.94
108.60 - 149.65  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 108.60
Range of Exercise Prices, maximum (usd per share) $ 149.65
Outstanding Options, Shares | shares 67,573
Outstanding Options, Weighted Average Remaining Contractual Life in Years 2 years 3 months 3 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 129.13
Exercisable Options, Shares | shares 67,573
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 129.13
149.66 - 180.62  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 149.66
Range of Exercise Prices, maximum (usd per share) $ 180.62
Outstanding Options, Shares | shares 80,583
Outstanding Options, Weighted Average Remaining Contractual Life in Years 4 years 4 months 2 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 178.07
Exercisable Options, Shares | shares 37,320
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 178.04
180.63 - 247.01  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 180.63
Range of Exercise Prices, maximum (usd per share) $ 247.01
Outstanding Options, Shares | shares 11,966
Outstanding Options, Weighted Average Remaining Contractual Life in Years 6 years 2 months 4 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 226.22
Exercisable Options, Shares | shares 1,578
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 210.73
247.02 - 255.58  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 247.02
Range of Exercise Prices, maximum (usd per share) $ 255.58
Outstanding Options, Shares | shares 117,265
Outstanding Options, Weighted Average Remaining Contractual Life in Years 6 years 3 months 29 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 250.43
Exercisable Options, Shares | shares 0
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 0
255.59 - 315.12  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 255.59
Range of Exercise Prices, maximum (usd per share) $ 315.12
Outstanding Options, Shares | shares 75,647
Outstanding Options, Weighted Average Remaining Contractual Life in Years 5 years 3 months 29 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 305.18
Exercisable Options, Shares | shares 19,617
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 304.39
315.13 - 324.77  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Exercise Prices, minimum (usd per share) 315.13
Range of Exercise Prices, maximum (usd per share) $ 324.77
Outstanding Options, Shares | shares 2,264
Outstanding Options, Weighted Average Remaining Contractual Life in Years 5 years 7 months 6 days
Outstanding Options, Weighted Average Exercise Price (usd per share) $ 324.77
Exercisable Options, Shares | shares 567
Exercisable Options, Weighted Average Exercise Price (usd per share) $ 324.77
v3.19.3.a.u2
Share-Based Compensation - Information for Restricted Stock Units under Equity Incentive Plan (Details) - $ / shares
12 Months Ended
Feb. 01, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Weighted Average Grant Date Fair Value        
Granted (usd per share)   $ 243.65 $ 294.50 $ 181.23
Market price of stock award   $ 251.04    
Restricted stock units        
Shares        
Nonvested, beginning of period (in shares)   597,296    
Granted (in shares)   543,938    
Vested (in shares)   (227,707)    
Forfeited (in shares)   (65,555)    
Nonvested, end of period (in shares)   847,972 597,296  
Weighted Average Grant Date Fair Value        
Nonvested, beginning of period (usd per share)   $ 194.48    
Granted (usd per share)   243.65    
Vested (usd per share)   154.96    
Forfeited (usd per share)   195.69    
Nonvested, end of period (usd per share)   $ 236.54 $ 194.48  
Vesting period of stock award   5 years    
Retention Plan for SVB Leerink | Restricted stock units        
Shares        
Granted (in shares) 125,160      
Weighted Average Grant Date Fair Value        
Market price of stock award $ 238.28      
v3.19.3.a.u2
Share-Based Compensation - Summary of Information Regarding Stock Option and Restricted Stock Activity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total intrinsic value of stock options exercised $ 23,088 $ 40,681 $ 36,173
Total grant date fair value of stock options vested 5,735 5,823 6,094
Restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total intrinsic value of restricted stock vested 56,101 63,917 40,925
Total grant date fair value of restricted stock vested $ 35,191 $ 28,813 $ 23,383
v3.19.3.a.u2
Variable Interest Entities - Carrying Amounts and Classification of Significant Variable Interests (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Variable Interest Entity [Line Items]        
Cash and cash equivalents $ 6,781,783 $ 3,571,539 $ 2,923,075 $ 2,545,750
Non-marketable and other equity securities 1,213,829 941,104    
Accrued interest receivable and other assets 1,745,233 951,261    
Total assets 71,004,903 56,927,979    
Other liabilities 2,041,752 1,006,359    
Total liabilities 64,383,823 51,663,136    
Investments in Affordable Housing Projects [Abstract]        
Investments in qualified affordable housing projects 458,476 318,575    
Related other liabilities of unfunded credit commitments 302,031 205,685    
Variable Interest Entity, Primary Beneficiary        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 7,629 9,058    
Non-marketable and other equity securities 270,057 221,646    
Accrued interest receivable and other assets 1,117 228    
Total assets 278,803 230,932    
Other liabilities 2,854 919    
Total liabilities 2,854 919    
Maximum Exposure to Loss in Unconsolidated VIEs 275,900      
Variable Interest Entity, Not Primary Beneficiary        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 0 0    
Non-marketable and other equity securities 689,360 568,272    
Accrued interest receivable and other assets 0 0    
Total assets 689,360 568,272    
Other liabilities 302,031 205,685    
Total liabilities 302,031 205,685    
Maximum Exposure to Loss in Unconsolidated VIEs 689,360 568,272    
Variable Interest Entity, Not Primary Beneficiary | Non-marketable securities        
Variable Interest Entity [Line Items]        
Maximum Exposure to Loss in Unconsolidated VIEs $ 689,360 $ 568,272    
v3.19.3.a.u2
Variable Interest Entities - Additional Information (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
entity
Dec. 31, 2018
USD ($)
Variable Interest Entity [Line Items]    
Investments in qualified affordable housing projects, net $ 458,476 $ 318,575
Other liabilities $ 302,031 205,685
Number of consolidated entities | entity 4  
Variable Interest Entity, Primary Beneficiary    
Variable Interest Entity [Line Items]    
Maximum exposure to loss in unconsolidated VIEs $ 275,900  
Variable Interest Entity, Not Primary Beneficiary    
Variable Interest Entity [Line Items]    
Maximum exposure to loss in unconsolidated VIEs $ 689,360 $ 568,272
v3.19.3.a.u2
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock - Average Required Reserve Balances (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]    
Average required reserve balances at FRB San Francisco $ 315,784 $ 455,866
v3.19.3.a.u2
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock - Shares Held at Federal Reserve Bank and Federal Home Loan Bank (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]    
FHLB stock holdings $ 17,250 $ 17,250
FRB stock holdings $ 43,008 $ 41,628
v3.19.3.a.u2
Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash and Cash Equivalents [Abstract]        
Cash and due from banks $ 6,492,443 $ 3,444,971    
Securities purchased under agreements to resell 289,340 123,611    
Other short-term investment securities 0 2,957    
Total cash and cash equivalents $ 6,781,783 $ 3,571,539 $ 2,923,075 $ 2,545,750
v3.19.3.a.u2
Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Footnote Information) (Details) - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Cash and Cash Equivalents [Abstract]    
Deposits at the Federal Reserve Bank earning interest at the Federal Funds target rate $ 3,700 $ 1,700
Interest-earning deposits in other financial institutions 2,100 1,200
Fair value of securities purchased under agreements to resell $ 295 $ 126
v3.19.3.a.u2
Cash and Cash Equivalents - Securities Purchased Under Agreements (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash and Cash Equivalents [Abstract]    
Average securities purchased under agreements to resell $ 166,205 $ 132,938
Maximum amount outstanding at any month-end during the year $ 613,247 $ 375,180
v3.19.3.a.u2
Investment Securities - Major Components of Investment Securities Portfolio (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Investment Holdings [Line Items]    
Amortized cost $ 13,894,348 $ 7,862,311
Unrealized Gains 140,713 12,082
Unrealized Losses (20,142) (84,350)
Available-for-sale securities 14,014,919 7,790,043
U.S. treasury securities    
Investment Holdings [Line Items]    
Amortized cost 6,815,874 4,762,182
Unrealized Gains 82,267 11,638
Unrealized Losses (4,131) (35,562)
Available-for-sale securities 6,894,010 4,738,258
U.S. agency debentures    
Investment Holdings [Line Items]    
Amortized cost 100,000 1,090,426
Unrealized Gains 0 61
Unrealized Losses (453) (6,370)
Available-for-sale securities 99,547 1,084,117
Foreign government debt securities    
Investment Holdings [Line Items]    
Amortized cost 9,037 5,815
Unrealized Gains 1 0
Unrealized Losses 0 (3)
Available-for-sale securities 9,038 5,812
Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Investment Holdings [Line Items]    
Amortized cost 4,109,372  
Unrealized Gains 39,438  
Unrealized Losses (19)  
Available-for-sale securities 4,148,791  
Residential mortgage-backed securities | Fixed rate    
Investment Holdings [Line Items]    
Amortized cost 1,520,414 1,922,618
Unrealized Gains 17,929 0
Unrealized Losses 0 (42,400)
Available-for-sale securities 1,538,343 1,880,218
Residential mortgage-backed securities | Variable rate    
Investment Holdings [Line Items]    
Amortized cost   81,270
Unrealized Gains   383
Unrealized Losses   (15)
Available-for-sale securities   $ 81,638
Agency-issued commercial mortgage-backed securities    
Investment Holdings [Line Items]    
Amortized cost 1,339,651  
Unrealized Gains 1,078  
Unrealized Losses (15,539)  
Available-for-sale securities $ 1,325,190  
v3.19.3.a.u2
Investment Securities - Activity of Available-for-Sale Securities (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Investments, Debt and Equity Securities [Abstract]      
Sales proceeds $ 2,189,087 $ 474,482 $ 580,871
Gross realized gains 1,250 127 5,113
Gross realized losses (5,155) (867) (10,302)
Net realized losses $ (3,905) $ (740) $ (5,189)
v3.19.3.a.u2
Investment Securities - Summary of Unrealized Losses on Available for Sale Securities (Detail)
$ in Thousands
Dec. 31, 2019
USD ($)
Investment
Dec. 31, 2018
USD ($)
Investment
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments $ 2,102,365 $ 957,319
Less than 12 months - Unrealized Losses (20,007) (5,412)
12 months or longer - Fair Value of Investments 449,850 6,039,639
12 months or longer - Unrealized Losses (135) (78,938)
Fair Value of Investments 2,552,215 6,996,958
Unrealized Losses $ (20,142) $ (84,350)
Number of investments in unrealized loss position | Investment 58 200
Number of investments with unrealized losses greater than 12 months | Investment 12 162
U.S. treasury securities    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments $ 971,572 $ 494,287
Less than 12 months - Unrealized Losses (3,996) (3,785)
12 months or longer - Fair Value of Investments 449,850 3,568,119
12 months or longer - Unrealized Losses (135) (31,777)
Fair Value of Investments 1,421,422 4,062,406
Unrealized Losses (4,131) (35,562)
U.S. agency debentures    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments 99,547 443,790
Less than 12 months - Unrealized Losses (453) (1,602)
12 months or longer - Fair Value of Investments 0 591,216
12 months or longer - Unrealized Losses 0 (4,768)
Fair Value of Investments 99,547 1,035,006
Unrealized Losses (453) (6,370)
Foreign government debt securities    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments 5,812  
Less than 12 months - Unrealized Losses (3)  
12 months or longer - Fair Value of Investments 0  
12 months or longer - Unrealized Losses 0  
Fair Value of Investments   5,812
Unrealized Losses   (3)
Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments 4,014  
Less than 12 months - Unrealized Losses (19)  
12 months or longer - Fair Value of Investments 0  
12 months or longer - Unrealized Losses 0  
Fair Value of Investments 4,014  
Unrealized Losses (19)  
Residential mortgage-backed securities | Fixed rate    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments   13,430
Less than 12 months - Unrealized Losses   (22)
12 months or longer - Fair Value of Investments   1,866,788
12 months or longer - Unrealized Losses   (42,378)
Fair Value of Investments   1,880,218
Unrealized Losses   (42,400)
Residential mortgage-backed securities | Variable rate    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments   0
Less than 12 months - Unrealized Losses   0
12 months or longer - Fair Value of Investments   13,516
12 months or longer - Unrealized Losses   (15)
Fair Value of Investments   13,516
Unrealized Losses   $ (15)
Agency-issued commercial mortgage-backed securities    
Investments, Unrealized Loss Position [Line Items]    
Less than 12 months - Fair Value of Investments 1,027,232  
Less than 12 months - Unrealized Losses (15,539)  
12 months or longer - Fair Value of Investments 0  
12 months or longer - Unrealized Losses 0  
Fair Value of Investments 1,027,232  
Unrealized Losses $ (15,539)  
v3.19.3.a.u2
Investment Securities - Summary of Remaining Contractual Principal Maturities for Available-for-Sale Securities (Detail) - Available-for-sale Securities
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Investments Classified By Contractual Maturity Date [Line Items]  
Total $ 14,014,919
One Year or Less 1,845,009
After One Year to Five Years 1,890,778
After Five Years to Ten Years 4,012,540
After Ten Years 6,266,592
U.S. treasury securities  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 6,894,010
One Year or Less 1,835,971
After One Year to Five Years 1,890,778
After Five Years to Ten Years 3,167,261
After Ten Years 0
U.S. agency debentures  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 99,547
One Year or Less 0
After One Year to Five Years 0
After Five Years to Ten Years 99,547
After Ten Years 0
Foreign government debt securities  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 9,038
One Year or Less 9,038
After One Year to Five Years 0
After Five Years to Ten Years 0
After Ten Years 0
Residential mortgage-backed securities | Agency-issued mortgage-backed securities  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 4,148,791
One Year or Less 0
After One Year to Five Years 0
After Five Years to Ten Years 0
After Ten Years 4,148,791
Residential mortgage-backed securities | Fixed rate  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 1,538,343
One Year or Less 0
After One Year to Five Years 0
After Five Years to Ten Years 1,858
After Ten Years 1,536,485
Agency-issued commercial mortgage-backed securities  
Investments Classified By Contractual Maturity Date [Line Items]  
Total 1,325,190
One Year or Less 0
After One Year to Five Years 0
After Five Years to Ten Years 743,874
After Ten Years $ 581,316
Lower Limit  
Investments Classified By Contractual Maturity Date [Line Items]  
Mortgage-backed securities contractual maturities (in years) 10 years
Upper Limit  
Investments Classified By Contractual Maturity Date [Line Items]  
Mortgage-backed securities contractual maturities (in years) 30 years
v3.19.3.a.u2
Investment Securities - Summary of Components and Unrealized Losses on Held-to-Maturity Securities (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Investment
Dec. 31, 2018
USD ($)
Investment
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost $ 13,842,946 $ 15,487,442
Unrealized Gains 289,763 17,040
Unrealized Losses (17,437) (316,246)
Fair Value 14,115,272 15,188,236
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 1,218,980 3,851,352
Unrealized Losses, Less than 12 months (5,727) (56,636)
Fair Value of Investments, 12 months or longer 1,368,956 8,092,085
Unrealized Losses, 12 months or longer (11,710) (259,610)
Fair Value of Investments 2,587,936 11,943,437
Unrealized Losses $ (17,437) $ (316,246)
Number of held-to-maturity investments with unrealized loss | Investment 266 1,244
Number of held-to-maturity investments in continuous loss more than 12 months | Investment 143 695
U.S. agency debentures    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost $ 518,728 $ 640,990
Unrealized Gains 6,640 2,148
Unrealized Losses (668) (4,850)
Fair Value 524,700 638,288
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 125,304 291,432
Unrealized Losses, Less than 12 months (668) (2,915)
Fair Value of Investments, 12 months or longer 0 66,624
Unrealized Losses, 12 months or longer 0 (1,935)
Fair Value of Investments 125,304 358,056
Unrealized Losses (668) (4,850)
Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 6,992,009 8,103,638
Unrealized Gains 142,209 5,011
Unrealized Losses (2,066) (157,767)
Fair Value 7,132,152 7,950,882
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 132,042 2,493,156
Unrealized Losses, Less than 12 months (420) (34,956)
Fair Value of Investments, 12 months or longer 181,585 3,972,690
Unrealized Losses, 12 months or longer (1,646) (122,811)
Fair Value of Investments 313,627 6,465,846
Unrealized Losses (2,066) (157,767)
Residential mortgage-backed securities | Fixed rate    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 1,608,032 2,183,204
Unrealized Gains 592 0
Unrealized Losses (8,502) (62,272)
Fair Value 1,600,122 2,120,932
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 350,868 16,952
Unrealized Losses, Less than 12 months (1,131) (109)
Fair Value of Investments, 12 months or longer 872,527 2,103,980
Unrealized Losses, 12 months or longer (7,371) (62,163)
Fair Value of Investments 1,223,395 2,120,932
Unrealized Losses (8,502) (62,272)
Residential mortgage-backed securities | Variable rate    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 178,611 214,483
Unrealized Gains 94 608
Unrealized Losses (259) (14)
Fair Value 178,446 215,077
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 143,265 3,364
Unrealized Losses, Less than 12 months (256) (1)
Fair Value of Investments, 12 months or longer 4,615 8,101
Unrealized Losses, 12 months or longer (3) (13)
Fair Value of Investments 147,880 11,465
Unrealized Losses (259) (14)
Agency-issued commercial mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 2,759,615 2,769,706
Unrealized Gains 56,914 6,969
Unrealized Losses (4,508) (64,374)
Fair Value 2,812,021 2,712,301
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 307,087 177,697
Unrealized Losses, Less than 12 months (1,818) (1,580)
Fair Value of Investments, 12 months or longer 310,229 1,600,277
Unrealized Losses, 12 months or longer (2,690) (62,794)
Fair Value of Investments 617,316 1,777,974
Unrealized Losses (4,508) (64,374)
Municipal bonds and notes    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 1,785,951 1,575,421
Unrealized Gains 83,314 2,304
Unrealized Losses (1,434) (26,969)
Fair Value 1,867,831 1,550,756
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value of Investments, Less than 12 months 160,414 868,751
Unrealized Losses, Less than 12 months (1,434) (17,075)
Fair Value of Investments, 12 months or longer 0 340,413
Unrealized Losses, 12 months or longer 0 (9,894)
Fair Value of Investments 160,414 1,209,164
Unrealized Losses $ (1,434) $ (26,969)
v3.19.3.a.u2
Investment Securities - Summary of Remaining Contractual Principal Maturities for Held-to-Maturity Securities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value $ 14,115,272 $ 15,188,236
U.S. agency debentures    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 524,700 638,288
Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 7,132,152 7,950,882
Residential mortgage-backed securities | Fixed rate    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 1,600,122 2,120,932
Residential mortgage-backed securities | Variable rate    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 178,446 215,077
Agency-issued commercial mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 2,812,021 2,712,301
Municipal bonds and notes    
Schedule of Held-to-maturity Securities [Line Items]    
Fair Value 1,867,831 $ 1,550,756
After One Year to Five Years - Amortized Cost 83,368  
After Five Years to Ten Years - Amortized Cost 387,278  
Held-to-maturity securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 13,842,946  
Fair Value 14,115,272  
One Year or Less - Amortized Cost 16,039  
One Year or Less - Fair Value 16,101  
After One Year to Five Years - Amortized Cost 283,227  
After One Year to Five Years - Fair Value 285,698  
After Five Years to Ten Years - Amortized Cost 2,236,089  
After Five Years to Ten Years - Fair Value 2,260,337  
After Ten Years - Amortized Cost 11,307,591  
After Ten Years - Fair Value 11,553,136  
Held-to-maturity securities | U.S. agency debentures    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 518,728  
Fair Value 524,700  
One Year or Less - Amortized Cost 0  
One Year or Less - Fair Value 0  
After One Year to Five Years - Amortized Cost 123,100  
After One Year to Five Years - Fair Value 123,969  
After Five Years to Ten Years - Amortized Cost 395,628  
After Five Years to Ten Years - Fair Value 400,731  
After Ten Years - Amortized Cost 0  
After Ten Years - Fair Value 0  
Held-to-maturity securities | Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 6,992,009  
Fair Value 7,132,152  
One Year or Less - Amortized Cost 2,066  
One Year or Less - Fair Value 2,117  
After One Year to Five Years - Amortized Cost 76,759  
After One Year to Five Years - Fair Value 76,956  
After Five Years to Ten Years - Amortized Cost 726,422  
After Five Years to Ten Years - Fair Value 725,854  
After Ten Years - Amortized Cost 6,186,762  
After Ten Years - Fair Value 6,327,225  
Held-to-maturity securities | Residential mortgage-backed securities | Fixed rate    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 1,608,032  
Fair Value 1,600,122  
One Year or Less - Amortized Cost 0  
One Year or Less - Fair Value 0  
After One Year to Five Years - Amortized Cost 0  
After One Year to Five Years - Fair Value 0  
After Five Years to Ten Years - Amortized Cost 624,128  
After Five Years to Ten Years - Fair Value 619,180  
After Ten Years - Amortized Cost 983,904  
After Ten Years - Fair Value 980,942  
Held-to-maturity securities | Residential mortgage-backed securities | Variable rate    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 178,611  
Fair Value 178,446  
One Year or Less - Amortized Cost 0  
One Year or Less - Fair Value 0  
After One Year to Five Years - Amortized Cost 0  
After One Year to Five Years - Fair Value 0  
After Five Years to Ten Years - Amortized Cost 0  
After Five Years to Ten Years - Fair Value 0  
After Ten Years - Amortized Cost 178,611  
After Ten Years - Fair Value 178,446  
Held-to-maturity securities | Agency-issued commercial mortgage-backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 2,759,615  
Fair Value 2,812,021  
One Year or Less - Amortized Cost 0  
One Year or Less - Fair Value 0  
After One Year to Five Years - Amortized Cost 0  
After One Year to Five Years - Fair Value 0  
After Five Years to Ten Years - Amortized Cost 102,633  
After Five Years to Ten Years - Fair Value 110,836  
After Ten Years - Amortized Cost 2,656,982  
After Ten Years - Fair Value 2,701,185  
Held-to-maturity securities | Municipal bonds and notes    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 1,785,951  
Fair Value 1,867,831  
One Year or Less - Amortized Cost 13,973  
One Year or Less - Fair Value 13,984  
After One Year to Five Years - Fair Value 84,773  
After Five Years to Ten Years - Fair Value 403,736  
After Ten Years - Amortized Cost 1,301,332  
After Ten Years - Fair Value $ 1,365,338  
v3.19.3.a.u2
Investment Securities - Major Components of Non-marketable and Other Securities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Investment Holdings [Line Items]      
Investments in qualified affordable housing projects, net $ 458,476 $ 318,575  
Total non-marketable and other securities 1,213,829 941,104  
Consolidated venture capital and private equity fund investments | Fair value accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 87,180 118,333  
Consolidated venture capital and private equity fund investments | Equity method accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 215,367 129,485  
Unconsolidated venture capital and private equity fund investments | Fair value accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 178,217   $ 201,098
Unconsolidated venture capital and private equity fund investments | Equity method accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 215,367 129,485  
Other investments | Fair value accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 55,255 25,668  
Other investments | Equity method accounting      
Investment Holdings [Line Items]      
Nonmarketable securities 152,863 121,721  
Equity securities | Fair value accounting      
Investment Holdings [Line Items]      
Other equity securities 59,200 20,398  
Debt funds | Equity method accounting      
Investment Holdings [Line Items]      
Nonmarketable securities $ 7,271 $ 5,826  
v3.19.3.a.u2
Investment Securities - Consolidated Venture Capital and Private Equity Fund Investments (Details) - Consolidated venture capital and private equity fund investments - Fair value accounting - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Investment Holdings [Line Items]    
Nonmarketable securities $ 87,180 $ 118,333
Strategic Investors Fund, LP    
Investment Holdings [Line Items]    
Nonmarketable securities $ 5,729 $ 12,452
Strategic Investors Fund, LP | Non-marketable securities    
Investment Holdings [Line Items]    
Ownership interest percentage 12.60% 12.60%
Capital Preferred Return Fund, LP    
Investment Holdings [Line Items]    
Nonmarketable securities $ 45,341 $ 53,957
Capital Preferred Return Fund, LP | Non-marketable securities    
Investment Holdings [Line Items]    
Ownership interest percentage 20.00% 20.00%
Growth Partners, LP    
Investment Holdings [Line Items]    
Nonmarketable securities $ 35,976 $ 50,845
Growth Partners, LP | Non-marketable securities    
Investment Holdings [Line Items]    
Ownership interest percentage 33.00% 33.00%
CP I, LP    
Investment Holdings [Line Items]    
Nonmarketable securities $ 134 $ 1,079
CP I, LP | Non-marketable securities    
Investment Holdings [Line Items]    
Ownership interest percentage 10.70% 10.70%
v3.19.3.a.u2
Investment Securities - Unconsolidated Venture Capital and Private Equity Fund Investments (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Investment
Dec. 31, 2018
Investment
Dec. 31, 2017
USD ($)
Upper Limit      
Investment Holdings [Line Items]      
Ownership interest percentage 5.00% 5.00%  
Unconsolidated venture capital and private equity fund investments | Fair value accounting      
Investment Holdings [Line Items]      
Nonmarketable securities | $ $ 178,217   $ 201,098
Non-marketable securities | Unconsolidated venture capital and private equity fund investments | Fair value accounting      
Investment Holdings [Line Items]      
Number of investments | Investment 205 213  
v3.19.3.a.u2
Investment Securities - Other Investments Without a Readily Determinable Fair Value (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Carrying value at December 31, 2018 $ 55,255
Year end Adjustments  
Impairment (460)
Upward changes for observable prices 1,929
Downward changes for observable prices (3,511)
Cumulative Adjustments  
Impairment (460)
Upward changes for observable prices 2,348
Downward changes for observable prices $ 5,030
v3.19.3.a.u2
Investment Securities - Nonmarketable Securities Under Equity Method Accounting (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Consolidated venture capital and private equity fund investments | Equity method accounting    
Investment Holdings [Line Items]    
Nonmarketable securities $ 215,367 $ 129,485
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund II, LP    
Investment Holdings [Line Items]    
Nonmarketable securities 3,612 4,670
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund III, LP    
Investment Holdings [Line Items]    
Nonmarketable securities 15,668 17,396
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund IV, LP    
Investment Holdings [Line Items]    
Nonmarketable securities 27,064 28,974
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund V funds    
Investment Holdings [Line Items]    
Nonmarketable securities 46,830 28,189
Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP    
Investment Holdings [Line Items]    
Nonmarketable securities 5,907 7,122
Consolidated venture capital and private equity fund investments | Equity method accounting | Other venture capital and private equity fund investments    
Investment Holdings [Line Items]    
Nonmarketable securities 116,286 43,134
Debt funds | Equity method accounting    
Investment Holdings [Line Items]    
Nonmarketable securities 7,271 5,826
Debt funds | Equity method accounting | Gold Hill Capital 2008, LP (ii)    
Investment Holdings [Line Items]    
Nonmarketable securities 5,525 3,901
Debt funds | Equity method accounting | Other debt funds    
Investment Holdings [Line Items]    
Nonmarketable securities 1,746 1,925
Other investments | Equity method accounting    
Investment Holdings [Line Items]    
Nonmarketable securities 152,863 121,721
Other investments | Equity method accounting | SPD Silicon Valley Bank Co., Ltd.    
Investment Holdings [Line Items]    
Nonmarketable securities 74,190 76,412
Other investments | Equity method accounting | Other investments    
Investment Holdings [Line Items]    
Nonmarketable securities $ 78,673 $ 45,309
Non-marketable securities | Consolidated venture capital and private equity fund investments | CP II, LP | Direct ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 1.30%  
Non-marketable securities | Consolidated venture capital and private equity fund investments | CP II, LP | Indirect ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 3.80%  
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund II, LP    
Investment Holdings [Line Items]    
Ownership interest percentage 8.60% 8.60%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund III, LP    
Investment Holdings [Line Items]    
Ownership interest percentage 5.90% 5.90%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund IV, LP    
Investment Holdings [Line Items]    
Ownership interest percentage 5.00% 5.00%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP    
Investment Holdings [Line Items]    
Ownership interest percentage 5.10% 5.10%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP | Direct ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 1.30%  
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP | Indirect ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 3.80%  
Non-marketable securities | Debt funds | Equity method accounting | Direct ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 11.50%  
Non-marketable securities | Debt funds | Equity method accounting | Indirect ownership interest    
Investment Holdings [Line Items]    
Ownership interest percentage 4.00%  
Non-marketable securities | Debt funds | Equity method accounting | Gold Hill Capital 2008, LP (ii)    
Investment Holdings [Line Items]    
Ownership interest percentage 15.50% 15.50%
Non-marketable securities | Other investments | Equity method accounting | SPD Silicon Valley Bank Co., Ltd.    
Investment Holdings [Line Items]    
Ownership interest percentage 50.00% 50.00%
v3.19.3.a.u2
Investment Securities - Qualified Affordable Housing Projects (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Investments in Affordable Housing Projects [Abstract]      
Investments in qualified affordable housing projects, net $ 458,476 $ 318,575  
Other liabilities 302,031 205,685  
Investment Holdings [Line Items]      
Tax credits and other tax benefits recognized 35,037 24,047 $ 17,296
Amortization expense included in provision for income taxes $ 28,267 18,876 $ 17,362
Low Income Housing Tax Credit Funds      
Investment Holdings [Line Items]      
Cumulative effect adjustment   $ 3,800  
v3.19.3.a.u2
Investment Securities - Components of Gains and Losses (Realized and Unrealized) on Investment Securities (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net $ 138,575 $ 88,834 $ 69,792
Losses on sales of securities 5,200    
OTTI 400 5,300 4,200
Gains on sales of investments   20,800 3,800
Non-marketable securities      
Gain (Loss) on Securities [Line Items]      
Less: Realized net losses on the sales and OTTI of non-marketable and other equity securities (4,744) 26,097 355
Net gains on non-marketable and other equity securities still held 133,831 114,931 70,147
Non-marketable securities | Consolidated venture capital and private equity fund investments | Fair value accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net 22,507 20,999 27,186
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net 73,813 49,341 14,472
Non-marketable securities | Unconsolidated venture capital and private equity fund investments | Fair value accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net 31,482 39,075 21,377
Non-marketable securities | Other investments | Fair value accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net 2,742 3,206 3,842
Non-marketable securities | Other investments | Equity method accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net (1,388) 1,155 (6,276)
Non-marketable securities | Debt funds | Equity method accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net 1,647 541 8,950
Other equity securities | Fair value accounting      
Gain (Loss) on Securities [Line Items]      
Gains on non-marketable and other equity securities, net $ 7,772 $ (25,483) $ 241
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Receivables [Abstract]    
Loans modified in TDRs $ 108,982 $ 83,695
Unfunded commitments available for funding $ 800  
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unearned income on loans $ 163,000 $ 173,000
Loans, net of unearned income 33,164,636 28,338,280
Commercial loans, excluding real estate secured and construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 28,428,121 24,456,728
Commercial loans, excluding real estate secured and construction | Software/internet    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 6,199,548 6,154,755
Commercial loans, excluding real estate secured and construction | Hardware    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 1,371,159 1,234,557
Commercial loans, excluding real estate secured and construction | Private equity/venture capital    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 17,801,324 14,110,560
Commercial loans, excluding real estate secured and construction | Life science/healthcare    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 2,368,048 2,385,612
Commercial loans, excluding real estate secured and construction | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 267,487 249,266
Commercial loans, excluding real estate secured and construction | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 420,555 321,978
Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 4,146,347 3,363,803
Real estate secured loans | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 820,730 710,397
Real estate secured loans | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 38,880 40,435
Real estate secured loans | Construction loans, premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 83,000 99,000
Construction loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 100,219 97,077
Consumer loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 3,776,686 3,033,643
Consumer loans | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 3,286,737 2,612,971
Consumer loans | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income $ 489,949 $ 420,672
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income (Additional Information) (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income $ 33,164,636 $ 28,338,280
Credit card receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 395,000 335,000
Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 4,146,347 3,363,803
Real estate secured loans | Construction loans, premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 83,000 99,000
Consumer loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 3,776,686 3,033,643
Consumer loans | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 3,286,737 2,612,971
Consumer loans | Real estate secured loans | Loans for personal residence    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 2,829,880 2,251,292
Consumer loans | Real estate secured loans | Loans to eligible employees    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income 401,396 290,194
Consumer loans | Real estate secured loans | Home equity lines of credit    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, net of unearned income $ 55,461 $ 71,485
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income, Broken Out by Portfolio Segment and Class of Financing Receivable (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income $ 33,164,636 $ 28,338,280
Commercial loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 29,387,950 25,304,637
Commercial loans | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 6,199,548 6,154,755
Commercial loans | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 1,371,159 1,234,557
Commercial loans | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 17,801,324 14,110,560
Commercial loans | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 2,368,048 2,385,612
Commercial loans | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 1,088,217 959,663
Commercial loans | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 559,654 459,490
Consumer loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 3,776,686 3,033,643
Consumer loans | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income 489,949 420,672
Consumer loans | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Loans, net of unearned income $ 3,286,737 $ 2,612,971
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Aging of Gross Loans, Broken out by Portfolio Segment and Class of Financing Receivable (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due $ 191,587 $ 159,113
Current 33,136,117 28,352,199
Loans Past Due 90 Days or More Still Accruing Interest 3,515 1,964
Total gross loans excluding impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 167,213 129,997
Current 33,007,482 28,211,241
Loans Past Due 90 Days or More Still Accruing Interest 3,515 1,964
Impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 24,374 29,116
Current 128,635 140,958
Loans Past Due 90 Days or More Still Accruing Interest 0 0
30 - 59 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 137,375 121,143
30 - 59 Days Past Due | Total gross loans excluding impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 132,279 118,300
30 - 59 Days Past Due | Impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 5,096 2,843
60 - 89 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 38,224 10,914
60 - 89 Days Past Due | Total gross loans excluding impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 31,419 9,733
60 - 89 Days Past Due | Impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 6,805 1,181
Equal to or Greater Than 90 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 15,988 27,056
Equal to or Greater Than 90 Days Past Due | Total gross loans excluding impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 3,515 1,964
Equal to or Greater Than 90 Days Past Due | Impaired loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 12,473 25,092
Commercial loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 160,119 122,726
Current 29,246,333 25,192,386
Loans Past Due 90 Days or More Still Accruing Interest 3,150 402
Commercial loans | Software/internet    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 24,064 35,456
Current 6,136,230 6,059,672
Loans Past Due 90 Days or More Still Accruing Interest 0 378
Commercial loans | Hardware    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 18,188 338
Current 1,357,379 1,233,956
Loans Past Due 90 Days or More Still Accruing Interest 0 4
Commercial loans | Private equity/venture capital    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 101,426 59,492
Current 17,715,964 14,054,940
Loans Past Due 90 Days or More Still Accruing Interest 3,150 0
Commercial loans | Life science/healthcare    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 8,865 16,918
Current 2,387,203 2,410,091
Loans Past Due 90 Days or More Still Accruing Interest 0 19
Commercial loans | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 7,543 2,967
Current 1,070,111 956,285
Loans Past Due 90 Days or More Still Accruing Interest 0 0
Commercial loans | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 33 7,555
Current 579,446 477,442
Loans Past Due 90 Days or More Still Accruing Interest 0 1
Commercial loans | 30 - 59 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 125,833 114,341
Commercial loans | 30 - 59 Days Past Due | Software/internet    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 19,839 28,134
Commercial loans | 30 - 59 Days Past Due | Hardware    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 104 300
Commercial loans | 30 - 59 Days Past Due | Private equity/venture capital    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 97,893 59,481
Commercial loans | 30 - 59 Days Past Due | Life science/healthcare    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 445 16,082
Commercial loans | 30 - 59 Days Past Due | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 7,543 2,953
Commercial loans | 30 - 59 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 9 7,391
Commercial loans | 60 - 89 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 31,136 7,983
Commercial loans | 60 - 89 Days Past Due | Software/internet    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 4,225 6,944
Commercial loans | 60 - 89 Days Past Due | Hardware    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 18,084 34
Commercial loans | 60 - 89 Days Past Due | Private equity/venture capital    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 383 11
Commercial loans | 60 - 89 Days Past Due | Life science/healthcare    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 8,420 817
Commercial loans | 60 - 89 Days Past Due | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 14
Commercial loans | 60 - 89 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 24 163
Commercial loans | Equal to or Greater Than 90 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 3,150 402
Commercial loans | Equal to or Greater Than 90 Days Past Due | Software/internet    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 378
Commercial loans | Equal to or Greater Than 90 Days Past Due | Hardware    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 4
Commercial loans | Equal to or Greater Than 90 Days Past Due | Private equity/venture capital    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 3,150 0
Commercial loans | Equal to or Greater Than 90 Days Past Due | Life science/healthcare    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 19
Commercial loans | Equal to or Greater Than 90 Days Past Due | Premium wine    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial loans | Equal to or Greater Than 90 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 1
Consumer, Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 7,094 7,271
Current 3,761,149 3,018,855
Loans Past Due 90 Days or More Still Accruing Interest 365 1,562
Consumer, Other | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 447 361
Current 489,831 420,359
Loans Past Due 90 Days or More Still Accruing Interest 0 0
Consumer, Other | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 6,647 6,910
Current 3,271,318 2,598,496
Loans Past Due 90 Days or More Still Accruing Interest 365 1,562
Consumer, Other | 30 - 59 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 6,446 3,959
Consumer, Other | 30 - 59 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 164 361
Consumer, Other | 30 - 59 Days Past Due | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 6,282 3,598
Consumer, Other | 60 - 89 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 283 1,750
Consumer, Other | 60 - 89 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 283 0
Consumer, Other | 60 - 89 Days Past Due | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 1,750
Consumer, Other | Equal to or Greater Than 90 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 365 1,562
Consumer, Other | Equal to or Greater Than 90 Days Past Due | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Consumer, Other | Equal to or Greater Than 90 Days Past Due | Real estate secured loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due $ 365 $ 1,562
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Impaired Loans and Allowance for Loan Losses, Broken out by Portfolio Segment and Class of Financing Receivable (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Financing Receivable, Impaired [Line Items]    
Total carrying value of impaired loans $ 153,009 $ 170,074
Total unpaid principal of impaired loans 214,036 199,908
Impaired Financing Receivables With Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 95,438 73,002
Impaired Financing Receivables With No Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is no related allowance for loan losses 57,571 97,072
Commercial loans    
Financing Receivable, Impaired [Line Items]    
Total carrying value of impaired loans 147,529 165,835
Total unpaid principal of impaired loans 205,509 193,939
Commercial loans | Software/internet    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 64,100 49,625
Impaired loans for which there is no related allowance for loan losses 31,472 65,225
Total carrying value of impaired loans 95,572 114,850
Total unpaid principal of impaired loans 109,736 131,858
Commercial loans | Hardware    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 2,143 1,256
Impaired loans for which there is no related allowance for loan losses 3,315 10,250
Total carrying value of impaired loans 5,458 11,506
Total unpaid principal of impaired loans 10,049 12,159
Commercial loans | Private equity/venture capital    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 0 0
Impaired loans for which there is no related allowance for loan losses 0 3,700
Total carrying value of impaired loans 0 3,700
Total unpaid principal of impaired loans 0 3,700
Commercial loans | Life science/healthcare    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 25,941 17,791
Impaired loans for which there is no related allowance for loan losses 5,671 16,276
Total carrying value of impaired loans 31,612 34,067
Total unpaid principal of impaired loans 70,600 44,446
Commercial loans | Premium wine    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 204 0
Impaired loans for which there is no related allowance for loan losses 11,718 1,301
Total carrying value of impaired loans 11,922 1,301
Total unpaid principal of impaired loans 12,010 1,365
Commercial loans | Other    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 1,284 411
Impaired loans for which there is no related allowance for loan losses 1,681 0
Total carrying value of impaired loans 2,965 411
Total unpaid principal of impaired loans 3,114 411
Commercial loans | Impaired Financing Receivables With Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 93,672 69,083
Commercial loans | Impaired Financing Receivables With No Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is no related allowance for loan losses 53,857 96,752
Consumer loans    
Financing Receivable, Impaired [Line Items]    
Total carrying value of impaired loans 5,480 4,239
Total unpaid principal of impaired loans 8,527 5,969
Consumer loans | Real estate secured loans    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 1,766 3,919
Impaired loans for which there is no related allowance for loan losses 3,714 320
Total carrying value of impaired loans 5,480 4,239
Total unpaid principal of impaired loans 8,527 5,969
Consumer loans | Impaired Financing Receivables With Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is a related allowance for loan losses 1,766 3,919
Consumer loans | Impaired Financing Receivables With No Related Allowance    
Financing Receivable, Impaired [Line Items]    
Impaired loans for which there is no related allowance for loan losses $ 3,714 $ 320
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Average Impaired Loans, Broken out by Portfolio Segment and Class of Financing Receivable (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Financing Receivable, Impaired [Line Items]      
Average impaired loans $ 160,347 $ 179,666 $ 193,120
Interest income recognized on impaired loans 4,582 2,664 3,566
Private equity/venture capital      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 2,264 1,327  
Commercial loans      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 153,181 175,280 189,802
Interest income recognized on impaired loans 4,528 2,649 3,566
Commercial loans | Software/internet      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 88,628 112,493 119,557
Interest income recognized on impaired loans 2,813 1,513 2,263
Commercial loans | Hardware      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 12,500 28,540 35,022
Interest income recognized on impaired loans 464 312 1,061
Commercial loans | Private equity/venture capital      
Financing Receivable, Impaired [Line Items]      
Average impaired loans     556
Interest income recognized on impaired loans 0 0 0
Commercial loans | Life science/healthcare      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 44,827 30,144 30,842
Interest income recognized on impaired loans 919 756 90
Commercial loans | Premium wine      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 2,912 2,605 3,249
Interest income recognized on impaired loans 311 68 152
Commercial loans | Other      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 2,050 171 576
Interest income recognized on impaired loans 21 0 0
Consumer loans      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 7,166 4,386 3,318
Interest income recognized on impaired loans 54 15 0
Consumer loans | Other      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 7 358 1,804
Interest income recognized on impaired loans 0 0 0
Consumer loans | Real estate secured loans      
Financing Receivable, Impaired [Line Items]      
Average impaired loans 7,159 4,028 1,514
Interest income recognized on impaired loans $ 54 $ 15 $ 0
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Activity in Allowance for Loan Losses Broken out by Portfolio Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance $ 280,903 $ 255,024 $ 225,366
Charge-offs (92,603) (67,917) (66,682)
Recoveries 21,038 11,636 8,538
Provision for (Reduction of) Loan Losses 94,183 84,292 85,939
Foreign Currency Translation Adjustments 1,403 (2,132) 1,863
Ending Balance 304,924 280,903 255,024
Commercial loans      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 260,966 238,583 213,182
Charge-offs (91,572) (67,628) (65,115)
Recoveries 20,782 11,149 7,175
Provision for (Reduction of) Loan Losses 91,814 80,953 81,553
Foreign Currency Translation Adjustments 1,428 (2,091) 1,788
Ending Balance 283,418 260,966 238,583
Commercial loans | Software/internet      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 103,567 96,104 97,388
Charge-offs (46,930) (42,315) (45,012)
Recoveries 11,363 5,664 4,649
Provision for (Reduction of) Loan Losses 31,766 45,068 38,462
Foreign Currency Translation Adjustments 457 (954) 617
Ending Balance 100,223 103,567 96,104
Commercial loans | Hardware      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 19,725 27,614 31,166
Charge-offs (10,056) (16,148) (10,414)
Recoveries 7,069 1,849 487
Provision for (Reduction of) Loan Losses 2,740 6,555 6,051
Foreign Currency Translation Adjustments 166 (145) 324
Ending Balance 19,644 19,725 27,614
Commercial loans | Private equity/venture capital      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 98,581 82,468 50,299
Charge-offs (2,047) (112) (323)
Recoveries 2,047 13 0
Provision for (Reduction of) Loan Losses 16,989 16,485 31,625
Foreign Currency Translation Adjustments 235 (273) 867
Ending Balance 115,805 98,581 82,468
Commercial loans | Life science/healthcare      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 32,180 24,924 25,446
Charge-offs (31,950) (6,662) (8,210)
Recoveries 267 348 189
Provision for (Reduction of) Loan Losses 38,178 14,347 7,414
Foreign Currency Translation Adjustments 570 (777) 85
Ending Balance 39,245 32,180 24,924
Commercial loans | Premium wine      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 3,355 3,532 4,115
Charge-offs (174) 0 0
Recoveries 0 0 0
Provision for (Reduction of) Loan Losses 1,813 (182) (540)
Foreign Currency Translation Adjustments 154 5 (43)
Ending Balance 5,148 3,355 3,532
Commercial loans | Other      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 3,558 3,941 4,768
Charge-offs (415) (2,391) (1,156)
Recoveries 36 3,275 1,850
Provision for (Reduction of) Loan Losses 328 (1,320) (1,459)
Foreign Currency Translation Adjustments (154) 53 (62)
Ending Balance 3,353 3,558 3,941
Consumer loans      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Beginning Balance 19,937 16,441 12,184
Charge-offs (1,031) (289) (1,567)
Recoveries 256 487 1,363
Provision for (Reduction of) Loan Losses 2,369 3,339 4,386
Foreign Currency Translation Adjustments (25) (41) 75
Ending Balance $ 21,506 $ 19,937 $ 16,441
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Activity in Allowance for Unfunded Commitments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Activity in Allowance for Unfunded Commitments [Abstract]      
Allowance for unfunded credit commitments, beginning balance $ 55,183 $ 51,770 $ 45,265
Provision for unfunded credit commitments 12,233 3,578 6,365
Foreign currency translation adjustments 240 (165) 140
Allowance for unfunded credit commitments, ending balance $ 67,656 $ 55,183 $ 51,770
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Allowance for Loan Losses Individually and Collectively Evaluated for Impairment (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment $ 44,859 $ 37,941
Financing Receivable, Individually Evaluated for Impairment 153,009 170,074
Collectively Evaluated for Impairment 260,065 242,962
Financing Receivable, Collectively Evaluated for Impairment 33,011,627 28,168,206
Commercial loans    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 44,648 37,675
Financing Receivable, Individually Evaluated for Impairment 147,529 165,835
Collectively Evaluated for Impairment 238,770 223,291
Financing Receivable, Collectively Evaluated for Impairment 29,240,421 25,138,802
Commercial loans | Software/internet    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 26,613 28,527
Financing Receivable, Individually Evaluated for Impairment 95,572 114,850
Collectively Evaluated for Impairment 73,610 75,040
Financing Receivable, Collectively Evaluated for Impairment 6,103,976 6,039,905
Commercial loans | Hardware    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 1,214 1,253
Financing Receivable, Individually Evaluated for Impairment 5,458 11,506
Collectively Evaluated for Impairment 18,430 18,472
Financing Receivable, Collectively Evaluated for Impairment 1,365,701 1,223,051
Commercial loans | Private equity/venture capital    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 0 0
Financing Receivable, Individually Evaluated for Impairment 0 3,700
Collectively Evaluated for Impairment 115,805 98,581
Financing Receivable, Collectively Evaluated for Impairment 17,801,324 14,106,860
Commercial loans | Life science/healthcare    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 16,414 7,484
Financing Receivable, Individually Evaluated for Impairment 31,612 34,067
Collectively Evaluated for Impairment 22,831 24,696
Financing Receivable, Collectively Evaluated for Impairment 2,336,436 2,351,545
Commercial loans | Premium wine    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 204 0
Financing Receivable, Individually Evaluated for Impairment 11,922 1,301
Collectively Evaluated for Impairment 4,944 3,355
Financing Receivable, Collectively Evaluated for Impairment 1,076,295 958,362
Commercial loans | Other    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 203 411
Financing Receivable, Individually Evaluated for Impairment 2,965 411
Collectively Evaluated for Impairment 3,150 3,147
Financing Receivable, Collectively Evaluated for Impairment 556,689 459,079
Consumer loans    
Financing Receivable, Impaired [Line Items]    
Individually Evaluated for Impairment 211 266
Financing Receivable, Individually Evaluated for Impairment 5,480 4,239
Collectively Evaluated for Impairment 21,295 19,671
Financing Receivable, Collectively Evaluated for Impairment $ 3,771,206 $ 3,029,404
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Credit Quality Indicators, Broken out by Portfolio Segment and Class of Financing Receivables (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable $ 33,327,704 $ 28,511,312
Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 32,361,879 27,492,604
Performing (Criticized)    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 812,816 848,634
Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 50,340 75,932
Non Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 102,669 94,142
Commercial loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 29,553,981 25,480,947
Commercial loans | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 6,255,866 6,209,978
Commercial loans | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,381,025 1,245,800
Commercial loans | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 17,817,390 14,118,132
Commercial loans | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 2,427,680 2,461,076
Commercial loans | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,089,576 960,553
Commercial loans | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 582,444 485,408
Commercial loans | Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 28,605,228 24,488,572
Commercial loans | Pass | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 5,704,283 5,574,332
Commercial loans | Pass | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,266,077 1,146,985
Commercial loans | Pass | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 17,813,128 14,098,281
Commercial loans | Pass | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 2,197,679 2,291,356
Commercial loans | Pass | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,053,021 909,965
Commercial loans | Pass | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 571,040 467,653
Commercial loans | Performing (Criticized)    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 801,224 826,540
Commercial loans | Performing (Criticized) | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 456,011 520,796
Commercial loans | Performing (Criticized) | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 109,490 87,309
Commercial loans | Performing (Criticized) | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 4,262 16,151
Commercial loans | Performing (Criticized) | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 198,389 135,653
Commercial loans | Performing (Criticized) | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 24,633 49,287
Commercial loans | Performing (Criticized) | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 8,439 17,344
Commercial loans | Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 50,340 75,612
Commercial loans | Performing Impaired | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 28,417 48,069
Commercial loans | Performing Impaired | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 3,315 10,250
Commercial loans | Performing Impaired | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 0 0
Commercial loans | Performing Impaired | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 5,211 16,276
Commercial loans | Performing Impaired | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 11,717 1,017
Commercial loans | Performing Impaired | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,680 0
Commercial loans | Non Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 97,189 90,223
Commercial loans | Non Performing Impaired | Software/internet    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 67,155 66,781
Commercial loans | Non Performing Impaired | Hardware    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 2,143 1,256
Commercial loans | Non Performing Impaired | Private equity/venture capital    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 0 3,700
Commercial loans | Non Performing Impaired | Life science/healthcare    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 26,401 17,791
Commercial loans | Non Performing Impaired | Premium wine    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 205 284
Commercial loans | Non Performing Impaired | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 1,285 411
Consumer loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 3,773,723 3,030,365
Consumer loans | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 3,283,445 2,609,645
Consumer loans | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 490,278 420,720
Consumer loans | Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 3,756,651 3,004,032
Consumer loans | Pass | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 3,266,748 2,584,261
Consumer loans | Pass | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 489,903 419,771
Consumer loans | Performing (Criticized)    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 11,592 22,094
Consumer loans | Performing (Criticized) | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 11,217 21,145
Consumer loans | Performing (Criticized) | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 375 949
Consumer loans | Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 0 320
Consumer loans | Performing Impaired | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 0 320
Consumer loans | Performing Impaired | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 0 0
Consumer loans | Non Performing Impaired    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 5,480 3,919
Consumer loans | Non Performing Impaired | Real estate secured loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable 5,480 3,919
Consumer loans | Non Performing Impaired | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Financing receivable $ 0 $ 0
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Summary of Loans Modified in Troubled Debt Restructurings (TDRs) by Portfolio Segment and Class of Financing Receivables (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
troubled_debt_restructuring
Dec. 31, 2018
USD ($)
troubled_debt_restructuring
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Number of TDRs | troubled_debt_restructuring 23 17
Loans modified in TDRs $ 108,982 $ 83,695
Commercial loans    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs 106,878 83,375
Commercial loans | Software/internet    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs 71,136 58,089
Commercial loans | Hardware    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs 1,685 9,665
Commercial loans | Life science/healthcare    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs 20,600 12,738
Commercial loans | Premium wine    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs 13,457 2,883
Consumer loans | Other    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Loans modified in TDRs $ 2,104 $ 320
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
troubled_debt_restructuring
Dec. 31, 2018
USD ($)
troubled_debt_restructuring
Dec. 31, 2017
USD ($)
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Number of TDRs | troubled_debt_restructuring 23 17  
Loans modified in TDRs during the period $ 90,171 $ 41,074 $ 93,843
Partial charge-offs on loans classified as TDRs 11,300 4,600 3,000
Commercial loans      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 88,378 40,754 93,843
Commercial loans | Software/internet      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 62,367 30,429 42,184
Commercial loans | Hardware      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 1,685 9,665 51,132
Commercial loans | Private equity/venture capital      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 0 0 350
Commercial loans | Life science/healthcare      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 13,309 660 0
Commercial loans | Premium wine      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 11,017 0 177
Consumer loans | Other      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 1,793 320 0
Payment deferrals      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period 86,900 $ 41,100 93,500
Partial forgiveness of principal      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
Loans modified in TDRs during the period $ 3,300   $ 300
v3.19.3.a.u2
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs within Previous 12 months Subsequently Defaulted (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Financing Receivable, Troubled Debt Restructuring [Line Items]      
TDRs modified within the previous 12 months that defaulted in the period $ 47,933 $ 0 $ 0
Commercial loans | Software/internet      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
TDRs modified within the previous 12 months that defaulted in the period 37,294 0 0
Commercial loans | Life science/healthcare      
Financing Receivable, Troubled Debt Restructuring [Line Items]      
TDRs modified within the previous 12 months that defaulted in the period $ 10,639 $ 0 $ 0
v3.19.3.a.u2
Premises and Equipment - Summary of Premises and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Abstract]    
Computer software $ 261,643 $ 217,017
Computer hardware 82,643 70,247
Leasehold improvements 121,907 98,237
Furniture and equipment 46,300 42,319
Total 512,493 427,820
Accumulated depreciation and amortization (350,617) (298,607)
Premises and equipment, net $ 161,876 $ 129,213
v3.19.3.a.u2
Premises and Equipment - Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Property, Plant and Equipment [Abstract]      
Depreciation and amortization expense $ 42.0 $ 38.1 $ 38.0
v3.19.3.a.u2
Leases - Lease Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Lessee, Lease, Description [Line Items]      
Lease right-of-use assets $ 197,365 $ 146,000 $ 0
Lease liabilities 218,847 $ 178,000 $ 0
SVB Leerink      
Lessee, Lease, Description [Line Items]      
Lease right-of-use assets 21,700    
Lease liabilities $ 30,000    
v3.19.3.a.u2
Leases - Lease Expense Components (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Leases [Abstract]  
Operating lease cost $ 41,049
Short-term lease cost 1,823
Variable lease cost 3,477
Less: sublease income (4,492)
Total lease expense, net 41,857
Cash paid for operating leases 44,976
Lease obligations in exchange for obtaining right-of-use assets, operating leases $ 33,167
Weighted-average remaining term (in years) - operating leases 6 years 3 months 14 days
Weighted-average discount rate - operating leases 2.92%
v3.19.3.a.u2
Leases - Schedule of Future Lease Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Leases [Abstract]      
2020 $ 44,791    
2021 42,683    
2022 37,669    
2023 36,914    
2024 26,602    
2025 and thereafter 52,128    
Total lease payments 240,787    
Less: imputed interest (21,940)    
Total lease liability 218,847 $ 178,000 $ 0
Operating leases not yet commenced $ 29,100    
Lower Limit      
Lessee, Lease, Description [Line Items]      
Term of leases not yet commenced 2 years    
Upper Limit      
Lessee, Lease, Description [Line Items]      
Term of leases not yet commenced 5 years    
v3.19.3.a.u2
Leases - Operating Leases, Future Minimum Payments Due (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Leases [Abstract]    
2019 $ 38,609  
2020 37,575  
2021 35,854  
2022 31,659  
2023 30,904  
2024 and thereafter 49,071  
Total minimum future payments 223,672  
Rent expense for premises and equipment leased under operating leases $ 34,600 $ 31,300
v3.19.3.a.u2
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Jan. 04, 2019
Dec. 31, 2018
Goodwill [Line Items]      
Intangible assets $ 60,900,000    
Goodwill 137,823,000   $ 0
Amortization expense 11,500,000    
Goodwill impairment $ 0    
SVB Leerink      
Goodwill [Line Items]      
Intangible assets   $ 60,900,000  
Goodwill   $ 137,823,000  
v3.19.3.a.u2
Goodwill and Other Intangible Assets - Goodwill (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Beginning balance at December 31, 2018 $ 0
Acquisitions 137,823
Ending balance at December 31, 2019 $ 137,823
v3.19.3.a.u2
Goodwill and Other Intangible Assets - Other Intangible Assets (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Other intangible assets:  
Estimated Fair Value $ 60,900
Accumulated Amortization 11,483
Net Carrying Amount 49,417
Customer relationships  
Other intangible assets:  
Estimated Fair Value 42,000
Accumulated Amortization 3,818
Net Carrying Amount 38,182
Other  
Other intangible assets:  
Estimated Fair Value 18,900
Accumulated Amortization 7,665
Net Carrying Amount $ 11,235
v3.19.3.a.u2
Goodwill and Other Intangible Assets - Future Amortization Expense (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2020 $ 5,382
2021 4,732
2022 4,732
2023 4,732
2024 4,732
2025 and thereafter 25,107
Net Carrying Amount $ 49,417
v3.19.3.a.u2
Deposits - Composition of Deposits (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Deposits [Abstract]    
Noninterest-bearing demand deposits $ 40,841,570 $ 39,103,422
Interest bearing checking and savings 568,256 648,468
Money market 17,749,736 7,498,205
Money market deposits in foreign offices 352,437 152,781
Sweep deposits in foreign offices 2,057,715 1,875,298
Time 188,093 50,726
Total deposits $ 61,757,807 $ 49,328,900
v3.19.3.a.u2
Deposits - Additional Information (Details) - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Deposits [Abstract]    
Time deposits equal to or greater than $250,000 $ 180 $ 42
Time deposits equal to or greater than $250,000 maturing within one year $ 177  
v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt - Outstanding Short Term Borrowings and Long Term Debt (Details) - USD ($)
Dec. 31, 2019
Dec. 20, 2019
Dec. 31, 2018
Jan. 31, 2015
Sep. 30, 2010
Debt Outstanding [Line Items]          
Short-term borrowings $ 17,430,000   $ 631,412,000    
Total long-term debt $ 347,987,000   $ 696,465,000    
3.50% Senior Notes          
Debt Outstanding [Line Items]          
Principal value       $ 350,000,000  
Stated interest rate 3.50%   3.50%    
5.375% Senior Notes          
Debt Outstanding [Line Items]          
Principal value   $ 350,000,000     $ 350,000,000
Stated interest rate 5.375%        
Senior Notes | 3.50% Senior Notes          
Debt Outstanding [Line Items]          
Principal value $ 350,000,000        
Total long-term debt 347,987,000   $ 347,639,000    
Senior Notes | 5.375% Senior Notes          
Debt Outstanding [Line Items]          
Total long-term debt 0   $ 348,826,000    
Stated interest rate     5.375%    
Short-term FHLB advances          
Debt Outstanding [Line Items]          
Short-term borrowings 0   $ 300,000,000    
Securities sold under agreement to repurchase          
Debt Outstanding [Line Items]          
Short-term borrowings 0   319,414,000    
Other short-term borrowings          
Debt Outstanding [Line Items]          
Principal value 17,430,000        
Short-term borrowings $ 17,430,000   $ 11,998,000    
v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt - Aggregate Annual Maturities of Long-Term Debt Obligations (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Debt Disclosure [Abstract]    
2020 $ 0  
2021 0  
2022 0  
2023 0  
2024 0  
2025 and thereafter 347,987  
Total $ 347,987 $ 696,465
v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt - Interest Expense and Senior Notes (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 20, 2019
Jan. 31, 2015
Sep. 30, 2010
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Debt Disclosure [Abstract]            
Interest expense on debt       $ 35,100,000 $ 46,600,000 $ 36,100,000
Weighted average interest rate on short-term borrowings         2.62%  
Debt Instrument [Line Items]            
Long-term debt       347,987,000 $ 696,465,000  
3.50% Senior Notes            
Debt Instrument [Line Items]            
Principal value   $ 350,000,000        
Proceeds from issuance of senior notes, net of discount and issuance cost   $ 346,400,000        
Debt issuance costs       1,800,000    
Discount on debt       200,000    
5.375% Senior Notes            
Debt Instrument [Line Items]            
Principal value $ 350,000,000   $ 350,000,000      
Proceeds from issuance of senior notes, net of discount and issuance cost     345,000,000      
Payments for settlement of 3.875% Convertible Notes     $ 250,000,000      
Debt Instrument, Redemption Price 358,400,000          
Redemption Premium $ 9,000,000.0          
Senior Notes | 3.50% Senior Notes            
Debt Instrument [Line Items]            
Principal value       350,000,000    
Long-term debt       347,987,000 347,639,000  
Senior Notes | 5.375% Senior Notes            
Debt Instrument [Line Items]            
Long-term debt       $ 0 $ 348,826,000  
v3.19.3.a.u2
Short-Term Borrowings and Long-Term Debt - Short-term Borrowings (Details)
$ in Billions
Dec. 31, 2019
USD ($)
Short-term FHLB advances  
Short-term Debt [Line Items]  
FHLB advances $ 4.7
Amount of unused FHLB credit facility 4.3
FRB advances  
Short-term Debt [Line Items]  
Carrying value of collateral pledged 1.0
Line of credit, remaining borrowing capacity 1.0
Uncommitted federal funds lines  
Short-term Debt [Line Items]  
Line of credit, remaining borrowing capacity 1.9
Master repurchase agreements  
Short-term Debt [Line Items]  
Line of credit, remaining borrowing capacity $ 3.3
v3.19.3.a.u2
Derivative Financial Instruments - Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Maximum length of time over which forecasted transactions are hedged 5 years  
Derivative [Line Items]    
Fair Value, Derivative Assets $ 167,341 $ 108,901
Fair Value, Derivative Liabilities 137,984 98,050
Total Derivative Assets, Fair Value 332,814 258,139
Total Derivative Liabilities, Fair Value 137,984 98,050
Interest rate swaps    
Derivative [Line Items]    
Fair Value, Derivative Assets 22,676  
Fair Value, Derivative Liabilities 25,623  
Foreign exchange forwards    
Derivative [Line Items]    
Fair Value, Derivative Assets 114,546 98,643
Fair Value, Derivative Liabilities 96,899 86,800
Client foreign currency options    
Derivative [Line Items]    
Fair Value, Derivative Assets 1,308 1,759
Fair Value, Derivative Liabilities 1,308 1,759
Client interest rate derivatives    
Derivative [Line Items]    
Fair Value, Derivative Assets 28,811 8,499
Fair Value, Derivative Liabilities 14,154 9,491
Derivatives designated as hedging instruments | Interest rate swaps | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 1,915,000 0
Fair Value, Derivative Assets 22,676 0
Derivatives designated as hedging instruments | Interest rate swaps | Other liability    
Derivative [Line Items]    
Derivative Liabilities, Notional or Contractual Amount 3,085,000 0
Fair Value, Derivative Liabilities 25,623 0
Derivatives not designated as hedging instruments    
Derivative [Line Items]    
Fair Value, Derivative Assets 310,138 258,139
Fair Value, Derivative Liabilities 112,361 98,050
Derivatives not designated as hedging instruments | Foreign exchange forwards | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 0 263,733
Fair Value, Derivative Assets 0 4,767
Derivatives not designated as hedging instruments | Foreign exchange forwards | Other liability    
Derivative [Line Items]    
Derivative Liabilities, Notional or Contractual Amount 300,250 178,310
Fair Value, Derivative Liabilities 2,154 1,094
Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 225,893 223,532
Fair Value, Derivative Assets 165,473 149,238
Derivatives not designated as hedging instruments | Client foreign exchange forwards | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 4,661,517 2,759,878
Fair Value, Derivative Assets 114,546 93,876
Derivatives not designated as hedging instruments | Client foreign exchange forwards | Other liability    
Derivative [Line Items]    
Derivative Liabilities, Notional or Contractual Amount 4,326,059 2,568,085
Fair Value, Derivative Liabilities 94,745 85,706
Derivatives not designated as hedging instruments | Client foreign currency options | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 154,985 93,556
Fair Value, Derivative Assets 1,308 1,759
Derivatives not designated as hedging instruments | Client foreign currency options | Other liability    
Derivative [Line Items]    
Derivative Liabilities, Notional or Contractual Amount 154,985 93,579
Fair Value, Derivative Liabilities 1,308 1,759
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Derivative [Line Items]    
Derivative Assets, Notional or Contractual Amount 1,275,190 1,020,416
Fair Value, Derivative Assets 28,811 8,499
Reduction in derivative assets due to rules of clearing houses   (400)
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Derivative [Line Items]    
Derivative Liabilities, Notional or Contractual Amount 1,372,914 1,337,328
Fair Value, Derivative Liabilities 14,154 $ 9,491
Reduction in derivative liabilities due to rules of clearing houses $ (17,400)  
v3.19.3.a.u2
Derivative Financial Instruments - Summary of Derivative Activity and Related Impact on Consolidated Statements of Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Interest rate risks | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives $ (5,358) $ 0 $ 1,046
Interest rate risks | Derivatives designated as hedging instruments | Interest income—loans      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (5,358) 0 0
Interest rate risks | Derivatives designated as hedging instruments | Interest expense—borrowings      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives 0 0 1,053
Interest rate risks | Derivatives designated as hedging instruments | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives 0 0 (7)
Foreign exchange forward and option contracts | Derivatives not designated as hedging instruments      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (409) (321) 875
Foreign exchange forward and option contracts | Derivatives not designated as hedging instruments | Revaluations of internal foreign currency instruments, net | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives 1,444 (373) 33,161
Foreign exchange forward and option contracts | Derivatives not designated as hedging instruments | Foreign exchange forward contracts, net | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (1,853) 52 (32,286)
Other derivative instruments | Derivatives not designated as hedging instruments      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives 754 987 913
Other derivative instruments | Derivatives not designated as hedging instruments | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (1,190) (179) (564)
Other derivative instruments | Derivatives not designated as hedging instruments | Revaluations of internal foreign currency instruments, net | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (15,146) 4,998 10,882
Other derivative instruments | Derivatives not designated as hedging instruments | Foreign exchange forward contracts, net | Other noninterest income      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives 15,900 (4,011) (9,969)
Equity warrant assets      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives (2,240) 24,417 11,862
Equity warrant assets | Derivatives not designated as hedging instruments | Gains on equity warrant assets, net      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized gains (losses) on derivatives $ 138,078 $ 89,142 $ 54,555
v3.19.3.a.u2
Derivative Financial Instruments - Balance Sheet Offsetting, Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Derivative Assets    
Gross Amounts of Recognized Assets $ 167,341 $ 108,901
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Assets Presented in the Statement of Financial Position 167,341 108,901
Financial Instruments (89,112) (47,242)
Cash Collateral Received (17,430) (11,998)
Net Amount 60,799 49,661
Reverse repurchase, securities borrowing, and similar arrangements    
Gross Amounts of Recognized Assets 289,340 123,611
Gross Amounts offset in the Statement of Financial Position 0 0
Securities purchased under agreements to resell 289,340 123,611
Financial Instruments (289,340) (123,611)
Cash Collateral Received 0 0
Net Amount 0 0
Total    
Gross Amounts of Recognized Assets 456,681 232,512
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Assets Presented in the Statement of Financial Position 456,681 232,512
Financial Instruments (378,452) (170,853)
Cash Collateral Received (17,430) (11,998)
Net Amount 60,799 49,661
Interest rate swaps    
Derivative Assets    
Gross Amounts of Recognized Assets 22,676  
Gross Amounts offset in the Statement of Financial Position 0  
Net Amounts of Assets Presented in the Statement of Financial Position 22,676  
Financial Instruments (22,598)  
Cash Collateral Received 0  
Net Amount 78  
Foreign exchange forwards    
Derivative Assets    
Gross Amounts of Recognized Assets 114,546 98,643
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Assets Presented in the Statement of Financial Position 114,546 98,643
Financial Instruments (36,855) (38,213)
Cash Collateral Received (17,095) (11,825)
Net Amount 60,596 48,605
Client foreign currency options    
Derivative Assets    
Gross Amounts of Recognized Assets 1,308 1,759
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Assets Presented in the Statement of Financial Position 1,308 1,759
Financial Instruments (848) (613)
Cash Collateral Received (335) (90)
Net Amount 125 1,056
Client interest rate derivatives    
Derivative Assets    
Gross Amounts of Recognized Assets 28,811 8,499
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Assets Presented in the Statement of Financial Position 28,811 8,499
Financial Instruments (28,811) (8,416)
Cash Collateral Received 0 (83)
Net Amount $ 0 $ 0
v3.19.3.a.u2
Derivative Financial Instruments - Balance Sheet Offsetting, Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Derivative Liabilities    
Gross Amounts of Recognized Liabilities $ 137,984 $ 98,050
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 137,984 98,050
Financial Instruments (56,521) (25,832)
Cash Collateral Pledged (38,913) (29,939)
Net Amount 42,550 42,279
Repurchase, securities lending, and similar arrangements    
Securities Sold under Agreements to Repurchase, Gross 0 319,414
Securities Sold under Agreements to Repurchase, Asset 0 0
Securities Sold under Agreements to Repurchase 0 319,414
Financial Instruments 0 0
Cash Collateral Pledged 0 0
Net Amount 0 319,414
Total    
Gross Amounts of Recognized Liabilities 137,984 417,464
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 137,984 417,464
Financial Instruments (56,521) (25,832)
Cash Collateral Pledged (38,913) (29,939)
Net Amount 42,550 361,693
Interest rate swaps    
Derivative Liabilities    
Gross Amounts of Recognized Liabilities 25,623  
Gross Amounts offset in the Statement of Financial Position 0  
Net Amounts of Liabilities Presented in the Statement of Financial Position 25,623  
Financial Instruments (22,676)  
Cash Collateral Pledged (2,947)  
Net Amount 0  
Foreign exchange forwards    
Derivative Liabilities    
Gross Amounts of Recognized Liabilities 96,899 86,800
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 96,899 86,800
Financial Instruments (33,314) (24,778)
Cash Collateral Pledged (22,030) (20,732)
Net Amount 41,555 41,290
Client foreign currency options    
Derivative Liabilities    
Gross Amounts of Recognized Liabilities 1,308 1,759
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 1,308 1,759
Financial Instruments (531) (1,054)
Cash Collateral Pledged 0 0
Net Amount 777 705
Client interest rate derivatives    
Derivative Liabilities    
Gross Amounts of Recognized Liabilities 14,154 9,491
Gross Amounts offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 14,154 9,491
Financial Instruments 0 0
Cash Collateral Pledged (13,936) (9,207)
Net Amount $ 218 $ 284
v3.19.3.a.u2
Noninterest Income - Summary of Noninterest Income (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue from Contract with Customer [Abstract]                      
Gains on investment securities, net                 $ 134,670 $ 88,094 $ 64,603
Gains on equity warrant assets, net                 138,078 89,142 54,555
Client investment fees                 182,068 130,360 56,136
Foreign exchange fees                 159,262 138,812 115,760
Credit card fees                 118,719 94,072 76,543
Deposit service charges                 89,200 76,097 58,715
Lending related fees                 49,920 41,949 43,265
Letters of credit and standby letters of credit fees                 42,669 34,600 28,544
Investment banking revenue                 195,177 0 0
Commissions                 56,346 0 0
Other                 55,370 51,858 59,110
Noninterest income $ 313,344 $ 294,009 $ 333,750 $ 280,376 $ 186,707 $ 210,070 $ 192,689 $ 155,518 $ 1,221,479 $ 744,984 $ 557,231
v3.19.3.a.u2
Noninterest Income - Gains on Investment Securities, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue from Contract with Customer [Abstract]      
Gains on non-marketable and other equity securities, net $ 138,575 $ 88,834 $ 69,792
Losses on sales of available-for-sale debt securities, net (3,905) (740) (5,189)
Gains on investment securities, net $ 134,670 $ 88,094 $ 64,603
v3.19.3.a.u2
Noninterest Income - Gains on Equity Warrant Assets, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue from Contract with Customer [Abstract]      
Gains on exercises, net $ 107,168 $ 58,186 $ 48,275
Terminations (3,502) (5,964) (4,422)
Changes in fair value, net 34,412 36,920 10,702
Gains on equity warrant assets, net $ 138,078 $ 89,142 $ 54,555
v3.19.3.a.u2
Noninterest Income - Client Investment Fees (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers $ 880,951 $ 511,656  
Sweep money market fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers 104,236 75,654 $ 28,485
Asset management fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers 28,665 23,882 16,831
Repurchase agreement fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers 49,167 30,824 10,820
Client investment fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers $ 182,068 $ 130,360 $ 56,136
v3.19.3.a.u2
Noninterest Income - Foreign Exchange Fees (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers $ 880,951 $ 511,656  
Revenue not from contracts with customer 340,528 233,328  
Foreign exchange fees 159,262 138,812 $ 115,760
Spot contract commissions      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers 145,915 127,459 104,344
Forward contract commissions      
Disaggregation of Revenue [Line Items]      
Revenue not from contracts with customer 13,068 10,940 10,934
Option premium fees      
Disaggregation of Revenue [Line Items]      
Revenue not from contracts with customer $ 279 $ 413 $ 482
v3.19.3.a.u2
Noninterest Income - Credit Card Fees (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]      
Card interchange fees, net $ 93,553 $ 74,381 $ 60,224
Revenue from contracts with customers 880,951 511,656  
Revenue not from contracts with customer 340,528 233,328  
Total credit card fees 118,719 94,072 76,543
Merchant service fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers 18,355 14,420 11,584
Card service fees      
Disaggregation of Revenue [Line Items]      
Revenue not from contracts with customer $ 6,811 $ 5,271 $ 4,735
v3.19.3.a.u2
Noninterest Income - Lending Related Fees (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]      
Lending related fees $ 49,920 $ 41,949 $ 43,265
Unused commitment fees      
Disaggregation of Revenue [Line Items]      
Lending related fees 34,829 32,452 34,110
Other      
Disaggregation of Revenue [Line Items]      
Lending related fees $ 15,091 $ 9,497 $ 9,155
v3.19.3.a.u2
Noninterest Income - Investment Banking Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue from Contract with Customer [Abstract]      
Underwriting fees $ 153,306 $ 0 $ 0
Advisory fees 37,846 0 0
Private placements and other 4,025 0 0
Total investment banking revenue $ 195,177 $ 0 $ 0
v3.19.3.a.u2
Noninterest Income - Summary of Other Noninterest Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers $ 880,951 $ 511,656  
Net gains (losses) on revaluation of foreign currency instruments, net of foreign exchange forward contracts(1) 345 666 $ 1,788
(Losses) gains on extinguishment of debt (8,960) 0 2,731
Other service revenue 31,463 28,176 33,377
Other 55,370 51,858 59,110
Fund management fees      
Disaggregation of Revenue [Line Items]      
Revenue from contracts with customers $ 32,522 $ 23,016 $ 21,214
v3.19.3.a.u2
Noninterest Income - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 $ 880,951 $ 511,656  
Revenue not from contracts with customer                 340,528 233,328  
Noninterest income $ 313,344 $ 294,009 $ 333,750 $ 280,376 $ 186,707 $ 210,070 $ 192,689 $ 155,518 1,221,479 744,984 $ 557,231
Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 592,185 483,918  
Revenue not from contracts with customer                 45,737 36,384  
Noninterest income                 637,922 520,302  
SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 2,563 2,329  
Revenue not from contracts with customer                 803 (48)  
Noninterest income                 3,366 2,281  
SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 26,850 23,016  
Revenue not from contracts with customer                 95,544 78,165  
Noninterest income                 122,394 101,181  
SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 257,195    
Revenue not from contracts with customer                 7,321    
Noninterest income                 264,516    
Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 2,158 2,393  
Revenue not from contracts with customer                 191,123 118,827  
Noninterest income                 193,281 121,220  
Client investment fees                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 182,068 130,360 56,136
Client investment fees | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 180,152 128,834  
Client investment fees | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 1,916 1,526  
Client investment fees | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Client investment fees | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Client investment fees | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Spot contract commissions                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 145,915 127,459 104,344
Spot contract commissions | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 144,930 126,445  
Spot contract commissions | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 510 691  
Spot contract commissions | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Spot contract commissions | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Spot contract commissions | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 475 323  
Card interchange fees, gross                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 154,953 134,502  
Card interchange fees, gross | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 154,197 134,074  
Card interchange fees, gross | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Card interchange fees, gross | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Card interchange fees, gross | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Card interchange fees, gross | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 756 428  
Merchant service fees                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 18,355 14,420  
Merchant service fees | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 18,355 14,415  
Merchant service fees | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 4  
Merchant service fees | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Merchant service fees | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Merchant service fees | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 1  
Deposit service charges                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 89,200 76,097  
Deposit service charges | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 88,136 74,348  
Deposit service charges | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 137 108  
Deposit service charges | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Deposit service charges | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Deposit service charges | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 927 1,641  
Investment banking revenue                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 195,177    
Investment banking revenue | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Investment banking revenue | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Investment banking revenue | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Investment banking revenue | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 195,177    
Investment banking revenue | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Commissions                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 56,346    
Commissions | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Commissions | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Commissions | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Commissions | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 56,346    
Commissions | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Fund management fees                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 32,522 23,016 $ 21,214
Fund management fees | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Fund management fees | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Fund management fees | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 26,850 23,016  
Fund management fees | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 5,672    
Fund management fees | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Correspondent bank rebates                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 6,415 5,802  
Correspondent bank rebates | Global Commercial Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 6,415 5,802  
Correspondent bank rebates | SVB Private Bank                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Correspondent bank rebates | SVB Capital                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0 0  
Correspondent bank rebates | SVB Leerink                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 0    
Correspondent bank rebates | Other Income                      
Disaggregation of Revenue [Line Items]                      
Revenue from contracts with customers                 $ 0 $ 0  
v3.19.3.a.u2
Other Noninterest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Other Income and Expenses [Abstract]      
Lending and other client related processing costs $ 28,491 $ 24,237 $ 23,768
Correspondent bank fees 14,503 13,713 12,976
Investment banking activities 13,733 0 0
Trade order execution costs 10,813 0 0
Telephone 9,861 9,404 10,647
Data processing services 12,536 10,811 10,251
Dues and publications 4,603 4,605 3,263
Postage and supplies 3,198 2,799 2,797
Other 54,841 21,682 21,419
Total other noninterest expense $ 152,579 $ 87,251 $ 85,121
v3.19.3.a.u2
Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current provision:                      
Federal                 $ 296,400 $ 249,358 $ 263,231
State                 132,357 123,264 67,046
Deferred expense (benefit):                      
Federal                 (1,530) (11,777) 24,654
State                 (1,542) (9,284) 532
Income tax expense $ 94,061 $ 105,075 $ 119,114 $ 107,435 $ 105,000 $ 95,308 $ 77,287 $ 73,966 $ 425,685 $ 351,561 $ 355,463
v3.19.3.a.u2
Income Taxes - Reconciliation between Federal Statutory Income Tax Rate and Effective Income Tax Rate (Details)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Federal statutory income tax rate 21.00% 21.00% 35.00%
State income taxes, net of the federal tax effect 7.00% 7.20% 5.80%
Net deferred tax assets revaluation (TCJ Act) 0.00% 0.00% 4.30%
Meals and entertainment 0.40% 0.30% 0.30%
Disallowed officer's compensation 0.20% 0.20% 0.10%
FDIC premiums 0.20% 0.50% 0.00%
Share-based compensation expense on incentive stock options and ESPP (0.60%) (1.40%) (2.10%)
Qualified affordable housing project tax credits (0.30%) (0.30%) (0.40%)
Tax-exempt interest income (0.60%) (0.60%) (0.30%)
Other, net (0.10%) (0.40%) (0.70%)
Effective income tax rate 27.20% 26.50% 42.00%
v3.19.3.a.u2
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Deferred tax assets:    
Allowance for loan losses $ 103,267 $ 93,580
Net unrealized losses on AFS debt securities 0 19,704
Share-based compensation expense 14,233 10,642
State income taxes 16,097 13,854
Accrued compensation 22,578 8,291
Deferred rent 0 7,940
Lease liability 60,635 0
Other accruals 12,383 7,061
Net operating loss 6,386 2,447
Goodwill and intangibles 3,141 0
Other 7,923 11,339
Deferred tax assets 246,643 174,858
Valuation allowance (5,919) (2,107)
Net deferred tax assets after valuation allowance 240,724 172,751
Deferred tax liabilities:    
Derivative equity warrant assets (45,533) (32,861)
Change in accounting method (section 481(a)) (1,841) (8,034)
Net unrealized gains on AFS debt securities (33,480) 0
Non-marketable and other equity securities (54,239) (45,759)
Premises and equipment and other intangibles (16,459) (10,284)
Right-of-use asset and deferred rent assets (50,493) 0
Other (10,246) (10,380)
Deferred tax liabilities (212,291) (107,318)
Net deferred tax assets $ 28,433 $ 65,433
v3.19.3.a.u2
Income Taxes - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating Loss Carryforwards [Line Items]        
Valuation allowance $ (5,919) $ (2,107)    
Unrecognized tax benefit 13,778 14,139 $ 12,683 $ 5,711
Unrecognized tax benefits that if recognized would reduce income tax expense 9,900      
Reconciliation of Unrecognized Tax Benefit        
Operating Loss Carryforwards [Line Items]        
Unrecognized tax benefit 12,612 12,689 $ 11,505 $ 5,269
Federal        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards 2,200 2,200    
Foreign Tax Authority        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards $ 20,800 $ 7,600    
v3.19.3.a.u2
Income Taxes - Changes in Unrecognized Tax Benefit (Including Interest and Penalties) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Beginning Balance $ 14,139 $ 12,683 $ 5,711
Additions for tax positions for current year 3,712 4,171 3,141
Additions for tax positions for prior years 889 1,454 4,132
Reduction for tax positions for prior years (1,408) (2,108) (224)
Lapse of the applicable statute of limitations (2,395) (521) (77)
Reduction as a result of settlement (1,159) (1,540)  
Ending Balance 13,778 14,139 12,683
Reconciliation of Unrecognized Tax Benefit      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Beginning Balance 12,689 11,505 5,269
Additions for tax positions for current year 3,712 4,171 3,141
Additions for tax positions for prior years 63 631 3,378
Reduction for tax positions for prior years (884) (1,865) (223)
Lapse of the applicable statute of limitations (1,826) (435) (60)
Reduction as a result of settlement (1,142) (1,318)  
Ending Balance 12,612 12,689 11,505
Interest and Penalties      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Beginning Balance 1,450 1,178 442
Additions for tax positions for current year 0 0 0
Additions for tax positions for prior years 826 823 754
Reduction for tax positions for prior years (524) (243) (1)
Lapse of the applicable statute of limitations (569) (86) (17)
Reduction as a result of settlement (17) (222)  
Ending Balance $ 1,166 $ 1,450 $ 1,178
v3.19.3.a.u2
Employee Compensation and Benefit Plans - Expenses Incurred Under Certain Employee Compensation and Benefit Plans (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]      
Incentive Compensation Plan $ 143,888 $ 160,293 $ 125,584
Direct Drive Incentive Compensation Plan 37,315 40,578 18,721
Retention Program 2,438 1,438 1,317
Warrant Incentive Plan 14,881 9,112 15,386
Deferred Compensation Plan 0 0 203
SVBFG 401(k) Plan 25,687 21,323 17,860
SVBFG ESOP 4,197 6,435 4,719
SVB Leerink      
Segment Reporting Information [Line Items]      
Incentive Compensation Plan 106,871 0 0
Retention Award $ 12,015 $ 0 $ 0
v3.19.3.a.u2
Employee Compensation and Benefit Plans - Additional Information (Details) - USD ($)
12 Months Ended
Jan. 04, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Employee Benefits Disclosure [Line Items]        
Maximum percentage of base salary that may be deferred under the DC Plan   50.00%    
Maximum percentage of eligible bonus payment that may be deferred under the DC Plan   100.00%    
Deferrals under the DC Plan   $ 6,900,000 $ 5,500,000 $ 5,500,000
DC Plan investment gains (losses)   $ 6,900,000 (1,700,000) 4,700,000
Amortization period   30 years    
EHOP loan term, option one   5 years    
EHOP loan term, option three   10 years    
Employee Home Ownership Program, Fixed Rate Loan Term, Option Two   30 years    
Maximum loan amount percentage lesser of purchase price or the appraised value   85.00%    
Employee Home Ownership Program, Loan Term, Option Two   7 years    
Employee Home Ownership Program, Fixed Rate Loan Term, Option One   15 years    
SVB Leerink        
Employee Benefits Disclosure [Line Items]        
Incentive Compensation Plan, Deferred Portion Of Compensation Settled In Restricted Stock Awards   25.00%    
Incentive Compensation Plan, Deferred Portion Of Compensation Settled In Cash   75.00%    
Incentive Compensation Plan, Deferred Compensation Vesting Period   5 years    
Retention pool for acquiree employees $ 60,000,000      
Retention Award, Deferred Portion Of Compensation Settled In Cash   50.00%    
Retention Award, Deferred Portion Of Compensation Settled In Restricted Stock Awards   50.00%    
Vesting period of retention pool for acquiree employees 5 years      
Employee Home Ownership Plan | 12 month LIBOR        
Employee Benefits Disclosure [Line Items]        
Basis spread on EHOP loans   2.25%    
Defined Contribution Plan, The 401(k) Plan        
Employee Benefits Disclosure [Line Items]        
Maximum percentage of pre-tax income employees are allowed to contribute towards 401(k) plan   75.00%    
Maximum annual amount allowable for employee contributions   $ 19,000 $ 18,500 $ 18,000
Maximum percentage of employer matching contributions towards 401(k) plan   5.00%    
Employee Stock Ownership Plan (ESOP), Plan        
Employee Benefits Disclosure [Line Items]        
Maximum percentage of employee's eligible pay earned in the fiscal year contributed by the company in cash or common stock towards ESOP   10.00%    
ESOP contributions vesting period   5 years    
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Summary Information Related to Commitments to Extend Credit (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]        
Fixed interest rate commitments $ 2,434,042 $ 1,839,190    
Variable interest rate commitments 19,309,317 14,821,815    
Total loan commitments available for funding 21,743,359 16,661,005    
Commercial and standby letters of credit 2,778,561 2,252,016    
Total unfunded credit commitments 24,521,920 18,913,021    
Commitments unavailable for funding 3,051,075 2,723,835    
Allowance for unfunded credit commitments $ 67,656 $ 55,183 $ 51,770 $ 45,265
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Summary of Commercial and Standby Letters of Credit (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Other Commitments [Line Items]  
Expires In One Year or Less $ 2,679,736
Expires After One Year 98,825
Total Amount Outstanding 2,778,561
Maximum Amount of Future Payments 2,778,561
Financial standby letters of credit  
Other Commitments [Line Items]  
Expires In One Year or Less 2,566,623
Expires After One Year 79,207
Total Amount Outstanding 2,645,830
Maximum Amount of Future Payments 2,645,830
Performance standby letters of credit  
Other Commitments [Line Items]  
Expires In One Year or Less 105,993
Expires After One Year 19,618
Total Amount Outstanding 125,611
Maximum Amount of Future Payments 125,611
Commercial letters of credit  
Other Commitments [Line Items]  
Expires In One Year or Less 7,120
Expires After One Year 0
Total Amount Outstanding 7,120
Maximum Amount of Future Payments $ 7,120
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Consolidated venture capital and private equity fund investments    
Commitments and Contingencies Disclosure [Line Items]    
Commitments Expiration Period 10 years  
Consolidated venture capital and private equity fund investments | Lower Limit    
Commitments and Contingencies Disclosure [Line Items]    
Fund Commitments Investment Cycle 5 years  
Consolidated venture capital and private equity fund investments | Upper Limit    
Commitments and Contingencies Disclosure [Line Items]    
Fund Commitments Investment Cycle 7 years  
Standby Letter of Credit    
Commitments and Contingencies Disclosure [Line Items]    
Deferred revenue $ 17.2 $ 14.1
Collateral in the form of cash $ 1,600.0  
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Total Capital Commitments, Unfunded Capital Commitments, and Our Ownership in Each Fund (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Investment
Dec. 31, 2018
Other Commitments [Line Items]    
SVBFG Unfunded Commitments $ 5,346  
Capital Preferred Return Fund, LP    
Other Commitments [Line Items]    
SVBFG Unfunded Commitments 1,540  
Growth Partners, LP    
Other Commitments [Line Items]    
SVBFG Unfunded Commitments 2,468  
Strategic Investors Fund, LP    
Other Commitments [Line Items]    
SVBFG Unfunded Commitments $ 1,338  
Consolidated venture capital and private equity fund investments | CP II, LP | Non-marketable securities | Direct ownership interest    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 1.30%  
Consolidated venture capital and private equity fund investments | CP II, LP | Non-marketable securities | Indirect ownership interest    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 3.80%  
Upper Limit    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 5.00% 5.00%
Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP | Non-marketable securities    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 5.10% 5.10%
Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP | Non-marketable securities | Direct ownership interest    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 1.30%  
Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP | Non-marketable securities | Indirect ownership interest    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 3.80%  
Equity method accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund II, LP | Non-marketable securities    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 8.60% 8.60%
Equity method accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund III, LP | Non-marketable securities    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 5.90% 5.90%
Equity method accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund IV, LP | Non-marketable securities    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 5.00% 5.00%
Equity method accounting | Consolidated venture capital and private equity fund investments | Other fund investments | Non-marketable securities    
Other Commitments [Line Items]    
Number of other funds with investment commitments | Investment 211  
Equity method accounting | Upper Limit | Consolidated venture capital and private equity fund investments | Other fund investments | Non-marketable securities    
Other Commitments [Line Items]    
SVBFG Ownership interest percentage 5.00%  
Parent Company    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 467,664  
SVBFG Unfunded Commitments 19,092  
Parent Company | CP II, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments 1,200  
SVBFG Unfunded Commitments $ 162  
SVBFG Ownership interest percentage 5.10%  
Parent Company | Strategic Investors Fund II, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 15,000  
SVBFG Unfunded Commitments $ 1,050  
SVBFG Ownership interest percentage 8.60%  
Parent Company | Strategic Investors Fund III, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 15,000  
SVBFG Unfunded Commitments $ 1,275  
SVBFG Ownership interest percentage 5.90%  
Parent Company | Strategic Investors Fund IV, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 12,239  
SVBFG Unfunded Commitments $ 2,325  
SVBFG Ownership interest percentage 5.00%  
Parent Company | Strategic Investors Fund V funds    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 515  
SVBFG Unfunded Commitments 131  
Parent Company | Other venture capital and private equity fund investments    
Other Commitments [Line Items]    
SVBFG Capital Commitments 21,801  
SVBFG Unfunded Commitments 5,732  
Parent Company | Debt funds (equity method accounting)    
Other Commitments [Line Items]    
SVBFG Capital Commitments 58,493  
SVBFG Unfunded Commitments 0  
Parent Company | Other fund investments    
Other Commitments [Line Items]    
SVBFG Capital Commitments 284,758  
SVBFG Unfunded Commitments 6,119  
Parent Company | CP I, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments 6,000  
SVBFG Unfunded Commitments $ 270  
SVBFG Ownership interest percentage 10.70%  
Parent Company | Capital Preferred Return Fund, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 12,688  
SVBFG Unfunded Commitments $ 0  
SVBFG Ownership interest percentage 20.00%  
Parent Company | Growth Partners, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 24,670  
SVBFG Unfunded Commitments $ 1,340  
SVBFG Ownership interest percentage 33.00%  
Parent Company | Strategic Investors Fund, LP    
Other Commitments [Line Items]    
SVBFG Capital Commitments $ 15,300  
SVBFG Unfunded Commitments $ 688  
SVBFG Ownership interest percentage 12.60%  
v3.19.3.a.u2
Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Remaining Unfunded Commitments to Venture Capital or Private Equity Funds by our Consolidated Managed Funds (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Other Commitments [Line Items]  
Unfunded Commitments $ 5,346
Strategic Investors Fund, LP  
Other Commitments [Line Items]  
Unfunded Commitments 1,338
Capital Preferred Return Fund, LP  
Other Commitments [Line Items]  
Unfunded Commitments 1,540
Growth Partners, LP  
Other Commitments [Line Items]  
Unfunded Commitments $ 2,468
v3.19.3.a.u2
Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities $ 14,014,919 $ 7,790,043
Fair Value, Derivative Assets 167,341 108,901
Fair Value, Derivative Liabilities 137,984 98,050
Interest rate swaps    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 22,676  
Fair Value, Derivative Liabilities 25,623  
Client interest rate derivatives    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 28,811 8,499
Fair Value, Derivative Liabilities 14,154 9,491
Derivatives not designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 310,138 258,139
Fair Value, Derivative Liabilities 112,361 98,050
Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 165,473 149,238
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 28,811 8,499
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 14,154 9,491
U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 6,894,010 4,738,258
U.S. agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 99,547 1,084,117
Foreign government debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 9,038 5,812
Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 4,148,791  
Residential mortgage-backed securities | Fixed rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,538,343 1,880,218
Residential mortgage-backed securities | Variable rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities   81,638
Agency-issued commercial mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,325,190  
Measured on a recurring basis    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 14,014,919 7,790,043
Total assets 14,672,330 8,388,011
Total liabilities 137,984 98,050
Measured on a recurring basis | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 115,854 100,402
Measured on a recurring basis | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 98,207 88,559
Measured on a recurring basis | Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 165,473 149,238
Measured on a recurring basis | Derivatives not designated as hedging instruments | Interest rate swaps | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 22,676  
Measured on a recurring basis | Derivatives not designated as hedging instruments | Interest rate swaps | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 25,623  
Measured on a recurring basis | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 28,811 8,499
Measured on a recurring basis | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 14,154 9,491
Measured on a recurring basis | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 324,597 339,829
Measured on a recurring basis | Consolidated venture capital and private equity fund investments | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 134 1,079
Measured on a recurring basis | Other securities | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 59,200 20,398
Measured on a recurring basis | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 6,894,010 4,738,258
Measured on a recurring basis | U.S. agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 99,547 1,084,117
Measured on a recurring basis | Foreign government debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 9,038 5,812
Measured on a recurring basis | Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 4,148,791  
Measured on a recurring basis | Residential mortgage-backed securities | Fixed rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,538,343 1,880,218
Measured on a recurring basis | Residential mortgage-backed securities | Variable rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities   81,638
Measured on a recurring basis | Agency-issued commercial mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,325,190  
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 6,903,048 4,744,070
Total assets 6,920,338 4,745,251
Total liabilities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Interest rate swaps | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0  
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Interest rate swaps | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0  
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 17,290 1,181
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Consolidated venture capital and private equity fund investments | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other securities | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 17,290 1,181
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 6,894,010 4,738,258
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign government debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 9,038 5,812
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0  
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Residential mortgage-backed securities | Fixed rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Residential mortgage-backed securities | Variable rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities   0
Measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Agency-issued commercial mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0  
Measured on a recurring basis | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 7,111,871 3,045,973
Total assets 7,325,557 3,178,130
Total liabilities 137,984 98,050
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 115,854 100,402
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 98,207 88,559
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 4,435 4,039
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Interest rate swaps | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 22,676  
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Interest rate swaps | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 25,623  
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 28,811 8,499
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 14,154 9,491
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 41,910 19,217
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Consolidated venture capital and private equity fund investments | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 0 0
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Other securities | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 41,910 19,217
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | U.S. agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 99,547 1,084,117
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Foreign government debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 4,148,791  
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Residential mortgage-backed securities | Fixed rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,538,343 1,880,218
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Residential mortgage-backed securities | Variable rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities   81,638
Measured on a recurring basis | Significant Other Observable Inputs (Level 2) | Agency-issued commercial mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 1,325,190  
Measured on a recurring basis | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Total assets 161,172 146,278
Total liabilities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Foreign exchange forward and option contracts | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Equity warrant assets | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 161,038 145,199
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Interest rate swaps | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0  
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Interest rate swaps | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0  
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Assets 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Derivative Liabilities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 134 1,079
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Consolidated venture capital and private equity fund investments | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 134 1,079
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Other securities | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | U.S. agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Foreign government debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Residential mortgage-backed securities | Agency-issued mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0  
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Residential mortgage-backed securities | Fixed rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0 0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Residential mortgage-backed securities | Variable rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities   0
Measured on a recurring basis | Significant Unobservable Inputs (Level 3) | Agency-issued commercial mortgage-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0  
Measured on a recurring basis | Net asset value | Consolidated venture capital and private equity fund investments | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Nonmarketable securities $ 265,263 $ 318,352
v3.19.3.a.u2
Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Footnote Information) (Details) - Measured on a recurring basis - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 14,672,330 $ 8,388,011
Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 161,172 146,278
Significant Unobservable Inputs (Level 3) | Noncontrolling Interests    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 120 $ 964
v3.19.3.a.u2
Fair Value of Financial Instruments - Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis (Details) - Measured on a recurring basis - Fair value accounting - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Beginning Balance $ 146,278 $ 122,250 $ 130,853
Total Realized and Unrealized Gains (Losses) Included in Income 133,922 88,439 55,234
Purchases 575 0 0
Sales/Exits (131,352) (78,752) (76,861)
Issuances 16,453 17,941 14,537
Distributions and Other Settlements 3 (297) 0
Transfers Out of Level 3 (4,707) (3,303) (1,513)
Ending Balance 161,172 146,278 122,250
Equity warrant assets      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Beginning Balance 145,199 121,331 128,813
Total Realized and Unrealized Gains (Losses) Included in Income 133,910 87,982 54,263
Purchases 575 0 0
Sales/Exits (130,392) (78,752) (74,769)
Issuances 16,453 17,941 14,537
Distributions and Other Settlements 0 0 0
Transfers Out of Level 3 (4,707) (3,303) (1,513)
Ending Balance 161,038 145,199 121,331
Non-marketable securities | Unconsolidated venture capital and private equity fund investments      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Beginning Balance 1,079 919 2,040
Total Realized and Unrealized Gains (Losses) Included in Income 12 457 971
Purchases 0 0 0
Sales/Exits (960) 0 (2,092)
Issuances 0 0 0
Distributions and Other Settlements 3 (297) 0
Transfers Out of Level 3 0 0 0
Ending Balance $ 134 $ 1,079 $ 919
v3.19.3.a.u2
Fair Value of Financial Instruments - Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total unrealized gains, net $ 34,469 $ 37,724
Unrealized (losses) gains attributable to noncontrolling interests (199) 143
Venture capital and private equity funds | Fair value accounting    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total unrealized gains, net (222) 160
Equity warrant assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total unrealized gains, net $ 34,691 $ 37,564
v3.19.3.a.u2
Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Details) - Significant Unobservable Inputs (Level 3)
$ in Thousands
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Equity warrant assets (private portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair Value $ 160,692 $ 142,442
Equity warrant assets (public portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair Value 346 2,757
Venture capital and private equity fund investments    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair Value $ 134 $ 1,079
Volatility | Equity warrant assets (private portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.382 0.385
Volatility | Equity warrant assets (public portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.507 0.547
Risk-Free Interest Rate | Equity warrant assets (private portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.016 0.025
Risk-Free Interest Rate | Equity warrant assets (public portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.019 0.026
Sales restrictions discount | Equity warrant assets (public portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.136 0.185
Marketability discount | Equity warrant assets (private portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.175 0.177
Remaining life assumption | Equity warrant assets (private portfolio)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Weighted Average 0.450 0.450
v3.19.3.a.u2
Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Footnote Information) (Details)
12 Months Ended
Dec. 31, 2019
Equity warrant assets (public portfolio) | Lower Limit  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Duration of the sale restrictions 3 months
Equity warrant assets (public portfolio) | Upper Limit  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Duration of the sale restrictions 6 months
Equity warrant assets (public portfolio) | Sales restrictions discount | Lower Limit  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Weighted Average 0.10
Equity warrant assets (public portfolio) | Sales restrictions discount | Upper Limit  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Weighted Average 0.20
Equity warrant assets (private portfolio)  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Weighted average contractual remaining term 6 years 1 month 6 days
Estimated remaining life 2 years 9 months 18 days
v3.19.3.a.u2
Fair Value of Financial Instruments - Summary of Estimated Fair Values of Financial Instruments not Carried at Fair Value (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities $ 14,115,272 $ 15,188,236
Net loans 32,859,712 28,057,377
Time deposits 188,093 50,726
Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 6,781,783 3,571,539
Held-to-maturity securities 13,842,946 15,487,442
Non-marketable securities not measured at net asset value 195,405 131,453
Non-marketable securities measured at net asset value 235,351 151,247
FHLB and FRB stock 60,258 58,878
Non-maturity deposits 61,569,714 49,278,174
Time deposits 188,093 50,726
Commitments to extend credit 0 0
Carrying Amount | Other short-term borrowings    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term borrowings 17,430 631,412
Carrying Amount | 3.50% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes 347,987 347,639
Carrying Amount | 5.375% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes   348,826
Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 6,781,783 3,571,539
Held-to-maturity securities 14,115,272 15,188,236
Non-marketable securities not measured at net asset value 195,405 131,453
Non-marketable securities measured at net asset value 235,351 151,247
FHLB and FRB stock 60,258 58,878
Non-maturity deposits 61,569,714 49,278,174
Time deposits 187,980 50,337
Commitments to extend credit 27,197 22,930
Estimated Fair Value | Other short-term borrowings    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term borrowings 17,430 631,412
Estimated Fair Value | 3.50% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes 366,856 336,088
Estimated Fair Value | 5.375% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes   361,281
Estimated Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 6,781,783 3,571,539
Held-to-maturity securities 0 0
Non-marketable securities not measured at net asset value 0 0
FHLB and FRB stock 0 0
Non-maturity deposits 61,569,714 49,278,174
Time deposits 0 0
Commitments to extend credit 0 0
Estimated Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other short-term borrowings    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term borrowings 0 0
Estimated Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | 5.375% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes   0
Estimated Fair Value | Significant Other Observable Inputs (Level 2)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 0 0
Held-to-maturity securities 14,115,272 15,188,236
Non-marketable securities not measured at net asset value 0 0
FHLB and FRB stock 0 0
Non-maturity deposits 0 0
Time deposits 187,980 50,337
Commitments to extend credit 0 0
Estimated Fair Value | Significant Other Observable Inputs (Level 2) | Other short-term borrowings    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term borrowings 17,430 631,412
Estimated Fair Value | Significant Other Observable Inputs (Level 2) | 3.50% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes 366,856 336,088
Estimated Fair Value | Significant Other Observable Inputs (Level 2) | 5.375% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes   361,281
Estimated Fair Value | Significant Unobservable Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 0 0
Held-to-maturity securities 0 0
Non-marketable securities not measured at net asset value 195,405 131,453
FHLB and FRB stock 60,258 58,878
Non-maturity deposits 0 0
Time deposits 0 0
Commitments to extend credit 27,197 22,930
Estimated Fair Value | Significant Unobservable Inputs (Level 3) | Other short-term borrowings    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term borrowings 0 0
Estimated Fair Value | Significant Unobservable Inputs (Level 3) | 5.375% Senior Notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior Notes   0
Commercial loans | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 29,104,532 25,043,671
Commercial loans | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 29,615,176 25,463,968
Commercial loans | Estimated Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 0 0
Commercial loans | Estimated Fair Value | Significant Other Observable Inputs (Level 2)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 0 0
Commercial loans | Estimated Fair Value | Significant Unobservable Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 29,615,176 25,463,968
Consumer loans | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 3,755,180 3,013,706
Consumer loans | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 3,820,804 3,064,093
Consumer loans | Estimated Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 0 0
Consumer loans | Estimated Fair Value | Significant Other Observable Inputs (Level 2)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans 0 0
Consumer loans | Estimated Fair Value | Significant Unobservable Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Net loans $ 3,820,804 $ 3,064,093
v3.19.3.a.u2
Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Carrying Amount $ 500,614
Fair Value 500,614
Unfunded Commitments 22,140
Non-marketable securities | Consolidated venture capital and private equity fund investments | Fair value accounting  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Carrying Amount 265,263
Fair Value 265,263
Unfunded Commitments 10,579
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Carrying Amount 215,367
Fair Value 215,367
Unfunded Commitments 10,675
Non-marketable securities | Debt funds | Equity method accounting  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Carrying Amount 7,271
Fair Value 7,271
Unfunded Commitments 0
Non-marketable securities | Other investments | Equity method accounting  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Carrying Amount 12,713
Fair Value 12,713
Unfunded Commitments $ 886
v3.19.3.a.u2
Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Footnote Information) (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair value $ 500,614
Unfunded commitments 22,140
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair value 265,263
Unfunded commitments 10,579
Non-marketable securities | Fair value accounting | Noncontrolling Interests | Consolidated venture capital and private equity fund investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair value 64,600
Unfunded commitments $ 4,000
Non-marketable securities | Fair value accounting | Lower Limit | Consolidated venture capital and private equity fund investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 10 years
Non-marketable securities | Fair value accounting | Upper Limit | Consolidated venture capital and private equity fund investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 13 years
Non-marketable securities | Equity method accounting | Consolidated venture capital and private equity fund investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair value $ 215,367
Unfunded commitments 10,675
Non-marketable securities | Equity method accounting | Other investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair value 12,713
Unfunded commitments $ 886
Non-marketable securities | Equity method accounting | Lower Limit | Other investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 5 years
Non-marketable securities | Equity method accounting | Upper Limit | Other investments  
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 8 years
v3.19.3.a.u2
Regulatory Matters - Capital Ratios for Company and Bank under Federal Regulatory Guidelines (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
SVB Financial Group    
CET 1 risk-based capital, Actual Capital Ratios 12.58% 13.41%
CET 1 risk-based capital, Required Capital Ratios 7.00% 6.40%
CET 1 risk-based capital, Actual Capital Amounts $ 5,857,744 $ 5,167,270
CET 1 risk-based capital, Required Capital Amounts $ 3,260,424 $ 2,456,151
Tier 1 risk-based capital, Actual Capital Ratios 13.43% 13.58%
Tier 1 risk-based capital, Required Capital Ratios 8.50% 7.90%
Tier 1 risk-based capital, Well Capitalized Capital Ratios 6.00% 6.00%
Tier 1 risk-based capital, Actual Capital Amounts $ 6,257,442 $ 5,231,476
Tier 1 risk-based capital, Required Capital Amounts 3,959,086 3,034,068
Tier 1 risk-based capital, Well Capitalized Capital Amounts $ 2,794,649 $ 2,311,671
Total risk-based capital, Actual Capital Ratios 14.23% 14.45%
Total risk-based capital, Required Capital Ratios 10.50% 9.90%
Total risk-based capital, Well Capitalized Capital Ratios 10.00% 10.00%
Total risk-based capital, Actual Capital Amounts $ 6,630,022 $ 5,567,562
Total risk-based capital, Required Capital Amounts 4,890,636 3,804,625
Total risk-based capital, Well Capitalized Capital Amounts $ 4,657,748 $ 3,852,785
Tier 1 leverage, Actual Capital Ratios 9.06% 9.06%
Tier 1 leverage, Required Capital Ratios 4.00% 4.00%
Tier 1 leverage, Actual Capital Amounts $ 6,257,442 $ 5,231,476
Tier 1 leverage, Required Capital Amounts $ 2,763,146 $ 2,308,592
Silicon Valley Bank    
CET 1 risk-based capital, Actual Capital Ratios 11.12% 12.41%
CET 1 risk-based capital, Required Capital Ratios 7.00% 6.40%
CET 1 risk-based capital, Well Capitalized Capital Ratios 6.50% 6.50%
CET 1 risk-based capital, Actual Capital Amounts $ 4,949,393 $ 4,604,689
CET 1 risk-based capital, Required Capital Amounts 3,115,151 2,365,385
CET 1 risk-based capital, Well Capitalized Capital Amounts $ 2,892,640 $ 2,411,765
Tier 1 risk-based capital, Actual Capital Ratios 11.12% 12.41%
Tier 1 risk-based capital, Required Capital Ratios 8.50% 7.90%
Tier 1 risk-based capital, Well Capitalized Capital Ratios 8.00% 8.00%
Tier 1 risk-based capital, Actual Capital Amounts $ 4,949,393 $ 4,604,689
Tier 1 risk-based capital, Required Capital Amounts 3,782,683 2,921,946
Tier 1 risk-based capital, Well Capitalized Capital Amounts $ 3,560,172 $ 2,968,326
Total risk-based capital, Actual Capital Ratios 11.96% 13.32%
Total risk-based capital, Required Capital Ratios 10.50% 9.90%
Total risk-based capital, Well Capitalized Capital Ratios 10.00% 10.00%
Total risk-based capital, Actual Capital Amounts $ 5,321,850 $ 4,940,776
Total risk-based capital, Required Capital Amounts 4,672,726 3,664,028
Total risk-based capital, Well Capitalized Capital Amounts $ 4,450,215 $ 3,710,408
Tier 1 leverage, Actual Capital Ratios 7.30% 8.10%
Tier 1 leverage, Required Capital Ratios 4.00% 4.00%
Tier 1 leverage, Well Capitalized Capital Ratios 5.00% 5.00%
Tier 1 leverage, Actual Capital Amounts $ 4,949,393 $ 4,604,689
Tier 1 leverage, Required Capital Amounts 2,713,367 2,272,912
Tier 1 leverage, Well Capitalized Capital Amounts $ 3,391,709 $ 2,841,139
v3.19.3.a.u2
Segment Reporting - Additional Information (Details)
12 Months Ended
Dec. 31, 2019
Segment
Segment Reporting [Abstract]  
Number of reportable segments 4
v3.19.3.a.u2
Segment Reporting - Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]                      
Net interest income $ 533,668 $ 520,644 $ 529,403 $ 512,886 $ 514,460 $ 493,222 $ 466,443 $ 419,863 $ 2,096,601 $ 1,893,988 $ 1,420,369
Provision for credit losses                 (106,416) (87,870) (92,304)
Noninterest income 313,344 294,009 333,750 280,376 186,707 210,070 192,689 155,518 1,221,479 744,984 557,231
Noninterest expense $ (460,752) $ (391,324) $ (383,522) $ (365,664) $ (307,592) $ (309,445) $ (305,739) $ (265,417) (1,601,262) (1,188,193) (1,010,655)
Income before income tax expense                 1,610,402 1,362,909 874,641
Total average loans, net of unearned income                 29,916,207 25,630,520 21,159,394
Total average assets                 63,211,630 55,229,060 48,380,272
Total average deposits                 55,056,950 48,075,344 42,745,148
Global Commercial Bank                      
Segment Reporting Information [Line Items]                      
Noninterest income                 637,922 520,302  
Income before income tax expense                 1,521,645 1,269,678  
SVB Private Bank                      
Segment Reporting Information [Line Items]                      
Noninterest income                 3,366 2,281  
Income before income tax expense                 11,868 38,780  
SVB Capital                      
Segment Reporting Information [Line Items]                      
Noninterest income                 122,394 101,181  
Income before income tax expense                 91,634 78,412  
SVB Leerink                      
Segment Reporting Information [Line Items]                      
Noninterest income                 264,516    
Income before income tax expense                 13,090 0  
Operating segments | Global Commercial Bank                      
Segment Reporting Information [Line Items]                      
Net interest income                 1,850,391 1,623,488 1,274,366
Provision for credit losses                 (91,814) (80,953) (81,553)
Noninterest income                 637,922 520,302 392,101
Noninterest expense                 (874,854) (793,159) (707,666)
Income before income tax expense                     877,248
Total average loans, net of unearned income                 26,031,284 22,354,305 18,479,793
Total average assets                 56,043,321 48,854,416 43,704,667
Total average deposits                 53,053,665 46,039,570 41,043,731
Operating segments | SVB Private Bank                      
Segment Reporting Information [Line Items]                      
Net interest income                 51,022 64,902 58,131
Provision for credit losses                 (2,369) (3,339) (4,386)
Noninterest income                 3,366 2,281 2,175
Noninterest expense                 (40,151) (25,064) (17,693)
Income before income tax expense                     38,227
Total average loans, net of unearned income                 3,341,188 2,850,271 2,423,078
Total average assets                 3,371,052 2,871,743 2,445,220
Total average deposits                 1,524,232 1,502,308 1,303,542
Operating segments | SVB Capital                      
Segment Reporting Information [Line Items]                      
Net interest income                 38 23 48
Provision for credit losses                 0 0 0
Noninterest income                 122,394 101,181 58,992
Noninterest expense                 (30,798) (22,792) (19,340)
Income before income tax expense                     39,700
Total average loans, net of unearned income                 0 0 0
Total average assets                 405,152 380,543 325,939
Total average deposits                 0 0 0
Operating segments | SVB Leerink                      
Segment Reporting Information [Line Items]                      
Net interest income                 1,252 0 0
Provision for credit losses                 0 0 0
Noninterest income                 264,516 0 0
Noninterest expense                 (252,678) 0 0
Income before income tax expense                     0
Total average loans, net of unearned income                 0 0 0
Total average assets                 397,650 0 0
Total average deposits                 0 0 0
Other Items                      
Segment Reporting Information [Line Items]                      
Net interest income                 193,898 205,575 87,824
Provision for credit losses                 (12,233) (3,578) (6,365)
Noninterest income                 193,281 121,220 103,963
Noninterest expense                 (402,781) (347,178) (265,956)
Income before income tax expense                 (27,835) (23,961) (80,534)
Total average loans, net of unearned income                 543,735 425,944 256,523
Total average assets                 2,994,455 3,122,358 1,904,446
Total average deposits                 $ 479,053 $ 533,466 $ 397,875
v3.19.3.a.u2
Segment Reporting - Segment Information (Additional Information) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]      
Goodwill $ 137,823 $ 0  
Operating segments | Global Commercial Bank      
Segment Reporting Information [Line Items]      
Depreciation and amortization 20,400 $ 21,800 $ 25,300
Operating segments | SVB Leerink      
Segment Reporting Information [Line Items]      
Goodwill $ 137,800    
v3.19.3.a.u2
Parent Company Only Condensed Financial Information - Condensed Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Assets:          
Cash and cash equivalents $ 6,781,783   $ 3,571,539 $ 2,923,075 $ 2,545,750
Investment securities 29,071,694   24,218,589    
Net loans 32,859,712   28,057,377    
Lease right-of-use assets 197,365 $ 146,000 0    
Other assets 1,745,233   951,261    
Total assets 71,004,903   56,927,979    
Liabilities and total equity          
Lease liabilities 218,847 $ 178,000 0    
Other liabilities 2,041,752   1,006,359    
Total liabilities 64,383,823   51,663,136    
SVBFG stockholders' equity 6,470,307   5,116,209    
Total liabilities and total equity 71,004,903   56,927,979    
Parent Company          
Assets:          
Cash and cash equivalents 800,926   553,049 $ 457,324 $ 500,014
Investment securities 474,842   510,836    
Net loans 15,245   0    
Lease right-of-use assets 71,847   0    
Other assets 214,167   204,301    
Total assets 7,043,195   5,939,967    
Liabilities and total equity          
Other liabilities 136,903   127,293    
Total liabilities 572,889   823,758    
SVBFG stockholders' equity 6,470,306   5,116,209    
Total liabilities and total equity 7,043,195   5,939,967    
Parent Company | 3.50% Senior Notes          
Liabilities and total equity          
Senior Notes 347,987   347,639    
Parent Company | 5.375% Senior Notes          
Liabilities and total equity          
Senior Notes 0   348,826    
Lease liabilities 87,999   0    
Parent Company | Bank Subsidiary          
Assets:          
Investment in subsidiaries 5,034,095   4,554,813    
Parent Company | Nonbank Subsidiaries          
Assets:          
Investment in subsidiaries $ 432,073   $ 116,968    
v3.19.3.a.u2
Parent Company Only Condensed Financial Information - Condensed Statements of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Income Statements, Captions [Line Items]                      
Interest income $ 588,735 $ 583,892 $ 585,767 $ 551,014 $ 542,897 $ 513,313 $ 481,301 $ 432,398 $ 2,309,408 $ 1,969,909 $ 1,465,140
Interest expense (55,067) (63,248) (56,364) (38,128) (28,437) (20,091) (14,858) (12,535) (212,807) (75,921) (44,771)
Gains on equity warrant assets, net                 138,078 89,142 54,555
Gains on investment securities, net                 134,670 88,094 64,603
Income tax (expense) benefit (94,061) (105,075) (119,114) (107,435) (105,000) (95,308) (77,287) (73,966) (425,685) (351,561) (355,463)
Net income available to common stockholders $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 1,136,856 973,840 490,506
Parent Company                      
Condensed Income Statements, Captions [Line Items]                      
Interest income                 4,473 3,307 2,077
Interest expense                 (31,666) (32,037) (34,932)
Dividend income from bank subsidiary                 733,000 140,000 90,000
Gains on equity warrant assets, net                 138,078 89,142 54,555
Gains on investment securities, net                 45,345 13,546 37,132
Fund management fees and other noninterest income                 21,567 26,388 24,613
General and administrative expenses                 (94,712) (70,976) (63,077)
Income tax (expense) benefit                 (40,218) (14,383) 10,367
Loss before net income of subsidiaries                 775,867 154,987 120,735
Net income available to common stockholders                 1,136,856 973,840 490,506
Parent Company | Bank Subsidiary                      
Condensed Income Statements, Captions [Line Items]                      
Loss before net income of subsidiaries                 1,036,618 933,641 446,769
Equity in undistributed net income of subsidiaries                 303,618 793,641 356,769
Parent Company | Nonbank Subsidiaries                      
Condensed Income Statements, Captions [Line Items]                      
Loss before net income of subsidiaries                 57,371 25,212 13,002
Equity in undistributed net income of subsidiaries                 $ 57,371 $ 25,212 $ 13,002
v3.19.3.a.u2
Parent Company Only Condensed Financial Information - Condensed Statements of Comprehensive Income (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Statement of Income Captions [Line Items]                      
Net income available to common stockholders $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 $ 1,136,856 $ 973,840 $ 490,506
Other comprehensive income (loss), net of tax                 138,565 (52,648) (24,902)
Comprehensive income attributable to SVBFG                 1,275,421 921,192 465,604
Parent Company                      
Condensed Statement of Income Captions [Line Items]                      
Net income available to common stockholders                 1,136,856 973,840 490,506
Foreign currency translation gains (losses)                 2,319 (4,107) 3,769
Changes in fair value on cash flow hedges                 (2,130) 0 0
Changes in unrealized holding gains and losses on AFS securities                 2,310 120 22,285
Equity in other comprehensive income (loss) of bank and nonbank subsidiaries                 136,066 (19,171) (50,956)
Reclassifications to retained earnings for the adoption of new accounting guidance                 0 (29,490) 0
Other comprehensive income (loss), net of tax                 138,565 (52,648) (24,902)
Comprehensive income attributable to SVBFG                 $ 1,275,421 $ 921,192 $ 465,604
v3.19.3.a.u2
Parent Company Only Condensed Financial Information - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Adjustments to reconcile net income to net cash used for operating activities:      
Gains on equity warrant assets, net $ (138,078) $ (89,142) $ (54,555)
Gains on investment securities, net (134,670) (88,094) (45,547)
Amortization of share-based compensation 66,815 45,675 36,900
Other, net (74,240) (54,039) 15,909
Net cash provided by operating activities 1,164,129 933,562 646,865
Cash flows from investing activities:      
Net (increase) decrease in loans (4,773,775) (5,175,409) (3,170,099)
Acquisition of SVB Leerink 102,328 0 0
Net cash used for investing activities (9,371,882) (4,800,375) (5,970,496)
Cash flows from financing activities:      
Principal payments of long-term debt (358,395) 0 (97,781)
Proceeds from issuance of common stock, ESPP and ESOP 24,818 18,387 27,003
Net proceeds from the issuance of preferred stock 340,138 0 0
Common stock repurchase (352,511) (147,123) 0
Net cash provided by financing activities 11,417,997 4,515,277 5,700,956
Net increase in cash and cash equivalents 3,210,244 648,464 377,325
Cash and cash equivalents at beginning of period 3,571,539 2,923,075 2,545,750
Cash and cash equivalents at end of period 6,781,783 3,571,539 2,923,075
Parent Company      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income available to common stockholders 1,136,856 973,840 490,506
Adjustments to reconcile net income to net cash used for operating activities:      
Gains on equity warrant assets, net (138,078) (89,142) (54,555)
Gains on investment securities, net (45,345) (13,546) (17,060)
Distributions of earnings from investment securities 49,776 47,596 14,015
Net income of subsidiaries (775,867) (154,987) (120,735)
Cash dividends from bank subsidiary 733,000 140,000 90,000
Amortization of share-based compensation 66,815 45,675 36,900
Decrease in other assets 27,205 51,169 12,959
Increase in other liabilities 21,391 21,619 11,774
Other, net 8,084 (31,024) 316
Net cash provided by operating activities 765,715 187,334 125,084
Cash flows from investing activities:      
Net decrease (increase) in investment securities from purchases, sales and maturities 128,635 73,742 (152,015)
Net (increase) decrease in loans (15,245) 0 13,337
Net cash used for investing activities (171,888) 37,127 (143,231)
Cash flows from financing activities:      
Principal payments of long-term debt (358,395) 0 (51,546)
Proceeds from issuance of common stock, ESPP and ESOP 24,818 18,387 27,003
Net proceeds from the issuance of preferred stock 340,138 0 0
Common stock repurchase 352,511 147,123 0
Net cash provided by financing activities (345,950) (128,736) (24,543)
Net increase in cash and cash equivalents 247,877 95,725 (42,690)
Cash and cash equivalents at beginning of period 553,049 457,324 500,014
Cash and cash equivalents at end of period 800,926 553,049 457,324
Bank Subsidiary | Parent Company      
Adjustments to reconcile net income to net cash used for operating activities:      
Net income of subsidiaries (1,036,618) (933,641) (446,769)
Cash flows from investing activities:      
Increase (decrease) in investment in subsidiaries (42,952) (31,292) (38,927)
Nonbank Subsidiaries | Parent Company      
Adjustments to reconcile net income to net cash used for operating activities:      
Net income of subsidiaries (57,371) (25,212) (13,002)
Cash flows from investing activities:      
Increase (decrease) in investment in subsidiaries 23,275 (5,323) 34,374
Acquisition of SVB Leerink $ 265,601 $ 0 $ 0
v3.19.3.a.u2
Unaudited Quarterly Financial Data - Supplemental Consolidated Financial Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Interest income $ 588,735 $ 583,892 $ 585,767 $ 551,014 $ 542,897 $ 513,313 $ 481,301 $ 432,398 $ 2,309,408 $ 1,969,909 $ 1,465,140
Interest expense 55,067 63,248 56,364 38,128 28,437 20,091 14,858 12,535 212,807 75,921 44,771
Net interest income 533,668 520,644 529,403 512,886 514,460 493,222 466,443 419,863 2,096,601 1,893,988 1,420,369
Provision for credit losses 17,383 36,536 23,946 28,551 13,644 17,174 29,080 27,972 106,416 87,870 92,304
Noninterest income 313,344 294,009 333,750 280,376 186,707 210,070 192,689 155,518 1,221,479 744,984 557,231
Noninterest expense 460,752 391,324 383,522 365,664 307,592 309,445 305,739 265,417 1,601,262 1,188,193 1,010,655
Income before income tax expense 368,877 386,793 455,685 399,047 379,931 376,673 324,313 281,992      
Income tax expense 94,061 105,075 119,114 107,435 105,000 95,308 77,287 73,966 425,685 351,561 355,463
Net income before noncontrolling interests 274,816 281,718 336,571 291,612 274,931 281,365 247,026 208,026 1,184,717 1,011,348 519,178
Net income attributable to noncontrolling interests (11,960) (14,437) (18,584) (2,880) (8,667) (6,548) (9,228) (13,065) (47,861) (37,508) (28,672)
Net income available to common stockholders $ 262,856 $ 267,281 $ 317,987 $ 288,732 $ 266,264 $ 274,817 $ 237,798 $ 194,961 $ 1,136,856 $ 973,840 $ 490,506
Earnings per common share—basic (usd per share) $ 5.10 $ 5.19 $ 6.12 $ 5.49 $ 5.01 $ 5.16 $ 4.48 $ 3.69 $ 21.90 $ 18.35 $ 9.33
Earnings per common share—diluted (usd per share) $ 5.06 $ 5.15 $ 6.08 $ 5.44 $ 4.96 $ 5.10 $ 4.42 $ 3.63 $ 21.73 $ 18.11 $ 9.20
v3.19.3.a.u2
Label Element Value
Accounting Standards Update 2016-01 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 74,595,000
Accounting Standards Update 2016-01 [Member] | Parent [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 74,595,000
Accounting Standards Update 2016-01 [Member] | AOCI Attributable to Parent [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption (29,171,000)
Accounting Standards Update 2016-01 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 103,766,000
Accounting Standards Update 2017-08 [Member] | Parent [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption (583,000) [1]
Accounting Standards Update 2014-09 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption (5,802,000)
Accounting Standards Update 2014-09 [Member] | Parent [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption (5,802,000)
Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (5,802,000)
[1]
See Note 2- "Summary of Significant Accounting Policies" of the "Notes to Consolidated Financial Statements" under Part II, Item 8 of this report for additional details.